data_2jzc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jzc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 110.231 -0.285 . . . . 1.0 110.231 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -167.65 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -130.17 133.86 46.89 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.828 0.451 . . . . 1.0 110.659 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.21 166.99 10.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -133.85 109.02 8.79 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -103.1 130.47 50.26 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.93 137.18 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 t -142.63 137.91 30.33 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.849 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 63.4 m -92.65 -14.15 28.52 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.55 -93.63 0.05 OUTLIER Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -179.55 0.78 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -62.12 132.22 52.1 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.955 -0.387 . . . . 1.0 109.955 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -62.54 149.54 88.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.71 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.8 -62.6 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.719 1.613 . . . . 1.0 112.037 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -142.45 138.82 16.76 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 119.117 -0.468 . . . . 1.0 110.621 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.43 -31.17 46.81 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 121.781 1.654 . . . . 1.0 113.52 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.92 -36.95 67.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.969 0.414 . . . . 1.0 111.28 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.89 -41.97 97.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.858 0.361 . . . . 1.0 110.758 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.3 t -61.44 -38.29 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' SER . 14.8 m -51.6 -42.86 62.27 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.0 t -51.81 -41.4 61.71 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.558 0.218 . . . . 1.0 110.538 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.8 t -75.38 -12.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.453 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.25 40.23 2.09 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.65 0.262 . . . . 1.0 110.432 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' SER . 44.4 m -129.71 -164.6 1.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.731 0.777 . . . . 1.0 109.512 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -53.14 -46.15 68.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.995 -1.457 . . . . 1.0 110.42 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -57.97 -53.49 57.66 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 122.059 -0.4 . . . . 1.0 111.196 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 73.7 t80 -63.42 -44.69 93.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.697 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.427 ' SG ' ' NZ ' ' A' ' 113' ' ' LYS . 45.5 t -57.84 -51.48 69.41 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -55.95 -47.9 76.74 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 121.487 0.66 . . . . 1.0 110.266 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -64.81 -29.54 70.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.084 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tp -65.86 -54.16 30.37 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.54 0.525 . . . . 1.0 111.36 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -32.32 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.294 -0.867 . . . . 1.0 109.093 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -75.38 -13.08 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.881 -1.054 . . . . 1.0 109.173 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 199' ' ' GLN . 0.1 OUTLIER -101.4 -1.14 34.04 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.707 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 82.71 41.68 8.76 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.911 -1.137 . . . . 1.0 111.259 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 10.2 p90 -27.02 159.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 123.548 0.739 . . . . 1.0 112.241 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -149.19 -73.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 121.382 -0.824 . . . . 1.0 108.956 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -149.02 106.14 3.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 130.24 35.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.012 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.1 133.7 62.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.4 tt -142.71 140.93 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.44 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -170.26 137.13 1.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.726 178.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -168.56 -172.06 1.58 Allowed 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.426 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.07 168.85 3.61 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.502 -1.039 . . . . 1.0 110.502 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.597 ' NH2' HD22 ' A' ' 72' ' ' ASN . 71.1 ttp85 -168.71 -74.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.597 HD22 ' NH2' ' A' ' 71' ' ' ARG . 89.8 m-20 -63.73 -46.44 85.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 1.0 110.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.73 -17.13 61.15 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 m 59.07 18.59 6.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.713 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 m 50.46 -163.85 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.192 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' PHE . 67.9 mt-10 -145.2 -44.74 0.22 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.429 ' C ' ' H ' ' A' ' 79' ' ' HIS . 33.4 m-85 54.36 108.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -70.44 44.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.8 0.334 . . . . 1.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.429 ' H ' ' C ' ' A' ' 77' ' ' PHE . 93.9 m-70 44.97 48.65 9.4 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.228 0.537 . . . . 1.0 111.146 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.37 -38.61 90.23 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.65 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.21 -50.35 80.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.617 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -71.78 -37.53 70.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -57.21 -48.07 79.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -77.65 -13.34 59.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.383 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.37 54.07 3.44 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 110.966 -0.853 . . . . 1.0 110.966 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.43 -178.76 51.44 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 109.831 -1.308 . . . . 1.0 109.831 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -129.85 121.04 25.94 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -80.49 111.46 16.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.342 -0.244 . . . . 1.0 110.342 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -72.38 -108.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.48 1.067 0 O-C-N 123.661 0.6 . . . . 1.0 111.653 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.196 0.522 . . . . 1.0 110.485 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.426 ' NE ' ' OH ' ' A' ' 107' ' ' TYR . 9.8 mmp_? -111.56 114.73 27.99 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.09 122.75 9.21 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.426 ' OH ' ' NE ' ' A' ' 105' ' ' ARG . 5.3 m-85 -133.63 151.78 51.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.18 147.66 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -108.0 143.95 35.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.449 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 39.9 tpp 56.76 -79.55 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 O-C-N 124.136 0.898 . . . . 1.0 110.287 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 109' ' ' LEU . 54.3 t30 -168.09 78.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.39 8.51 80.31 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.427 ' NZ ' ' SG ' ' A' ' 54' ' ' CYS . 64.1 tttm -64.59 -75.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.25 128.9 50.13 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.204 -1.036 . . . . 1.0 108.204 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -108.02 103.77 13.06 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 119.442 -0.313 . . . . 1.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.56 116.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.8 mt -137.1 144.16 32.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.815 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.93 120.55 2.05 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -155.17 52.83 0.62 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.228 0.537 . . . . 1.0 110.749 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 18.1 p-10 -169.29 129.72 1.08 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE2' ' OE1' ' A' ' 68' ' ' GLN . 58.4 m-85 -128.03 90.99 3.18 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.2 p 42.12 31.25 0.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.712 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.6 t -149.61 27.87 0.8 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.325 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 127' ' ' SER . 16.1 mttt -170.35 -5.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 71.0 mtp -43.08 -54.88 4.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.855 0.36 . . . . 1.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -59.43 -29.13 67.54 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.74 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.428 ' OG ' ' NH2' ' A' ' 130' ' ' ARG . 1.9 t -65.59 -38.96 90.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 16.0 mm -72.6 -46.04 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.126 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' SER . 64.4 mt -60.1 -57.86 9.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.456 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.428 ' NH2' ' OG ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -48.78 -41.07 31.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 111.392 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.22 -48.25 79.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.155 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -100.64 -66.67 0.89 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.119 0.485 . . . . 1.0 110.281 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' ILE . 53.6 p 55.51 84.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.515 ' H ' ' HZ3' ' A' ' 153' ' ' LYS . 60.2 m-20 -149.23 -47.8 0.14 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.311 -0.404 . . . . 1.0 109.928 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.16 139.3 7.04 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.22 145.52 28.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.37 96.5 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.2 p -104.89 122.15 45.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.494 ' CD2' ' H ' ' A' ' 140' ' ' ALA . 1.3 p80 -64.0 -36.05 82.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.265 . . . . 1.0 111.139 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.494 ' H ' ' CD2' ' A' ' 139' ' ' HIS . . . -173.14 10.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.591 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.97 108.77 1.04 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.0 -43.98 94.84 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 1.0 110.331 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.67 -50.81 34.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.4 m -52.09 -50.46 61.55 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.539 -0.33 . . . . 1.0 111.791 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -29.07 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.182 -0.303 . . . . 1.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -53.91 48.48 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.905 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.17 -51.13 65.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 1.0 110.132 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.8 t -52.83 -28.24 21.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.444 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -51.86 22.52 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.879 0.371 . . . . 1.0 110.982 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.6 ttp-105 -64.77 -26.1 68.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.764 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.7 mt -90.8 17.08 8.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.972 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.5 p30 42.34 26.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.501 0.501 . . . . 1.0 111.472 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.515 ' HZ3' ' H ' ' A' ' 134' ' ' ASP . 30.9 mtpt -79.38 121.08 82.44 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.306 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.62 113.93 3.15 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.367 1.378 . . . . 1.0 110.712 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.29 171.87 7.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.591 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 156' ' ' ILE . 3.2 mp -118.4 120.01 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.78 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 76.2 t -90.89 117.11 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 O-C-N 122.518 -0.114 . . . . 1.0 110.713 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 13.3 m -85.17 100.57 11.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.08 140.22 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -100.9 84.67 2.73 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 30.7 p-10 -64.03 -32.18 73.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.018 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 t -60.84 -46.08 91.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.025 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.411 ' CD2' HD22 ' A' ' 166' ' ' ASN . 10.8 mp -90.21 -178.91 5.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 28.0 ttt -165.31 -27.76 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.461 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -66.2 -22.14 66.33 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.411 HD22 ' CD2' ' A' ' 163' ' ' LEU . 84.1 m-20 -61.59 113.61 2.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.117 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.01 -32.56 74.15 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.836 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.04 -47.07 75.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.32 -42.01 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.342 0.592 . . . . 1.0 109.922 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -50.59 -45.56 57.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.539 -0.912 . . . . 1.0 108.539 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.68 -26.4 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.877 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -68.06 -58.88 3.78 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 120.01 -0.676 . . . . 1.0 109.409 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -43.52 -24.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.72 0.295 . . . . 1.0 111.774 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.41 -40.26 81.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.145 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -55.74 -45.49 77.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.52 -46.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.98 0.419 . . . . 1.0 109.896 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -46.07 -43.01 14.27 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.439 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.6 mt -70.55 -32.25 69.61 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.832 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.15 -107.43 0.24 Allowed Glycine 0 N--CA 1.468 0.781 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.527 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 180' ' ' TYR . 66.5 t80 -169.95 42.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 180' ' ' TYR . 14.8 p -31.91 137.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 123.663 0.602 . . . . 1.0 109.479 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -54.43 101.7 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.319 0.963 . . . . 1.0 110.661 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 77.2 p -114.76 133.2 56.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.798 -1.092 . . . . 1.0 109.088 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.33 138.7 6.56 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 157.09 70.52 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 122.304 -0.248 . . . . 1.0 110.515 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -56.89 82.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 122.307 2.005 . . . . 1.0 112.991 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 m -134.86 148.9 50.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.95 -25.88 63.86 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.124 -0.36 . . . . 1.0 111.016 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.57 ' HG1' ' N ' ' A' ' 190' ' ' GLY . 19.3 p -89.91 -35.61 15.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.541 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.57 ' N ' ' HG1' ' A' ' 189' ' ' THR . . . -88.74 -41.81 5.9 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.94 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.93 -36.24 82.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.808 0.304 . . . . 1.0 111.483 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 pt -66.0 -33.91 66.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.348 . . . . 1.0 111.023 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.56 91.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.639 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -71.66 -38.19 61.4 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.428 -0.669 . . . . 1.0 111.428 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.408 ' O ' ' OH ' ' A' ' 60' ' ' TYR . 7.7 mt -63.28 -54.85 30.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.848 0.356 . . . . 1.0 111.255 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -61.68 -36.39 80.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.1 -39.21 82.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 14.9 m -65.59 -17.96 64.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.854 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 93.9 mt-30 -104.14 29.97 5.57 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.047 -0.408 . . . . 1.0 110.624 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 22.6 p -141.37 -33.02 0.52 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -141.58 154.1 45.23 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -118.07 157.51 26.72 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.584 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 8.4 tp -84.32 136.29 33.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -52.76 135.24 46.03 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.289 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -45.39 101.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.511 1.474 . . . . 1.0 113.015 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -142.12 82.78 13.02 Favored Pre-proline 0 N--CA 1.471 0.625 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.54 93.04 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.963 1.775 . . . . 1.0 111.464 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.73 150.37 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.654 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 CA--C 1.532 0.266 0 O-C-N 123.715 0.634 . . . . 1.0 110.665 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.534 -0.543 . . . . 1.0 109.534 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -103.4 6.5 37.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -71.25 106.55 3.87 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.13 121.01 43.66 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.384 0.427 . . . . 1.0 110.197 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 mt -87.61 110.97 20.78 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.07 128.62 43.14 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -123.3 122.52 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 t -146.48 137.65 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 139' ' ' HIS . 77.2 m -105.36 -24.97 12.57 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.3 20.57 67.55 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.42 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 p -139.7 155.9 47.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.475 0.31 . . . . 1.0 110.218 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' PRO . 16.8 m -94.16 148.64 35.49 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 118.727 -0.654 . . . . 1.0 110.817 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' VAL . 87.2 Cg_exo -46.22 -178.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 121.629 1.553 . . . . 1.0 112.395 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -56.57 144.42 64.27 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-O 119.234 -0.412 . . . . 1.0 110.632 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.55 -30.6 6.2 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.793 1.662 . . . . 1.0 113.497 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -73.26 -39.55 65.32 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.81 0.3 . . . . 1.0 111.81 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.74 -40.86 69.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.97 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.6 -41.61 93.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 50' ' ' SER . 30.0 m -52.15 -45.89 65.2 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.139 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.98 -33.13 10.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 1.0 110.556 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.78 -22.09 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.996 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.98 33.44 4.39 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 120.809 0.337 . . . . 1.0 110.254 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 46' ' ' SER . 22.4 p -110.59 -167.71 1.22 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -60.74 -28.83 68.98 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.66 -50.68 71.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.493 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -35.91 73.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 71.1 m -51.63 -51.0 59.2 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.775 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -73.07 -43.76 61.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.684 0.278 . . . . 1.0 111.654 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -65.91 -28.95 69.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.971 0.415 . . . . 1.0 110.535 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.2 mt -61.35 -52.42 64.73 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.42 -36.67 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 120.305 -0.558 . . . . 1.0 109.874 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -72.52 -33.78 67.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.695 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 70.1 t80 -77.87 0.57 23.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.997 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 42.08 22.23 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.751 -1.214 . . . . 1.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -49.3 -176.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.534 0.667 . . . . 1.0 111.825 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.5 p -172.48 -42.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -168.38 105.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.1 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.04 135.83 33.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.31 136.41 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -138.99 141.82 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -143.64 149.37 37.2 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 77' ' ' PHE . 47.5 p90 -163.14 126.29 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.02 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.78 -171.17 44.71 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 109.774 -1.33 . . . . 1.0 109.774 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.561 ' N ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 55.54 118.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.377 0.608 . . . . 1.0 110.914 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -61.85 -20.49 63.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.111 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.546 ' C ' ' H ' ' A' ' 75' ' ' SER . 48.3 t80 -56.5 -14.97 3.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.384 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 m -60.59 3.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.391 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 73' ' ' TYR . 3.5 m 63.54 139.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.861 0.363 . . . . 1.0 110.264 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.44 137.17 57.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 69' ' ' PHE . 3.7 m-85 -64.41 -93.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 49.69 45.97 24.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.023 0.439 . . . . 1.0 110.859 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.402 ' ND1' ' O ' ' A' ' 77' ' ' PHE . 35.1 m80 -157.26 -53.87 0.08 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.648 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.47 -48.87 75.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.098 0.475 . . . . 1.0 111.043 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.39 -44.12 77.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.196 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.93 -31.56 72.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.27 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -70.91 -44.31 66.49 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.027 0.442 . . . . 1.0 110.437 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLY . 1.1 mmp_? -99.1 30.03 3.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' ARG . . . 21.15 73.71 0.01 OUTLIER Glycine 0 N--CA 1.486 1.98 0 N-CA-C 111.531 -0.627 . . . . 1.0 111.531 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.74 -179.1 52.01 Favored Glycine 0 C--N 1.322 -0.222 0 N-CA-C 109.846 -1.302 . . . . 1.0 109.846 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -138.34 135.96 35.9 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.493 ' CZ ' HE21 ' A' ' 106' ' ' GLN . 53.0 ttt85 -54.43 149.6 10.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.442 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -107.0 -155.36 0.55 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.497 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 85.4 p . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.849 0.356 . . . . 1.0 111.252 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.486 ' H ' ' NH1' ' A' ' 105' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 110.208 -0.293 . . . . 1.0 110.208 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' H ' ' A' ' 104' ' ' ALA . 1.5 mpt_? -135.37 145.75 47.66 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.159 0.504 . . . . 1.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.493 HE21 ' CZ ' ' A' ' 88' ' ' ARG . 1.8 pm0 -156.83 129.05 7.38 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.8 -0.636 . . . . 1.0 109.694 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -147.21 169.11 20.04 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.69 148.27 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.2 mt -114.39 -178.83 3.46 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.585 0.553 . . . . 1.0 109.562 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 tpt 53.21 -134.67 1.63 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.664 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.86 35.9 0.9 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.013 0.435 . . . . 1.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.59 71.54 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.518 -0.633 . . . . 1.0 111.518 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -96.21 -15.92 21.75 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.392 0.277 . . . . 1.0 111.635 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.91 133.57 41.39 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -116.88 93.73 4.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.8 p -106.89 116.59 50.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 CA-C-O 122.219 1.009 . . . . 1.0 109.053 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.2 pt -117.81 146.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 114.076 -1.42 . . . . 1.0 108.658 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -122.94 131.83 8.39 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 109.63 -1.388 . . . . 1.0 109.63 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 120' ' ' ASP . 45.0 t80 59.01 152.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 1.0 110.768 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 38.8 t70 -168.24 163.66 13.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.353 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.446 ' O ' ' CD2' ' A' ' 121' ' ' PHE . 40.4 p90 -70.77 119.27 14.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 124' ' ' LYS . 18.1 m 56.88 135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.421 0.629 . . . . 1.0 111.558 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 t -74.87 38.43 0.12 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.263 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 122' ' ' SER . 36.9 ttpt -64.45 -29.56 70.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.477 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.49 ' SD ' ' NE2' ' A' ' 126' ' ' GLN . 3.6 ppp? -45.18 -32.0 1.69 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.49 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 88.5 mm-40 -58.23 -28.72 65.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.676 -0.693 . . . . 1.0 111.044 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.1 t -80.54 -33.17 36.49 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.742 0.306 . . . . 1.0 110.803 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' A' ' 128' ' ' ILE . 1.6 mp -63.63 -39.93 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.723 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.9 pt -49.11 -41.54 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -46.08 -32.66 3.0 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.514 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.45 -27.64 62.64 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.4 -62.27 1.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.333 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.2 p 51.36 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.527 ' N ' ' HZ1' ' A' ' 153' ' ' LYS . 56.5 m-20 -145.14 -43.92 0.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.41 120.52 4.86 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.52 137.33 56.41 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.3 mt -122.92 124.37 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.7 p -134.3 133.61 40.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.427 ' CD2' ' SG ' ' A' ' 35' ' ' CYS . 37.8 m-70 -69.89 -38.22 76.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.631 0.253 . . . . 1.0 110.788 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.47 19.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.326 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.67 100.6 0.44 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.6 m -56.72 -41.46 77.48 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.478 -0.425 . . . . 1.0 110.48 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.74 -48.77 26.68 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.3 m -56.52 -42.77 78.99 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.842 -0.211 . . . . 1.0 111.309 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 92.6 mt -66.35 -26.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 1.0 110.852 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -46.9 82.84 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.663 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -70.42 -53.55 16.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.097 0.475 . . . . 1.0 109.826 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.9 m -53.19 -25.21 13.04 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 49.8 tp -74.86 -45.77 40.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.859 0.362 . . . . 1.0 111.438 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -76.56 -18.99 58.37 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.279 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.9 mt -85.03 4.03 35.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.9 p30 41.56 47.89 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.389 0.43 . . . . 1.0 111.688 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.527 ' HZ1' ' N ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -105.68 147.1 34.11 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 119.205 -0.426 . . . . 1.0 111.569 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.63 85.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.46 1.44 . . . . 1.0 111.542 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 153' ' ' LYS . 66.9 tp -89.94 137.49 32.29 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.816 -0.553 . . . . 1.0 111.324 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.3 134.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.084 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.63 128.69 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 120.788 0.328 . . . . 1.0 110.652 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 12.3 m -83.6 102.47 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.88 146.84 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.746 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.9 t30 86.44 103.78 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.887 0.742 . . . . 1.0 110.065 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -167.59 66.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.203 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -64.65 86.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.215 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 165' ' ' ASP . 34.8 tp -168.41 77.03 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 ttt 67.19 -36.74 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.707 0.629 . . . . 1.0 110.984 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 163' ' ' LEU . 66.7 m-20 -77.17 -3.02 37.4 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.077 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -52.86 -37.92 60.87 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.766 0.317 . . . . 1.0 110.369 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.12 -38.17 87.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.135 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -68.11 -38.97 82.87 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.367 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.53 -31.31 64.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.133 0.492 . . . . 1.0 110.692 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.37 -49.09 67.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.51 -27.41 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.79 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.77 -61.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.097 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -51.94 -31.98 31.14 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -60.79 -52.71 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.015 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.26 -42.66 81.97 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.22 -52.84 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -51.96 -44.32 63.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.701 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.33 17.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.134 -0.321 . . . . 1.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 39.29 89.8 0.01 OUTLIER Glycine 0 C--N 1.352 1.423 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -155.48 -22.39 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.51 152.64 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.83 0.348 . . . . 1.0 110.495 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -71.39 130.63 41.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.6 p -98.11 138.67 35.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.586 -0.734 . . . . 1.0 109.541 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 185' ' ' ALA . 35.7 t -157.77 177.32 11.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 184' ' ' CYS . . . -136.93 155.99 76.07 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 110.164 -0.31 . . . . 1.0 110.164 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -69.58 65.62 1.68 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.089 1.86 . . . . 1.0 112.404 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 m -134.06 145.5 49.46 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.014 0.435 . . . . 1.0 109.898 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -55.13 -29.34 57.49 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -84.03 -41.03 17.66 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.089 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.14 93.86 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.978 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.35 -39.54 90.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 119.711 -0.185 . . . . 1.0 111.314 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.73 -45.84 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.61 82.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.53 -36.61 91.74 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.08 -54.63 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.94 0.4 . . . . 1.0 110.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -59.66 -21.29 60.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.432 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.85 3.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.774 0.321 . . . . 1.0 110.46 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.6 p -67.46 -22.53 65.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.769 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.53 -43.72 69.01 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.075 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 21.7 m -79.1 -43.66 23.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.842 0.353 . . . . 1.0 110.698 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.53 125.25 40.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.266 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -120.82 108.59 14.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.24 135.8 57.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -52.67 146.88 16.43 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.778 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.45 103.77 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.357 1.371 . . . . 1.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -141.1 96.5 7.21 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.74 114.03 3.86 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 121.13 1.22 . . . . 1.0 111.345 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.75 -43.41 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.531 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.463 0.221 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.242 -179.486 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -144.79 -36.34 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -71.16 92.74 1.01 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.95 111.94 24.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.73 117.98 21.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE2' ' NE2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -102.69 124.3 47.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.18 128.4 71.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.2 p -129.1 129.82 45.7 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' SG ' ' CE1' ' A' ' 69' ' ' PHE . 97.2 m -88.69 164.26 15.39 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.89 37.67 0.75 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.69 -0.564 . . . . 1.0 111.69 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 35' ' ' CYS . . . 67.64 -61.51 0.36 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.386 0.274 . . . . 1.0 110.602 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -64.96 147.41 53.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 1.0 109.978 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.6 81.36 24.09 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.88 -59.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.953 1.768 . . . . 1.0 111.505 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 92.14 18.29 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -74.05 8.32 2.12 Favored 'Trans proline' 0 N--CA 1.508 2.339 0 CA-C-N 120.831 1.333 . . . . 1.0 112.442 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.0 110.555 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.02 -35.02 74.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.546 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.37 -40.5 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 78.3 p -50.52 -45.33 56.59 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.839 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -51.57 -39.99 58.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.05 0.452 . . . . 1.0 110.301 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 41.8 t -79.67 -16.21 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.057 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 tp -130.96 39.74 3.55 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.826 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.639 ' HG ' ' H ' ' A' ' 51' ' ' ASP . 42.5 t -132.61 -157.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.639 ' H ' ' HG ' ' A' ' 50' ' ' SER . 22.6 p-10 -60.28 -44.27 95.48 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.98 -51.58 65.75 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.592 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 5.9 t80 -67.8 -36.79 81.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.972 0.415 . . . . 1.0 109.905 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 t -57.64 -47.96 80.79 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.429 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -63.07 -46.47 87.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.66 -28.39 69.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.406 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.25 -51.24 70.4 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.945 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.35 -44.9 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.06 -37.6 77.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.33 -21.58 64.74 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.661 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 104.3 35.94 3.24 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 118.016 -1.435 . . . . 1.0 111.355 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' O ' ' A' ' 61' ' ' GLY . 49.8 p90 13.61 130.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 124.86 1.264 . . . . 1.0 112.719 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -145.3 -81.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 122.007 -0.433 . . . . 1.0 110.448 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -169.33 111.24 0.48 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.221 -0.445 . . . . 1.0 109.83 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -92.35 121.59 33.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 66' ' ' ILE . 2.3 mp -102.88 133.02 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.434 -1.321 . . . . 1.0 107.434 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.7 mm -114.6 132.76 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.509 ' NE2' ' CE2' ' A' ' 32' ' ' PHE . 15.6 mp0 -131.78 163.09 29.0 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.582 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CE1' ' SG ' ' A' ' 35' ' ' CYS . 17.7 m-85 -157.22 -179.64 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.183 0.516 . . . . 1.0 109.735 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 72' ' ' ASN . . . -59.1 -29.89 66.16 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.292 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 68.01 -38.32 0.36 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.98 0.459 . . . . 1.0 111.256 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 70' ' ' GLY . 19.0 m120 -62.16 -43.93 97.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.781 0.324 . . . . 1.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.26 -45.76 86.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 p 56.31 166.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.841 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.2 t 52.36 68.88 0.75 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.821 0.343 . . . . 1.0 111.138 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -170.95 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.602 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -166.77 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.613 -0.267 . . . . 1.0 110.609 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.26 -44.62 95.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.832 0.349 . . . . 1.0 110.073 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.08 -28.78 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.733 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.74 -48.36 77.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.155 0.503 . . . . 1.0 110.161 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.28 -45.44 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -64.37 -36.4 84.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -52.23 -46.65 65.79 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.581 0.229 . . . . 1.0 110.441 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.19 -17.43 64.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.092 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.02 52.64 35.61 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.12 -1.192 . . . . 1.0 110.12 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.38 -167.76 25.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -128.33 126.95 41.78 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -55.38 145.42 22.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.616 0.246 . . . . 1.0 110.624 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -145.6 179.18 7.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.211 -179.303 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.564 ' CB ' ' H ' ' A' ' 119' ' ' PHE . . . . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.562 0.22 . . . . 1.0 110.411 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -141.41 169.2 18.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -158.79 132.48 7.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.333 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -136.39 151.06 49.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.764 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.7 t -100.83 96.07 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.527 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mp -87.57 159.77 18.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 tpt 57.03 -88.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.402 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -172.47 62.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.763 0.316 . . . . 1.0 110.686 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.55 27.09 63.96 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.627 -0.589 . . . . 1.0 111.627 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -114.19 -50.36 2.81 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.597 0.359 . . . . 1.0 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mt -95.36 111.86 23.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.855 0.359 . . . . 1.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -105.83 101.24 10.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 p -105.53 111.64 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.709 0.766 . . . . 1.0 109.641 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 pt -125.86 122.77 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.388 -1.278 . . . . 1.0 109.167 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.59 -82.01 0.04 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.548 -0.834 . . . . 1.0 111.453 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.564 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 3.6 m-85 47.72 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.941 0.4 . . . . 1.0 110.005 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -163.19 154.24 16.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 122' ' ' SER . 63.8 t80 -160.11 172.95 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.654 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 44.3 t -52.99 -17.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.26 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.8 m -164.19 103.56 0.86 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.606 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -171.03 -26.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.772 0.32 . . . . 1.0 110.555 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.1 -49.96 75.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.861 0.362 . . . . 1.0 110.71 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -61.82 -25.55 67.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.358 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p -76.41 -44.69 34.97 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.971 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.06 -44.48 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.627 -0.261 . . . . 1.0 110.617 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 133' ' ' SER . 79.4 mt -59.04 -51.94 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -39.14 10.25 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.053 0.454 . . . . 1.0 110.905 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -63.54 -32.17 73.55 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.141 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -112.57 -67.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.784 0.434 . . . . 1.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' ILE . 26.0 t 54.32 89.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.757 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -134.38 -50.1 0.79 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.335 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 29.9 tp -165.7 146.32 6.83 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.38 140.03 44.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.7 pt -123.02 127.89 74.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.6 m -88.85 -161.88 0.8 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -169.99 -36.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.6 48.21 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.809 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.88 112.5 0.53 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.632 ' N ' HE22 ' A' ' 168' ' ' GLN . 35.2 m -74.2 -25.19 59.55 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.698 0.285 . . . . 1.0 110.685 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.94 86.04 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.0 m -72.91 -35.77 67.13 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.841 -0.211 . . . . 1.0 110.756 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 53.6 mt -61.37 -30.37 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.771 0.32 . . . . 1.0 110.989 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 tp -52.35 -52.74 51.72 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.137 0.421 . . . . 1.0 112.137 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -65.69 -46.95 77.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.285 0.564 . . . . 1.0 111.074 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.426 ' H ' ' HG ' ' A' ' 148' ' ' SER . 1.3 m -53.01 -26.92 17.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.121 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.4 mt -79.7 -49.26 12.35 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.356 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -62.51 -37.95 88.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.682 -0.236 . . . . 1.0 110.923 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.28 4.77 4.18 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 58.8 t30 53.72 23.28 3.6 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.71 -0.223 . . . . 1.0 111.123 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.66 122.84 46.24 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -45.9 171.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.659 1.572 . . . . 1.0 112.6 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.475 ' O ' ' CE3' ' A' ' 182' ' ' TRP . 4.0 tt -156.92 151.75 25.86 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.514 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.1 mm -123.35 128.23 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.9 137.16 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.36 115.38 27.35 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.37 97.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.654 0.264 . . . . 1.0 111.667 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.477 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 20.2 p-10 -148.46 -58.47 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.255 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 163' ' ' LEU . 73.2 m-20 -102.3 14.01 33.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.083 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 27.9 t -69.79 36.9 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.889 0.376 . . . . 1.0 110.837 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 161' ' ' ASP . 52.7 mt -63.42 -39.59 94.9 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.515 ' C ' ' H ' ' A' ' 166' ' ' ASN . 23.8 ptt? -52.28 141.45 19.2 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.229 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 167' ' ' HIS . 4.8 m-20 69.24 -37.07 0.36 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.202 0.314 . . . . 1.0 110.749 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 164' ' ' MET . 20.2 t-20 58.97 -0.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.612 0.365 . . . . 1.0 111.336 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' A' ' 165' ' ' ASP . 24.6 m170 -73.48 -43.42 60.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.866 0.365 . . . . 1.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.632 HE22 ' N ' ' A' ' 142' ' ' THR . 22.6 mm100 -64.92 -49.47 70.31 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.937 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -59.58 -29.68 68.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.92 0.39 . . . . 1.0 110.013 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.49 -54.67 8.59 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.009 -0.542 . . . . 1.0 110.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.39 -41.39 73.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.45 -64.15 0.96 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 120.466 -0.494 . . . . 1.0 110.196 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.4 -27.76 2.81 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.337 0.589 . . . . 1.0 111.089 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -82.96 -40.48 20.02 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.055 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.04 -45.45 93.52 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.696 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.14 -52.71 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -52.34 -38.88 59.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.348 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.13 6.31 49.13 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.63 89.77 0.07 OUTLIER Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.291 -1.124 . . . . 1.0 110.291 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -40.65 79.35 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.135 0.974 . . . . 1.0 111.156 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 179' ' ' GLY . 3.2 p -73.8 65.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.531 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . 0.485 ' C ' ' O ' ' A' ' 181' ' ' VAL . 6.0 m-90 30.4 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 99.9 p -108.6 131.45 54.85 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 30.5 p -162.58 130.17 3.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.861 -1.063 . . . . 1.0 108.387 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.92 157.09 74.34 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 118.92 -0.562 . . . . 1.0 110.851 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.76 69.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.516 2.833 0 C-N-CA 123.253 2.635 . . . . 1.0 114.393 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 185' ' ' ALA . 43.7 m -132.2 146.67 52.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 24.7 mp0 -49.34 -51.69 32.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.494 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.7 p -67.15 -43.04 83.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.66 -0.245 . . . . 1.0 110.578 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -52.6 -53.36 32.85 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 121.427 -0.416 . . . . 1.0 112.145 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.83 -40.98 99.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.926 0.363 . . . . 1.0 110.71 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.45 -44.54 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -58.85 -49.35 78.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 1.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.5 98.81 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 42.6 mt -63.82 -43.47 96.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.713 0.292 . . . . 1.0 110.546 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -66.91 -40.02 87.56 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -64.41 -49.58 70.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.698 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 200' ' ' THR . 1.3 m -61.13 -22.39 64.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.308 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -74.56 10.46 1.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.017 0.437 . . . . 1.0 110.194 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 198' ' ' SER . 20.4 m -164.09 -54.66 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.816 0.341 . . . . 1.0 110.844 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.7 mt-10 -66.89 116.17 7.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.026 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -103.05 165.59 10.93 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 tp -110.45 -164.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.52 137.54 22.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -79.2 44.47 1.7 Allowed 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.812 1.675 . . . . 1.0 111.915 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.39 84.8 15.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.41 166.03 5.1 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.113 1.876 . . . . 1.0 112.186 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.06 -46.81 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.337 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 51.6 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.852 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -168.79 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.826 0.346 . . . . 1.0 110.544 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -74.3 139.47 44.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . -142.9 165.1 28.29 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -109.27 122.51 47.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -108.62 141.6 40.32 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.15 148.15 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.955 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -144.78 139.84 28.08 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.735 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.83 8.34 5.73 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.19 108.71 0.23 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.66 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.966 -0.138 . . . . 1.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.0 p 48.85 -167.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.751 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.4 m -97.69 113.57 63.75 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 123.186 0.304 . . . . 1.0 110.657 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.12 -13.78 17.03 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.05 1.833 . . . . 1.0 111.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -124.92 85.16 57.9 Favored Pre-proline 0 N--CA 1.477 0.899 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.32 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.17 -23.06 27.9 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.145 1.897 . . . . 1.0 111.698 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -80.98 -46.66 14.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.64 -49.88 74.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.861 0.362 . . . . 1.0 111.046 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.47 -39.14 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.19 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.651 ' HG ' ' H ' ' A' ' 47' ' ' CYS . 17.0 p -50.01 -57.88 6.64 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.651 ' H ' ' HG ' ' A' ' 46' ' ' SER . 77.4 m -51.71 -41.41 61.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.971 0.415 . . . . 1.0 110.342 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.5 t -71.2 -17.89 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.038 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 tp -140.65 44.19 1.84 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.039 0.447 . . . . 1.0 110.862 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.6 t -123.59 -167.59 1.64 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.5 ' N ' ' OG ' ' A' ' 50' ' ' SER . 41.2 m-20 -50.73 -40.07 53.47 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.912 -1.04 . . . . 1.0 111.175 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -60.45 -55.22 36.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.79 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -67.28 -39.86 86.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.998 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 91.0 m -48.36 -53.7 16.57 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -77.47 -46.75 21.53 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.45 -30.27 68.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.867 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.69 -45.04 93.31 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.482 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -63.59 -30.32 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 119.946 -0.702 . . . . 1.0 109.608 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -63.01 -16.4 59.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.0 111.087 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.74 -18.83 14.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.09 35.37 5.8 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 121.39 -0.433 . . . . 1.0 112.1 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -93.15 154.4 18.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.21 0.529 . . . . 1.0 109.652 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 m -137.77 -6.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.031 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -143.0 144.98 32.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.436 0.636 . . . . 1.0 110.69 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.68 122.98 18.21 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.712 -1.131 . . . . 1.0 109.28 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -120.66 142.94 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.529 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.05 137.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.006 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -62.51 144.1 56.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.23 120.26 16.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' ASN . . . -64.21 -11.01 44.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 63.41 -68.51 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.888 0.405 . . . . 1.0 110.877 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' GLY . 77.7 m-20 -61.28 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -65.87 -50.19 65.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.98 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t 51.16 -147.79 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.803 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t 55.93 -161.1 0.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.592 0.234 . . . . 1.0 110.699 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 54.7 -166.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.466 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.2 t80 53.3 98.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.652 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -59.4 166.67 2.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.019 -0.363 . . . . 1.0 110.019 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -73.21 54.51 0.41 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.752 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.15 -43.44 92.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.285 0.564 . . . . 1.0 110.405 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' GLY . 22.3 m -58.2 -43.66 86.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.571 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -68.85 -42.78 76.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.262 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.91 -48.17 67.43 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.693 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.441 HH22 ' CG ' ' A' ' 51' ' ' ASP . 57.9 ttm-85 -76.13 -16.68 59.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.756 -0.377 . . . . 1.0 110.368 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.55 54.21 1.36 Allowed Glycine 0 N--CA 1.474 1.192 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . -80.36 169.31 52.53 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.736 -1.345 . . . . 1.0 109.736 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -132.4 129.36 39.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 90' ' ' SER . 56.8 ttp180 -57.61 151.15 17.69 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 40.46 -86.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.794 0.684 . . . . 1.0 111.286 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' ARG . 93.1 p . . . . . 0 CA--C 1.527 0.089 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.435 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.424 HH12 ' CG1' ' A' ' 116' ' ' VAL . 50.9 ptt85 -141.01 163.5 32.81 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.94 129.63 8.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.492 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.16 161.38 38.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.35 128.73 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.1 mm? -104.79 157.66 17.05 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.173 0.511 . . . . 1.0 109.646 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.9 mmt 54.84 -87.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.819 -1.082 . . . . 1.0 110.282 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LEU . 2.6 p30 -169.3 72.36 0.08 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.21 -0.19 59.9 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -73.41 -57.26 4.13 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.901 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.88 120.23 37.26 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.858 0.724 . . . . 1.0 110.8 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.5 126.06 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.177 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.424 ' CG1' HH12 ' A' ' 105' ' ' ARG . 57.6 t -101.56 114.25 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.143 -1.428 . . . . 1.0 107.143 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.05 140.78 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.839 0.712 . . . . 1.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.54 -40.88 66.98 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 110.011 -1.235 . . . . 1.0 110.011 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.0 t80 61.68 135.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.297 0.239 . . . . 1.0 110.508 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -170.08 128.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -161.25 142.99 11.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.169 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.3 p 46.85 -114.53 0.54 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.198 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 124' ' ' LYS . 60.6 p -61.36 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.161 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.534 ' HG3' ' H ' ' A' ' 125' ' ' MET . 16.3 pttt -170.64 -73.09 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.534 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 64.4 mtt -71.79 -55.96 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.578 0.228 . . . . 1.0 111.469 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.96 -33.04 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.34 . . . . 1.0 111.276 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.2 m -72.44 -43.93 63.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.0 mt -64.93 -46.35 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 1.0 112.076 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.6 pt -62.61 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 121.874 0.845 . . . . 1.0 110.789 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -56.45 -46.04 80.54 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.95 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.75 -55.86 28.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -73.9 -22.69 59.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.345 -176.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 95.6 p 35.67 76.15 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.831 0.852 . . . . 1.0 112.588 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 135' ' ' LEU . 22.5 t70 -164.58 -151.18 0.15 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.041 -0.725 . . . . 1.0 109.041 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.483 ' H ' ' CG ' ' A' ' 134' ' ' ASP . 4.0 mm? -91.35 126.24 36.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.13 0.491 . . . . 1.0 109.687 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.0 p -97.1 155.36 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.801 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.01 96.35 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.995 -1.002 . . . . 1.0 108.52 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 t -96.42 123.44 40.08 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.426 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 1.8 t60 -73.51 -50.78 19.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.645 0.26 . . . . 1.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 25.11 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.03 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -63.93 -34.13 89.11 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.4 -44.73 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.926 0.393 . . . . 1.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -65.54 -41.58 96.11 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 111.151 -0.779 . . . . 1.0 111.151 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.9 t -69.65 -40.66 76.36 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 122.51 -0.406 . . . . 1.0 111.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.54 -29.75 39.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.369 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.6 tp -50.11 -51.37 43.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.033 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -65.65 -38.99 90.89 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.721 0.772 . . . . 1.0 110.339 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 m -51.08 -25.26 4.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.433 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.47 -55.35 4.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.073 0.768 . . . . 1.0 113.073 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.413 ' C ' ' H ' ' A' ' 152' ' ' ASN . 13.5 ptm180 -63.99 -26.61 68.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.909 0.385 . . . . 1.0 110.457 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.26 -0.91 6.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 150' ' ' ARG . 62.9 t30 56.33 37.7 29.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.37 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.95 144.7 42.37 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.086 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.27 -177.41 2.98 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 121.865 1.71 . . . . 1.0 110.877 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 155' ' ' LEU . 2.0 pt? -158.78 171.95 19.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.177 -0.919 . . . . 1.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.32 120.34 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.618 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.37 127.76 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.848 0.356 . . . . 1.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 96.8 m -72.77 104.81 4.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.01 147.73 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 83.48 102.49 0.05 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.976 0.798 . . . . 1.0 110.278 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -168.76 -76.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.6 m 49.17 35.92 8.17 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.06 0.457 . . . . 1.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.68 -40.66 97.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.184 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.9 ttm -162.88 52.3 0.18 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.006 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.29 -41.71 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.181 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 71.52 -51.62 0.69 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.701 0.626 . . . . 1.0 110.319 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -60.93 -23.77 65.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.806 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.426 ' NE2' ' CE1' ' A' ' 139' ' ' HIS . 11.6 tm0? -42.11 -50.71 4.73 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.332 -0.395 . . . . 1.0 111.305 -176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -67.09 -36.27 81.61 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.101 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -66.17 -38.09 87.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.452 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.6 mm -65.06 -43.63 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.99 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.51 -52.26 8.77 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.823 0.344 . . . . 1.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.25 -51.91 30.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.981 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -61.04 -30.31 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 1.0 110.574 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 179' ' ' GLY . 0.7 OUTLIER -63.96 -36.62 84.57 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.024 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.3 t -57.69 -44.5 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.671 0.272 . . . . 1.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -63.41 -50.22 70.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.831 0.348 . . . . 1.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.2 mt -90.76 0.67 57.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.313 0.578 . . . . 1.0 110.212 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . -173.51 87.23 0.08 OUTLIER Glycine 0 C--O 1.223 -0.575 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -48.25 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.457 0.74 . . . . 1.0 110.308 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.4 p -89.96 146.73 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.107 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -66.93 127.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 p -107.14 133.87 51.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.6 m -162.71 124.79 2.66 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.74 154.98 75.95 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.712 -0.661 . . . . 1.0 110.175 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.5 63.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.513 2.638 0 C-N-CA 122.458 2.106 . . . . 1.0 113.547 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 185' ' ' ALA . 79.4 p -128.12 141.95 51.34 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 17.2 mp0 -65.45 -25.36 67.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.276 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.5 t -89.11 -31.57 17.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.897 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.36 -34.3 12.45 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 112.015 -0.434 . . . . 1.0 112.015 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 34.7 mt -62.41 -41.52 98.74 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.449 -0.442 . . . . 1.0 111.364 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.28 -39.33 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.6 79.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.389 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.48 -53.99 25.5 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.415 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.94 -32.98 72.49 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.716 -0.284 . . . . 1.0 110.387 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -59.16 -48.6 81.03 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.503 -0.479 . . . . 1.0 109.99 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.54 -47.79 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.188 -0.32 . . . . 1.0 111.395 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.477 ' HG ' ' N ' ' A' ' 199' ' ' GLN . 83.3 p -59.79 -32.95 71.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.21 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.477 ' N ' ' HG ' ' A' ' 198' ' ' SER . 84.1 mt-30 -100.16 28.35 4.97 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.778 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 62.1 m -150.45 -30.74 0.2 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.328 -0.249 . . . . 1.0 110.328 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -150.8 151.94 33.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.174 0.511 . . . . 1.0 109.751 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -130.39 156.78 44.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.344 -0.844 . . . . 1.0 110.089 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.39 164.61 19.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.183 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -61.73 148.35 87.32 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.904 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.99 99.63 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.742 1.628 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -140.61 87.43 11.52 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 107.36 2.46 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.019 1.813 . . . . 1.0 111.685 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.64 84.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.224 -0.444 . . . . 1.0 109.932 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.798 0.333 . . . . 1.0 110.467 179.758 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 120.401 0.143 . . . . 1.0 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -164.04 73.82 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.932 -0.396 . . . . 1.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.78 111.32 12.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.559 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.45 160.2 14.53 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.0 tp -130.15 102.73 6.36 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -99.42 127.62 45.48 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.849 0.46 . . . . 1.0 110.018 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.61 145.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 t -144.01 138.63 28.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.523 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.19 -35.57 76.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.852 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.5 -104.12 1.38 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.371 -1.092 . . . . 1.0 110.371 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.46 -159.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -63.42 172.01 2.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 p -162.34 82.81 1.67 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.9 -32.77 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.054 1.836 . . . . 1.0 111.065 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.6 110.45 3.15 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 118.746 -0.645 . . . . 1.0 110.267 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -84.76 -21.68 3.25 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.613 1.542 . . . . 1.0 112.36 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -81.17 -31.89 33.85 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.58 -51.6 12.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.093 0.473 . . . . 1.0 110.472 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -56.74 -32.06 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.995 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 98.3 p -62.39 -19.26 63.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.691 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.5 p -51.07 -38.54 52.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 1.0 110.601 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.61 -18.76 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.112 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mt -143.63 41.19 1.44 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.939 0.496 . . . . 1.0 109.774 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -124.26 -156.13 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.103 -0.702 . . . . 1.0 109.103 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -54.5 -46.81 73.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.747 -0.66 . . . . 1.0 112.033 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.13 -55.41 35.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.536 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -71.0 -45.63 63.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.455 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 47.5 t -56.77 -32.02 65.2 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.46 0.647 . . . . 1.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -78.83 -49.86 12.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.82 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -70.08 -58.29 3.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.888 -0.597 . . . . 1.0 112.606 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 61' ' ' GLY . 3.2 mm? -49.45 -42.01 41.76 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.289 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.7 mm -69.69 -42.33 80.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -50.46 -51.9 42.79 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.122 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.433 ' C ' ' H ' ' A' ' 62' ' ' PHE . 97.1 m-85 -91.89 -17.81 24.68 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . 75.54 -16.21 4.11 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.562 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 60' ' ' TYR . 27.9 m-85 38.09 -115.54 0.15 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.261 -0.4 . . . . 1.0 111.448 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.0 t -160.43 -59.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -165.64 130.2 2.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.367 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.44 143.33 29.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.637 0.775 . . . . 1.0 110.533 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.8 mm -123.28 130.46 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.5 tt -145.29 141.86 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.243 0.544 . . . . 1.0 109.538 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.528 HE21 ' CE ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -160.58 151.79 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.043 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' OE2' ' A' ' 76' ' ' GLU . 95.8 m-85 -99.96 -60.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.315 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.01 -37.62 3.3 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 111.314 -0.715 . . . . 1.0 111.314 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.3 mmt-85 -97.13 122.65 40.39 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.81 -38.07 89.75 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.973 0.416 . . . . 1.0 110.262 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -54.03 -15.91 1.67 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.936 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -55.08 -80.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.242 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.3 m 52.88 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.667 0.27 . . . . 1.0 111.454 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -168.0 -44.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.908 0.385 . . . . 1.0 111.462 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -69.15 103.57 1.94 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.21 -83.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.267 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -169.08 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.035 0.445 . . . . 1.0 110.272 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.65 -17.59 60.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.32 -36.59 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' GLY . 41.4 mm-40 -66.87 -39.64 87.6 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.52 -0.764 . . . . 1.0 110.128 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -51.96 -38.02 55.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.12 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -18.0 62.59 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' GLN . . . 88.53 41.74 6.0 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.34 168.16 54.81 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -137.84 133.83 34.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -62.39 155.94 23.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.894 -0.322 . . . . 1.0 110.848 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.79 -5.83 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.407 0.442 . . . . 1.0 110.888 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.4 m . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.093 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.07 0.462 . . . . 1.0 111.665 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ptt85 -133.47 147.81 51.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -150.05 117.98 6.28 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -137.04 161.28 36.51 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.09 147.94 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.316 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 111' ' ' ASN . 2.0 mp -123.82 123.14 39.8 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.5 tpp 55.83 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.268 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' LEU . 20.6 t-20 -167.39 78.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.793 0.33 . . . . 1.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.41 5.28 77.05 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.011 -0.835 . . . . 1.0 111.011 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -66.51 -23.44 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 tp -174.04 105.68 0.12 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -109.89 115.32 29.59 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.38 108.45 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.87 100.04 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.938 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.68 -25.01 43.7 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 109.889 -1.284 . . . . 1.0 109.889 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -58.69 137.4 57.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.898 0.38 . . . . 1.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -166.41 170.54 12.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -81.56 96.06 7.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.226 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.6 p 46.53 -164.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.784 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.54 8.5 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.15 0.5 . . . . 1.0 110.054 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -144.42 44.87 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.528 ' CE ' HE21 ' A' ' 68' ' ' GLN . 18.1 mmt -52.98 -41.67 64.81 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.668 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -54.83 -26.96 38.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.683 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 51.2 p -83.66 -38.85 20.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.836 0.35 . . . . 1.0 111.245 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.02 -44.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.718 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.85 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -55.14 -38.81 68.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.173 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.48 -43.58 84.23 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -96.07 -61.06 1.5 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.03 0.443 . . . . 1.0 110.293 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 m 55.96 79.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -139.99 -49.37 0.47 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.65 0.262 . . . . 1.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.39 139.06 6.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.47 140.44 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 79.3 mt -119.18 125.9 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 139' ' ' HIS . 27.5 t -87.6 -164.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.424 ' N ' ' OG ' ' A' ' 138' ' ' SER . 79.4 t60 -139.03 -3.38 1.6 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 110.395 -0.224 . . . . 1.0 110.395 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.09 -56.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.099 0.476 . . . . 1.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 136.8 126.14 2.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 1.9 t -174.07 -131.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.435 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -73.76 -27.16 67.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -54.75 -44.81 73.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 89.1 mt -65.69 -26.75 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 122.173 -0.329 . . . . 1.0 110.902 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -54.57 34.68 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.25 -44.55 91.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.534 0.683 . . . . 1.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.7 p -49.08 -22.78 0.99 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.125 -0.943 . . . . 1.0 113.3 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.4 mt -82.46 -45.42 14.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.852 0.358 . . . . 1.0 111.611 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -68.8 -21.85 64.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.308 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.03 -3.0 57.72 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 53.06 34.34 16.93 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.593 0.235 . . . . 1.0 110.557 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.81 115.7 48.38 Favored Pre-proline 0 N--CA 1.481 1.11 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -50.94 155.22 6.12 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 CA-C-N 120.658 1.271 . . . . 1.0 112.308 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.14 170.31 19.73 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.274 1.035 . . . . 1.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.43 138.18 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.685 -1.598 . . . . 1.0 109.278 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.7 p -119.89 138.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 120.631 0.253 . . . . 1.0 110.815 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 14.3 t -72.35 125.27 26.97 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 184' ' ' CYS . 25.1 t -123.54 139.81 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.145 -0.687 . . . . 1.0 109.145 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 64.5 t30 57.11 -176.09 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.02 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.485 ' H ' ' CG ' ' A' ' 160' ' ' ASN . 65.5 m-20 59.76 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.838 0.711 . . . . 1.0 111.077 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.8 m 53.59 -90.94 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.847 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 66.5 mt -3.79 78.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.104 1.362 . . . . 1.0 113.14 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 62.1 mmm -60.83 -41.14 95.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.14 -0.937 . . . . 1.0 110.617 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.46 121.58 17.29 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.05 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -64.91 -34.27 78.0 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.77 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -55.63 -39.54 70.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.097 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.7 -52.39 64.49 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -66.88 -28.59 68.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.821 0.343 . . . . 1.0 110.574 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.78 -51.99 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.441 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.9 -27.27 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.41 -58.3 3.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -52.18 -43.88 64.38 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.862 -1.063 . . . . 1.0 112.353 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -64.71 -41.99 95.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.421 -0.512 . . . . 1.0 109.844 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.433 ' CD2' ' OH ' ' A' ' 180' ' ' TYR . 3.8 m-85 -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.206 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 179' ' ' GLY . 99.7 t -64.12 -35.32 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -48.09 -43.61 30.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.233 -0.894 . . . . 1.0 109.295 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.64 -29.91 67.49 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 82.47 -5.79 71.89 Favored Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.339 -1.104 . . . . 1.0 110.339 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.433 ' OH ' ' CD2' ' A' ' 175' ' ' PHE . 0.3 OUTLIER -62.53 -4.73 2.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.949 -0.625 . . . . 1.0 111.284 -177.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.33 147.47 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.171 0.441 . . . . 1.0 110.156 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 19.6 m-90 -76.71 131.65 38.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m -88.08 138.6 31.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -135.53 149.77 49.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.1 150.34 70.88 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.59 -0.893 . . . . 1.0 108.59 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.17 58.19 5.54 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 122.201 1.934 . . . . 1.0 113.183 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 173.08 6.5 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.88 -57.71 5.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.8 m -88.84 -30.27 19.07 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.585 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -59.19 -47.71 89.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.353 -0.699 . . . . 1.0 111.353 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.42 -43.0 91.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 117.083 0.441 . . . . 1.0 111.155 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.46 -43.65 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.59 -38.51 72.11 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.38 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.24 91.38 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.418 -0.673 . . . . 1.0 111.418 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -52.68 63.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -60.84 -35.33 76.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.141 -0.936 . . . . 1.0 109.432 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.03 -45.23 86.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.885 0.374 . . . . 1.0 110.097 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 84.2 p -67.5 -20.49 65.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.66 -24.73 14.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.01 0.433 . . . . 1.0 109.873 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.1 m -74.63 -40.08 61.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.505 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -120.18 139.7 52.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.794 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -119.18 101.61 8.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.054 0.542 . . . . 1.0 109.977 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.83 131.18 46.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -67.99 150.19 97.87 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 106.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.508 2.362 0 C-N-CA 121.891 1.727 . . . . 1.0 113.624 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.81 84.69 9.63 Favored Pre-proline 0 N--CA 1.478 0.953 0 N-CA-C 109.932 -0.395 . . . . 1.0 109.932 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -57.32 127.33 25.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.624 1.55 . . . . 1.0 112.036 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.04 -33.48 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.675 -0.491 . . . . 1.0 109.675 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.537 0.461 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.861 -178.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 109.768 -0.456 . . . . 1.0 109.768 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -165.96 -76.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -132.73 101.48 5.3 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.006 0.522 . . . . 1.0 110.019 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.68 119.5 38.95 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.07 121.59 27.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.76 0.314 . . . . 1.0 110.22 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CE1' ' CZ ' ' A' ' 132' ' ' TYR . 6.9 m-85 -103.63 122.13 44.37 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.2 t -118.36 99.04 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.5 p -93.23 120.75 33.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.236 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 139' ' ' HIS . 71.5 m -61.25 -27.48 68.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -138.47 31.6 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.721 -0.952 . . . . 1.0 110.721 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.37 -112.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.892 -0.181 . . . . 1.0 110.71 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.5 p -71.3 112.74 7.68 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.5 131.48 95.1 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.874 -0.584 . . . . 1.0 110.358 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.77 -174.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.3 1.333 . . . . 1.0 112.477 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.99 144.96 90.01 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.034 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.78 -33.22 49.38 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.789 1.66 . . . . 1.0 113.086 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.32 -35.39 61.24 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.633 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -66.88 -45.04 79.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.799 0.333 . . . . 1.0 111.531 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.72 -37.03 74.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.954 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -46.54 -27.53 1.15 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.181 0.515 . . . . 1.0 110.986 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.6 t -53.89 -38.09 64.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.78 . . . . 1.0 110.559 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.5 m -80.53 -4.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.302 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.52 40.18 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.224 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.9 m -135.62 -166.12 1.8 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.898 0.856 . . . . 1.0 109.823 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -54.6 -44.84 73.41 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.95 -1.477 . . . . 1.0 110.327 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 23.4 mp0 -52.27 -52.07 54.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.534 0.207 . . . . 1.0 110.55 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.58 -37.33 76.92 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.432 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.2 t -49.77 -45.98 50.23 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.745 0.307 . . . . 1.0 111.552 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -72.66 -44.59 61.67 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 1.0 111.429 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.35 -36.01 80.53 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.596 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -58.17 -47.23 84.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.619 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.544 ' CG1' ' HZ1' ' A' ' 113' ' ' LYS . 1.5 mp -68.67 -28.95 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.86 -43.02 59.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.91 -0.587 . . . . 1.0 110.906 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -76.57 -11.05 59.81 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.047 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 83.64 37.83 11.43 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.61 -0.805 . . . . 1.0 111.505 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 63' ' ' VAL . 1.6 p90 -48.43 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 120.936 0.398 . . . . 1.0 111.17 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' N ' ' CD2' ' A' ' 62' ' ' PHE . 8.7 p -172.15 -31.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.001 0.429 . . . . 1.0 109.952 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.504 ' NH1' ' NZ ' ' A' ' 115' ' ' LYS . 56.1 ttt85 -167.02 108.52 0.66 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.5 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.07 130.47 36.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.252 -0.648 . . . . 1.0 109.252 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.09 135.88 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.09 144.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -119.98 124.36 45.74 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.158 -1.052 . . . . 1.0 108.158 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CE1' ' NH2' ' A' ' 105' ' ' ARG . 2.0 t80 -59.04 -169.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.302 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.82 -109.08 0.35 Allowed Glycine 0 N--CA 1.463 0.481 0 N-CA-C 110.664 -0.974 . . . . 1.0 110.664 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -65.17 124.28 21.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.71 0.291 . . . . 1.0 110.723 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.63 -37.99 88.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.775 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.36 -44.49 88.84 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.461 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 99.3 p -63.91 169.73 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.289 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.3 p -153.61 73.37 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.335 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.95 169.39 4.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.83 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 45.8 76.1 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.938 0.399 . . . . 1.0 110.736 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.37 -34.96 77.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.22 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -167.86 22.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.388 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.88 -30.19 66.5 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.839 0.352 . . . . 1.0 110.6 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' GLY . 74.6 t -58.91 -47.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -72.72 -42.15 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.884 0.373 . . . . 1.0 111.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -52.64 -43.37 65.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.954 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -83.1 -16.9 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.93 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.38 -55.86 0.41 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . 46.06 78.02 0.09 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 112.686 -0.166 . . . . 1.0 112.686 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.21 109.96 19.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -59.64 150.48 27.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.925 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.5 16.92 3.37 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.479 0.657 . . . . 1.0 109.549 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.469 0.5 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.441 179.881 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.958 0.408 . . . . 1.0 111.493 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.429 ' NH2' ' CE1' ' A' ' 69' ' ' PHE . 10.5 ptp180 -130.12 151.69 50.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.593 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -157.98 109.46 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.52 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -143.14 -172.96 3.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.75 -0.463 . . . . 1.0 109.75 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.54 162.26 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.84 -174.17 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.2 mtt 53.82 54.09 10.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.496 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 52.49 33.47 13.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.72 25.03 68.35 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 120.894 -0.67 . . . . 1.0 112.499 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.544 ' HZ1' ' CG1' ' A' ' 58' ' ' ILE . 16.6 tptm -83.21 -49.86 9.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.4 0.6 . . . . 1.0 112.034 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.73 132.84 56.42 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.186 0.517 . . . . 1.0 112.033 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' NZ ' ' NH1' ' A' ' 64' ' ' ARG . 49.3 mtmt -106.23 152.45 23.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -134.23 132.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.6 mt -145.06 123.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.795 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.26 -16.24 76.75 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.15 -1.18 . . . . 1.0 110.15 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.4 t80 54.69 -99.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -169.67 130.17 1.03 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.19 108.64 4.24 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.1 p -168.07 160.64 12.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.123 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.8 t -76.69 5.27 7.86 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.237 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -72.33 -42.73 65.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.293 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.1 ttm -46.14 -34.21 4.09 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.709 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.96 -28.47 57.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.624 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -79.35 -35.18 41.32 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.421 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 128' ' ' ILE . 1.6 mp -64.55 -27.82 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.762 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.2 mt -52.13 -51.45 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 120.316 -0.553 . . . . 1.0 109.739 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -48.47 -30.95 5.67 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.383 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -52.4 -47.23 66.4 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 121.263 -0.175 . . . . 1.0 111.276 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.595 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.2 p90 -117.1 -53.68 2.45 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.341 0.401 . . . . 1.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 47.4 m 50.25 79.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.869 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -120.14 -53.45 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 tp -168.8 148.39 4.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.065 -0.654 . . . . 1.0 110.481 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.17 149.76 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.47 100.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 t -116.33 127.14 54.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.407 ' CD2' ' H ' ' A' ' 139' ' ' HIS . 13.2 p80 -80.69 67.86 6.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.226 -0.443 . . . . 1.0 109.875 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.85 34.37 23.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.994 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.558 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -62.41 -34.77 90.37 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.8 m 69.03 -16.75 0.22 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.46 0.304 . . . . 1.0 110.413 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -84.25 -54.18 3.08 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.706 -0.557 . . . . 1.0 111.706 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.0 p -79.54 -32.22 42.15 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.47 0.308 . . . . 1.0 111.365 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.27 -28.2 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 120.693 0.283 . . . . 1.0 110.86 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.9 mt -56.29 -51.08 69.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.807 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -65.17 -53.1 50.05 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 121.426 0.632 . . . . 1.0 110.865 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 88.0 p -58.32 -24.93 61.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 1.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.2 tp -76.7 -57.34 3.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.633 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.482 ' C ' ' H ' ' A' ' 152' ' ' ASN . 39.6 ptt180 -62.36 -28.05 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.171 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.7 4.6 1.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 150' ' ' ARG . 22.7 m120 58.41 11.96 1.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.233 0.333 . . . . 1.0 110.274 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -92.5 142.33 25.77 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.67 167.9 25.22 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.719 1.613 . . . . 1.0 111.481 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 155' ' ' LEU . 1.9 pt? -156.65 156.52 33.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.295 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.412 ' CG2' ' SG ' ' A' ' 184' ' ' CYS . 16.8 mm -110.13 109.72 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.58 118.27 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.11 103.65 2.37 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 85.5 t -90.09 137.88 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.1 170.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.011 0.434 . . . . 1.0 110.769 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 49.82 74.75 0.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.715 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.1 t -171.2 -49.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.13 0.49 . . . . 1.0 110.129 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.0 pp -145.52 142.87 29.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.092 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.2 mmm -90.22 86.65 6.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.573 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 167' ' ' HIS . 15.3 t0 -161.16 -19.52 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.962 -0.385 . . . . 1.0 109.962 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 58.7 6.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.67 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.428 ' H ' ' C ' ' A' ' 165' ' ' ASP . 52.8 t-80 -66.25 -36.63 83.49 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 172' ' ' ALA . 5.3 pt20 -61.57 -41.6 97.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.974 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -53.96 -29.56 43.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.83 0.348 . . . . 1.0 111.024 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -70.45 -53.47 16.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.09 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.5 mt -83.63 -51.3 14.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 110.487 -0.19 . . . . 1.0 110.487 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 168' ' ' GLN . . . -45.05 -52.97 8.39 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -69.36 -56.13 8.4 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -51.04 -26.98 6.95 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.9 0.381 . . . . 1.0 110.791 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.31 -38.84 66.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.243 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.7 m -55.53 -29.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 120.918 0.39 . . . . 1.0 111.875 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -59.46 -48.49 81.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.942 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.6 mt -104.48 24.7 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.288 0.566 . . . . 1.0 110.409 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.644 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.3 82.57 0.04 OUTLIER Glycine 0 C--O 1.221 -0.703 0 N-CA-C 108.44 -1.864 . . . . 1.0 108.44 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -46.35 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 O-C-N 125.063 1.096 . . . . 1.0 110.692 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.644 ' N ' ' O ' ' A' ' 179' ' ' GLY . 6.3 p -73.24 139.63 19.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.534 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -63.9 116.85 6.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.2 m -108.75 133.63 52.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.562 -0.744 . . . . 1.0 109.875 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 156' ' ' ILE . 28.5 p -165.1 131.32 2.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.697 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.65 79.47 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.43 79.11 0.24 Allowed 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.704 2.27 . . . . 1.0 113.68 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.5 p -130.62 177.14 7.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 2.2 pm0 -68.64 -63.86 0.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.56 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.5 m -75.13 -43.56 51.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.022 0.439 . . . . 1.0 111.547 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -51.85 -51.24 40.61 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.969 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.97 -41.46 97.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.3 0.55 . . . . 1.0 111.743 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.76 -42.93 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.94 76.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 1.0 110.153 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.71 -46.44 61.26 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.66 -44.41 97.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.043 -0.354 . . . . 1.0 110.043 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -64.63 -37.91 89.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.57 86.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.4 t -60.16 -21.2 61.37 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.01 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -101.28 31.67 3.6 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.668 0.27 . . . . 1.0 110.792 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 18.2 p -143.01 -31.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.12 152.21 12.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.336 -0.546 . . . . 1.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -99.08 144.03 28.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.688 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -54.78 173.91 0.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.519 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.13 116.08 22.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-O 118.991 -0.528 . . . . 1.0 110.739 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.61 118.17 2.82 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 CA-C-N 120.919 1.364 . . . . 1.0 112.749 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -142.06 87.81 9.56 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 85.79 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.347 1.365 . . . . 1.0 112.436 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.74 -26.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.257 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.469 0.525 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.864 -178.908 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -116.96 65.19 0.72 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.06 156.09 39.59 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.7 134.77 51.7 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.772 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.65 119.57 32.2 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.743 -0.598 . . . . 1.0 109.466 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -101.42 129.94 47.54 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.25 138.04 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.73 129.62 42.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.491 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.56 34.75 2.67 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.971 0.415 . . . . 1.0 110.066 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.92 -160.13 53.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 -37.37 86.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.477 0.179 . . . . 1.0 111.059 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.1 p -133.18 150.45 52.0 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 110.067 -0.345 . . . . 1.0 110.067 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.12 121.01 76.93 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 119.309 -0.377 . . . . 1.0 110.93 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.58 -59.63 1.12 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 CA-C-N 120.562 1.236 . . . . 1.0 112.386 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -144.81 145.31 27.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.906 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.76 -19.8 30.93 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 121.748 1.632 . . . . 1.0 111.813 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -77.23 -33.9 56.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.806 0.336 . . . . 1.0 110.875 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.46 -48.7 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 1.0 110.72 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -63.21 -34.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 1.0 109.76 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 50' ' ' SER . 6.4 m -52.52 -44.31 65.65 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.655 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -49.01 -38.56 23.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.73 0.3 . . . . 1.0 110.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.11 -14.1 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.271 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.59 35.17 4.24 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.993 0.425 . . . . 1.0 110.333 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 46' ' ' SER . 20.9 m -114.05 -167.55 1.23 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.16 -27.17 63.35 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.707 -1.133 . . . . 1.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.75 -47.57 65.93 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.241 -0.583 . . . . 1.0 110.485 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.2 t80 -69.22 -40.83 77.72 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.7 t -49.99 -48.48 52.3 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -66.78 -44.27 81.8 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.817 0.342 . . . . 1.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -73.64 -30.58 63.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.29 0.567 . . . . 1.0 109.833 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' PHE . 5.7 tt -58.78 -50.0 75.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.312 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -66.59 -31.07 51.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.268 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -59.8 -10.55 3.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.713 -0.222 . . . . 1.0 110.634 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -103.6 -10.59 18.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.218 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.53 13.39 55.58 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 121.188 -0.53 . . . . 1.0 112.384 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -84.71 160.61 20.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.56 3.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.769 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -148.75 142.4 25.5 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.544 0.688 . . . . 1.0 110.554 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -141.99 116.41 9.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.341 -0.845 . . . . 1.0 108.899 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mm -100.69 137.88 26.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tt -146.13 141.24 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.029 0.443 . . . . 1.0 109.833 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.09 158.91 5.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -174.82 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.963 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.27 147.44 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.558 ' NE ' ' HG ' ' A' ' 74' ' ' SER . 80.2 ttt180 -155.73 83.83 1.03 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 1.0 110.282 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -68.28 -22.31 64.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.281 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -57.22 -29.6 63.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.558 ' HG ' ' NE ' ' A' ' 71' ' ' ARG . 84.4 p -149.97 -105.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.066 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.7 m -140.63 147.87 40.02 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 19.8 mp0 -84.2 -119.66 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.79 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -66.55 109.98 2.99 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.77 -57.42 5.64 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.108 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -173.23 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.06 -45.04 82.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.096 0.474 . . . . 1.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.88 -46.59 96.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.937 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.35 -26.45 68.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.009 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.98 -49.82 76.43 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.244 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -62.53 -17.38 59.69 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.083 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.77 54.9 7.83 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 110.179 -1.168 . . . . 1.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.15 -165.53 41.39 Favored Glycine 0 N--CA 1.466 0.669 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -134.6 135.03 41.91 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.004 0.431 . . . . 1.0 110.095 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -60.55 153.28 23.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.922 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -106.45 0.48 24.81 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 91.8 p . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 120.96 0.41 . . . . 1.0 111.117 -179.373 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -136.25 158.6 44.03 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.498 ' NE2' ' H ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -155.17 126.17 7.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.498 ' H ' ' NE2' ' A' ' 106' ' ' GLN . 2.0 m-85 -132.16 148.32 52.47 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.0 t -104.61 104.98 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.149 -0.932 . . . . 1.0 108.807 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -99.76 123.17 43.75 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.407 ' C ' ' H ' ' A' ' 112' ' ' GLY . 65.9 mtt 42.7 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.538 0.569 . . . . 1.0 112.538 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 54.96 7.8 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.757 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 110' ' ' MET . . . 75.29 24.02 72.18 Favored Glycine 0 N--CA 1.462 0.427 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -56.99 -39.47 74.72 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.046 -0.353 . . . . 1.0 110.046 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.8 tp -129.78 128.36 42.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -108.65 119.4 39.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.102 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.31 112.63 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.1 pt -115.08 158.66 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-N 115.144 -0.935 . . . . 1.0 108.954 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -115.44 95.05 0.69 Allowed Glycine 0 N--CA 1.474 1.205 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.76 -173.46 4.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -146.42 156.21 43.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.641 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -69.14 127.93 34.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.233 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.6 p -169.35 33.83 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.676 0.274 . . . . 1.0 110.448 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 29.6 p 51.6 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.653 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -179.88 -29.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.671 0.607 . . . . 1.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtm -55.38 -48.43 74.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.916 0.389 . . . . 1.0 110.923 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.402 ' O ' ' NE ' ' A' ' 130' ' ' ARG . 51.6 tt0 -55.29 -30.08 59.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 m -86.15 -51.79 6.08 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.965 0.412 . . . . 1.0 111.937 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.85 -43.33 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.199 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.33 -57.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.739 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 126' ' ' GLN . 18.1 ptp180 -69.2 -33.93 74.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.478 0.548 . . . . 1.0 112.478 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.17 -46.28 86.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.011 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.73 -65.38 1.15 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.78 0.324 . . . . 1.0 111.86 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 p -60.68 172.68 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.706 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -157.69 23.49 0.28 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.2 tp -158.69 138.03 11.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.85 155.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.08 102.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 81.9 p -89.71 113.24 24.72 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.42 0.629 . . . . 1.0 109.667 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.401 ' O ' ' N ' ' A' ' 141' ' ' GLY . 59.7 t-80 -69.69 136.44 51.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.24 -63.87 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.394 0.887 . . . . 1.0 113.394 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 139' ' ' HIS . . . -167.94 -80.44 0.04 OUTLIER Glycine 0 C--N 1.345 1.05 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.0 p 56.55 166.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.741 0.781 . . . . 1.0 110.76 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.35 -15.51 80.85 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 114.542 -1.208 . . . . 1.0 110.966 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 91.5 p -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.053 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.01 -27.09 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.606 -0.438 . . . . 1.0 112.033 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 51.1 tp -57.02 -48.0 79.55 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.27 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -68.87 -51.99 34.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.631 . . . . 1.0 110.364 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.2 m -51.18 -25.22 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.766 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -77.01 -46.41 23.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.857 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -67.54 -32.83 73.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.54 -0.755 . . . . 1.0 111.24 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.75 -9.67 58.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 61.9 t30 54.88 35.27 23.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -109.46 151.28 42.07 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-O 119.294 -0.384 . . . . 1.0 110.393 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -43.13 143.59 1.96 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.007 1.804 . . . . 1.0 112.017 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 52.3 tp -152.88 134.71 14.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.69 129.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.942 0.777 . . . . 1.0 109.013 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.17 130.53 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 117.986 0.357 . . . . 1.0 110.069 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 71.0 m -83.35 103.4 12.69 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.164 0.507 . . . . 1.0 109.663 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.36 143.41 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 160' ' ' ASN . 0.2 OUTLIER -147.62 175.32 10.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.936 0.398 . . . . 1.0 110.028 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -61.69 171.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.624 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.6 p -62.3 96.46 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.179 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 tp -66.38 -164.85 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.144 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.8 ttp -62.34 -52.47 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.835 0.35 . . . . 1.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 167' ' ' HIS . 75.9 m-20 -71.05 -42.7 69.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.115 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.71 0.86 0.16 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.287 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 165' ' ' ASP . 34.6 m170 -73.55 -35.91 65.56 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.93 0.395 . . . . 1.0 110.459 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -65.29 -50.88 64.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.642 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.3 -33.32 74.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.441 . . . . 1.0 110.207 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.04 -52.43 65.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.707 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.85 -36.01 67.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.568 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.102 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -49.32 -28.58 5.02 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.25 0.548 . . . . 1.0 110.423 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -85.43 -45.74 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.014 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.01 -20.51 60.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.258 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 180' ' ' TYR . 14.3 p -62.17 -52.08 64.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.976 0 C-N-CA 121.02 -0.272 . . . . 1.0 110.532 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 179' ' ' GLY . 57.7 mt-10 -58.79 -19.6 42.4 Favored 'General case' 0 CA--C 1.522 -0.11 0 O-C-N 121.931 -0.481 . . . . 1.0 111.048 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.77 3.2 0.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.676 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 177' ' ' GLU . . . 144.64 10.37 0.33 Allowed Glycine 0 N--CA 1.474 1.201 0 N-CA-C 111.089 -0.805 . . . . 1.0 111.089 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 176' ' ' VAL . 27.5 t80 72.23 100.38 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 1.0 109.237 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 182' ' ' TRP . 11.8 p -92.79 58.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.594 0.235 . . . . 1.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 181' ' ' VAL . 4.3 m-90 33.03 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.044 0.449 . . . . 1.0 110.303 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 93.8 p -88.08 132.75 34.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.95 142.55 46.8 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -111.31 155.86 42.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 119.158 -0.448 . . . . 1.0 110.755 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.32 37.73 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.785 1.656 . . . . 1.0 113.214 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 185' ' ' ALA . 73.5 p -131.32 143.09 50.25 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 24.8 mp0 -64.53 -46.33 83.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.474 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.0 m -64.4 -28.57 69.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.581 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.53 -31.89 17.53 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.45 -47.34 79.45 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 111.778 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.0 pt -52.66 -34.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.022 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.96 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.3 98.39 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 49.8 mt -64.66 -35.42 80.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.932 0.396 . . . . 1.0 110.359 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -69.89 -37.36 75.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.421 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -70.28 -44.95 67.32 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.062 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -66.58 -30.09 70.31 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.002 0.371 . . . . 1.0 112.002 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -86.16 11.67 11.39 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.176 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.2 p -146.37 -64.3 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.519 -0.31 . . . . 1.0 110.242 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.6 mt-10 -71.63 129.21 38.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.748 0.308 . . . . 1.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.07 170.84 8.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.83 138.49 54.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -57.49 143.25 75.22 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.11 100.35 1.37 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.719 1.613 . . . . 1.0 111.964 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -142.02 82.87 13.08 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.85 112.64 1.16 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.914 1.742 . . . . 1.0 111.873 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.34 -73.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.515 -0.474 . . . . 1.0 110.073 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.015 -179.913 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.691 0.282 . . . . 1.0 110.938 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -167.58 -61.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -128.42 142.23 51.17 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.076 0.465 . . . . 1.0 110.167 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.28 167.4 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.85 120.19 19.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -118.73 133.56 55.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.403 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.7 140.29 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 t -143.96 141.24 30.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.034 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.8 m -83.19 143.51 30.43 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.675 ' H ' ' NE2' ' A' ' 139' ' ' HIS . . . -71.01 62.12 0.97 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.36 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.791 0.348 . . . . 1.0 110.775 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.4 p 53.18 100.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -59.68 125.36 79.76 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.035 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.71 -54.68 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.021 1.147 . . . . 1.0 111.927 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.417 ' CE2' ' OD1' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -142.76 144.54 30.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.92 -7.71 15.48 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.968 1.778 . . . . 1.0 111.545 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -66.99 -46.09 75.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.781 0.324 . . . . 1.0 111.083 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.67 -40.98 98.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.78 0.324 . . . . 1.0 110.617 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.23 -44.63 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.6 t -54.82 -48.2 73.11 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.166 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.3 m -51.65 -49.8 61.58 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.272 -0.267 . . . . 1.0 111.369 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 30.0 m -78.94 5.79 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.672 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.04 30.96 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.598 ' HG ' ' H ' ' A' ' 51' ' ' ASP . 14.3 t -119.23 -164.12 1.03 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.598 ' H ' ' HG ' ' A' ' 50' ' ' SER . 76.1 m-20 -50.83 -42.42 58.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.922 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -62.76 -53.82 48.5 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 121.171 0.51 . . . . 1.0 110.218 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 54.6 t80 -61.99 -45.43 93.66 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.244 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 89.4 m -51.94 -49.62 62.77 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.32 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 78.0 mt-30 -73.14 -52.3 14.72 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.077 0.465 . . . . 1.0 110.593 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -57.02 -24.94 57.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.694 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.15 -45.32 95.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 1.0 110.018 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.42 -43.39 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.747 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.418 ' OE1' ' N ' ' A' ' 59' ' ' GLN . 1.1 mp0 -55.56 -16.83 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.469 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -98.5 -19.06 17.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.371 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 102.65 40.52 2.52 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 118.111 -1.383 . . . . 1.0 111.676 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 61' ' ' GLY . 13.3 p90 -13.22 146.57 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 124.33 1.052 . . . . 1.0 112.143 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.8 t -146.86 -78.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.777 0.717 . . . . 1.0 109.583 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -151.82 110.68 3.84 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.4 tp -92.25 127.6 37.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.03 146.31 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.6 tt -138.75 141.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.473 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 9.8 tp-100 -70.18 -86.38 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.528 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 t80 50.89 -174.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.249 0.219 . . . . 1.0 110.491 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.56 76.03 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -67.18 175.99 2.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.894 0.378 . . . . 1.0 110.039 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -61.61 -29.86 70.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.392 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -60.09 -21.58 61.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.255 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m 53.3 -95.8 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.055 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 t 56.83 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.159 0.504 . . . . 1.0 111.166 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 78' ' ' GLU . 75.2 mt-10 -79.4 132.45 36.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.116 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 54.5 t80 -78.07 12.51 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.211 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 76' ' ' GLU . 78.8 tt0 62.58 137.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.74 0.65 . . . . 1.0 109.745 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -67.83 66.1 0.09 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.928 0.394 . . . . 1.0 110.05 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 -57.53 3.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.323 0.582 . . . . 1.0 111.618 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.7 m -57.43 -43.3 82.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.538 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.31 -39.83 95.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.298 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -52.45 -46.03 66.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.998 0.428 . . . . 1.0 110.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.44 ' NH2' ' OG ' ' A' ' 50' ' ' SER . 30.3 mmt180 -71.66 -16.44 62.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.06 59.65 1.94 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.61 -168.02 39.61 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 110.087 -1.205 . . . . 1.0 110.087 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -133.35 127.72 34.11 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 113.1 24.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.728 0.299 . . . . 1.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -84.2 -76.51 0.3 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.095 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.531 0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.405 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -141.35 154.15 45.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.682 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -156.18 131.62 9.48 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.349 -0.611 . . . . 1.0 109.349 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -132.1 143.77 50.24 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.465 -0.569 . . . . 1.0 109.465 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -127.88 140.57 48.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 111' ' ' ASN . 10.9 mp -101.61 147.96 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.2 mtp 46.66 -89.74 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.442 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 109' ' ' LEU . 16.9 m120 -155.86 81.5 1.01 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.804 0.335 . . . . 1.0 110.476 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.74 23.3 75.39 Favored Glycine 0 N--CA 1.469 0.853 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -73.14 -75.05 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.571 -0.37 . . . . 1.0 110.671 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.92 126.96 53.63 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.476 0.485 . . . . 1.0 109.947 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -105.64 101.25 10.78 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.473 -0.195 . . . . 1.0 110.473 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.05 109.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -117.53 139.6 15.03 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 109.914 -1.275 . . . . 1.0 109.914 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -170.11 140.82 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -160.52 155.97 25.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.013 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.401 ' O ' ' N ' ' A' ' 123' ' ' THR . 82.7 t80 -161.16 98.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.289 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 64.35 -67.52 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.525 0.516 . . . . 1.0 110.819 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PHE . 30.3 m -154.78 121.65 5.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -148.6 5.48 0.7 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 125' ' ' MET . 3.9 mpp? -59.22 -57.25 13.86 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.17 -29.01 65.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.951 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.3 m -70.85 -43.4 68.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.435 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.8 -50.05 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 1.0 112.367 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 133' ' ' SER . 1.2 pp -63.78 -54.02 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.926 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -47.03 -37.36 9.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.072 -0.393 . . . . 1.0 111.068 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.94 -48.22 78.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.12 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -100.22 -64.25 1.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.811 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 129' ' ' ILE . 34.2 p 57.09 74.26 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -134.8 -44.87 0.73 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.956 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.9 tp -169.13 151.03 4.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.68 146.51 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.18 105.73 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 138.13 40.34 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.675 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -60.11 -169.65 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.042 0.449 . . . . 1.0 110.176 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.17 45.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.431 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 139' ' ' HIS . . . -62.38 -128.11 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.7 m -163.44 -50.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.576 -0.367 . . . . 1.0 110.771 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.73 -52.51 5.86 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 92.1 p -55.15 -42.69 73.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.743 0.306 . . . . 1.0 110.88 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.74 -49.69 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.6 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.59 -31.24 6.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.001 0.188 . . . . 1.0 111.403 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.27 -50.79 29.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.999 0.428 . . . . 1.0 110.287 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.888 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.36 -46.64 31.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.764 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.98 -37.39 86.94 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.876 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.07 -11.61 59.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.61 36.51 26.83 Favored 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 123.473 0.483 . . . . 1.0 110.049 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -122.95 147.16 50.55 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.925 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -45.19 165.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.205 1.936 . . . . 1.0 112.47 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 59.9 tp -152.03 140.73 20.86 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.039 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.09 123.83 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -116.0 133.3 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 117.801 0.273 . . . . 1.0 111.169 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 77.4 m -72.66 105.13 4.15 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.28 141.52 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.874 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.56 -157.16 0.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.064 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 t70 58.34 21.29 8.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.451 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.5 m -85.75 90.15 7.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.687 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.55 -41.19 98.44 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.897 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' ASN . 43.3 ttp -130.1 -53.05 1.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.506 0.322 . . . . 1.0 110.755 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.417 ' OD1' ' CE2' ' A' ' 41' ' ' PHE . 4.0 p-10 -66.72 69.61 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.138 0.494 . . . . 1.0 110.635 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 164' ' ' MET . 76.7 m-20 -65.45 -25.82 67.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.383 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -51.18 -32.3 22.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.839 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.509 ' NE2' ' CD2' ' A' ' 139' ' ' HIS . 19.6 mm100 -60.7 -47.79 84.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.529 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -69.1 -30.14 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.487 0.184 . . . . 1.0 111.013 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.14 -54.16 45.08 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.02 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 175' ' ' PHE . 17.0 tt -68.61 -34.85 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.25 -65.04 0.63 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.294 0.569 . . . . 1.0 110.623 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.02 -34.26 28.71 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.065 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.04 -31.44 56.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.407 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' ILE . 3.5 t80 -63.19 -47.13 83.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.849 0.357 . . . . 1.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.53 -44.64 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -54.75 -46.85 74.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.113 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.33 9.47 42.99 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.071 0.462 . . . . 1.0 110.365 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 173.66 91.11 0.08 OUTLIER Glycine 0 C--O 1.212 -1.239 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -49.51 70.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.086 0.954 . . . . 1.0 111.174 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.6 p -73.8 141.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.889 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -59.25 114.04 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.263 0.554 . . . . 1.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.5 t -87.0 135.96 33.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.443 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.62 170.79 17.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.23 74.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.622 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.62 57.49 1.42 Allowed 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.558 2.172 . . . . 1.0 112.882 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.9 p -131.65 147.05 52.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -59.48 -51.91 67.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.616 0.245 . . . . 1.0 111.19 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 26.1 m -65.27 -24.86 67.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.925 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.04 -36.02 8.61 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 116.183 -0.462 . . . . 1.0 112.087 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -40.97 85.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 117.235 0.518 . . . . 1.0 111.556 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.0 pt -55.58 -34.66 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 1.0 110.833 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.7 78.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.189 0.518 . . . . 1.0 109.775 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.78 -46.16 94.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.236 -0.746 . . . . 1.0 111.236 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.92 -44.13 97.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.912 0.356 . . . . 1.0 110.312 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -63.32 -52.14 63.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.623 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.56 71.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.177 -0.305 . . . . 1.0 110.177 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 97.1 p -60.48 -34.05 73.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.965 -0.294 . . . . 1.0 111.304 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -102.64 32.8 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 1.0 111.135 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 19.6 m -159.84 -29.17 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.159 -0.338 . . . . 1.0 110.607 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -108.75 152.13 25.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -122.21 170.82 9.51 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.6 tp -119.73 136.24 54.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -62.61 152.25 81.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.196 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -37.9 109.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.826 2.35 . . . . 1.0 112.554 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 206' ' ' PHE . 0.1 OUTLIER -61.53 151.75 76.62 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.332 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.03 -8.01 18.59 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.961 1.774 . . . . 1.0 111.705 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.7 p -49.96 132.57 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.608 0.242 . . . . 1.0 111.06 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.467 0.405 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.449 179.82 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.452 ' CD ' ' HZ2' ' A' ' 115' ' ' LYS . 67.8 mt-10 . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.64 0.257 . . . . 1.0 110.613 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -92.39 -73.4 0.55 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.3 110.87 7.03 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.4 125.11 52.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.844 0.458 . . . . 1.0 109.991 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 mp -91.73 107.19 19.04 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.188 0.518 . . . . 1.0 109.63 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -85.07 125.81 33.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.081 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.91 130.09 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -145.52 136.68 24.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.74 -26.6 31.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.451 . . . . 1.0 109.835 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.25 -112.09 3.93 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.95 -156.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.571 0.224 . . . . 1.0 110.627 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.507 ' HG1' ' H ' ' A' ' 39' ' ' VAL . 1.8 t -53.6 170.53 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.507 ' H ' ' HG1' ' A' ' 38' ' ' THR . 16.7 t -139.67 82.75 17.65 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.62 16.37 1.97 Allowed 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.481 2.121 . . . . 1.0 111.702 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.08 65.0 28.28 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.98 -17.55 41.09 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.028 1.818 . . . . 1.0 111.941 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -79.99 -30.85 39.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.499 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.47 -44.92 56.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.797 0.332 . . . . 1.0 110.645 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 -29.41 46.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.029 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.5 p -51.31 -38.47 53.15 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.118 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -47.33 -28.34 1.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 1.0 110.605 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -92.23 -23.91 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.839 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 46' ' ' SER . 0.7 OUTLIER -120.67 24.79 10.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.968 0.507 . . . . 1.0 110.194 -177.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 46' ' ' SER . 40.3 t -104.72 -161.76 0.84 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.459 ' N ' ' OG ' ' A' ' 50' ' ' SER . 63.0 m-20 -71.27 -28.52 64.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.28 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.59 -51.51 69.51 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.855 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.7 t80 -70.14 -39.15 75.56 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.185 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.7 t -52.67 -46.2 67.12 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.678 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -71.66 -44.14 64.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.113 0.482 . . . . 1.0 110.586 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -68.41 -26.45 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' PHE . 56.1 tp -57.19 -44.64 83.78 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.11 -33.63 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -34.56 75.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.43 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -72.31 -18.89 61.75 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.71 34.38 2.85 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 37.33 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.862 0.465 . . . . 1.0 111.462 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.86 -95.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 122.618 0.367 . . . . 1.0 110.36 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -168.42 149.87 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -130.29 118.07 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.98 132.01 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 tp -114.56 141.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -166.51 -166.98 0.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.03 164.49 32.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.38 -35.35 90.86 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.53 147.65 51.61 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.993 0.425 . . . . 1.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -62.96 -35.18 79.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.274 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -60.95 -49.18 78.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 96.5 p -77.27 102.05 6.53 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.186 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.4 p -169.98 88.91 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.992 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.28 -87.11 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 47.24 94.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.819 0.343 . . . . 1.0 110.145 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.87 -70.83 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.161 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -174.66 66.0 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.837 0.351 . . . . 1.0 110.318 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.34 -41.39 98.87 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.829 0.347 . . . . 1.0 110.339 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.23 -45.86 95.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.863 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -66.53 -46.89 74.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.794 0.33 . . . . 1.0 110.84 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -55.52 -45.66 77.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.932 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' NH1' ' OG ' ' A' ' 50' ' ' SER . 0.4 OUTLIER -74.16 -17.16 60.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.475 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.96 50.32 3.96 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.12 177.49 54.3 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 109.487 -1.445 . . . . 1.0 109.487 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -124.44 121.98 36.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -63.45 159.81 17.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.881 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -131.27 -178.8 5.0 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.563 -179.706 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.016 0.436 . . . . 1.0 110.196 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -131.36 161.72 31.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.821 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -155.95 119.61 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.75 159.84 40.06 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.52 143.61 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.8 mm? -95.88 137.42 34.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.9 mmm 47.12 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.014 0.821 . . . . 1.0 111.272 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 109' ' ' LEU . 19.8 p-10 -156.83 70.46 0.64 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.973 0.416 . . . . 1.0 110.551 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.2 27.13 64.63 Favored Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.576 -0.61 . . . . 1.0 111.576 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -91.9 -7.14 50.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.826 0.313 . . . . 1.0 110.728 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.65 131.55 0.89 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 99.3 mttt -98.73 141.66 31.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.83 112.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.87 130.82 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.139 0.576 . . . . 1.0 109.82 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -22.97 68.87 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -117.71 169.52 9.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.875 0.47 . . . . 1.0 110.438 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -168.6 173.71 7.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.112 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 122' ' ' SER . 88.2 t80 -65.62 166.98 9.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.43 . . . . 1.0 109.843 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.478 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 40.7 t 53.15 96.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.807 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 89.9 m -58.71 164.86 2.52 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.5 tptm 68.86 108.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.431 0.457 . . . . 1.0 110.263 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 126' ' ' GLN . 0.0 OUTLIER -49.77 -36.74 27.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.122 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.471 ' N ' ' SD ' ' A' ' 125' ' ' MET . 57.8 tt0 -57.3 -32.37 66.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.2 m -78.72 -34.84 45.59 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.835 0.35 . . . . 1.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.379 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -58.29 -48.97 83.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -59.45 -44.9 92.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.59 -0.277 . . . . 1.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -53.26 -42.9 66.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.504 -0.317 . . . . 1.0 111.411 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -98.43 -68.45 0.8 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p 71.52 33.37 1.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.03 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.74 -66.4 0.91 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.198 -0.668 . . . . 1.0 109.198 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 44.3 tp -165.95 142.84 5.3 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.818 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.38 147.24 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.01 125.51 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.145 -1.058 . . . . 1.0 108.145 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.7 p -137.57 134.58 35.78 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.7 -34.53 58.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.65 34.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.669 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 143' ' ' GLY . . . -61.67 -37.01 93.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.5 m 65.19 -65.49 0.16 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.099 0.476 . . . . 1.0 111.021 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' GLY . . . -66.52 -32.68 82.38 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 44.8 m -73.92 -33.89 64.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.769 0.319 . . . . 1.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.4 -28.74 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 120.974 0.416 . . . . 1.0 110.769 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -47.91 -51.11 24.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.618 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -63.18 -44.47 95.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.314 0.578 . . . . 1.0 110.859 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.0 m -59.88 -24.62 64.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.479 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.36 -48.4 23.21 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.3 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -75.08 -22.47 58.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.832 -0.622 . . . . 1.0 111.35 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.87 -6.75 50.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 51.41 31.07 6.8 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.171 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.414 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 78.9 mttt -108.8 155.86 39.95 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 123.326 0.391 . . . . 1.0 110.026 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -42.66 139.27 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.683 1.589 . . . . 1.0 111.91 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -153.82 122.91 6.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 156' ' ' ILE . 0.1 OUTLIER -117.52 120.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.71 0.631 . . . . 1.0 109.731 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.08 115.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 94.7 m -72.33 102.5 3.15 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.29 137.07 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -130.48 171.98 12.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 29.0 p-10 -97.02 14.55 25.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.512 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 t -156.67 -136.49 0.05 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.563 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt 64.88 114.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 tpt 67.82 173.19 0.27 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.317 -0.402 . . . . 1.0 109.927 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.61 -65.6 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -154.22 9.41 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.814 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -62.97 -33.43 75.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.009 -0.367 . . . . 1.0 110.009 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.32 -38.52 77.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 1.0 110.412 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -78.45 -32.52 48.48 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.633 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.07 -50.2 67.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.707 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.88 -38.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.34 -56.33 4.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.196 0.998 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -49.84 -52.36 33.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.882 -1.053 . . . . 1.0 110.922 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.63 -30.88 70.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 1.0 110.478 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -74.89 -55.21 6.03 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.783 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.22 -25.89 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.692 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -48.55 -52.03 24.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.485 -0.932 . . . . 1.0 108.485 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.24 -29.96 70.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.701 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 129.75 81.53 0.27 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 112.106 -0.398 . . . . 1.0 112.106 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 36.6 46.88 0.48 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.62 0.724 . . . . 1.0 111.505 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 182' ' ' TRP . 2.5 p -48.12 -61.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.671 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . 0.509 ' CD1' ' O ' ' A' ' 181' ' ' VAL . 10.4 m0 -156.73 62.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.991 0.807 . . . . 1.0 110.377 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -111.93 130.43 55.85 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.363 -0.835 . . . . 1.0 108.99 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 49.2 t -164.26 127.44 2.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.071 -0.715 . . . . 1.0 109.071 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 153.14 70.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 110.686 -0.116 . . . . 1.0 110.686 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 84.26 0.45 Allowed 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.077 1.851 . . . . 1.0 112.588 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.9 m -132.19 148.82 52.48 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -48.19 -54.83 12.09 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.185 -0.206 . . . . 1.0 111.37 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.6 m -73.25 -44.98 58.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.986 0.422 . . . . 1.0 111.049 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -55.9 -44.81 87.47 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.029 -0.532 . . . . 1.0 112.427 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -40.98 71.36 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.93 0.365 . . . . 1.0 110.172 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.99 -45.44 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.29 66.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.017 0.437 . . . . 1.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -54.56 -40.19 69.06 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -47.94 71.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.454 0.645 . . . . 1.0 109.928 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -59.99 -45.65 92.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.859 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.13 -52.0 66.71 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.035 0.445 . . . . 1.0 110.946 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.409 ' O ' ' NZ ' ' A' ' 202' ' ' LYS . 39.9 p -65.09 -21.52 66.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.02 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -110.18 31.3 6.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.727 0.411 . . . . 1.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 56.3 m -145.88 -27.05 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.37 151.36 35.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 198' ' ' SER . 75.6 mmtt -128.29 142.99 50.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.918 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.18 -161.24 0.79 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.938 -0.574 . . . . 1.0 109.569 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -73.2 144.91 85.17 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.886 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.84 -47.19 27.7 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.527 1.485 . . . . 1.0 113.374 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -139.73 86.4 13.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.241 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.4 -64.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.039 1.826 . . . . 1.0 111.721 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.17 145.59 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.075 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -133.51 -117.39 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -76.53 94.8 3.77 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.707 0.289 . . . . 1.0 110.913 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.33 166.26 12.17 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.2 mt -132.26 101.0 5.19 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.495 ' CD1' ' OH ' ' A' ' 132' ' ' TYR . 6.1 m-85 -95.0 127.12 40.81 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.023 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 137' ' ' ILE . 5.5 p -127.21 125.68 66.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.7 p -143.52 137.38 28.43 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.254 -0.884 . . . . 1.0 109.46 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.8 m -103.45 140.32 37.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.0 -89.48 0.03 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.263 -0.735 . . . . 1.0 111.263 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.56 -78.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.867 0.365 . . . . 1.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -167.12 160.51 13.96 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.297 -0.41 . . . . 1.0 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.16 144.49 87.35 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.744 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.78 -46.6 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.966 1.777 . . . . 1.0 111.054 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -139.32 160.72 60.85 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 123.069 0.23 . . . . 1.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.17 -10.62 29.49 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 122.089 1.859 . . . . 1.0 112.011 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -73.96 -29.56 62.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.876 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.15 -53.84 47.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.072 -0.251 . . . . 1.0 110.897 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.92 -42.67 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.711 0.291 . . . . 1.0 110.581 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.2 t -51.95 -53.19 44.23 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.102 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 53' ' ' PHE . 90.9 m -47.21 -36.14 8.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.771 -0.195 . . . . 1.0 111.294 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.9 t -72.8 -26.18 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 120.775 0.321 . . . . 1.0 111.439 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.24 33.28 3.09 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.365 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.2 t -98.35 -173.71 2.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' N ' ' OG ' ' A' ' 50' ' ' SER . 11.5 m-20 -56.38 -27.64 56.83 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.374 -1.284 . . . . 1.0 110.904 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -71.81 -53.56 12.94 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.669 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 47' ' ' CYS . 3.3 m-85 -68.55 -37.67 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.146 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 93.7 m -53.2 -45.9 68.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.639 0.256 . . . . 1.0 111.039 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.92 -40.96 71.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -67.99 -27.79 66.87 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -60.22 -39.41 86.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.358 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mm -48.89 -41.12 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.564 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -65.97 -40.94 91.72 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.303 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -65.43 -23.28 66.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.027 -0.36 . . . . 1.0 110.027 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' C ' ' CG ' ' A' ' 62' ' ' PHE . . . 93.49 20.3 32.56 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.784 -0.526 . . . . 1.0 111.784 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CG ' ' C ' ' A' ' 61' ' ' GLY . 1.4 p90 43.02 78.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 117.801 0.801 . . . . 1.0 111.024 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.7 -85.76 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -168.81 135.05 1.78 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 tt -133.25 131.39 40.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.47 127.33 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -108.48 132.35 56.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -146.65 153.99 40.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.22 -151.33 0.39 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.012 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.94 -114.94 0.01 OUTLIER Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 72' ' ' ASN . 35.6 ttt180 -165.58 -149.96 0.12 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.231 -0.57 . . . . 1.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.417 ' H ' ' HG2' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -59.51 -41.63 90.34 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.136 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.7 t -140.7 132.45 27.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.195 -0.457 . . . . 1.0 109.99 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 m -157.99 163.12 38.1 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.31 23.67 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.845 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -67.53 85.18 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 80' ' ' LEU . 70.8 mm-40 -61.91 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.657 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -73.89 33.6 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.741 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 78' ' ' GLU . 1.9 pp -62.46 -32.47 73.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 1.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.2 t -62.81 -51.55 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.859 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -72.85 -32.51 65.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.279 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -50.96 -43.98 60.5 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.22 -0.445 . . . . 1.0 109.819 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.437 ' NE ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -79.37 -16.23 56.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.051 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.84 28.87 5.76 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.97 158.17 53.47 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -134.63 128.93 34.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.841 0.353 . . . . 1.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -52.82 159.93 1.03 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.99 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.43 152.07 37.47 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.145 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.456 0.169 . . . . 1.0 111.321 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.4 mmt-85 -123.42 119.19 29.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -160.69 119.44 2.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.275 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.44 161.42 27.12 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.31 135.77 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -95.35 133.88 38.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.439 . . . . 1.0 109.964 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.4 mmm 50.01 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.924 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -148.94 48.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.383 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 27.45 29.14 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 111.955 -0.458 . . . . 1.0 111.955 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.4 -12.27 54.74 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.3 tp -168.0 137.34 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -102.98 140.39 37.31 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.62 142.19 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.078 -1.082 . . . . 1.0 108.078 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' ILE . 18.9 pt -142.53 131.14 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.99 -139.72 0.04 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CE2' ' O ' ' A' ' 120' ' ' ASP . 78.5 t80 -57.73 161.31 3.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.921 0.391 . . . . 1.0 110.498 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' CE2' ' A' ' 119' ' ' PHE . 54.3 p-10 -153.64 -177.06 6.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.076 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -65.16 153.97 39.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 79.5 p -59.3 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.917 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.7 m -61.65 106.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -168.01 -54.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.343 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 52.5 mtm -44.99 -45.88 10.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 1.0 111.572 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -59.25 -31.1 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.737 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -80.57 -52.28 7.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.798 0.332 . . . . 1.0 111.813 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.69 -43.72 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.876 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -54.06 -53.2 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.23 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -51.1 -30.04 14.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.521 0.201 . . . . 1.0 111.06 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.86 -42.47 58.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.688 -0.233 . . . . 1.0 110.9 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.58 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.1 p90 -123.1 -51.88 1.88 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.58 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 82.8 p 48.65 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.943 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -137.22 -52.39 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.2 tp -167.35 148.14 5.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.6 151.55 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 73.7 mt -117.71 115.63 49.17 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 108.177 -1.046 . . . . 1.0 108.177 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.9 p -85.21 -161.38 0.58 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -159.74 83.97 0.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 52.28 17.61 0.76 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.81 -147.88 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -164.01 -60.6 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 -26.68 73.9 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 123.792 0.683 . . . . 1.0 111.946 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.5 m -70.3 -36.62 74.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.681 0.277 . . . . 1.0 111.313 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.18 -40.61 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.847 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -50.09 -40.84 46.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.798 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -52.11 66.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.512 0.672 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.8 p -70.36 -22.62 62.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.239 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.23 -53.32 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.157 0.428 . . . . 1.0 112.157 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -67.29 -31.75 72.28 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.583 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 mp -70.04 -1.63 10.42 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 58.53 34.03 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.391 0.432 . . . . 1.0 110.6 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 97.8 mttt -113.2 126.32 28.38 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.44 157.15 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.416 1.41 . . . . 1.0 111.941 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.4 tt -152.44 144.39 23.73 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.272 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 156' ' ' ILE . 0.0 OUTLIER -111.31 116.55 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.71 117.32 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 57.2 m -74.07 104.35 4.86 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.427 -0.582 . . . . 1.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.01 138.51 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -160.24 -165.51 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.827 0.346 . . . . 1.0 110.174 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -65.34 -168.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.422 ' HG ' HE21 ' A' ' 169' ' ' GLN . 46.6 m -156.72 81.35 0.95 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.956 0.407 . . . . 1.0 109.927 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -35.36 12.66 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.797 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.1 mmt -82.51 36.15 0.47 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.193 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 167' ' ' HIS . 25.6 t70 54.89 31.23 15.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.663 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.02 74.89 0.08 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.068 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' ASP . 85.2 t60 -57.93 -30.38 65.89 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.995 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -49.72 -40.28 40.11 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.15 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.17 -46.56 86.58 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -45.41 -37.45 5.1 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.09 -42.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.148 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -48.99 -60.58 2.65 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.867 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.74 -25.19 62.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.049 0.452 . . . . 1.0 110.393 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -72.58 -53.69 11.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.472 -0.785 . . . . 1.0 110.446 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 179' ' ' GLY . 58.0 t80 -64.47 -34.91 79.31 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.29 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.6 t -54.86 -56.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.281 0.363 . . . . 1.0 110.189 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.03 -30.63 15.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.149 -0.62 . . . . 1.0 109.939 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.26 21.32 12.77 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.499 -0.773 . . . . 1.0 113.013 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 175' ' ' PHE . . . -151.37 -24.63 0.05 OUTLIER Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 180' ' ' TYR . 73.1 t80 54.42 23.52 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 109.879 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 182' ' ' TRP . 3.2 p -50.18 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.19 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . 0.56 ' C ' ' O ' ' A' ' 181' ' ' VAL . 7.0 m-90 -9.74 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 124.004 0.815 . . . . 1.0 109.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 88.9 p -86.74 134.83 33.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.829 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -125.02 156.9 37.42 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.24 -0.891 . . . . 1.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.38 154.04 76.73 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.643 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.41 58.34 0.48 Allowed 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.588 2.192 . . . . 1.0 112.358 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 m -135.72 147.16 48.36 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.62 -48.71 28.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.0 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 13.3 t -69.68 -44.18 71.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.027 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -51.75 -51.66 37.96 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.245 -0.434 . . . . 1.0 112.134 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.78 -43.63 90.49 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.45 0.147 . . . . 1.0 110.63 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.14 -44.73 80.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.612 0.244 . . . . 1.0 110.46 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -54.1 -56.68 15.81 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.873 0.324 . . . . 1.0 111.873 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -58.53 -30.27 64.97 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -48.07 63.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.983 0.42 . . . . 1.0 110.54 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -64.22 -40.64 96.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.71 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.74 88.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.2 m -71.27 -23.26 61.94 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.967 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -105.0 30.76 5.29 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.899 0.381 . . . . 1.0 110.753 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.1 p -141.7 -21.25 0.73 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.29 153.23 27.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.07 0.462 . . . . 1.0 109.771 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.75 153.92 32.6 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.178 -0.919 . . . . 1.0 109.219 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.86 136.97 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.8 153.02 8.9 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.711 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.2 106.57 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.391 1.394 . . . . 1.0 111.148 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -140.82 87.16 11.35 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.46 111.58 3.29 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.562 1.508 . . . . 1.0 111.763 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.24 98.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.057 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.465 0.288 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.561 -179.825 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mp -65.43 -44.54 94.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.5 mt 57.12 79.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.939 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -58.92 136.06 57.76 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.231 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -167.65 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -130.17 133.86 46.89 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.828 0.451 . . . . 1.0 110.659 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.21 166.99 10.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -133.85 109.02 8.79 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -103.1 130.47 50.26 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.93 137.18 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 t -142.63 137.91 30.33 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.849 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 63.4 m -92.65 -14.15 28.52 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.55 -93.63 0.05 OUTLIER Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -179.55 0.78 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -62.12 132.22 52.1 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.955 -0.387 . . . . 1.0 109.955 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -62.54 149.54 88.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.71 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.8 -62.6 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.719 1.613 . . . . 1.0 112.037 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -142.45 138.82 16.76 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 119.117 -0.468 . . . . 1.0 110.621 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.43 -31.17 46.81 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 121.781 1.654 . . . . 1.0 113.52 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.92 -36.95 67.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.969 0.414 . . . . 1.0 111.28 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.89 -41.97 97.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.858 0.361 . . . . 1.0 110.758 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.3 t -61.44 -38.29 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' SER . 14.8 m -51.6 -42.86 62.27 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.0 t -51.81 -41.4 61.71 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.558 0.218 . . . . 1.0 110.538 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.8 t -75.38 -12.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.453 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.25 40.23 2.09 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.65 0.262 . . . . 1.0 110.432 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' SER . 44.4 m -129.71 -164.6 1.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.731 0.777 . . . . 1.0 109.512 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -53.14 -46.15 68.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.995 -1.457 . . . . 1.0 110.42 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -57.97 -53.49 57.66 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 122.059 -0.4 . . . . 1.0 111.196 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 73.7 t80 -63.42 -44.69 93.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.697 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.427 ' SG ' ' NZ ' ' A' ' 113' ' ' LYS . 45.5 t -57.84 -51.48 69.41 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -55.95 -47.9 76.74 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 121.487 0.66 . . . . 1.0 110.266 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -64.81 -29.54 70.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.084 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tp -65.86 -54.16 30.37 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.54 0.525 . . . . 1.0 111.36 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -32.32 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.294 -0.867 . . . . 1.0 109.093 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -75.38 -13.08 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.881 -1.054 . . . . 1.0 109.173 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 199' ' ' GLN . 0.1 OUTLIER -101.4 -1.14 34.04 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.707 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 82.71 41.68 8.76 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.911 -1.137 . . . . 1.0 111.259 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 10.2 p90 -27.02 159.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 123.548 0.739 . . . . 1.0 112.241 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -149.19 -73.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 121.382 -0.824 . . . . 1.0 108.956 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -149.02 106.14 3.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 130.24 35.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.012 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.1 133.7 62.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.4 tt -142.71 140.93 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.44 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -170.26 137.13 1.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.726 178.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -168.56 -172.06 1.58 Allowed 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.426 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.07 168.85 3.61 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.502 -1.039 . . . . 1.0 110.502 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.597 ' NH2' HD22 ' A' ' 72' ' ' ASN . 71.1 ttp85 -168.71 -74.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.597 HD22 ' NH2' ' A' ' 71' ' ' ARG . 89.8 m-20 -63.73 -46.44 85.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 1.0 110.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.73 -17.13 61.15 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 m 59.07 18.59 6.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.713 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 m 50.46 -163.85 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.192 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' PHE . 67.9 mt-10 -145.2 -44.74 0.22 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.545 ' CZ ' ' CE1' ' A' ' 98' ' ' PHE . 33.4 m-85 54.36 108.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -70.44 44.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.8 0.334 . . . . 1.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.429 ' H ' ' C ' ' A' ' 77' ' ' PHE . 93.9 m-70 44.97 48.65 9.4 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.228 0.537 . . . . 1.0 111.146 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.37 -38.61 90.23 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.65 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.21 -50.35 80.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.617 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -71.78 -37.53 70.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -57.21 -48.07 79.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -77.65 -13.34 59.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.383 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.37 54.07 3.44 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 110.966 -0.853 . . . . 1.0 110.966 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.43 -178.76 51.44 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 109.831 -1.308 . . . . 1.0 109.831 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -129.85 121.04 25.94 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -80.49 111.46 16.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.342 -0.244 . . . . 1.0 110.342 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' NE2' ' A' ' 91' ' ' GLN . 94.4 mt-10 -72.38 -108.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.2 t -32.04 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.661 0.6 . . . . 1.0 111.653 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 25.8 mp0 -58.93 94.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.645 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -168.53 98.65 0.41 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.26 83.19 22.27 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.97 -76.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.16 1.907 . . . . 1.0 112.943 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.9 pt -87.71 8.78 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.273 0.629 . . . . 1.0 111.243 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 98' ' ' PHE . 1.1 m-20 58.25 -119.93 1.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 119.195 -0.431 . . . . 1.0 110.421 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 36.91 -93.04 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.626 0.37 . . . . 1.0 111.54 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CE1' ' CZ ' ' A' ' 77' ' ' PHE . 84.5 t80 -128.26 -8.14 5.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.208 0.603 . . . . 1.0 109.938 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.18 65.12 3.6 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.307 -0.717 . . . . 1.0 111.307 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 102' ' ' ASP . 76.8 m -62.09 -44.82 95.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.962 0.411 . . . . 1.0 110.459 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.86 36.97 2.1 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.564 -1.015 . . . . 1.0 110.564 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.442 ' OD1' ' NH1' ' A' ' 105' ' ' ARG . 16.0 t70 -145.9 131.19 18.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.173 -0.306 . . . . 1.0 110.173 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.9 p -99.26 6.16 46.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.971 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -108.4 62.07 0.61 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.196 0.522 . . . . 1.0 110.485 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.442 ' NH1' ' OD1' ' A' ' 102' ' ' ASP . 9.8 mmp_? -111.56 114.73 27.99 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.09 122.75 9.21 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.426 ' OH ' ' NE ' ' A' ' 105' ' ' ARG . 5.3 m-85 -133.63 151.78 51.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.18 147.66 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -108.0 143.95 35.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.449 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 39.9 tpp 56.76 -79.55 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 O-C-N 124.136 0.898 . . . . 1.0 110.287 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 109' ' ' LEU . 54.3 t30 -168.09 78.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.39 8.51 80.31 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.427 ' NZ ' ' SG ' ' A' ' 54' ' ' CYS . 64.1 tttm -64.59 -75.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.25 128.9 50.13 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.204 -1.036 . . . . 1.0 108.204 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -108.02 103.77 13.06 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 119.442 -0.313 . . . . 1.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.56 116.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.8 mt -137.1 144.16 32.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.815 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.93 120.55 2.05 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -155.17 52.83 0.62 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.228 0.537 . . . . 1.0 110.749 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 18.1 p-10 -169.29 129.72 1.08 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE2' ' OE1' ' A' ' 68' ' ' GLN . 58.4 m-85 -128.03 90.99 3.18 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.2 p 42.12 31.25 0.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.712 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.6 t -149.61 27.87 0.8 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.325 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 127' ' ' SER . 16.1 mttt -170.35 -5.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 71.0 mtp -43.08 -54.88 4.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.855 0.36 . . . . 1.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -59.43 -29.13 67.54 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.74 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.428 ' OG ' ' NH2' ' A' ' 130' ' ' ARG . 1.9 t -65.59 -38.96 90.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 16.0 mm -72.6 -46.04 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.126 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' SER . 64.4 mt -60.1 -57.86 9.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.456 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.428 ' NH2' ' OG ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -48.78 -41.07 31.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 111.392 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.22 -48.25 79.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.155 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -100.64 -66.67 0.89 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.119 0.485 . . . . 1.0 110.281 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' ILE . 53.6 p 55.51 84.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.515 ' H ' ' HZ3' ' A' ' 153' ' ' LYS . 60.2 m-20 -149.23 -47.8 0.14 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.311 -0.404 . . . . 1.0 109.928 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.16 139.3 7.04 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.22 145.52 28.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.37 96.5 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.2 p -104.89 122.15 45.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.494 ' CD2' ' H ' ' A' ' 140' ' ' ALA . 1.3 p80 -64.0 -36.05 82.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.265 . . . . 1.0 111.139 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.494 ' H ' ' CD2' ' A' ' 139' ' ' HIS . . . -173.14 10.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.591 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.97 108.77 1.04 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.0 -43.98 94.84 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 1.0 110.331 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.67 -50.81 34.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.4 m -52.09 -50.46 61.55 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.539 -0.33 . . . . 1.0 111.791 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -29.07 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.182 -0.303 . . . . 1.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -53.91 48.48 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.905 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.17 -51.13 65.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 1.0 110.132 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.8 t -52.83 -28.24 21.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.444 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -51.86 22.52 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.879 0.371 . . . . 1.0 110.982 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.6 ttp-105 -64.77 -26.1 68.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.764 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.7 mt -90.8 17.08 8.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.972 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.5 p30 42.34 26.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.501 0.501 . . . . 1.0 111.472 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.515 ' HZ3' ' H ' ' A' ' 134' ' ' ASP . 30.9 mtpt -79.38 121.08 82.44 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.306 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.62 113.93 3.15 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.367 1.378 . . . . 1.0 110.712 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.29 171.87 7.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.591 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 156' ' ' ILE . 3.2 mp -118.4 120.01 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.78 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 76.2 t -90.89 117.11 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 O-C-N 122.518 -0.114 . . . . 1.0 110.713 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 13.3 m -85.17 100.57 11.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.08 140.22 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -100.9 84.67 2.73 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 30.7 p-10 -64.03 -32.18 73.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.018 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 t -60.84 -46.08 91.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.025 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.411 ' CD2' HD22 ' A' ' 166' ' ' ASN . 10.8 mp -90.21 -178.91 5.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 28.0 ttt -165.31 -27.76 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.461 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -66.2 -22.14 66.33 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.411 HD22 ' CD2' ' A' ' 163' ' ' LEU . 84.1 m-20 -61.59 113.61 2.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.117 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.01 -32.56 74.15 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.836 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.04 -47.07 75.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.32 -42.01 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.342 0.592 . . . . 1.0 109.922 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -50.59 -45.56 57.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.539 -0.912 . . . . 1.0 108.539 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.68 -26.4 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.877 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -68.06 -58.88 3.78 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 120.01 -0.676 . . . . 1.0 109.409 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -43.52 -24.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.72 0.295 . . . . 1.0 111.774 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.41 -40.26 81.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.145 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -55.74 -45.49 77.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.52 -46.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.98 0.419 . . . . 1.0 109.896 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -46.07 -43.01 14.27 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.439 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.6 mt -70.55 -32.25 69.61 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.832 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.15 -107.43 0.24 Allowed Glycine 0 N--CA 1.468 0.781 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.527 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 180' ' ' TYR . 66.5 t80 -169.95 42.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 180' ' ' TYR . 14.8 p -31.91 137.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 123.663 0.602 . . . . 1.0 109.479 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -54.43 101.7 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.319 0.963 . . . . 1.0 110.661 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 77.2 p -114.76 133.2 56.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.798 -1.092 . . . . 1.0 109.088 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.33 138.7 6.56 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 157.09 70.52 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 122.304 -0.248 . . . . 1.0 110.515 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -56.89 82.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 122.307 2.005 . . . . 1.0 112.991 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 m -134.86 148.9 50.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.95 -25.88 63.86 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.124 -0.36 . . . . 1.0 111.016 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.57 ' HG1' ' N ' ' A' ' 190' ' ' GLY . 19.3 p -89.91 -35.61 15.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.541 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.57 ' N ' ' HG1' ' A' ' 189' ' ' THR . . . -88.74 -41.81 5.9 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.94 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.93 -36.24 82.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.808 0.304 . . . . 1.0 111.483 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 pt -66.0 -33.91 66.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.348 . . . . 1.0 111.023 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.56 91.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.639 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -71.66 -38.19 61.4 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.428 -0.669 . . . . 1.0 111.428 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.408 ' O ' ' OH ' ' A' ' 60' ' ' TYR . 7.7 mt -63.28 -54.85 30.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.848 0.356 . . . . 1.0 111.255 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -61.68 -36.39 80.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.1 -39.21 82.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 14.9 m -65.59 -17.96 64.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.854 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 93.9 mt-30 -104.14 29.97 5.57 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.047 -0.408 . . . . 1.0 110.624 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 22.6 p -141.37 -33.02 0.52 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -141.58 154.1 45.23 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -118.07 157.51 26.72 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.584 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 8.4 tp -84.32 136.29 33.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -52.76 135.24 46.03 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.289 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -45.39 101.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.511 1.474 . . . . 1.0 113.015 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -142.12 82.78 13.02 Favored Pre-proline 0 N--CA 1.471 0.625 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.54 93.04 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.963 1.775 . . . . 1.0 111.464 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.73 150.37 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.654 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 211' ' ' ASN . 24.7 m 55.88 109.75 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.715 0.634 . . . . 1.0 110.665 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -67.53 66.93 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.802 0.334 . . . . 1.0 110.551 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.445 ' ND2' ' OE1' ' A' ' 215' ' ' GLU . 0.6 OUTLIER -169.81 142.9 2.05 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 110.241 -0.281 . . . . 1.0 110.241 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 214' ' ' PHE . 71.7 Cg_endo -73.64 177.43 8.03 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.779 1.653 . . . . 1.0 111.297 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.0 m -49.44 -11.54 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.721 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 212' ' ' PRO . 63.5 t80 -54.61 -43.2 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.445 ' OE1' ' ND2' ' A' ' 211' ' ' ASN . 70.8 tt0 -46.98 -39.24 12.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.458 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -60.33 -39.94 88.87 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.8 tp -44.81 -34.11 2.19 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.609 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.92 -33.99 77.11 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.055 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.44 -52.23 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -64.98 -40.97 95.77 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.086 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 25.0 m -68.66 -25.44 64.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.291 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 77.0 mt 56.63 -88.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.051 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -84.5 122.88 29.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.964 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 91.0 p . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.191 -0.909 . . . . 1.0 110.399 179.536 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.256 -1.538 . . . . 1.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.3 -50.08 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.162 0.506 . . . . 1.0 109.828 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.1 mt 56.31 74.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.427 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -72.48 179.38 3.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.534 -0.543 . . . . 1.0 109.534 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -103.4 6.5 37.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -71.25 106.55 3.87 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.13 121.01 43.66 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.384 0.427 . . . . 1.0 110.197 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 mt -87.61 110.97 20.78 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.07 128.62 43.14 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -123.3 122.52 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 t -146.48 137.65 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 139' ' ' HIS . 77.2 m -105.36 -24.97 12.57 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.3 20.57 67.55 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.42 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 p -139.7 155.9 47.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.475 0.31 . . . . 1.0 110.218 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' PRO . 16.8 m -94.16 148.64 35.49 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 118.727 -0.654 . . . . 1.0 110.817 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' VAL . 87.2 Cg_exo -46.22 -178.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 121.629 1.553 . . . . 1.0 112.395 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -56.57 144.42 64.27 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-O 119.234 -0.412 . . . . 1.0 110.632 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.55 -30.6 6.2 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.793 1.662 . . . . 1.0 113.497 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -73.26 -39.55 65.32 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.81 0.3 . . . . 1.0 111.81 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.74 -40.86 69.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.97 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.6 -41.61 93.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 50' ' ' SER . 30.0 m -52.15 -45.89 65.2 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.139 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.98 -33.13 10.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 1.0 110.556 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.78 -22.09 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.996 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.98 33.44 4.39 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 120.809 0.337 . . . . 1.0 110.254 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 46' ' ' SER . 22.4 p -110.59 -167.71 1.22 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -60.74 -28.83 68.98 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.66 -50.68 71.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.493 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -35.91 73.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 71.1 m -51.63 -51.0 59.2 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.775 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -73.07 -43.76 61.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.684 0.278 . . . . 1.0 111.654 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -65.91 -28.95 69.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.971 0.415 . . . . 1.0 110.535 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.2 mt -61.35 -52.42 64.73 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.42 -36.67 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 120.305 -0.558 . . . . 1.0 109.874 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -72.52 -33.78 67.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.695 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 70.1 t80 -77.87 0.57 23.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.997 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 42.08 22.23 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.751 -1.214 . . . . 1.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -49.3 -176.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.534 0.667 . . . . 1.0 111.825 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.5 p -172.48 -42.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -168.38 105.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.1 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.04 135.83 33.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.31 136.41 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -138.99 141.82 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -143.64 149.37 37.2 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 77' ' ' PHE . 47.5 p90 -163.14 126.29 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.02 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.78 -171.17 44.71 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 109.774 -1.33 . . . . 1.0 109.774 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.561 ' N ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 55.54 118.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.377 0.608 . . . . 1.0 110.914 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -61.85 -20.49 63.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.111 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.546 ' C ' ' H ' ' A' ' 75' ' ' SER . 48.3 t80 -56.5 -14.97 3.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.384 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 m -60.59 3.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.391 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 73' ' ' TYR . 3.5 m 63.54 139.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.861 0.363 . . . . 1.0 110.264 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.44 137.17 57.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 69' ' ' PHE . 3.7 m-85 -64.41 -93.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 49.69 45.97 24.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.023 0.439 . . . . 1.0 110.859 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.402 ' ND1' ' O ' ' A' ' 77' ' ' PHE . 35.1 m80 -157.26 -53.87 0.08 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.648 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.47 -48.87 75.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.098 0.475 . . . . 1.0 111.043 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.39 -44.12 77.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.196 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.93 -31.56 72.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.27 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -70.91 -44.31 66.49 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.027 0.442 . . . . 1.0 110.437 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLY . 1.1 mmp_? -99.1 30.03 3.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' ARG . . . 21.15 73.71 0.01 OUTLIER Glycine 0 N--CA 1.486 1.98 0 N-CA-C 111.531 -0.627 . . . . 1.0 111.531 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.74 -179.1 52.01 Favored Glycine 0 C--N 1.322 -0.222 0 N-CA-C 109.846 -1.302 . . . . 1.0 109.846 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -138.34 135.96 35.9 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.493 ' CZ ' HE21 ' A' ' 106' ' ' GLN . 53.0 ttt85 -54.43 149.6 10.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.442 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -107.0 -155.36 0.55 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.497 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 85.4 p 51.52 12.66 0.17 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.849 0.356 . . . . 1.0 111.252 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 89' ' ' GLU . 22.4 mp0 55.23 11.57 0.57 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.82 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 90' ' ' SER . 97.3 mttt -71.69 166.83 21.12 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.102 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.09 121.68 42.94 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.006 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.61 109.59 1.66 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 CA-C-N 120.658 1.271 . . . . 1.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' GLN . 32.3 pt -85.72 -7.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.232 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.8 t0 64.18 -69.61 0.08 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.08 0.862 . . . . 1.0 110.191 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ILE . 86.3 mt-30 -58.37 152.09 18.43 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.303 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -67.77 1.27 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.836 0.35 . . . . 1.0 110.369 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 97' ' ' GLN . . . 83.17 6.82 87.68 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.3 -0.72 . . . . 1.0 111.3 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 27.0 p 37.06 60.73 0.97 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.164 0.507 . . . . 1.0 112.229 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.462 ' CA ' HH21 ' A' ' 105' ' ' ARG . . . -178.62 -156.89 18.09 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 18.5 p-10 -159.22 75.77 0.68 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.703 0.287 . . . . 1.0 110.293 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.0 p -136.58 -27.35 1.05 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.688 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.486 ' H ' ' NH1' ' A' ' 105' ' ' ARG . . . -174.59 103.4 0.1 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.25 0.344 . . . . 1.0 110.208 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' H ' ' A' ' 104' ' ' ALA . 1.5 mpt_? -135.37 145.75 47.66 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.159 0.504 . . . . 1.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.493 HE21 ' CZ ' ' A' ' 88' ' ' ARG . 1.8 pm0 -156.83 129.05 7.38 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.8 -0.636 . . . . 1.0 109.694 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -147.21 169.11 20.04 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.69 148.27 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.2 mt -114.39 -178.83 3.46 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.585 0.553 . . . . 1.0 109.562 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 tpt 53.21 -134.67 1.63 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.664 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.86 35.9 0.9 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.013 0.435 . . . . 1.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.59 71.54 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.518 -0.633 . . . . 1.0 111.518 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -96.21 -15.92 21.75 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.392 0.277 . . . . 1.0 111.635 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.91 133.57 41.39 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -116.88 93.73 4.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.8 p -106.89 116.59 50.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 CA-C-O 122.219 1.009 . . . . 1.0 109.053 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.2 pt -117.81 146.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 114.076 -1.42 . . . . 1.0 108.658 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -122.94 131.83 8.39 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 109.63 -1.388 . . . . 1.0 109.63 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 120' ' ' ASP . 45.0 t80 59.01 152.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 1.0 110.768 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 38.8 t70 -168.24 163.66 13.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.353 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.446 ' O ' ' CD2' ' A' ' 121' ' ' PHE . 40.4 p90 -70.77 119.27 14.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 124' ' ' LYS . 18.1 m 56.88 135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.421 0.629 . . . . 1.0 111.558 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 t -74.87 38.43 0.12 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.263 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 122' ' ' SER . 36.9 ttpt -64.45 -29.56 70.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.477 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.49 ' SD ' ' NE2' ' A' ' 126' ' ' GLN . 3.6 ppp? -45.18 -32.0 1.69 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.49 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 88.5 mm-40 -58.23 -28.72 65.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.676 -0.693 . . . . 1.0 111.044 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.1 t -80.54 -33.17 36.49 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.742 0.306 . . . . 1.0 110.803 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' A' ' 128' ' ' ILE . 1.6 mp -63.63 -39.93 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.723 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.9 pt -49.11 -41.54 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -46.08 -32.66 3.0 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.514 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.45 -27.64 62.64 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.4 -62.27 1.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.333 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.2 p 51.36 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.527 ' N ' ' HZ1' ' A' ' 153' ' ' LYS . 56.5 m-20 -145.14 -43.92 0.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.41 120.52 4.86 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.52 137.33 56.41 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.3 mt -122.92 124.37 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.7 p -134.3 133.61 40.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.427 ' CD2' ' SG ' ' A' ' 35' ' ' CYS . 37.8 m-70 -69.89 -38.22 76.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.631 0.253 . . . . 1.0 110.788 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.47 19.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.326 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.67 100.6 0.44 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.69 ' H ' HH21 ' A' ' 216' ' ' ARG . 19.6 m -56.72 -41.46 77.48 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.478 -0.425 . . . . 1.0 110.48 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.74 -48.77 26.68 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.3 m -56.52 -42.77 78.99 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.842 -0.211 . . . . 1.0 111.309 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 92.6 mt -66.35 -26.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 1.0 110.852 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -46.9 82.84 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.663 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -70.42 -53.55 16.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.097 0.475 . . . . 1.0 109.826 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.9 m -53.19 -25.21 13.04 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 49.8 tp -74.86 -45.77 40.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.859 0.362 . . . . 1.0 111.438 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -76.56 -18.99 58.37 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.279 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.9 mt -85.03 4.03 35.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.9 p30 41.56 47.89 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.389 0.43 . . . . 1.0 111.688 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.527 ' HZ1' ' N ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -105.68 147.1 34.11 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 119.205 -0.426 . . . . 1.0 111.569 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.63 85.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.46 1.44 . . . . 1.0 111.542 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 153' ' ' LYS . 66.9 tp -89.94 137.49 32.29 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.816 -0.553 . . . . 1.0 111.324 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.3 134.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.084 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.63 128.69 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 120.788 0.328 . . . . 1.0 110.652 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 12.3 m -83.6 102.47 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.88 146.84 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.746 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.9 t30 86.44 103.78 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.887 0.742 . . . . 1.0 110.065 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -167.59 66.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.203 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -64.65 86.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.215 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 165' ' ' ASP . 34.8 tp -168.41 77.03 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 ttt 67.19 -36.74 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.707 0.629 . . . . 1.0 110.984 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 163' ' ' LEU . 66.7 m-20 -77.17 -3.02 37.4 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.077 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -52.86 -37.92 60.87 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.766 0.317 . . . . 1.0 110.369 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.12 -38.17 87.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.135 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -68.11 -38.97 82.87 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.367 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.53 -31.31 64.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.133 0.492 . . . . 1.0 110.692 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.37 -49.09 67.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.51 -27.41 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.79 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.77 -61.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.097 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -51.94 -31.98 31.14 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -60.79 -52.71 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.015 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.26 -42.66 81.97 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.22 -52.84 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -51.96 -44.32 63.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.701 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.33 17.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.134 -0.321 . . . . 1.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 39.29 89.8 0.01 OUTLIER Glycine 0 C--N 1.352 1.423 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -155.48 -22.39 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.51 152.64 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.83 0.348 . . . . 1.0 110.495 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -71.39 130.63 41.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.6 p -98.11 138.67 35.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.586 -0.734 . . . . 1.0 109.541 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 185' ' ' ALA . 35.7 t -157.77 177.32 11.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 184' ' ' CYS . . . -136.93 155.99 76.07 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 110.164 -0.31 . . . . 1.0 110.164 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -69.58 65.62 1.68 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.089 1.86 . . . . 1.0 112.404 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 m -134.06 145.5 49.46 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.014 0.435 . . . . 1.0 109.898 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -55.13 -29.34 57.49 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -84.03 -41.03 17.66 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.089 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.14 93.86 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.978 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.35 -39.54 90.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 119.711 -0.185 . . . . 1.0 111.314 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.73 -45.84 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.61 82.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.53 -36.61 91.74 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.08 -54.63 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.94 0.4 . . . . 1.0 110.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -59.66 -21.29 60.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.432 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.85 3.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.774 0.321 . . . . 1.0 110.46 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.6 p -67.46 -22.53 65.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.769 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.53 -43.72 69.01 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.075 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 21.7 m -79.1 -43.66 23.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.842 0.353 . . . . 1.0 110.698 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.53 125.25 40.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.266 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -120.82 108.59 14.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.24 135.8 57.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -52.67 146.88 16.43 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.778 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.45 103.77 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.357 1.371 . . . . 1.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -141.1 96.5 7.21 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.74 114.03 3.86 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 121.13 1.22 . . . . 1.0 111.345 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.75 -43.41 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.531 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 37.4 m -162.51 166.1 25.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.242 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -100.4 104.38 15.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -167.4 60.56 0.53 Allowed Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' A' ' 214' ' ' PHE . 74.2 Cg_endo -67.18 -158.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.505 2.152 0 C-N-CA 122.256 1.971 . . . . 1.0 112.141 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 45.6 t -48.52 -12.58 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.845 0.355 . . . . 1.0 111.604 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 212' ' ' PRO . 70.4 t80 -59.42 -45.29 91.96 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -54.39 -43.16 71.2 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.895 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.69 HH21 ' H ' ' A' ' 142' ' ' THR . 1.5 mpt_? -60.24 -38.15 82.57 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.565 -0.531 . . . . 1.0 109.565 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 tp -53.11 -34.73 57.98 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.139 0.495 . . . . 1.0 110.206 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.03 -40.49 97.9 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.552 -0.749 . . . . 1.0 109.94 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.8 -49.66 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.798 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -59.69 -31.43 69.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.637 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 25.2 m -61.66 -23.04 65.82 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.587 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 41.3 pt -121.55 154.82 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.388 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 60.3 t80 53.43 100.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.373 -179.601 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.466 -1.454 . . . . 1.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.1 pt -66.54 -170.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.919 0.39 . . . . 1.0 110.067 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.6 mp -85.97 97.06 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -153.39 72.12 0.92 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -144.79 -36.34 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -71.16 92.74 1.01 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.95 111.94 24.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.73 117.98 21.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE2' ' NE2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -102.69 124.3 47.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.18 128.4 71.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.2 p -129.1 129.82 45.7 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' SG ' ' CE1' ' A' ' 69' ' ' PHE . 97.2 m -88.69 164.26 15.39 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.89 37.67 0.75 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.69 -0.564 . . . . 1.0 111.69 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 35' ' ' CYS . . . 67.64 -61.51 0.36 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.386 0.274 . . . . 1.0 110.602 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -64.96 147.41 53.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 1.0 109.978 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.6 81.36 24.09 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.88 -59.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.953 1.768 . . . . 1.0 111.505 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 92.14 18.29 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -74.05 8.32 2.12 Favored 'Trans proline' 0 N--CA 1.508 2.339 0 CA-C-N 120.831 1.333 . . . . 1.0 112.442 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.0 110.555 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.02 -35.02 74.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.546 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.37 -40.5 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 78.3 p -50.52 -45.33 56.59 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.839 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -51.57 -39.99 58.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.05 0.452 . . . . 1.0 110.301 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 41.8 t -79.67 -16.21 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.057 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 tp -130.96 39.74 3.55 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.826 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.639 ' HG ' ' H ' ' A' ' 51' ' ' ASP . 42.5 t -132.61 -157.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.639 ' H ' ' HG ' ' A' ' 50' ' ' SER . 22.6 p-10 -60.28 -44.27 95.48 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.98 -51.58 65.75 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.592 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 5.9 t80 -67.8 -36.79 81.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.972 0.415 . . . . 1.0 109.905 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 t -57.64 -47.96 80.79 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.429 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -63.07 -46.47 87.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.66 -28.39 69.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.406 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.25 -51.24 70.4 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.945 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.35 -44.9 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.06 -37.6 77.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.33 -21.58 64.74 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.661 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 104.3 35.94 3.24 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 118.016 -1.435 . . . . 1.0 111.355 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' O ' ' A' ' 61' ' ' GLY . 49.8 p90 13.61 130.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 124.86 1.264 . . . . 1.0 112.719 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -145.3 -81.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 122.007 -0.433 . . . . 1.0 110.448 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -169.33 111.24 0.48 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.221 -0.445 . . . . 1.0 109.83 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -92.35 121.59 33.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 66' ' ' ILE . 2.3 mp -102.88 133.02 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.434 -1.321 . . . . 1.0 107.434 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.7 mm -114.6 132.76 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.509 ' NE2' ' CE2' ' A' ' 32' ' ' PHE . 15.6 mp0 -131.78 163.09 29.0 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.582 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CE1' ' SG ' ' A' ' 35' ' ' CYS . 17.7 m-85 -157.22 -179.64 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.183 0.516 . . . . 1.0 109.735 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 72' ' ' ASN . . . -59.1 -29.89 66.16 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.292 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 68.01 -38.32 0.36 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.98 0.459 . . . . 1.0 111.256 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 70' ' ' GLY . 19.0 m120 -62.16 -43.93 97.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.781 0.324 . . . . 1.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.26 -45.76 86.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 p 56.31 166.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.841 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.2 t 52.36 68.88 0.75 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.821 0.343 . . . . 1.0 111.138 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.571 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 17.8 pt-20 -170.95 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.602 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.519 ' H ' HE22 ' A' ' 97' ' ' GLN . 74.9 t80 -166.77 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.613 -0.267 . . . . 1.0 110.609 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.26 -44.62 95.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.832 0.349 . . . . 1.0 110.073 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.08 -28.78 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.733 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.74 -48.36 77.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.155 0.503 . . . . 1.0 110.161 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.28 -45.44 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -64.37 -36.4 84.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -52.23 -46.65 65.79 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.581 0.229 . . . . 1.0 110.441 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.19 -17.43 64.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.092 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.02 52.64 35.61 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.12 -1.192 . . . . 1.0 110.12 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.38 -167.76 25.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -128.33 126.95 41.78 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -55.38 145.42 22.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.616 0.246 . . . . 1.0 110.624 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -145.6 179.18 7.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m 65.82 -152.41 0.25 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.211 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -148.55 169.71 19.69 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 58.58 157.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.665 0.603 . . . . 1.0 110.362 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 94' ' ' PRO . 17.9 tt -158.42 87.97 2.32 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.749 -0.463 . . . . 1.0 109.749 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 93' ' ' ILE . 98.8 Cg_exo -50.02 -127.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.511 2.549 0 C-N-CA 122.591 2.194 . . . . 1.0 112.924 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.5 tt -65.2 4.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 121.56 -0.713 . . . . 1.0 110.733 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 94' ' ' PRO . 2.5 m-20 70.18 -134.71 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 -177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.571 ' NE2' ' H ' ' A' ' 76' ' ' GLU . 47.9 tp60 42.42 -93.95 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.495 0.589 . . . . 1.0 112.175 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -98.9 -21.8 16.11 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 96' ' ' ASP . . . 81.56 1.44 90.14 Favored Glycine 0 N--CA 1.467 0.723 0 CA-C-N 115.826 -0.624 . . . . 1.0 111.684 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 58.3 m 52.67 -163.93 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.765 0.283 . . . . 1.0 111.13 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.76 176.4 52.77 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.483 -1.047 . . . . 1.0 110.483 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.0 t0 54.62 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.594 0.235 . . . . 1.0 111.045 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.7 m 50.74 88.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.564 ' CB ' ' H ' ' A' ' 119' ' ' PHE . . . -86.75 -109.13 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.411 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -141.41 169.2 18.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -158.79 132.48 7.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.333 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -136.39 151.06 49.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.764 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.7 t -100.83 96.07 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.527 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mp -87.57 159.77 18.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 tpt 57.03 -88.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.402 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -172.47 62.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.763 0.316 . . . . 1.0 110.686 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.55 27.09 63.96 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.627 -0.589 . . . . 1.0 111.627 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -114.19 -50.36 2.81 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.597 0.359 . . . . 1.0 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mt -95.36 111.86 23.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.855 0.359 . . . . 1.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -105.83 101.24 10.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 p -105.53 111.64 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.709 0.766 . . . . 1.0 109.641 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 pt -125.86 122.77 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.388 -1.278 . . . . 1.0 109.167 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.59 -82.01 0.04 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.548 -0.834 . . . . 1.0 111.453 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.564 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 3.6 m-85 47.72 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.941 0.4 . . . . 1.0 110.005 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -163.19 154.24 16.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 122' ' ' SER . 63.8 t80 -160.11 172.95 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.654 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 44.3 t -52.99 -17.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.26 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.8 m -164.19 103.56 0.86 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.606 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -171.03 -26.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.772 0.32 . . . . 1.0 110.555 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.1 -49.96 75.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.861 0.362 . . . . 1.0 110.71 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -61.82 -25.55 67.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.358 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p -76.41 -44.69 34.97 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.971 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.06 -44.48 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.627 -0.261 . . . . 1.0 110.617 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 133' ' ' SER . 79.4 mt -59.04 -51.94 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -39.14 10.25 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.053 0.454 . . . . 1.0 110.905 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -63.54 -32.17 73.55 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.141 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -112.57 -67.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.784 0.434 . . . . 1.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' ILE . 26.0 t 54.32 89.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.757 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -134.38 -50.1 0.79 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.335 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 29.9 tp -165.7 146.32 6.83 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.38 140.03 44.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.7 pt -123.02 127.89 74.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.6 m -88.85 -161.88 0.8 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -169.99 -36.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.6 48.21 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.809 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.88 112.5 0.53 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.632 ' N ' HE22 ' A' ' 168' ' ' GLN . 35.2 m -74.2 -25.19 59.55 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.698 0.285 . . . . 1.0 110.685 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.94 86.04 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.0 m -72.91 -35.77 67.13 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.841 -0.211 . . . . 1.0 110.756 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 53.6 mt -61.37 -30.37 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.771 0.32 . . . . 1.0 110.989 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 tp -52.35 -52.74 51.72 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.137 0.421 . . . . 1.0 112.137 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -65.69 -46.95 77.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.285 0.564 . . . . 1.0 111.074 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.426 ' H ' ' HG ' ' A' ' 148' ' ' SER . 1.3 m -53.01 -26.92 17.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.121 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.4 mt -79.7 -49.26 12.35 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.356 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -62.51 -37.95 88.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.682 -0.236 . . . . 1.0 110.923 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.28 4.77 4.18 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 58.8 t30 53.72 23.28 3.6 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.71 -0.223 . . . . 1.0 111.123 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.66 122.84 46.24 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -45.9 171.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.659 1.572 . . . . 1.0 112.6 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.475 ' O ' ' CE3' ' A' ' 182' ' ' TRP . 4.0 tt -156.92 151.75 25.86 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.514 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.1 mm -123.35 128.23 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.9 137.16 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.36 115.38 27.35 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.37 97.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.654 0.264 . . . . 1.0 111.667 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.477 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 20.2 p-10 -148.46 -58.47 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.255 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 163' ' ' LEU . 73.2 m-20 -102.3 14.01 33.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.083 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 27.9 t -69.79 36.9 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.889 0.376 . . . . 1.0 110.837 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 161' ' ' ASP . 52.7 mt -63.42 -39.59 94.9 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.515 ' C ' ' H ' ' A' ' 166' ' ' ASN . 23.8 ptt? -52.28 141.45 19.2 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.229 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 167' ' ' HIS . 4.8 m-20 69.24 -37.07 0.36 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.202 0.314 . . . . 1.0 110.749 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 164' ' ' MET . 20.2 t-20 58.97 -0.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.612 0.365 . . . . 1.0 111.336 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' A' ' 165' ' ' ASP . 24.6 m170 -73.48 -43.42 60.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.866 0.365 . . . . 1.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.632 HE22 ' N ' ' A' ' 142' ' ' THR . 22.6 mm100 -64.92 -49.47 70.31 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.937 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -59.58 -29.68 68.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.92 0.39 . . . . 1.0 110.013 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.49 -54.67 8.59 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.009 -0.542 . . . . 1.0 110.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.39 -41.39 73.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.45 -64.15 0.96 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 120.466 -0.494 . . . . 1.0 110.196 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.4 -27.76 2.81 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.337 0.589 . . . . 1.0 111.089 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -82.96 -40.48 20.02 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.055 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.04 -45.45 93.52 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.696 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.14 -52.71 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -52.34 -38.88 59.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.348 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.13 6.31 49.13 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.63 89.77 0.07 OUTLIER Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.291 -1.124 . . . . 1.0 110.291 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -40.65 79.35 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.135 0.974 . . . . 1.0 111.156 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 179' ' ' GLY . 3.2 p -73.8 65.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.531 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . 0.485 ' C ' ' O ' ' A' ' 181' ' ' VAL . 6.0 m-90 30.4 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 99.9 p -108.6 131.45 54.85 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 30.5 p -162.58 130.17 3.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.861 -1.063 . . . . 1.0 108.387 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.92 157.09 74.34 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 118.92 -0.562 . . . . 1.0 110.851 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.76 69.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.516 2.833 0 C-N-CA 123.253 2.635 . . . . 1.0 114.393 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 185' ' ' ALA . 43.7 m -132.2 146.67 52.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 24.7 mp0 -49.34 -51.69 32.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.494 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.7 p -67.15 -43.04 83.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.66 -0.245 . . . . 1.0 110.578 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -52.6 -53.36 32.85 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 121.427 -0.416 . . . . 1.0 112.145 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.83 -40.98 99.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.926 0.363 . . . . 1.0 110.71 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.45 -44.54 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -58.85 -49.35 78.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 1.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.5 98.81 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 42.6 mt -63.82 -43.47 96.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.713 0.292 . . . . 1.0 110.546 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -66.91 -40.02 87.56 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -64.41 -49.58 70.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.698 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 200' ' ' THR . 1.3 m -61.13 -22.39 64.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.308 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -74.56 10.46 1.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.017 0.437 . . . . 1.0 110.194 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 198' ' ' SER . 20.4 m -164.09 -54.66 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.816 0.341 . . . . 1.0 110.844 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.7 mt-10 -66.89 116.17 7.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.026 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -103.05 165.59 10.93 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 tp -110.45 -164.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.52 137.54 22.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -79.2 44.47 1.7 Allowed 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.812 1.675 . . . . 1.0 111.915 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.39 84.8 15.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.41 166.03 5.1 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.113 1.876 . . . . 1.0 112.186 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.06 -46.81 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.337 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 51.6 p -170.21 164.11 9.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.852 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.84 100.61 3.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.601 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.423 ' ND2' ' OE2' ' A' ' 215' ' ' GLU . 27.6 m120 -142.24 68.11 21.64 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 122.768 0.427 . . . . 1.0 110.622 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 214' ' ' PHE . 31.4 Cg_exo -60.44 165.12 11.72 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.638 1.559 . . . . 1.0 111.169 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 44.4 m -46.33 -18.74 0.06 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.994 0.426 . . . . 1.0 110.731 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.403 ' N ' ' C ' ' A' ' 212' ' ' PRO . 48.3 t80 -60.44 -45.08 94.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.096 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.423 ' OE2' ' ND2' ' A' ' 211' ' ' ASN . 43.6 tt0 -50.92 -45.13 60.27 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 110.195 -0.298 . . . . 1.0 110.195 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -55.86 -40.54 73.05 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.92 -43.31 81.32 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.386 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.53 -32.94 52.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.7 t -68.28 -48.01 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -72.31 -24.12 61.27 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.444 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 25.2 m -60.91 -49.55 77.01 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.576 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 28.3 pt -72.52 147.87 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.145 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -61.38 -44.81 96.53 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.179 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.981 -1.009 . . . . 1.0 110.375 -179.797 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.203 -1.559 . . . . 1.0 109.203 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.1 tp -160.04 140.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.792 0.33 . . . . 1.0 110.174 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.506 ' CD1' ' H ' ' A' ' 26' ' ' ILE . 3.6 mp -70.62 -42.9 77.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.264 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 61.99 55.45 2.53 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.192 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -168.79 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.826 0.346 . . . . 1.0 110.544 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -74.3 139.47 44.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . -142.9 165.1 28.29 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -109.27 122.51 47.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -108.62 141.6 40.32 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.15 148.15 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.955 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -144.78 139.84 28.08 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.735 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.83 8.34 5.73 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.19 108.71 0.23 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.66 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.966 -0.138 . . . . 1.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.0 p 48.85 -167.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.751 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.4 m -97.69 113.57 63.75 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 123.186 0.304 . . . . 1.0 110.657 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.12 -13.78 17.03 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.05 1.833 . . . . 1.0 111.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -124.92 85.16 57.9 Favored Pre-proline 0 N--CA 1.477 0.899 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.32 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.17 -23.06 27.9 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.145 1.897 . . . . 1.0 111.698 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -80.98 -46.66 14.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.64 -49.88 74.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.861 0.362 . . . . 1.0 111.046 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.47 -39.14 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.19 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.651 ' HG ' ' H ' ' A' ' 47' ' ' CYS . 17.0 p -50.01 -57.88 6.64 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.651 ' H ' ' HG ' ' A' ' 46' ' ' SER . 77.4 m -51.71 -41.41 61.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.971 0.415 . . . . 1.0 110.342 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.5 t -71.2 -17.89 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.038 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 tp -140.65 44.19 1.84 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.039 0.447 . . . . 1.0 110.862 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.6 t -123.59 -167.59 1.64 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' N ' ' OG ' ' A' ' 50' ' ' SER . 41.2 m-20 -50.73 -40.07 53.47 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.912 -1.04 . . . . 1.0 111.175 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -60.45 -55.22 36.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.79 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -67.28 -39.86 86.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.998 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 91.0 m -48.36 -53.7 16.57 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -77.47 -46.75 21.53 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.45 -30.27 68.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.867 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.69 -45.04 93.31 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.482 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -63.59 -30.32 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 119.946 -0.702 . . . . 1.0 109.608 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -63.01 -16.4 59.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.0 111.087 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.74 -18.83 14.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.09 35.37 5.8 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 121.39 -0.433 . . . . 1.0 112.1 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -93.15 154.4 18.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.21 0.529 . . . . 1.0 109.652 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 m -137.77 -6.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.031 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -143.0 144.98 32.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.436 0.636 . . . . 1.0 110.69 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.68 122.98 18.21 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.712 -1.131 . . . . 1.0 109.28 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -120.66 142.94 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.529 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.05 137.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.006 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -62.51 144.1 56.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.23 120.26 16.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' ASN . . . -64.21 -11.01 44.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 63.41 -68.51 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.888 0.405 . . . . 1.0 110.877 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' GLY . 77.7 m-20 -61.28 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -65.87 -50.19 65.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.98 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t 51.16 -147.79 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.803 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t 55.93 -161.1 0.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.592 0.234 . . . . 1.0 110.699 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 54.7 -166.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.466 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.2 t80 53.3 98.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.652 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -59.4 166.67 2.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.019 -0.363 . . . . 1.0 110.019 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.408 ' ND1' ' CZ ' ' A' ' 98' ' ' PHE . 46.7 m-70 -73.21 54.51 0.41 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.752 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.15 -43.44 92.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.285 0.564 . . . . 1.0 110.405 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' GLY . 22.3 m -58.2 -43.66 86.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.571 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -68.85 -42.78 76.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.262 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.91 -48.17 67.43 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.693 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.441 HH22 ' CG ' ' A' ' 51' ' ' ASP . 57.9 ttm-85 -76.13 -16.68 59.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.756 -0.377 . . . . 1.0 110.368 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.55 54.21 1.36 Allowed Glycine 0 N--CA 1.474 1.192 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . -80.36 169.31 52.53 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.736 -1.345 . . . . 1.0 109.736 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -132.4 129.36 39.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 90' ' ' SER . 56.8 ttp180 -57.61 151.15 17.69 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 40.46 -86.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.794 0.684 . . . . 1.0 111.286 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' ARG . 93.1 p -160.06 97.7 1.28 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.435 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 55.2 67.62 0.99 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.246 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -145.28 162.74 36.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.097 0.475 . . . . 1.0 109.853 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.78 118.74 21.31 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.281 -0.872 . . . . 1.0 111.157 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.02 149.12 36.15 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.132 1.221 . . . . 1.0 111.026 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.6 pt -93.35 9.02 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.2 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 66.31 -65.57 0.19 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.201 0.938 . . . . 1.0 109.6 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -63.88 -146.7 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.57 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.408 ' CZ ' ' ND1' ' A' ' 79' ' ' HIS . 56.5 m-85 -126.4 9.93 7.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.958 0.503 . . . . 1.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.55 66.55 2.39 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.7 m 53.89 -96.83 0.06 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.487 0.184 . . . . 1.0 110.584 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.54 9.01 0.02 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.44 -70.05 0.21 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.833 0.349 . . . . 1.0 110.407 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.7 p -91.91 34.91 0.98 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.155 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 54.3 -148.6 0.46 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.36 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.424 HH12 ' CG1' ' A' ' 116' ' ' VAL . 50.9 ptt85 -141.01 163.5 32.81 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.94 129.63 8.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.492 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.16 161.38 38.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.35 128.73 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.1 mm? -104.79 157.66 17.05 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.173 0.511 . . . . 1.0 109.646 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.9 mmt 54.84 -87.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.819 -1.082 . . . . 1.0 110.282 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LEU . 2.6 p30 -169.3 72.36 0.08 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.21 -0.19 59.9 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -73.41 -57.26 4.13 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.901 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.88 120.23 37.26 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.858 0.724 . . . . 1.0 110.8 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.5 126.06 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.177 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.424 ' CG1' HH12 ' A' ' 105' ' ' ARG . 57.6 t -101.56 114.25 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.143 -1.428 . . . . 1.0 107.143 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.05 140.78 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.839 0.712 . . . . 1.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.54 -40.88 66.98 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 110.011 -1.235 . . . . 1.0 110.011 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.0 t80 61.68 135.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.297 0.239 . . . . 1.0 110.508 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -170.08 128.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -161.25 142.99 11.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.169 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.3 p 46.85 -114.53 0.54 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.198 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 124' ' ' LYS . 60.6 p -61.36 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.161 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.534 ' HG3' ' H ' ' A' ' 125' ' ' MET . 16.3 pttt -170.64 -73.09 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.534 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 64.4 mtt -71.79 -55.96 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.578 0.228 . . . . 1.0 111.469 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.96 -33.04 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.34 . . . . 1.0 111.276 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.2 m -72.44 -43.93 63.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.0 mt -64.93 -46.35 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 1.0 112.076 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.6 pt -62.61 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 121.874 0.845 . . . . 1.0 110.789 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -56.45 -46.04 80.54 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.95 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.75 -55.86 28.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -73.9 -22.69 59.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.345 -176.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 95.6 p 35.67 76.15 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.831 0.852 . . . . 1.0 112.588 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 135' ' ' LEU . 22.5 t70 -164.58 -151.18 0.15 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.041 -0.725 . . . . 1.0 109.041 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.483 ' H ' ' CG ' ' A' ' 134' ' ' ASP . 4.0 mm? -91.35 126.24 36.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.13 0.491 . . . . 1.0 109.687 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.0 p -97.1 155.36 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.801 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.01 96.35 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.995 -1.002 . . . . 1.0 108.52 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 t -96.42 123.44 40.08 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.426 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 1.8 t60 -73.51 -50.78 19.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.645 0.26 . . . . 1.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 25.11 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.03 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -63.93 -34.13 89.11 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.4 -44.73 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.926 0.393 . . . . 1.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -65.54 -41.58 96.11 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 111.151 -0.779 . . . . 1.0 111.151 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.9 t -69.65 -40.66 76.36 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 122.51 -0.406 . . . . 1.0 111.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.54 -29.75 39.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.369 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.6 tp -50.11 -51.37 43.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.033 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -65.65 -38.99 90.89 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.721 0.772 . . . . 1.0 110.339 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 m -51.08 -25.26 4.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.433 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.47 -55.35 4.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.073 0.768 . . . . 1.0 113.073 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.413 ' C ' ' H ' ' A' ' 152' ' ' ASN . 13.5 ptm180 -63.99 -26.61 68.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.909 0.385 . . . . 1.0 110.457 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.26 -0.91 6.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 150' ' ' ARG . 62.9 t30 56.33 37.7 29.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.37 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.95 144.7 42.37 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.086 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.27 -177.41 2.98 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 121.865 1.71 . . . . 1.0 110.877 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 155' ' ' LEU . 2.0 pt? -158.78 171.95 19.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.177 -0.919 . . . . 1.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.32 120.34 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.618 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.37 127.76 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.848 0.356 . . . . 1.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 96.8 m -72.77 104.81 4.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.01 147.73 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 83.48 102.49 0.05 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.976 0.798 . . . . 1.0 110.278 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -168.76 -76.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.6 m 49.17 35.92 8.17 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.06 0.457 . . . . 1.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.68 -40.66 97.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.184 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.9 ttm -162.88 52.3 0.18 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.006 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.29 -41.71 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.181 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 71.52 -51.62 0.69 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.701 0.626 . . . . 1.0 110.319 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -60.93 -23.77 65.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.806 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.426 ' NE2' ' CE1' ' A' ' 139' ' ' HIS . 11.6 tm0? -42.11 -50.71 4.73 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.332 -0.395 . . . . 1.0 111.305 -176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -67.09 -36.27 81.61 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.101 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -66.17 -38.09 87.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.452 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.6 mm -65.06 -43.63 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.99 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.51 -52.26 8.77 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.823 0.344 . . . . 1.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.25 -51.91 30.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.981 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -61.04 -30.31 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 1.0 110.574 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 179' ' ' GLY . 0.7 OUTLIER -63.96 -36.62 84.57 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.024 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.3 t -57.69 -44.5 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.671 0.272 . . . . 1.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -63.41 -50.22 70.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.831 0.348 . . . . 1.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.2 mt -90.76 0.67 57.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.313 0.578 . . . . 1.0 110.212 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . -173.51 87.23 0.08 OUTLIER Glycine 0 C--O 1.223 -0.575 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -48.25 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.457 0.74 . . . . 1.0 110.308 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.4 p -89.96 146.73 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.107 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -66.93 127.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 p -107.14 133.87 51.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.6 m -162.71 124.79 2.66 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.74 154.98 75.95 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.712 -0.661 . . . . 1.0 110.175 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.5 63.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.513 2.638 0 C-N-CA 122.458 2.106 . . . . 1.0 113.547 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 185' ' ' ALA . 79.4 p -128.12 141.95 51.34 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 17.2 mp0 -65.45 -25.36 67.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.276 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.5 t -89.11 -31.57 17.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.897 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.36 -34.3 12.45 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 112.015 -0.434 . . . . 1.0 112.015 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 34.7 mt -62.41 -41.52 98.74 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.449 -0.442 . . . . 1.0 111.364 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.28 -39.33 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.6 79.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.389 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.48 -53.99 25.5 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.415 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.94 -32.98 72.49 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.716 -0.284 . . . . 1.0 110.387 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -59.16 -48.6 81.03 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.503 -0.479 . . . . 1.0 109.99 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.54 -47.79 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.188 -0.32 . . . . 1.0 111.395 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.477 ' HG ' ' N ' ' A' ' 199' ' ' GLN . 83.3 p -59.79 -32.95 71.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.21 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.477 ' N ' ' HG ' ' A' ' 198' ' ' SER . 84.1 mt-30 -100.16 28.35 4.97 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.778 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 62.1 m -150.45 -30.74 0.2 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.328 -0.249 . . . . 1.0 110.328 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -150.8 151.94 33.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.174 0.511 . . . . 1.0 109.751 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -130.39 156.78 44.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.344 -0.844 . . . . 1.0 110.089 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.39 164.61 19.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.183 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -61.73 148.35 87.32 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.904 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.99 99.63 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.742 1.628 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -140.61 87.43 11.52 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 107.36 2.46 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.019 1.813 . . . . 1.0 111.685 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.64 84.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.224 -0.444 . . . . 1.0 109.932 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 78.2 p -68.84 -32.75 72.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.798 0.333 . . . . 1.0 110.467 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -83.09 21.2 1.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.988 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 213' ' ' SER . 0.5 OUTLIER -57.59 146.15 66.29 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.902 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.95 13.37 0.62 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.051 1.834 . . . . 1.0 111.855 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 211' ' ' ASN . 4.7 t -65.8 -58.62 5.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.949 0.404 . . . . 1.0 111.111 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -53.33 -39.31 63.98 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.12 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -59.56 -32.23 70.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.214 -0.448 . . . . 1.0 109.939 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -76.69 -49.74 15.36 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.787 0.327 . . . . 1.0 111.434 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 63.2 mt -64.34 -52.69 57.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.524 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.03 -50.88 65.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.459 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.08 -41.56 92.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.326 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.79 -33.93 76.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.573 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 27.6 m -60.91 -46.92 88.73 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.947 0.404 . . . . 1.0 110.465 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.4 tp -82.29 142.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.837 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -165.59 139.21 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.112 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.066 -0.968 . . . . 1.0 110.336 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.39 -21.07 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 tp -73.31 76.83 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.844 0.831 . . . . 1.0 110.387 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -159.09 -30.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -164.04 73.82 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.932 -0.396 . . . . 1.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.78 111.32 12.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.559 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.45 160.2 14.53 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.0 tp -130.15 102.73 6.36 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -99.42 127.62 45.48 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.849 0.46 . . . . 1.0 110.018 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.61 145.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 t -144.01 138.63 28.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.523 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.19 -35.57 76.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.852 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.5 -104.12 1.38 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.371 -1.092 . . . . 1.0 110.371 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.46 -159.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -63.42 172.01 2.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 p -162.34 82.81 1.67 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.9 -32.77 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.054 1.836 . . . . 1.0 111.065 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.6 110.45 3.15 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 118.746 -0.645 . . . . 1.0 110.267 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -84.76 -21.68 3.25 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.613 1.542 . . . . 1.0 112.36 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -81.17 -31.89 33.85 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.58 -51.6 12.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.093 0.473 . . . . 1.0 110.472 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -56.74 -32.06 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.995 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 98.3 p -62.39 -19.26 63.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.691 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.5 p -51.07 -38.54 52.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 1.0 110.601 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.61 -18.76 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.112 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mt -143.63 41.19 1.44 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.939 0.496 . . . . 1.0 109.774 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -124.26 -156.13 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.103 -0.702 . . . . 1.0 109.103 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -54.5 -46.81 73.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.747 -0.66 . . . . 1.0 112.033 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.13 -55.41 35.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.536 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -71.0 -45.63 63.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.455 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 47.5 t -56.77 -32.02 65.2 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.46 0.647 . . . . 1.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -78.83 -49.86 12.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.82 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -70.08 -58.29 3.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.888 -0.597 . . . . 1.0 112.606 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 61' ' ' GLY . 3.2 mm? -49.45 -42.01 41.76 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.289 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.7 mm -69.69 -42.33 80.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -50.46 -51.9 42.79 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.122 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.433 ' C ' ' H ' ' A' ' 62' ' ' PHE . 97.1 m-85 -91.89 -17.81 24.68 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . 75.54 -16.21 4.11 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.562 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 60' ' ' TYR . 27.9 m-85 38.09 -115.54 0.15 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.261 -0.4 . . . . 1.0 111.448 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.0 t -160.43 -59.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -165.64 130.2 2.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.367 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.44 143.33 29.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.637 0.775 . . . . 1.0 110.533 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.8 mm -123.28 130.46 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.5 tt -145.29 141.86 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.243 0.544 . . . . 1.0 109.538 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.528 HE21 ' CE ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -160.58 151.79 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.043 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' OE2' ' A' ' 76' ' ' GLU . 95.8 m-85 -99.96 -60.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.315 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.449 ' H ' ' CG2' ' A' ' 103' ' ' THR . . . 89.01 -37.62 3.3 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 111.314 -0.715 . . . . 1.0 111.314 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.614 HH22 ' HE ' ' A' ' 216' ' ' ARG . 62.3 mmt-85 -97.13 122.65 40.39 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.81 -38.07 89.75 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.973 0.416 . . . . 1.0 110.262 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -54.03 -15.91 1.67 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.936 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -55.08 -80.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.242 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.3 m 52.88 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.667 0.27 . . . . 1.0 111.454 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -168.0 -44.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.908 0.385 . . . . 1.0 111.462 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -69.15 103.57 1.94 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.21 -83.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.267 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -169.08 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.035 0.445 . . . . 1.0 110.272 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.65 -17.59 60.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.32 -36.59 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' GLY . 41.4 mm-40 -66.87 -39.64 87.6 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.52 -0.764 . . . . 1.0 110.128 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -51.96 -38.02 55.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.12 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -18.0 62.59 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' GLN . . . 88.53 41.74 6.0 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.34 168.16 54.81 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -137.84 133.83 34.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -62.39 155.94 23.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.894 -0.322 . . . . 1.0 110.848 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.79 -5.83 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.407 0.442 . . . . 1.0 110.888 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.4 m -70.31 143.52 52.01 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 92' ' ' LYS . 16.8 mm100 -64.24 128.51 36.09 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 91' ' ' GLN . 61.3 mttp 60.17 127.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.99 -0.745 . . . . 1.0 108.99 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.1 tt -51.75 102.57 0.32 Allowed Pre-proline 0 CA--C 1.552 1.022 0 CA-C-N 117.666 0.212 . . . . 1.0 111.45 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.515 ' C ' ' H ' ' A' ' 96' ' ' ASP . 33.0 Cg_exo -63.27 -141.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.221 0 CA-C-N 120.357 1.163 . . . . 1.0 111.601 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.44 7.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.226 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 94' ' ' PRO . 66.2 t0 63.28 -116.64 0.49 Allowed 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -56.9 -168.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.846 0.355 . . . . 1.0 110.62 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.514 ' C ' ' H ' ' A' ' 100' ' ' CYS . 0.1 OUTLIER -67.37 -20.93 65.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' SG ' ' A' ' 100' ' ' CYS . . . 66.35 -11.82 0.51 Allowed Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.96 -0.563 . . . . 1.0 111.872 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.514 ' H ' ' C ' ' A' ' 98' ' ' PHE . 1.2 m 171.95 -86.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.404 -0.961 . . . . 1.0 108.404 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 173.74 120.91 0.59 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.283 -1.127 . . . . 1.0 110.283 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -171.41 -120.76 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.449 ' CG2' ' H ' ' A' ' 70' ' ' GLY . 46.8 p -152.0 71.47 0.97 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -155.22 62.66 0.63 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.07 0.462 . . . . 1.0 111.665 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ptt85 -133.47 147.81 51.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -150.05 117.98 6.28 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -137.04 161.28 36.51 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.09 147.94 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.316 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 111' ' ' ASN . 2.0 mp -123.82 123.14 39.8 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.5 tpp 55.83 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.268 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' LEU . 20.6 t-20 -167.39 78.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.793 0.33 . . . . 1.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.41 5.28 77.05 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.011 -0.835 . . . . 1.0 111.011 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -66.51 -23.44 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 tp -174.04 105.68 0.12 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -109.89 115.32 29.59 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.38 108.45 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.87 100.04 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.938 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.68 -25.01 43.7 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 109.889 -1.284 . . . . 1.0 109.889 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -58.69 137.4 57.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.898 0.38 . . . . 1.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -166.41 170.54 12.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -81.56 96.06 7.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.226 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.6 p 46.53 -164.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.784 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.54 8.5 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.15 0.5 . . . . 1.0 110.054 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -144.42 44.87 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.528 ' CE ' HE21 ' A' ' 68' ' ' GLN . 18.1 mmt -52.98 -41.67 64.81 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.668 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -54.83 -26.96 38.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.683 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 51.2 p -83.66 -38.85 20.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.836 0.35 . . . . 1.0 111.245 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.02 -44.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.718 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.85 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -55.14 -38.81 68.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.173 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.48 -43.58 84.23 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -96.07 -61.06 1.5 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.03 0.443 . . . . 1.0 110.293 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 m 55.96 79.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -139.99 -49.37 0.47 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.65 0.262 . . . . 1.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.39 139.06 6.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.47 140.44 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 79.3 mt -119.18 125.9 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 139' ' ' HIS . 27.5 t -87.6 -164.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.424 ' N ' ' OG ' ' A' ' 138' ' ' SER . 79.4 t60 -139.03 -3.38 1.6 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 110.395 -0.224 . . . . 1.0 110.395 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.09 -56.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.099 0.476 . . . . 1.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 136.8 126.14 2.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 1.9 t -174.07 -131.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.435 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -73.76 -27.16 67.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -54.75 -44.81 73.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 89.1 mt -65.69 -26.75 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 122.173 -0.329 . . . . 1.0 110.902 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -54.57 34.68 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.25 -44.55 91.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.534 0.683 . . . . 1.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.7 p -49.08 -22.78 0.99 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.125 -0.943 . . . . 1.0 113.3 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.4 mt -82.46 -45.42 14.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.852 0.358 . . . . 1.0 111.611 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -68.8 -21.85 64.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.308 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.03 -3.0 57.72 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 53.06 34.34 16.93 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.593 0.235 . . . . 1.0 110.557 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.81 115.7 48.38 Favored Pre-proline 0 N--CA 1.481 1.11 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -50.94 155.22 6.12 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 CA-C-N 120.658 1.271 . . . . 1.0 112.308 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.14 170.31 19.73 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.274 1.035 . . . . 1.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.43 138.18 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.685 -1.598 . . . . 1.0 109.278 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.7 p -119.89 138.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 120.631 0.253 . . . . 1.0 110.815 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 14.3 t -72.35 125.27 26.97 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 184' ' ' CYS . 25.1 t -123.54 139.81 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.145 -0.687 . . . . 1.0 109.145 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 64.5 t30 57.11 -176.09 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.02 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.485 ' H ' ' CG ' ' A' ' 160' ' ' ASN . 65.5 m-20 59.76 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.838 0.711 . . . . 1.0 111.077 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.8 m 53.59 -90.94 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.847 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 66.5 mt -3.79 78.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.104 1.362 . . . . 1.0 113.14 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 62.1 mmm -60.83 -41.14 95.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.14 -0.937 . . . . 1.0 110.617 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.46 121.58 17.29 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.05 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -64.91 -34.27 78.0 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.77 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -55.63 -39.54 70.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.097 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.7 -52.39 64.49 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -66.88 -28.59 68.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.821 0.343 . . . . 1.0 110.574 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.78 -51.99 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.441 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.9 -27.27 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.41 -58.3 3.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -52.18 -43.88 64.38 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.862 -1.063 . . . . 1.0 112.353 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -64.71 -41.99 95.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.421 -0.512 . . . . 1.0 109.844 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.433 ' CD2' ' OH ' ' A' ' 180' ' ' TYR . 3.8 m-85 -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.206 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 179' ' ' GLY . 99.7 t -64.12 -35.32 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -48.09 -43.61 30.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.233 -0.894 . . . . 1.0 109.295 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.64 -29.91 67.49 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 82.47 -5.79 71.89 Favored Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.339 -1.104 . . . . 1.0 110.339 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.433 ' OH ' ' CD2' ' A' ' 175' ' ' PHE . 0.3 OUTLIER -62.53 -4.73 2.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.949 -0.625 . . . . 1.0 111.284 -177.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.33 147.47 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.171 0.441 . . . . 1.0 110.156 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 19.6 m-90 -76.71 131.65 38.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m -88.08 138.6 31.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -135.53 149.77 49.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.1 150.34 70.88 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.59 -0.893 . . . . 1.0 108.59 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.17 58.19 5.54 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 122.201 1.934 . . . . 1.0 113.183 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 173.08 6.5 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.88 -57.71 5.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.8 m -88.84 -30.27 19.07 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.585 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -59.19 -47.71 89.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.353 -0.699 . . . . 1.0 111.353 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.42 -43.0 91.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 117.083 0.441 . . . . 1.0 111.155 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.46 -43.65 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.59 -38.51 72.11 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.38 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.24 91.38 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.418 -0.673 . . . . 1.0 111.418 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -52.68 63.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -60.84 -35.33 76.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.141 -0.936 . . . . 1.0 109.432 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.03 -45.23 86.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.885 0.374 . . . . 1.0 110.097 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 84.2 p -67.5 -20.49 65.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.66 -24.73 14.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.01 0.433 . . . . 1.0 109.873 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.1 m -74.63 -40.08 61.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.505 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -120.18 139.7 52.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.794 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -119.18 101.61 8.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.054 0.542 . . . . 1.0 109.977 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.83 131.18 46.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -67.99 150.19 97.87 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 106.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.508 2.362 0 C-N-CA 121.891 1.727 . . . . 1.0 113.624 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.81 84.69 9.63 Favored Pre-proline 0 N--CA 1.478 0.953 0 N-CA-C 109.932 -0.395 . . . . 1.0 109.932 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -57.32 127.33 25.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.624 1.55 . . . . 1.0 112.036 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.04 -33.48 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.675 -0.491 . . . . 1.0 109.675 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 211' ' ' ASN . 50.6 m 55.38 -111.09 0.6 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.861 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.32 -79.34 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 209' ' ' SER . 8.1 p-10 -133.42 78.1 63.95 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 122.943 0.497 . . . . 1.0 110.22 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 214' ' ' PHE . 71.8 Cg_exo -55.32 -136.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.67 0 C-N-CA 123.019 2.48 . . . . 1.0 112.521 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 96.4 p -68.35 8.04 0.51 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.853 0.358 . . . . 1.0 110.212 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.499 ' H ' ' C ' ' A' ' 212' ' ' PRO . 65.1 t80 -60.85 -45.1 95.84 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.154 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.88 -54.78 25.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.815 0.34 . . . . 1.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.614 ' HE ' HH22 ' A' ' 71' ' ' ARG . 84.9 mtp180 -62.22 -39.54 93.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.889 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 tp -48.95 -47.64 43.67 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.098 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 76.2 mt -58.05 -42.12 84.75 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.468 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.58 -50.55 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -61.46 -36.97 81.9 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.788 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 32.3 m -61.36 -44.58 96.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.759 0.314 . . . . 1.0 110.432 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 84.4 mt -80.35 129.3 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.479 ' CD2' ' N ' ' A' ' 224' ' ' SER . 59.4 t80 57.33 162.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.012 0.434 . . . . 1.0 111.176 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.479 ' N ' ' CD2' ' A' ' 223' ' ' TYR . 46.9 t . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.259 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.435 -1.466 . . . . 1.0 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 27' ' ' GLU . 9.5 tt -169.7 -37.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.2 mm -61.73 69.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 123.605 0.566 . . . . 1.0 110.406 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 25' ' ' ILE . 76.8 tt0 -176.78 95.13 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.822 -0.626 . . . . 1.0 109.768 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -165.96 -76.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -132.73 101.48 5.3 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.006 0.522 . . . . 1.0 110.019 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.68 119.5 38.95 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.07 121.59 27.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.76 0.314 . . . . 1.0 110.22 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CE1' ' CZ ' ' A' ' 132' ' ' TYR . 6.9 m-85 -103.63 122.13 44.37 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.2 t -118.36 99.04 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.5 p -93.23 120.75 33.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.236 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 139' ' ' HIS . 71.5 m -61.25 -27.48 68.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -138.47 31.6 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.721 -0.952 . . . . 1.0 110.721 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.37 -112.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.892 -0.181 . . . . 1.0 110.71 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.5 p -71.3 112.74 7.68 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.5 131.48 95.1 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.874 -0.584 . . . . 1.0 110.358 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.77 -174.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.3 1.333 . . . . 1.0 112.477 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.99 144.96 90.01 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.034 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.78 -33.22 49.38 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.789 1.66 . . . . 1.0 113.086 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.32 -35.39 61.24 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.633 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -66.88 -45.04 79.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.799 0.333 . . . . 1.0 111.531 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.72 -37.03 74.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.954 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -46.54 -27.53 1.15 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.181 0.515 . . . . 1.0 110.986 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.6 t -53.89 -38.09 64.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.78 . . . . 1.0 110.559 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.5 m -80.53 -4.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.302 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.52 40.18 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.224 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.9 m -135.62 -166.12 1.8 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.898 0.856 . . . . 1.0 109.823 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -54.6 -44.84 73.41 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.95 -1.477 . . . . 1.0 110.327 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 23.4 mp0 -52.27 -52.07 54.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.534 0.207 . . . . 1.0 110.55 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.58 -37.33 76.92 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.432 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.2 t -49.77 -45.98 50.23 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.745 0.307 . . . . 1.0 111.552 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -72.66 -44.59 61.67 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 1.0 111.429 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.35 -36.01 80.53 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.596 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -58.17 -47.23 84.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.619 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.544 ' CG1' ' HZ1' ' A' ' 113' ' ' LYS . 1.5 mp -68.67 -28.95 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.86 -43.02 59.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.91 -0.587 . . . . 1.0 110.906 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -76.57 -11.05 59.81 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.047 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 83.64 37.83 11.43 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.61 -0.805 . . . . 1.0 111.505 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 63' ' ' VAL . 1.6 p90 -48.43 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 120.936 0.398 . . . . 1.0 111.17 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' N ' ' CD2' ' A' ' 62' ' ' PHE . 8.7 p -172.15 -31.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.001 0.429 . . . . 1.0 109.952 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.504 ' NH1' ' NZ ' ' A' ' 115' ' ' LYS . 56.1 ttt85 -167.02 108.52 0.66 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.5 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.07 130.47 36.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.252 -0.648 . . . . 1.0 109.252 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.09 135.88 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.09 144.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -119.98 124.36 45.74 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.158 -1.052 . . . . 1.0 108.158 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CE1' ' NH2' ' A' ' 105' ' ' ARG . 2.0 t80 -59.04 -169.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.302 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.82 -109.08 0.35 Allowed Glycine 0 N--CA 1.463 0.481 0 N-CA-C 110.664 -0.974 . . . . 1.0 110.664 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -65.17 124.28 21.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.71 0.291 . . . . 1.0 110.723 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.63 -37.99 88.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.775 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.36 -44.49 88.84 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.461 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 99.3 p -63.91 169.73 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.289 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.3 p -153.61 73.37 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.335 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.95 169.39 4.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.83 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 45.8 76.1 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.938 0.399 . . . . 1.0 110.736 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.37 -34.96 77.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.22 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -167.86 22.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.388 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.88 -30.19 66.5 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.839 0.352 . . . . 1.0 110.6 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' GLY . 74.6 t -58.91 -47.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -72.72 -42.15 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.884 0.373 . . . . 1.0 111.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -52.64 -43.37 65.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.954 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -83.1 -16.9 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.93 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.38 -55.86 0.41 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . 46.06 78.02 0.09 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 112.686 -0.166 . . . . 1.0 112.686 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.21 109.96 19.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' NH1' ' O ' ' A' ' 97' ' ' GLN . 26.6 mmm180 -59.64 150.48 27.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.925 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.5 16.92 3.37 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.479 0.657 . . . . 1.0 109.549 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t -168.6 -173.79 2.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.441 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -151.78 54.83 0.84 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.506 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.59 -45.37 87.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.444 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.2 pt -109.63 145.03 31.1 Favored Pre-proline 0 CA--C 1.554 1.129 0 O-C-N 123.354 0.409 . . . . 1.0 110.741 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.81 -55.54 3.75 Favored 'Trans proline' 0 N--CA 1.509 2.433 0 C-N-CA 122.053 1.835 . . . . 1.0 113.203 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.5 tt -48.3 -40.95 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.807 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.4 t70 47.42 66.14 1.09 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.18 -0.463 . . . . 1.0 111.47 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.429 ' O ' ' NH1' ' A' ' 88' ' ' ARG . 58.1 tt0 -150.12 -84.24 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.486 ' CE1' ' NH1' ' A' ' 105' ' ' ARG . 81.4 t80 -128.29 -17.41 4.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.8 0.44 . . . . 1.0 110.62 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.22 66.97 2.14 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 101' ' ' GLY . 28.1 p -53.94 -44.62 70.81 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.716 0.294 . . . . 1.0 110.97 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.45 ' N ' ' SG ' ' A' ' 100' ' ' CYS . . . -62.15 -82.78 0.07 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.43 -109.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 t -173.18 -29.4 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.027 -0.36 . . . . 1.0 110.027 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -32.35 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.824 0.703 . . . . 1.0 111.493 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' CE1' ' A' ' 98' ' ' PHE . 10.5 ptp180 -130.12 151.69 50.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.593 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -157.98 109.46 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.52 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -143.14 -172.96 3.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.75 -0.463 . . . . 1.0 109.75 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.54 162.26 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.84 -174.17 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.2 mtt 53.82 54.09 10.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.496 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 52.49 33.47 13.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.72 25.03 68.35 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 120.894 -0.67 . . . . 1.0 112.499 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.544 ' HZ1' ' CG1' ' A' ' 58' ' ' ILE . 16.6 tptm -83.21 -49.86 9.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.4 0.6 . . . . 1.0 112.034 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.73 132.84 56.42 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.186 0.517 . . . . 1.0 112.033 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' NZ ' ' NH1' ' A' ' 64' ' ' ARG . 49.3 mtmt -106.23 152.45 23.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -134.23 132.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.6 mt -145.06 123.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.795 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.26 -16.24 76.75 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.15 -1.18 . . . . 1.0 110.15 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.4 t80 54.69 -99.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -169.67 130.17 1.03 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.19 108.64 4.24 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.1 p -168.07 160.64 12.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.123 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.8 t -76.69 5.27 7.86 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.237 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -72.33 -42.73 65.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.293 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.1 ttm -46.14 -34.21 4.09 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.709 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.96 -28.47 57.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.624 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -79.35 -35.18 41.32 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.421 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 128' ' ' ILE . 1.6 mp -64.55 -27.82 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.762 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.2 mt -52.13 -51.45 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 120.316 -0.553 . . . . 1.0 109.739 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -48.47 -30.95 5.67 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.383 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -52.4 -47.23 66.4 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 121.263 -0.175 . . . . 1.0 111.276 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.595 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.2 p90 -117.1 -53.68 2.45 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.341 0.401 . . . . 1.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 47.4 m 50.25 79.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.869 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -120.14 -53.45 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 tp -168.8 148.39 4.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.065 -0.654 . . . . 1.0 110.481 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.17 149.76 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.47 100.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 t -116.33 127.14 54.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.407 ' CD2' ' H ' ' A' ' 139' ' ' HIS . 13.2 p80 -80.69 67.86 6.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.226 -0.443 . . . . 1.0 109.875 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.85 34.37 23.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.994 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.558 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -62.41 -34.77 90.37 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.8 m 69.03 -16.75 0.22 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.46 0.304 . . . . 1.0 110.413 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -84.25 -54.18 3.08 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.706 -0.557 . . . . 1.0 111.706 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.0 p -79.54 -32.22 42.15 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.47 0.308 . . . . 1.0 111.365 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.27 -28.2 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 120.693 0.283 . . . . 1.0 110.86 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.9 mt -56.29 -51.08 69.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.807 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -65.17 -53.1 50.05 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 121.426 0.632 . . . . 1.0 110.865 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 88.0 p -58.32 -24.93 61.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 1.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.2 tp -76.7 -57.34 3.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.633 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.497 ' NH1' ' ND1' ' A' ' 210' ' ' HIS . 39.6 ptt180 -62.36 -28.05 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.171 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.7 4.6 1.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 150' ' ' ARG . 22.7 m120 58.41 11.96 1.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.233 0.333 . . . . 1.0 110.274 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -92.5 142.33 25.77 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.67 167.9 25.22 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.719 1.613 . . . . 1.0 111.481 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 155' ' ' LEU . 1.9 pt? -156.65 156.52 33.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.295 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.412 ' CG2' ' SG ' ' A' ' 184' ' ' CYS . 16.8 mm -110.13 109.72 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.58 118.27 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.11 103.65 2.37 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 85.5 t -90.09 137.88 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.1 170.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.011 0.434 . . . . 1.0 110.769 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 49.82 74.75 0.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.715 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.1 t -171.2 -49.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.13 0.49 . . . . 1.0 110.129 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.0 pp -145.52 142.87 29.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.092 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.2 mmm -90.22 86.65 6.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.573 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 167' ' ' HIS . 15.3 t0 -161.16 -19.52 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.962 -0.385 . . . . 1.0 109.962 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 58.7 6.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.67 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.428 ' H ' ' C ' ' A' ' 165' ' ' ASP . 52.8 t-80 -66.25 -36.63 83.49 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 172' ' ' ALA . 5.3 pt20 -61.57 -41.6 97.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.974 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -53.96 -29.56 43.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.83 0.348 . . . . 1.0 111.024 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -70.45 -53.47 16.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.09 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.5 mt -83.63 -51.3 14.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 110.487 -0.19 . . . . 1.0 110.487 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 168' ' ' GLN . . . -45.05 -52.97 8.39 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -69.36 -56.13 8.4 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -51.04 -26.98 6.95 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.9 0.381 . . . . 1.0 110.791 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.31 -38.84 66.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.243 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.7 m -55.53 -29.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 120.918 0.39 . . . . 1.0 111.875 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -59.46 -48.49 81.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.942 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.6 mt -104.48 24.7 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.288 0.566 . . . . 1.0 110.409 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.644 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.3 82.57 0.04 OUTLIER Glycine 0 C--O 1.221 -0.703 0 N-CA-C 108.44 -1.864 . . . . 1.0 108.44 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -46.35 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 O-C-N 125.063 1.096 . . . . 1.0 110.692 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.644 ' N ' ' O ' ' A' ' 179' ' ' GLY . 6.3 p -73.24 139.63 19.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.534 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -63.9 116.85 6.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.2 m -108.75 133.63 52.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.562 -0.744 . . . . 1.0 109.875 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 156' ' ' ILE . 28.5 p -165.1 131.32 2.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.697 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.65 79.47 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.43 79.11 0.24 Allowed 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.704 2.27 . . . . 1.0 113.68 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.5 p -130.62 177.14 7.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 2.2 pm0 -68.64 -63.86 0.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.56 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.5 m -75.13 -43.56 51.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.022 0.439 . . . . 1.0 111.547 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -51.85 -51.24 40.61 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.969 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.97 -41.46 97.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.3 0.55 . . . . 1.0 111.743 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.76 -42.93 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.94 76.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 1.0 110.153 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.71 -46.44 61.26 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.66 -44.41 97.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.043 -0.354 . . . . 1.0 110.043 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -64.63 -37.91 89.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.57 86.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.4 t -60.16 -21.2 61.37 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.01 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -101.28 31.67 3.6 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.668 0.27 . . . . 1.0 110.792 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 18.2 p -143.01 -31.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.12 152.21 12.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.336 -0.546 . . . . 1.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -99.08 144.03 28.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.688 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -54.78 173.91 0.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.519 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.13 116.08 22.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-O 118.991 -0.528 . . . . 1.0 110.739 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.61 118.17 2.82 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 CA-C-N 120.919 1.364 . . . . 1.0 112.749 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -142.06 87.81 9.56 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 85.79 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.347 1.365 . . . . 1.0 112.436 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.74 -26.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.257 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.4 p 75.78 132.17 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.864 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.652 ' HD1' ' H ' ' A' ' 210' ' ' HIS . 3.7 p-80 -62.33 -171.36 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.974 -0.38 . . . . 1.0 109.974 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.37 160.09 30.98 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.05 -98.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 122.304 2.003 . . . . 1.0 111.906 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.7 m -66.82 -36.35 82.16 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.832 0.349 . . . . 1.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.07 -33.56 52.58 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.659 0.266 . . . . 1.0 110.294 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -61.83 -24.22 66.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.416 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -82.01 -45.75 14.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.586 -0.279 . . . . 1.0 110.99 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.04 -42.87 96.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.647 -0.252 . . . . 1.0 110.536 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.2 mt -55.43 -44.75 76.59 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 55.1 t -74.29 -46.59 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -69.37 -6.94 33.12 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.757 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 26.0 m -46.85 -42.17 16.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.67 0.271 . . . . 1.0 110.972 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.16 143.69 15.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.507 . . . . 1.0 109.843 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 62.7 t80 52.32 97.95 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.028 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.09 -0.957 . . . . 1.0 110.305 -179.831 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.536 -1.426 . . . . 1.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.71 -46.09 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.2 pt -132.68 -36.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.353 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -146.55 173.11 12.61 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -116.96 65.19 0.72 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.06 156.09 39.59 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.7 134.77 51.7 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.772 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.65 119.57 32.2 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.743 -0.598 . . . . 1.0 109.466 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -101.42 129.94 47.54 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.25 138.04 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.73 129.62 42.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.491 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.56 34.75 2.67 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.971 0.415 . . . . 1.0 110.066 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.92 -160.13 53.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 -37.37 86.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.477 0.179 . . . . 1.0 111.059 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.1 p -133.18 150.45 52.0 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 110.067 -0.345 . . . . 1.0 110.067 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.12 121.01 76.93 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 119.309 -0.377 . . . . 1.0 110.93 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.58 -59.63 1.12 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 CA-C-N 120.562 1.236 . . . . 1.0 112.386 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -144.81 145.31 27.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.906 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.76 -19.8 30.93 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 121.748 1.632 . . . . 1.0 111.813 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -77.23 -33.9 56.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.806 0.336 . . . . 1.0 110.875 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.46 -48.7 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 1.0 110.72 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -63.21 -34.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 1.0 109.76 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 50' ' ' SER . 6.4 m -52.52 -44.31 65.65 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.655 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -49.01 -38.56 23.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.73 0.3 . . . . 1.0 110.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.11 -14.1 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.271 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.59 35.17 4.24 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.993 0.425 . . . . 1.0 110.333 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 46' ' ' SER . 20.9 m -114.05 -167.55 1.23 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.16 -27.17 63.35 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.707 -1.133 . . . . 1.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.75 -47.57 65.93 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.241 -0.583 . . . . 1.0 110.485 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.2 t80 -69.22 -40.83 77.72 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.7 t -49.99 -48.48 52.3 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -66.78 -44.27 81.8 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.817 0.342 . . . . 1.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -73.64 -30.58 63.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.29 0.567 . . . . 1.0 109.833 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' PHE . 5.7 tt -58.78 -50.0 75.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.312 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -66.59 -31.07 51.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.268 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -59.8 -10.55 3.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.713 -0.222 . . . . 1.0 110.634 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -103.6 -10.59 18.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.218 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.53 13.39 55.58 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 121.188 -0.53 . . . . 1.0 112.384 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -84.71 160.61 20.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.56 3.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.769 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -148.75 142.4 25.5 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.544 0.688 . . . . 1.0 110.554 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -141.99 116.41 9.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.341 -0.845 . . . . 1.0 108.899 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mm -100.69 137.88 26.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tt -146.13 141.24 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.029 0.443 . . . . 1.0 109.833 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.09 158.91 5.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -174.82 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.963 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.27 147.44 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.558 ' NE ' ' HG ' ' A' ' 74' ' ' SER . 80.2 ttt180 -155.73 83.83 1.03 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 1.0 110.282 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -68.28 -22.31 64.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.281 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -57.22 -29.6 63.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.558 ' HG ' ' NE ' ' A' ' 71' ' ' ARG . 84.4 p -149.97 -105.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.066 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.7 m -140.63 147.87 40.02 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 19.8 mp0 -84.2 -119.66 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.79 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -66.55 109.98 2.99 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.77 -57.42 5.64 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.108 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -173.23 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.06 -45.04 82.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.096 0.474 . . . . 1.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.88 -46.59 96.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.937 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.35 -26.45 68.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.009 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.98 -49.82 76.43 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.244 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -62.53 -17.38 59.69 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.083 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.77 54.9 7.83 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 110.179 -1.168 . . . . 1.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.15 -165.53 41.39 Favored Glycine 0 N--CA 1.466 0.669 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -134.6 135.03 41.91 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.004 0.431 . . . . 1.0 110.095 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' NH1' ' OD1' ' A' ' 96' ' ' ASP . 88.8 mtt-85 -60.55 153.28 23.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.922 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -106.45 0.48 24.81 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 92' ' ' LYS . 91.8 p 50.09 178.03 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.96 0.41 . . . . 1.0 111.117 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 57.72 2.01 0.15 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.198 -0.314 . . . . 1.0 111.59 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 90' ' ' SER . 68.5 mttm -139.68 16.02 2.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.343 0.257 . . . . 1.0 110.487 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.4 pt -144.89 82.43 10.08 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -81.98 -46.76 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.994 1.796 . . . . 1.0 110.534 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.8 pt -94.01 -3.36 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.934 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 97' ' ' GLN . 16.7 t70 62.73 -160.85 0.3 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.48 ' H ' ' CG ' ' A' ' 96' ' ' ASP . 11.4 mm100 59.53 -145.51 0.52 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -67.64 -19.81 65.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.794 -0.185 . . . . 1.0 110.643 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.79 68.08 1.7 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 102' ' ' ASP . 56.3 m -56.95 -156.41 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.782 0.325 . . . . 1.0 110.851 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.19 83.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.476 -0.65 . . . . 1.0 111.476 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 100' ' ' CYS . 7.0 m-20 -155.47 -64.57 0.12 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.07 20.23 0.19 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 110.275 -0.268 . . . . 1.0 110.275 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 58.33 -152.8 0.39 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.068 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -136.25 158.6 44.03 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.498 ' NE2' ' H ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -155.17 126.17 7.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.498 ' H ' ' NE2' ' A' ' 106' ' ' GLN . 2.0 m-85 -132.16 148.32 52.47 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.0 t -104.61 104.98 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.149 -0.932 . . . . 1.0 108.807 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -99.76 123.17 43.75 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.407 ' C ' ' H ' ' A' ' 112' ' ' GLY . 65.9 mtt 42.7 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.538 0.569 . . . . 1.0 112.538 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 54.96 7.8 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.757 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 110' ' ' MET . . . 75.29 24.02 72.18 Favored Glycine 0 N--CA 1.462 0.427 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -56.99 -39.47 74.72 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.046 -0.353 . . . . 1.0 110.046 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.8 tp -129.78 128.36 42.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -108.65 119.4 39.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.102 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.31 112.63 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.1 pt -115.08 158.66 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-N 115.144 -0.935 . . . . 1.0 108.954 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -115.44 95.05 0.69 Allowed Glycine 0 N--CA 1.474 1.205 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.76 -173.46 4.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -146.42 156.21 43.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.641 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -69.14 127.93 34.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.233 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.6 p -169.35 33.83 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.676 0.274 . . . . 1.0 110.448 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 29.6 p 51.6 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.653 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -179.88 -29.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.671 0.607 . . . . 1.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtm -55.38 -48.43 74.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.916 0.389 . . . . 1.0 110.923 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.402 ' O ' ' NE ' ' A' ' 130' ' ' ARG . 51.6 tt0 -55.29 -30.08 59.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 m -86.15 -51.79 6.08 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.965 0.412 . . . . 1.0 111.937 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.85 -43.33 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.199 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.33 -57.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.739 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 126' ' ' GLN . 18.1 ptp180 -69.2 -33.93 74.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.478 0.548 . . . . 1.0 112.478 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.17 -46.28 86.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.011 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.73 -65.38 1.15 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.78 0.324 . . . . 1.0 111.86 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 p -60.68 172.68 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.706 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -157.69 23.49 0.28 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.2 tp -158.69 138.03 11.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.85 155.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.08 102.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 81.9 p -89.71 113.24 24.72 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.42 0.629 . . . . 1.0 109.667 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.401 ' O ' ' N ' ' A' ' 141' ' ' GLY . 59.7 t-80 -69.69 136.44 51.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.24 -63.87 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.394 0.887 . . . . 1.0 113.394 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 139' ' ' HIS . . . -167.94 -80.44 0.04 OUTLIER Glycine 0 C--N 1.345 1.05 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.0 p 56.55 166.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.741 0.781 . . . . 1.0 110.76 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.35 -15.51 80.85 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 114.542 -1.208 . . . . 1.0 110.966 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 91.5 p -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.053 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.01 -27.09 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.606 -0.438 . . . . 1.0 112.033 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 51.1 tp -57.02 -48.0 79.55 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.27 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -68.87 -51.99 34.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.631 . . . . 1.0 110.364 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.2 m -51.18 -25.22 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.766 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -77.01 -46.41 23.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.857 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -67.54 -32.83 73.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.54 -0.755 . . . . 1.0 111.24 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.75 -9.67 58.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 61.9 t30 54.88 35.27 23.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -109.46 151.28 42.07 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-O 119.294 -0.384 . . . . 1.0 110.393 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -43.13 143.59 1.96 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.007 1.804 . . . . 1.0 112.017 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 52.3 tp -152.88 134.71 14.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.69 129.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.942 0.777 . . . . 1.0 109.013 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.17 130.53 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 117.986 0.357 . . . . 1.0 110.069 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 71.0 m -83.35 103.4 12.69 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.164 0.507 . . . . 1.0 109.663 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.36 143.41 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 160' ' ' ASN . 0.2 OUTLIER -147.62 175.32 10.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.936 0.398 . . . . 1.0 110.028 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -61.69 171.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.624 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.6 p -62.3 96.46 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.179 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 tp -66.38 -164.85 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.144 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.8 ttp -62.34 -52.47 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.835 0.35 . . . . 1.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 167' ' ' HIS . 75.9 m-20 -71.05 -42.7 69.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.115 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.71 0.86 0.16 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.287 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 165' ' ' ASP . 34.6 m170 -73.55 -35.91 65.56 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.93 0.395 . . . . 1.0 110.459 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -65.29 -50.88 64.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.642 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.3 -33.32 74.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.441 . . . . 1.0 110.207 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.04 -52.43 65.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.707 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.85 -36.01 67.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.568 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.102 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -49.32 -28.58 5.02 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.25 0.548 . . . . 1.0 110.423 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -85.43 -45.74 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.014 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.01 -20.51 60.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.258 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 180' ' ' TYR . 14.3 p -62.17 -52.08 64.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.976 0 C-N-CA 121.02 -0.272 . . . . 1.0 110.532 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 179' ' ' GLY . 57.7 mt-10 -58.79 -19.6 42.4 Favored 'General case' 0 CA--C 1.522 -0.11 0 O-C-N 121.931 -0.481 . . . . 1.0 111.048 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.77 3.2 0.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.676 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 177' ' ' GLU . . . 144.64 10.37 0.33 Allowed Glycine 0 N--CA 1.474 1.201 0 N-CA-C 111.089 -0.805 . . . . 1.0 111.089 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 176' ' ' VAL . 27.5 t80 72.23 100.38 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 1.0 109.237 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 182' ' ' TRP . 11.8 p -92.79 58.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.594 0.235 . . . . 1.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 181' ' ' VAL . 4.3 m-90 33.03 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.044 0.449 . . . . 1.0 110.303 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 93.8 p -88.08 132.75 34.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.95 142.55 46.8 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -111.31 155.86 42.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 119.158 -0.448 . . . . 1.0 110.755 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.32 37.73 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.785 1.656 . . . . 1.0 113.214 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 185' ' ' ALA . 73.5 p -131.32 143.09 50.25 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 24.8 mp0 -64.53 -46.33 83.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.474 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.0 m -64.4 -28.57 69.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.581 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.53 -31.89 17.53 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.45 -47.34 79.45 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 111.778 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.0 pt -52.66 -34.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.022 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.96 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.3 98.39 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 49.8 mt -64.66 -35.42 80.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.932 0.396 . . . . 1.0 110.359 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -69.89 -37.36 75.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.421 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -70.28 -44.95 67.32 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.062 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -66.58 -30.09 70.31 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.002 0.371 . . . . 1.0 112.002 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -86.16 11.67 11.39 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.176 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.2 p -146.37 -64.3 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.519 -0.31 . . . . 1.0 110.242 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.6 mt-10 -71.63 129.21 38.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.748 0.308 . . . . 1.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.07 170.84 8.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.83 138.49 54.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -57.49 143.25 75.22 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.11 100.35 1.37 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.719 1.613 . . . . 1.0 111.964 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -142.02 82.87 13.08 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.85 112.64 1.16 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.914 1.742 . . . . 1.0 111.873 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.34 -73.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.515 -0.474 . . . . 1.0 110.073 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 47.1 m 51.96 97.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.015 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.645 ' ND1' ' H ' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -163.51 -36.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.619 0.247 . . . . 1.0 111.107 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.645 ' H ' ' ND1' ' A' ' 210' ' ' HIS . 1.5 p-10 -173.46 61.76 0.26 Allowed Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.67 -89.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 121.647 1.565 . . . . 1.0 111.688 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 93.4 p -76.25 -1.24 25.53 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.116 0.484 . . . . 1.0 110.495 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -64.47 -32.6 74.3 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.591 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.503 ' CG ' ' H ' ' A' ' 216' ' ' ARG . 7.0 pt-20 -62.33 -58.51 7.42 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.646 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.503 ' H ' ' CG ' ' A' ' 215' ' ' GLU . 17.2 ptm180 -63.52 -34.89 78.77 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.068 0.461 . . . . 1.0 110.245 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 59.9 tp -51.21 -47.1 62.38 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.5 mt -59.3 -38.66 80.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.146 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.76 -51.51 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.14 -30.34 70.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.556 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 28.2 m -60.65 -49.6 76.87 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.767 0.318 . . . . 1.0 110.6 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 39.8 pt -78.9 149.85 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.249 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -66.1 134.09 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.926 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 118.153 -0.927 . . . . 1.0 110.425 179.736 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.573 -1.411 . . . . 1.0 109.573 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.409 ' H ' HD11 ' A' ' 25' ' ' ILE . 3.6 mp -64.1 -43.33 97.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.86 0.362 . . . . 1.0 110.318 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.9 mt -61.4 -43.51 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.191 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -142.32 143.19 32.67 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.938 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -167.58 -61.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -128.42 142.23 51.17 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.076 0.465 . . . . 1.0 110.167 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.28 167.4 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.85 120.19 19.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -118.73 133.56 55.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.403 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.7 140.29 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 t -143.96 141.24 30.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.034 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.8 m -83.19 143.51 30.43 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.675 ' H ' ' NE2' ' A' ' 139' ' ' HIS . . . -71.01 62.12 0.97 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.36 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.791 0.348 . . . . 1.0 110.775 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.4 p 53.18 100.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -59.68 125.36 79.76 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.035 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.71 -54.68 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.021 1.147 . . . . 1.0 111.927 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.417 ' CE2' ' OD1' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -142.76 144.54 30.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.92 -7.71 15.48 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.968 1.778 . . . . 1.0 111.545 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -66.99 -46.09 75.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.781 0.324 . . . . 1.0 111.083 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.67 -40.98 98.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.78 0.324 . . . . 1.0 110.617 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.23 -44.63 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.6 t -54.82 -48.2 73.11 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.166 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.3 m -51.65 -49.8 61.58 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.272 -0.267 . . . . 1.0 111.369 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 30.0 m -78.94 5.79 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.672 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.04 30.96 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.598 ' HG ' ' H ' ' A' ' 51' ' ' ASP . 14.3 t -119.23 -164.12 1.03 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.598 ' H ' ' HG ' ' A' ' 50' ' ' SER . 76.1 m-20 -50.83 -42.42 58.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.922 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -62.76 -53.82 48.5 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 121.171 0.51 . . . . 1.0 110.218 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 54.6 t80 -61.99 -45.43 93.66 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.244 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 89.4 m -51.94 -49.62 62.77 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.32 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 78.0 mt-30 -73.14 -52.3 14.72 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.077 0.465 . . . . 1.0 110.593 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -57.02 -24.94 57.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.694 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.15 -45.32 95.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 1.0 110.018 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.42 -43.39 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.747 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.418 ' OE1' ' N ' ' A' ' 59' ' ' GLN . 1.1 mp0 -55.56 -16.83 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.469 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -98.5 -19.06 17.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.371 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 102.65 40.52 2.52 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 118.111 -1.383 . . . . 1.0 111.676 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 61' ' ' GLY . 13.3 p90 -13.22 146.57 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 124.33 1.052 . . . . 1.0 112.143 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.8 t -146.86 -78.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.777 0.717 . . . . 1.0 109.583 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -151.82 110.68 3.84 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.4 tp -92.25 127.6 37.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.03 146.31 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.6 tt -138.75 141.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.473 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 9.8 tp-100 -70.18 -86.38 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.528 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 t80 50.89 -174.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.249 0.219 . . . . 1.0 110.491 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.56 76.03 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -67.18 175.99 2.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.894 0.378 . . . . 1.0 110.039 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -61.61 -29.86 70.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.392 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -60.09 -21.58 61.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.255 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m 53.3 -95.8 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.055 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 t 56.83 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.159 0.504 . . . . 1.0 111.166 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 78' ' ' GLU . 75.2 mt-10 -79.4 132.45 36.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.116 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD2' ' CZ ' ' A' ' 98' ' ' PHE . 54.5 t80 -78.07 12.51 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.211 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 76' ' ' GLU . 78.8 tt0 62.58 137.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.74 0.65 . . . . 1.0 109.745 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -67.83 66.1 0.09 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.928 0.394 . . . . 1.0 110.05 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 -57.53 3.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.323 0.582 . . . . 1.0 111.618 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.7 m -57.43 -43.3 82.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.538 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.31 -39.83 95.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.298 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -52.45 -46.03 66.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.998 0.428 . . . . 1.0 110.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' NH2' ' OG ' ' A' ' 50' ' ' SER . 30.3 mmt180 -71.66 -16.44 62.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.06 59.65 1.94 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.61 -168.02 39.61 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 110.087 -1.205 . . . . 1.0 110.087 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -133.35 127.72 34.11 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 113.1 24.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.728 0.299 . . . . 1.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -84.2 -76.51 0.3 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.095 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.3 m -70.74 140.97 51.52 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.405 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -170.6 132.26 0.94 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -138.82 -91.85 0.19 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.403 0.281 . . . . 1.0 110.375 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.93 156.45 25.66 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-O 118.796 -0.621 . . . . 1.0 109.502 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -35.26 159.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.645 2.23 . . . . 1.0 113.785 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 tt -58.14 -24.49 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.678 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -51.53 179.85 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.7 -0.227 . . . . 1.0 110.45 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 80.02 -40.85 0.21 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.905 -0.406 . . . . 1.0 109.905 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.47 ' CZ ' ' CD2' ' A' ' 77' ' ' PHE . 61.6 t80 -126.44 -18.61 4.83 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.483 0.313 . . . . 1.0 110.991 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.23 3.16 60.58 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.221 -0.751 . . . . 1.0 111.221 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.471 ' C ' ' HH ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -151.71 -10.14 0.21 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 110.009 -0.367 . . . . 1.0 110.009 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.45 -130.91 1.53 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.651 -0.979 . . . . 1.0 110.651 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' O ' ' NE ' ' A' ' 105' ' ' ARG . 22.1 p-10 -164.02 -175.57 4.1 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -38.24 -33.82 0.11 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.543 0.527 . . . . 1.0 111.233 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.85 93.76 4.58 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 98' ' ' PHE . 7.2 ptp85 -141.35 154.15 45.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.682 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -156.18 131.62 9.48 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.349 -0.611 . . . . 1.0 109.349 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.471 ' HH ' ' C ' ' A' ' 100' ' ' CYS . 9.9 m-85 -132.1 143.77 50.24 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.465 -0.569 . . . . 1.0 109.465 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -127.88 140.57 48.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 111' ' ' ASN . 10.9 mp -101.61 147.96 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.2 mtp 46.66 -89.74 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.442 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 109' ' ' LEU . 16.9 m120 -155.86 81.5 1.01 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.804 0.335 . . . . 1.0 110.476 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.74 23.3 75.39 Favored Glycine 0 N--CA 1.469 0.853 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -73.14 -75.05 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.571 -0.37 . . . . 1.0 110.671 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.92 126.96 53.63 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.476 0.485 . . . . 1.0 109.947 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -105.64 101.25 10.78 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.473 -0.195 . . . . 1.0 110.473 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.05 109.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -117.53 139.6 15.03 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 109.914 -1.275 . . . . 1.0 109.914 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -170.11 140.82 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -160.52 155.97 25.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.013 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.401 ' O ' ' N ' ' A' ' 123' ' ' THR . 82.7 t80 -161.16 98.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.289 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 64.35 -67.52 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.525 0.516 . . . . 1.0 110.819 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PHE . 30.3 m -154.78 121.65 5.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -148.6 5.48 0.7 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 125' ' ' MET . 3.9 mpp? -59.22 -57.25 13.86 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.17 -29.01 65.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.951 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.3 m -70.85 -43.4 68.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.435 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.8 -50.05 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 1.0 112.367 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 133' ' ' SER . 1.2 pp -63.78 -54.02 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.926 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -47.03 -37.36 9.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.072 -0.393 . . . . 1.0 111.068 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.94 -48.22 78.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.12 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -100.22 -64.25 1.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.811 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 129' ' ' ILE . 34.2 p 57.09 74.26 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -134.8 -44.87 0.73 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.956 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.9 tp -169.13 151.03 4.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.68 146.51 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.18 105.73 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 138.13 40.34 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.675 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -60.11 -169.65 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.042 0.449 . . . . 1.0 110.176 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.17 45.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.431 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 139' ' ' HIS . . . -62.38 -128.11 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.7 m -163.44 -50.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.576 -0.367 . . . . 1.0 110.771 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.73 -52.51 5.86 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 92.1 p -55.15 -42.69 73.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.743 0.306 . . . . 1.0 110.88 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.74 -49.69 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.6 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.59 -31.24 6.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.001 0.188 . . . . 1.0 111.403 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.27 -50.79 29.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.999 0.428 . . . . 1.0 110.287 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.888 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.36 -46.64 31.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.764 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.98 -37.39 86.94 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.876 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.07 -11.61 59.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.61 36.51 26.83 Favored 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 123.473 0.483 . . . . 1.0 110.049 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -122.95 147.16 50.55 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.925 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -45.19 165.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.205 1.936 . . . . 1.0 112.47 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 59.9 tp -152.03 140.73 20.86 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.039 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.09 123.83 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -116.0 133.3 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 117.801 0.273 . . . . 1.0 111.169 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 77.4 m -72.66 105.13 4.15 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.28 141.52 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.874 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.56 -157.16 0.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.064 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 t70 58.34 21.29 8.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.451 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.5 m -85.75 90.15 7.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.687 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.55 -41.19 98.44 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.897 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' ASN . 43.3 ttp -130.1 -53.05 1.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.506 0.322 . . . . 1.0 110.755 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.417 ' OD1' ' CE2' ' A' ' 41' ' ' PHE . 4.0 p-10 -66.72 69.61 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.138 0.494 . . . . 1.0 110.635 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 164' ' ' MET . 76.7 m-20 -65.45 -25.82 67.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.383 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -51.18 -32.3 22.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.839 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.509 ' NE2' ' CD2' ' A' ' 139' ' ' HIS . 19.6 mm100 -60.7 -47.79 84.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.529 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -69.1 -30.14 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.487 0.184 . . . . 1.0 111.013 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.14 -54.16 45.08 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.02 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 175' ' ' PHE . 17.0 tt -68.61 -34.85 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.25 -65.04 0.63 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.294 0.569 . . . . 1.0 110.623 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.02 -34.26 28.71 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.065 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.04 -31.44 56.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.407 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' ILE . 3.5 t80 -63.19 -47.13 83.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.849 0.357 . . . . 1.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.53 -44.64 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -54.75 -46.85 74.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.113 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.33 9.47 42.99 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.071 0.462 . . . . 1.0 110.365 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 173.66 91.11 0.08 OUTLIER Glycine 0 C--O 1.212 -1.239 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -49.51 70.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.086 0.954 . . . . 1.0 111.174 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.6 p -73.8 141.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.889 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -59.25 114.04 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.263 0.554 . . . . 1.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.5 t -87.0 135.96 33.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.443 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.62 170.79 17.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.23 74.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.622 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.62 57.49 1.42 Allowed 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.558 2.172 . . . . 1.0 112.882 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.9 p -131.65 147.05 52.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -59.48 -51.91 67.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.616 0.245 . . . . 1.0 111.19 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 26.1 m -65.27 -24.86 67.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.925 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.04 -36.02 8.61 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 116.183 -0.462 . . . . 1.0 112.087 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -40.97 85.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 117.235 0.518 . . . . 1.0 111.556 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.0 pt -55.58 -34.66 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 1.0 110.833 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.7 78.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.189 0.518 . . . . 1.0 109.775 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.78 -46.16 94.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.236 -0.746 . . . . 1.0 111.236 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.92 -44.13 97.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.912 0.356 . . . . 1.0 110.312 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -63.32 -52.14 63.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.623 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.56 71.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.177 -0.305 . . . . 1.0 110.177 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 97.1 p -60.48 -34.05 73.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.965 -0.294 . . . . 1.0 111.304 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -102.64 32.8 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 1.0 111.135 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 19.6 m -159.84 -29.17 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.159 -0.338 . . . . 1.0 110.607 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -108.75 152.13 25.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -122.21 170.82 9.51 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.6 tp -119.73 136.24 54.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -62.61 152.25 81.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.196 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -37.9 109.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.826 2.35 . . . . 1.0 112.554 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 206' ' ' PHE . 0.1 OUTLIER -61.53 151.75 76.62 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.332 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.03 -8.01 18.59 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.961 1.774 . . . . 1.0 111.705 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.7 p -49.96 132.57 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.608 0.242 . . . . 1.0 111.06 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.9 t -78.54 -74.73 0.26 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.449 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.628 ' CG ' ' H ' ' A' ' 211' ' ' ASN . 35.2 t60 -163.87 -150.87 0.16 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.628 ' H ' ' CG ' ' A' ' 210' ' ' HIS . 0.6 OUTLIER 34.62 63.46 1.92 Allowed Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 123.111 0.564 . . . . 1.0 111.072 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.79 -79.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.489 2.126 . . . . 1.0 112.032 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.4 m -60.0 -15.63 24.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.546 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.0 -51.99 65.8 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -51.24 -35.25 36.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.759 0.314 . . . . 1.0 110.689 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -59.81 -43.18 94.61 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 120.933 0.397 . . . . 1.0 110.191 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.1 tt -50.14 -37.32 33.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.875 0.369 . . . . 1.0 111.275 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 48.2 mt -60.88 -30.22 70.02 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.473 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.86 -47.42 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.49 -31.46 72.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.458 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 223' ' ' TYR . 19.9 m -60.75 -43.24 98.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.613 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.9 mt 58.77 -83.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.95 -0.568 . . . . 1.0 109.735 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 221' ' ' THR . 74.8 t80 -67.09 102.69 1.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.284 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.959 -1.02 . . . . 1.0 110.513 179.701 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 mt -63.59 -47.64 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.5 mt -131.86 -23.01 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.452 ' CD ' ' HZ2' ' A' ' 115' ' ' LYS . 67.8 mt-10 -66.82 88.68 0.15 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.613 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -92.39 -73.4 0.55 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.3 110.87 7.03 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.4 125.11 52.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.844 0.458 . . . . 1.0 109.991 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 mp -91.73 107.19 19.04 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.188 0.518 . . . . 1.0 109.63 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -85.07 125.81 33.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.081 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.91 130.09 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -145.52 136.68 24.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.74 -26.6 31.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.451 . . . . 1.0 109.835 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.25 -112.09 3.93 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.95 -156.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.571 0.224 . . . . 1.0 110.627 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.507 ' HG1' ' H ' ' A' ' 39' ' ' VAL . 1.8 t -53.6 170.53 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.507 ' H ' ' HG1' ' A' ' 38' ' ' THR . 16.7 t -139.67 82.75 17.65 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.62 16.37 1.97 Allowed 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.481 2.121 . . . . 1.0 111.702 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.08 65.0 28.28 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.98 -17.55 41.09 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.028 1.818 . . . . 1.0 111.941 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -79.99 -30.85 39.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.499 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.47 -44.92 56.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.797 0.332 . . . . 1.0 110.645 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 -29.41 46.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.029 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.5 p -51.31 -38.47 53.15 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.118 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -47.33 -28.34 1.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 1.0 110.605 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -92.23 -23.91 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.839 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 46' ' ' SER . 0.7 OUTLIER -120.67 24.79 10.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.968 0.507 . . . . 1.0 110.194 -177.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 46' ' ' SER . 40.3 t -104.72 -161.76 0.84 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.459 ' N ' ' OG ' ' A' ' 50' ' ' SER . 63.0 m-20 -71.27 -28.52 64.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.28 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.59 -51.51 69.51 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.855 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.7 t80 -70.14 -39.15 75.56 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.185 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.7 t -52.67 -46.2 67.12 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.678 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -71.66 -44.14 64.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.113 0.482 . . . . 1.0 110.586 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -68.41 -26.45 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' PHE . 56.1 tp -57.19 -44.64 83.78 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.11 -33.63 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -34.56 75.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.43 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -72.31 -18.89 61.75 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.71 34.38 2.85 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 37.33 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.862 0.465 . . . . 1.0 111.462 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.86 -95.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 122.618 0.367 . . . . 1.0 110.36 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -168.42 149.87 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -130.29 118.07 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.98 132.01 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 tp -114.56 141.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -166.51 -166.98 0.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.03 164.49 32.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.38 -35.35 90.86 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.53 147.65 51.61 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.993 0.425 . . . . 1.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -62.96 -35.18 79.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.274 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -60.95 -49.18 78.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 96.5 p -77.27 102.05 6.53 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.186 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.4 p -169.98 88.91 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.992 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.28 -87.11 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 47.24 94.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.819 0.343 . . . . 1.0 110.145 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.87 -70.83 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.161 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -174.66 66.0 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.837 0.351 . . . . 1.0 110.318 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.34 -41.39 98.87 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.829 0.347 . . . . 1.0 110.339 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 m -60.23 -45.86 95.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.863 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -66.53 -46.89 74.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.794 0.33 . . . . 1.0 110.84 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -55.52 -45.66 77.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.932 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' NH1' ' OG ' ' A' ' 50' ' ' SER . 0.4 OUTLIER -74.16 -17.16 60.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.475 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.96 50.32 3.96 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.12 177.49 54.3 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 109.487 -1.445 . . . . 1.0 109.487 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -124.44 121.98 36.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -63.45 159.81 17.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.881 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -131.27 -178.8 5.0 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t -58.89 141.89 52.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.563 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -151.91 143.11 23.27 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -80.5 -73.8 0.35 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.629 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.7 pp -59.67 151.56 61.64 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.95 -0.548 . . . . 1.0 110.221 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -42.26 174.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.42 2.08 . . . . 1.0 113.311 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.6 tp -64.53 -39.71 86.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.28 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 98' ' ' PHE . 88.5 m-20 48.94 55.38 9.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 50.52 -90.09 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.128 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.53 ' CE2' ' NE ' ' A' ' 105' ' ' ARG . 59.4 t80 -127.38 28.93 5.62 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.322 0.649 . . . . 1.0 110.133 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 22.3 74.63 Favored Glycine 0 N--CA 1.469 0.839 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 28.2 p -61.13 133.54 56.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.636 0.255 . . . . 1.0 110.463 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.07 -4.25 11.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -153.65 87.55 1.24 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.87 0.367 . . . . 1.0 110.058 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.8 p -61.04 103.4 0.27 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.333 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -171.02 67.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.016 0.436 . . . . 1.0 110.196 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.53 ' NE ' ' CE2' ' A' ' 98' ' ' PHE . 27.9 ptt-85 -131.36 161.72 31.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.821 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -155.95 119.61 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.75 159.84 40.06 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.52 143.61 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.8 mm? -95.88 137.42 34.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.9 mmm 47.12 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.014 0.821 . . . . 1.0 111.272 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 109' ' ' LEU . 19.8 p-10 -156.83 70.46 0.64 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.973 0.416 . . . . 1.0 110.551 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.2 27.13 64.63 Favored Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.576 -0.61 . . . . 1.0 111.576 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -91.9 -7.14 50.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.826 0.313 . . . . 1.0 110.728 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.65 131.55 0.89 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 99.3 mttt -98.73 141.66 31.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.83 112.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.87 130.82 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.139 0.576 . . . . 1.0 109.82 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -22.97 68.87 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -117.71 169.52 9.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.875 0.47 . . . . 1.0 110.438 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -168.6 173.71 7.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.112 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 122' ' ' SER . 88.2 t80 -65.62 166.98 9.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.43 . . . . 1.0 109.843 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.478 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 40.7 t 53.15 96.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.807 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 89.9 m -58.71 164.86 2.52 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.5 tptm 68.86 108.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.431 0.457 . . . . 1.0 110.263 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 126' ' ' GLN . 0.0 OUTLIER -49.77 -36.74 27.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.122 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.471 ' N ' ' SD ' ' A' ' 125' ' ' MET . 57.8 tt0 -57.3 -32.37 66.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.2 m -78.72 -34.84 45.59 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.835 0.35 . . . . 1.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.379 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -58.29 -48.97 83.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -59.45 -44.9 92.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.59 -0.277 . . . . 1.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -53.26 -42.9 66.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.504 -0.317 . . . . 1.0 111.411 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -98.43 -68.45 0.8 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p 71.52 33.37 1.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.03 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.74 -66.4 0.91 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.198 -0.668 . . . . 1.0 109.198 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 44.3 tp -165.95 142.84 5.3 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.818 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.38 147.24 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.01 125.51 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.145 -1.058 . . . . 1.0 108.145 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.7 p -137.57 134.58 35.78 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.7 -34.53 58.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.65 34.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.669 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 143' ' ' GLY . . . -61.67 -37.01 93.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.412 ' OG1' ' NH1' ' A' ' 216' ' ' ARG . 3.5 m 65.19 -65.49 0.16 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.099 0.476 . . . . 1.0 111.021 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' GLY . . . -66.52 -32.68 82.38 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 44.8 m -73.92 -33.89 64.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.769 0.319 . . . . 1.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.4 -28.74 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 120.974 0.416 . . . . 1.0 110.769 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -47.91 -51.11 24.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.618 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -63.18 -44.47 95.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.314 0.578 . . . . 1.0 110.859 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.0 m -59.88 -24.62 64.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.479 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.36 -48.4 23.21 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.3 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -75.08 -22.47 58.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.832 -0.622 . . . . 1.0 111.35 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.87 -6.75 50.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 51.41 31.07 6.8 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.171 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.414 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 78.9 mttt -108.8 155.86 39.95 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 123.326 0.391 . . . . 1.0 110.026 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -42.66 139.27 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.683 1.589 . . . . 1.0 111.91 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -153.82 122.91 6.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 156' ' ' ILE . 0.1 OUTLIER -117.52 120.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.71 0.631 . . . . 1.0 109.731 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.08 115.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 94.7 m -72.33 102.5 3.15 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.29 137.07 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -130.48 171.98 12.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 29.0 p-10 -97.02 14.55 25.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.512 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 t -156.67 -136.49 0.05 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.563 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt 64.88 114.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 tpt 67.82 173.19 0.27 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.317 -0.402 . . . . 1.0 109.927 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.61 -65.6 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -154.22 9.41 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.814 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -62.97 -33.43 75.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.009 -0.367 . . . . 1.0 110.009 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.32 -38.52 77.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 1.0 110.412 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -78.45 -32.52 48.48 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.633 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.07 -50.2 67.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.707 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.88 -38.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.34 -56.33 4.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.196 0.998 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -49.84 -52.36 33.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.882 -1.053 . . . . 1.0 110.922 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.63 -30.88 70.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 1.0 110.478 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -74.89 -55.21 6.03 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.783 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.22 -25.89 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.692 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -48.55 -52.03 24.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.485 -0.932 . . . . 1.0 108.485 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.24 -29.96 70.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.701 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 129.75 81.53 0.27 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 112.106 -0.398 . . . . 1.0 112.106 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 36.6 46.88 0.48 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.62 0.724 . . . . 1.0 111.505 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 182' ' ' TRP . 2.5 p -48.12 -61.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.671 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . 0.509 ' CD1' ' O ' ' A' ' 181' ' ' VAL . 10.4 m0 -156.73 62.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.991 0.807 . . . . 1.0 110.377 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -111.93 130.43 55.85 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.363 -0.835 . . . . 1.0 108.99 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 49.2 t -164.26 127.44 2.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.071 -0.715 . . . . 1.0 109.071 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 153.14 70.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 110.686 -0.116 . . . . 1.0 110.686 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 84.26 0.45 Allowed 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.077 1.851 . . . . 1.0 112.588 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.9 m -132.19 148.82 52.48 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -48.19 -54.83 12.09 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.185 -0.206 . . . . 1.0 111.37 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.6 m -73.25 -44.98 58.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.986 0.422 . . . . 1.0 111.049 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -55.9 -44.81 87.47 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.029 -0.532 . . . . 1.0 112.427 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -40.98 71.36 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.93 0.365 . . . . 1.0 110.172 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.99 -45.44 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.29 66.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.017 0.437 . . . . 1.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -54.56 -40.19 69.06 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -47.94 71.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.454 0.645 . . . . 1.0 109.928 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -59.99 -45.65 92.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.859 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.13 -52.0 66.71 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.035 0.445 . . . . 1.0 110.946 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.409 ' O ' ' NZ ' ' A' ' 202' ' ' LYS . 39.9 p -65.09 -21.52 66.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.02 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -110.18 31.3 6.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.727 0.411 . . . . 1.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 56.3 m -145.88 -27.05 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.37 151.36 35.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 198' ' ' SER . 75.6 mmtt -128.29 142.99 50.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.918 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.18 -161.24 0.79 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.938 -0.574 . . . . 1.0 109.569 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -73.2 144.91 85.17 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.886 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.84 -47.19 27.7 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.527 1.485 . . . . 1.0 113.374 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -139.73 86.4 13.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.241 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.4 -64.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.039 1.826 . . . . 1.0 111.721 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.17 145.59 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m -80.06 27.08 0.32 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.075 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 210' ' ' HIS . 14.0 t-80 53.89 57.14 6.28 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.806 0.336 . . . . 1.0 111.485 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.511 ' N ' ' CD ' ' A' ' 212' ' ' PRO . 19.6 m120 -106.59 -37.41 0.17 Allowed Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.968 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 211' ' ' ASN . 51.4 Cg_exo -56.75 -49.83 13.47 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 121.818 1.679 . . . . 1.0 113.162 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 50.2 m -65.34 -47.79 75.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.994 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.74 -51.45 64.9 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 120.772 0.32 . . . . 1.0 110.357 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -48.52 -43.25 35.11 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.86 0.362 . . . . 1.0 110.844 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.412 ' NH1' ' OG1' ' A' ' 142' ' ' THR . 41.8 mmm-85 -64.96 -39.27 93.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.855 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.6 tp -53.68 -41.71 67.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.941 0.401 . . . . 1.0 110.293 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.02 -28.77 68.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.505 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.4 t -75.34 -49.4 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.845 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -67.51 -12.49 60.46 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.198 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 26.0 m -63.22 -41.01 99.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.359 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 45.0 pt 38.71 32.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.071 0.548 . . . . 1.0 111.449 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -159.71 159.22 32.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.248 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.7 t . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.022 -0.99 . . . . 1.0 111.565 179.695 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 109.099 -1.6 . . . . 1.0 109.099 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 tp -65.12 140.77 19.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.952 0.406 . . . . 1.0 110.002 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.65 49.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.667 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -65.4 115.07 5.28 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -133.51 -117.39 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -76.53 94.8 3.77 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.707 0.289 . . . . 1.0 110.913 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.33 166.26 12.17 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.2 mt -132.26 101.0 5.19 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.495 ' CD1' ' OH ' ' A' ' 132' ' ' TYR . 6.1 m-85 -95.0 127.12 40.81 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.023 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 137' ' ' ILE . 5.5 p -127.21 125.68 66.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.7 p -143.52 137.38 28.43 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.254 -0.884 . . . . 1.0 109.46 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.8 m -103.45 140.32 37.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.0 -89.48 0.03 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.263 -0.735 . . . . 1.0 111.263 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.56 -78.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.867 0.365 . . . . 1.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -167.12 160.51 13.96 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.297 -0.41 . . . . 1.0 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.16 144.49 87.35 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.744 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.78 -46.6 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.966 1.777 . . . . 1.0 111.054 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -139.32 160.72 60.85 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 123.069 0.23 . . . . 1.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.17 -10.62 29.49 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 122.089 1.859 . . . . 1.0 112.011 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -73.96 -29.56 62.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.876 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.15 -53.84 47.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.072 -0.251 . . . . 1.0 110.897 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.92 -42.67 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.711 0.291 . . . . 1.0 110.581 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.2 t -51.95 -53.19 44.23 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.102 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 53' ' ' PHE . 90.9 m -47.21 -36.14 8.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.771 -0.195 . . . . 1.0 111.294 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.9 t -72.8 -26.18 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 120.775 0.321 . . . . 1.0 111.439 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.24 33.28 3.09 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.365 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.2 t -98.35 -173.71 2.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' N ' ' OG ' ' A' ' 50' ' ' SER . 11.5 m-20 -56.38 -27.64 56.83 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.374 -1.284 . . . . 1.0 110.904 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -71.81 -53.56 12.94 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.669 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 47' ' ' CYS . 3.3 m-85 -68.55 -37.67 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.146 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 93.7 m -53.2 -45.9 68.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.639 0.256 . . . . 1.0 111.039 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.92 -40.96 71.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -67.99 -27.79 66.87 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -60.22 -39.41 86.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.358 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mm -48.89 -41.12 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.564 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -65.97 -40.94 91.72 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.303 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -65.43 -23.28 66.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.027 -0.36 . . . . 1.0 110.027 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' C ' ' CG ' ' A' ' 62' ' ' PHE . . . 93.49 20.3 32.56 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.784 -0.526 . . . . 1.0 111.784 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CG ' ' C ' ' A' ' 61' ' ' GLY . 1.4 p90 43.02 78.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 117.801 0.801 . . . . 1.0 111.024 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.7 -85.76 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -168.81 135.05 1.78 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 tt -133.25 131.39 40.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.47 127.33 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -108.48 132.35 56.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -146.65 153.99 40.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.22 -151.33 0.39 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.012 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.94 -114.94 0.01 OUTLIER Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 72' ' ' ASN . 35.6 ttt180 -165.58 -149.96 0.12 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.231 -0.57 . . . . 1.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.417 ' H ' ' HG2' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -59.51 -41.63 90.34 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.136 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.7 t -140.7 132.45 27.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.195 -0.457 . . . . 1.0 109.99 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 m -157.99 163.12 38.1 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.31 23.67 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.845 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -67.53 85.18 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 80' ' ' LEU . 70.8 mm-40 -61.91 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.657 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.532 ' N ' ' NE2' ' A' ' 97' ' ' GLN . 22.4 p80 -73.89 33.6 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.741 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 78' ' ' GLU . 1.9 pp -62.46 -32.47 73.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 1.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.2 t -62.81 -51.55 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.859 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -72.85 -32.51 65.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.279 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -50.96 -43.98 60.5 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.22 -0.445 . . . . 1.0 109.819 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.437 ' NE ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -79.37 -16.23 56.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.051 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.84 28.87 5.76 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.97 158.17 53.47 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -134.63 128.93 34.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.841 0.353 . . . . 1.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -52.82 159.93 1.03 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.99 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.43 152.07 37.47 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m 57.55 -130.95 1.48 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.145 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -61.79 115.86 4.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -89.06 99.37 12.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.34 98.41 2.34 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 110.162 -0.311 . . . . 1.0 110.162 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.74 116.02 1.57 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.607 1.538 . . . . 1.0 110.173 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.3 pt -92.89 -18.13 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.347 0.594 . . . . 1.0 109.933 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 98' ' ' PHE . 65.3 m-20 -156.29 41.05 0.37 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.914 -1.039 . . . . 1.0 111.299 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 79' ' ' HIS . 12.5 tt0 63.39 -1.52 0.56 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.533 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -72.98 -22.04 60.75 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.106 -0.331 . . . . 1.0 110.106 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.09 48.06 12.02 Favored Glycine 0 N--CA 1.465 0.597 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 47.2 t -55.69 129.61 39.88 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.736 0.303 . . . . 1.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.21 164.71 36.65 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.701 -0.96 . . . . 1.0 110.701 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 103' ' ' THR . 53.6 t0 54.54 -129.85 2.15 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.801 -0.199 . . . . 1.0 110.497 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 82.0 p -66.78 -39.05 87.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.699 0.285 . . . . 1.0 110.322 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -170.27 -74.38 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.321 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.4 mmt-85 -123.42 119.19 29.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -160.69 119.44 2.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.275 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.44 161.42 27.12 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.31 135.77 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -95.35 133.88 38.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.439 . . . . 1.0 109.964 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.4 mmm 50.01 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.924 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -148.94 48.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.383 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 27.45 29.14 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 111.955 -0.458 . . . . 1.0 111.955 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.4 -12.27 54.74 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.3 tp -168.0 137.34 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -102.98 140.39 37.31 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.62 142.19 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.078 -1.082 . . . . 1.0 108.078 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' ILE . 18.9 pt -142.53 131.14 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.99 -139.72 0.04 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CE2' ' O ' ' A' ' 120' ' ' ASP . 78.5 t80 -57.73 161.31 3.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.921 0.391 . . . . 1.0 110.498 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' CE2' ' A' ' 119' ' ' PHE . 54.3 p-10 -153.64 -177.06 6.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.076 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -65.16 153.97 39.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 79.5 p -59.3 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.917 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.7 m -61.65 106.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -168.01 -54.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.343 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 52.5 mtm -44.99 -45.88 10.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 1.0 111.572 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -59.25 -31.1 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.737 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -80.57 -52.28 7.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.798 0.332 . . . . 1.0 111.813 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.69 -43.72 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.876 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -54.06 -53.2 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.23 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -51.1 -30.04 14.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.521 0.201 . . . . 1.0 111.06 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.86 -42.47 58.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.688 -0.233 . . . . 1.0 110.9 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.58 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.1 p90 -123.1 -51.88 1.88 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.58 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 82.8 p 48.65 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.943 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -137.22 -52.39 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.2 tp -167.35 148.14 5.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.6 151.55 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 73.7 mt -117.71 115.63 49.17 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 108.177 -1.046 . . . . 1.0 108.177 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.9 p -85.21 -161.38 0.58 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -159.74 83.97 0.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 52.28 17.61 0.76 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.81 -147.88 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -164.01 -60.6 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 -26.68 73.9 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 123.792 0.683 . . . . 1.0 111.946 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.5 m -70.3 -36.62 74.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.681 0.277 . . . . 1.0 111.313 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.18 -40.61 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.847 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -50.09 -40.84 46.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.798 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -52.11 66.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.512 0.672 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.8 p -70.36 -22.62 62.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.239 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.23 -53.32 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.157 0.428 . . . . 1.0 112.157 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -67.29 -31.75 72.28 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.583 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 mp -70.04 -1.63 10.42 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 58.53 34.03 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.391 0.432 . . . . 1.0 110.6 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 97.8 mttt -113.2 126.32 28.38 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.44 157.15 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.416 1.41 . . . . 1.0 111.941 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.4 tt -152.44 144.39 23.73 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.272 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 156' ' ' ILE . 0.0 OUTLIER -111.31 116.55 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.71 117.32 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 57.2 m -74.07 104.35 4.86 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.427 -0.582 . . . . 1.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.01 138.51 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -160.24 -165.51 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.827 0.346 . . . . 1.0 110.174 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -65.34 -168.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.422 ' HG ' HE21 ' A' ' 169' ' ' GLN . 46.6 m -156.72 81.35 0.95 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.956 0.407 . . . . 1.0 109.927 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -35.36 12.66 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.797 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.1 mmt -82.51 36.15 0.47 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.193 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 167' ' ' HIS . 25.6 t70 54.89 31.23 15.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.663 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.02 74.89 0.08 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.068 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' ASP . 85.2 t60 -57.93 -30.38 65.89 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.995 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -49.72 -40.28 40.11 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.15 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.17 -46.56 86.58 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -45.41 -37.45 5.1 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.09 -42.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.148 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -48.99 -60.58 2.65 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.867 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.74 -25.19 62.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.049 0.452 . . . . 1.0 110.393 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -72.58 -53.69 11.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.472 -0.785 . . . . 1.0 110.446 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 179' ' ' GLY . 58.0 t80 -64.47 -34.91 79.31 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.29 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.6 t -54.86 -56.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.281 0.363 . . . . 1.0 110.189 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.03 -30.63 15.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.149 -0.62 . . . . 1.0 109.939 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.26 21.32 12.77 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.499 -0.773 . . . . 1.0 113.013 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 175' ' ' PHE . . . -151.37 -24.63 0.05 OUTLIER Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 180' ' ' TYR . 73.1 t80 54.42 23.52 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 109.879 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 182' ' ' TRP . 3.2 p -50.18 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.19 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . 0.56 ' C ' ' O ' ' A' ' 181' ' ' VAL . 7.0 m-90 -9.74 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 124.004 0.815 . . . . 1.0 109.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 88.9 p -86.74 134.83 33.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.829 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -125.02 156.9 37.42 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.24 -0.891 . . . . 1.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.38 154.04 76.73 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.643 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.41 58.34 0.48 Allowed 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.588 2.192 . . . . 1.0 112.358 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 m -135.72 147.16 48.36 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.62 -48.71 28.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.0 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 13.3 t -69.68 -44.18 71.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.027 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -51.75 -51.66 37.96 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.245 -0.434 . . . . 1.0 112.134 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.78 -43.63 90.49 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.45 0.147 . . . . 1.0 110.63 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.14 -44.73 80.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.612 0.244 . . . . 1.0 110.46 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -54.1 -56.68 15.81 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.873 0.324 . . . . 1.0 111.873 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -58.53 -30.27 64.97 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -48.07 63.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.983 0.42 . . . . 1.0 110.54 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -64.22 -40.64 96.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.71 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.74 88.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.2 m -71.27 -23.26 61.94 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.967 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -105.0 30.76 5.29 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.899 0.381 . . . . 1.0 110.753 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.1 p -141.7 -21.25 0.73 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.29 153.23 27.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.07 0.462 . . . . 1.0 109.771 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.75 153.92 32.6 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.178 -0.919 . . . . 1.0 109.219 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.86 136.97 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.8 153.02 8.9 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.711 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.2 106.57 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.391 1.394 . . . . 1.0 111.148 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -140.82 87.16 11.35 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.46 111.58 3.29 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.562 1.508 . . . . 1.0 111.763 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 210' ' ' HIS . 22.0 t -63.24 98.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.057 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t 56.06 5.12 0.15 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.561 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.45 ' H ' ' C ' ' A' ' 208' ' ' VAL . 85.4 t60 49.47 93.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.716 0.293 . . . . 1.0 110.632 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 212' ' ' PRO . 7.3 p-10 -144.84 73.69 14.93 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 211' ' ' ASN . 83.1 Cg_exo -49.56 -121.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.433 0 C-N-CA 123.077 2.518 . . . . 1.0 112.548 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.2 t -85.05 4.15 35.35 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.911 -0.493 . . . . 1.0 109.932 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -57.63 -49.73 75.49 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -46.44 -50.34 16.92 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.116 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -58.29 -40.88 83.13 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.751 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.5 tt -52.74 -49.7 64.92 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 62.8 mt -51.02 -36.19 38.19 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.231 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.77 -46.97 87.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -56.41 -45.5 80.65 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.73 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' THR . . . . . 0.548 ' HG1' ' N ' ' A' ' 222' ' ' ILE . 81.3 p -63.1 -45.24 93.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.694 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.548 ' N ' ' HG1' ' A' ' 221' ' ' THR . 75.5 mt -84.28 115.54 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.29 -0.634 . . . . 1.0 109.29 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -80.38 106.15 12.17 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.749 -0.463 . . . . 1.0 109.749 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.096 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 110.231 -0.285 . . . . 1.0 110.231 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -167.65 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -130.17 133.86 46.89 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.828 0.451 . . . . 1.0 110.659 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.21 166.99 10.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -133.85 109.02 8.79 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -103.1 130.47 50.26 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.93 137.18 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 t -142.63 137.91 30.33 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.849 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.604 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 63.4 m -92.65 -14.15 28.52 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.55 -93.63 0.05 OUTLIER Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -179.55 0.78 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -62.12 132.22 52.1 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.955 -0.387 . . . . 1.0 109.955 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -62.54 149.54 88.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.71 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.8 -62.6 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.719 1.613 . . . . 1.0 112.037 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -142.45 138.82 16.76 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 119.117 -0.468 . . . . 1.0 110.621 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.43 -31.17 46.81 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 121.781 1.654 . . . . 1.0 113.52 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.92 -36.95 67.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.969 0.414 . . . . 1.0 111.28 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.89 -41.97 97.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.858 0.361 . . . . 1.0 110.758 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.3 t -61.44 -38.29 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' SER . 14.8 m -51.6 -42.86 62.27 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.0 t -51.81 -41.4 61.71 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.558 0.218 . . . . 1.0 110.538 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.8 t -75.38 -12.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.453 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.25 40.23 2.09 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.65 0.262 . . . . 1.0 110.432 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' SER . 44.4 m -129.71 -164.6 1.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.731 0.777 . . . . 1.0 109.512 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -53.14 -46.15 68.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.995 -1.457 . . . . 1.0 110.42 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -57.97 -53.49 57.66 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 122.059 -0.4 . . . . 1.0 111.196 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 73.7 t80 -63.42 -44.69 93.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.697 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.425 ' SG ' ' NZ ' ' A' ' 113' ' ' LYS . 45.5 t -57.84 -51.48 69.41 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -55.95 -47.9 76.74 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 121.487 0.66 . . . . 1.0 110.266 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -64.81 -29.54 70.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.084 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tp -65.86 -54.16 30.37 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.54 0.525 . . . . 1.0 111.36 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -32.32 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.294 -0.867 . . . . 1.0 109.093 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -75.38 -13.08 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.881 -1.054 . . . . 1.0 109.173 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 199' ' ' GLN . 0.1 OUTLIER -101.4 -1.14 34.04 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.707 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 82.71 41.68 8.76 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.911 -1.137 . . . . 1.0 111.259 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 10.2 p90 -27.02 159.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 123.548 0.739 . . . . 1.0 112.241 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -149.19 -73.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 121.382 -0.824 . . . . 1.0 108.956 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -149.02 106.14 3.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -89.14 130.24 35.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.012 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 65' ' ' LEU . 4.2 mp -131.1 133.7 62.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.4 tt -142.71 140.93 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.44 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -170.26 137.13 1.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.726 178.451 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -168.56 -172.06 1.58 Allowed 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.426 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.07 168.85 3.61 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.502 -1.039 . . . . 1.0 110.502 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.633 ' NH2' HD21 ' A' ' 72' ' ' ASN . 71.1 ttp85 -168.71 -74.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.633 HD21 ' NH2' ' A' ' 71' ' ' ARG . 89.8 m-20 -63.73 -46.44 85.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 1.0 110.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.73 -17.13 61.15 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 m 59.07 18.59 6.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.713 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 m 50.46 -163.85 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.192 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' PHE . 67.9 mt-10 -145.2 -44.74 0.22 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.411 ' C ' ' H ' ' A' ' 79' ' ' HIS . 33.4 m-85 54.36 108.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -70.44 44.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.8 0.334 . . . . 1.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 77' ' ' PHE . 93.9 m-70 44.97 48.65 9.4 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.228 0.537 . . . . 1.0 111.146 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.37 -38.61 90.23 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.65 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.21 -50.35 80.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.617 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -71.78 -37.53 70.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -57.21 -48.07 79.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -77.65 -13.34 59.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.383 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.37 54.07 3.44 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 110.966 -0.853 . . . . 1.0 110.966 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.43 -178.76 51.44 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 109.831 -1.308 . . . . 1.0 109.831 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -129.85 121.04 25.94 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -80.49 111.46 16.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.342 -0.244 . . . . 1.0 110.342 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -72.38 -108.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.48 1.067 0 O-C-N 123.661 0.6 . . . . 1.0 111.653 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.196 0.522 . . . . 1.0 110.485 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 117' ' ' ILE . 9.8 mmp_? -111.56 114.73 27.99 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.09 122.75 9.21 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.426 ' OH ' ' NE ' ' A' ' 105' ' ' ARG . 5.3 m-85 -133.63 151.78 51.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.4 ' C ' HD22 ' A' ' 109' ' ' LEU . 23.0 m -129.18 147.66 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -108.0 143.95 35.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.449 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 39.9 tpp 56.76 -79.55 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 O-C-N 124.136 0.898 . . . . 1.0 110.287 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 109' ' ' LEU . 54.3 t30 -168.09 78.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.39 8.51 80.31 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.425 ' NZ ' ' SG ' ' A' ' 54' ' ' CYS . 64.1 tttm -64.59 -75.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.25 128.9 50.13 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.204 -1.036 . . . . 1.0 108.204 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -108.02 103.77 13.06 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 119.442 -0.313 . . . . 1.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.56 116.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 105' ' ' ARG . 6.8 mt -137.1 144.16 32.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.815 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.93 120.55 2.05 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -155.17 52.83 0.62 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.228 0.537 . . . . 1.0 110.749 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 18.1 p-10 -169.29 129.72 1.08 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE2' ' OE1' ' A' ' 68' ' ' GLN . 58.4 m-85 -128.03 90.99 3.18 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.2 p 42.12 31.25 0.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.712 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.6 t -149.61 27.87 0.8 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.325 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 127' ' ' SER . 16.1 mttt -170.35 -5.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 71.0 mtp -43.08 -54.88 4.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.855 0.36 . . . . 1.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -59.43 -29.13 67.54 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.74 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.428 ' OG ' ' NH2' ' A' ' 130' ' ' ARG . 1.9 t -65.59 -38.96 90.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 16.0 mm -72.6 -46.04 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.126 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' SER . 64.4 mt -60.1 -57.86 9.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.456 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.428 ' NH2' ' OG ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -48.78 -41.07 31.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 111.392 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.22 -48.25 79.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.155 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -100.64 -66.67 0.89 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.119 0.485 . . . . 1.0 110.281 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' ILE . 53.6 p 55.51 84.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -149.23 -47.8 0.14 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.311 -0.404 . . . . 1.0 109.928 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.532 HD13 ' H ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -163.16 139.3 7.04 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.532 ' H ' HD13 ' A' ' 135' ' ' LEU . 4.3 m -138.22 145.52 28.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.37 96.5 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.2 p -104.89 122.15 45.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 35' ' ' CYS . 4.7 p-80 -64.0 -36.05 82.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.265 . . . . 1.0 111.139 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.14 10.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.591 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.97 108.77 1.04 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.0 -43.98 94.84 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 1.0 110.331 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.67 -50.81 34.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.4 m -52.09 -50.46 61.55 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.539 -0.33 . . . . 1.0 111.791 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -29.07 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.182 -0.303 . . . . 1.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.505 HD21 ' O ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -54.63 -53.91 48.48 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.905 -177.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.17 -51.13 65.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 1.0 110.132 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.8 t -52.83 -28.24 21.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.444 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.467 HD21 HD23 ' A' ' 203' ' ' LEU . 0.2 OUTLIER -71.15 -51.86 22.52 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.879 0.371 . . . . 1.0 110.982 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.6 ttp-105 -64.77 -26.1 68.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.764 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.7 mt -90.8 17.08 8.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.972 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.5 p30 42.34 26.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.501 0.501 . . . . 1.0 111.472 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 133' ' ' SER . 30.9 mtpt -79.38 121.08 82.44 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.306 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.41 ' O ' HD21 ' A' ' 135' ' ' LEU . 77.9 Cg_endo -79.62 113.93 3.15 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.367 1.378 . . . . 1.0 110.712 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 156' ' ' ILE . 0.4 OUTLIER -115.29 171.87 7.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.591 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 156' ' ' ILE . 3.2 mp -118.4 120.01 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.78 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 76.2 t -90.89 117.11 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 O-C-N 122.518 -0.114 . . . . 1.0 110.713 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 13.3 m -85.17 100.57 11.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.08 140.22 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.9 84.67 2.73 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 30.7 p-10 -64.03 -32.18 73.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.018 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 t -60.84 -46.08 91.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.025 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 163' ' ' LEU . 10.8 mp -90.21 -178.91 5.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 28.0 ttt -165.31 -27.76 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.461 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -66.2 -22.14 66.33 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -61.59 113.61 2.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.117 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.01 -32.56 74.15 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.836 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.04 -47.07 75.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.32 -42.01 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.342 0.592 . . . . 1.0 109.922 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -50.59 -45.56 57.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.539 -0.912 . . . . 1.0 108.539 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.68 -26.4 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.877 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -68.06 -58.88 3.78 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 120.01 -0.676 . . . . 1.0 109.409 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -43.52 -24.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.72 0.295 . . . . 1.0 111.774 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.41 -40.26 81.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.145 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -55.74 -45.49 77.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.52 -46.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.98 0.419 . . . . 1.0 109.896 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -46.07 -43.01 14.27 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.439 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.6 mt -70.55 -32.25 69.61 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.832 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.15 -107.43 0.24 Allowed Glycine 0 N--CA 1.468 0.781 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.527 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 180' ' ' TYR . 66.5 t80 -169.95 42.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 180' ' ' TYR . 14.8 p -31.91 137.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 123.663 0.602 . . . . 1.0 109.479 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -54.43 101.7 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.319 0.963 . . . . 1.0 110.661 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 77.2 p -114.76 133.2 56.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.798 -1.092 . . . . 1.0 109.088 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.33 138.7 6.56 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 157.09 70.52 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 122.304 -0.248 . . . . 1.0 110.515 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -56.89 82.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 122.307 2.005 . . . . 1.0 112.991 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 m -134.86 148.9 50.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.95 -25.88 63.86 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.124 -0.36 . . . . 1.0 111.016 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.3 p -89.91 -35.61 15.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.541 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.74 -41.81 5.9 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.94 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.93 -36.24 82.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.808 0.304 . . . . 1.0 111.483 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 pt -66.0 -33.91 66.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.348 . . . . 1.0 111.023 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.56 91.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.639 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -71.66 -38.19 61.4 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.428 -0.669 . . . . 1.0 111.428 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.408 ' O ' ' OH ' ' A' ' 60' ' ' TYR . 7.7 mt -63.28 -54.85 30.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.848 0.356 . . . . 1.0 111.255 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -61.68 -36.39 80.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.1 -39.21 82.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 14.9 m -65.59 -17.96 64.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.854 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 93.9 mt-30 -104.14 29.97 5.57 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.047 -0.408 . . . . 1.0 110.624 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 22.6 p -141.37 -33.02 0.52 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -141.58 154.1 45.23 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -118.07 157.51 26.72 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.584 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 149' ' ' LEU . 8.4 tp -84.32 136.29 33.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -52.76 135.24 46.03 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.289 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -45.39 101.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.511 1.474 . . . . 1.0 113.015 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -142.12 82.78 13.02 Favored Pre-proline 0 N--CA 1.471 0.625 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.54 93.04 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.963 1.775 . . . . 1.0 111.464 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.505 ' O ' HD21 ' A' ' 146' ' ' LEU . 7.1 p -60.73 150.37 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.654 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 CA--C 1.532 0.266 0 O-C-N 123.715 0.634 . . . . 1.0 110.665 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.534 -0.543 . . . . 1.0 109.534 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -103.4 6.5 37.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 63' ' ' VAL . 67.9 mttm -71.25 106.55 3.87 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.13 121.01 43.66 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.384 0.427 . . . . 1.0 110.197 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 mt -87.61 110.97 20.78 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CD1' HG22 ' A' ' 129' ' ' ILE . 85.6 m-85 -96.07 128.62 43.14 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -123.3 122.52 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 t -146.48 137.65 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.2 m -105.36 -24.97 12.57 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.3 20.57 67.55 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.42 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 p -139.7 155.9 47.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.475 0.31 . . . . 1.0 110.218 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' PRO . 16.8 m -94.16 148.64 35.49 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 118.727 -0.654 . . . . 1.0 110.817 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' VAL . 87.2 Cg_exo -46.22 -178.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 121.629 1.553 . . . . 1.0 112.395 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -56.57 144.42 64.27 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-O 119.234 -0.412 . . . . 1.0 110.632 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.55 -30.6 6.2 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.793 1.662 . . . . 1.0 113.497 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -73.26 -39.55 65.32 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.81 0.3 . . . . 1.0 111.81 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 186' ' ' PRO . 4.2 mm? -71.74 -40.86 69.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.97 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.6 -41.61 93.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 50' ' ' SER . 30.0 m -52.15 -45.89 65.2 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.139 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.98 -33.13 10.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 1.0 110.556 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.78 -22.09 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.996 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.98 33.44 4.39 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 120.809 0.337 . . . . 1.0 110.254 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 46' ' ' SER . 22.4 p -110.59 -167.71 1.22 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -60.74 -28.83 68.98 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.66 -50.68 71.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.493 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -35.91 73.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 71.1 m -51.63 -51.0 59.2 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.775 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -73.07 -43.76 61.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.684 0.278 . . . . 1.0 111.654 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -65.91 -28.95 69.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.971 0.415 . . . . 1.0 110.535 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.2 mt -61.35 -52.42 64.73 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.6 mp -57.42 -36.67 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 120.305 -0.558 . . . . 1.0 109.874 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -72.52 -33.78 67.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.695 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 70.1 t80 -77.87 0.57 23.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.997 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 42.08 22.23 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.751 -1.214 . . . . 1.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -49.3 -176.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.534 0.667 . . . . 1.0 111.825 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 64' ' ' ARG . 10.5 p -172.48 -42.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' HG13 ' A' ' 63' ' ' VAL . 47.5 ttm-85 -168.38 105.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.1 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.04 135.83 33.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.31 136.41 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -138.99 141.82 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -143.64 149.37 37.2 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 77' ' ' PHE . 47.5 p90 -163.14 126.29 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.02 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.78 -171.17 44.71 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 109.774 -1.33 . . . . 1.0 109.774 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.564 ' H ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 55.54 118.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.377 0.608 . . . . 1.0 110.914 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -61.85 -20.49 63.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.111 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 75' ' ' SER . 48.3 t80 -56.5 -14.97 3.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.384 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 m -60.59 3.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.391 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 73' ' ' TYR . 3.5 m 63.54 139.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.861 0.363 . . . . 1.0 110.264 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.44 137.17 57.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 69' ' ' PHE . 3.7 m-85 -64.41 -93.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 49.69 45.97 24.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.023 0.439 . . . . 1.0 110.859 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.402 ' ND1' ' O ' ' A' ' 77' ' ' PHE . 35.1 m80 -157.26 -53.87 0.08 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.648 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.47 -48.87 75.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.098 0.475 . . . . 1.0 111.043 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.39 -44.12 77.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.196 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.93 -31.56 72.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.27 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -70.91 -44.31 66.49 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.027 0.442 . . . . 1.0 110.437 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLY . 1.1 mmp_? -99.1 30.03 3.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' ARG . . . 21.15 73.71 0.01 OUTLIER Glycine 0 N--CA 1.486 1.98 0 N-CA-C 111.531 -0.627 . . . . 1.0 111.531 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.74 -179.1 52.01 Favored Glycine 0 C--N 1.322 -0.222 0 N-CA-C 109.846 -1.302 . . . . 1.0 109.846 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -138.34 135.96 35.9 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -54.43 149.6 10.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.442 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -107.0 -155.36 0.55 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.49 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 85.4 p . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.849 0.356 . . . . 1.0 111.252 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' C ' HH11 ' A' ' 105' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 110.208 -0.293 . . . . 1.0 110.208 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.479 HH11 ' C ' ' A' ' 104' ' ' ALA . 1.5 mpt_? -135.37 145.75 47.66 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.159 0.504 . . . . 1.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.83 129.05 7.38 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.8 -0.636 . . . . 1.0 109.694 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -147.21 169.11 20.04 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.69 148.27 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 114' ' ' LEU . 19.2 mt -114.39 -178.83 3.46 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.585 0.553 . . . . 1.0 109.562 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 tpt 53.21 -134.67 1.63 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.664 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.86 35.9 0.9 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.013 0.435 . . . . 1.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.59 71.54 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.518 -0.633 . . . . 1.0 111.518 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -96.21 -15.92 21.75 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.392 0.277 . . . . 1.0 111.635 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' A' ' 109' ' ' LEU . 4.4 mm? -96.91 133.57 41.39 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -116.88 93.73 4.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.8 p -106.89 116.59 50.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 CA-C-O 122.219 1.009 . . . . 1.0 109.053 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.2 pt -117.81 146.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 114.076 -1.42 . . . . 1.0 108.658 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -122.94 131.83 8.39 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 109.63 -1.388 . . . . 1.0 109.63 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 120' ' ' ASP . 45.0 t80 59.01 152.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 1.0 110.768 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 38.8 t70 -168.24 163.66 13.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.353 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.446 ' O ' ' CD2' ' A' ' 121' ' ' PHE . 40.4 p90 -70.77 119.27 14.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 124' ' ' LYS . 18.1 m 56.88 135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.421 0.629 . . . . 1.0 111.558 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 t -74.87 38.43 0.12 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.263 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 122' ' ' SER . 36.9 ttpt -64.45 -29.56 70.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.477 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -45.18 -32.0 1.69 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.132 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -58.23 -28.72 65.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.676 -0.693 . . . . 1.0 111.044 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.1 t -80.54 -33.17 36.49 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.742 0.306 . . . . 1.0 110.803 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 128' ' ' ILE . 1.6 mp -63.63 -39.93 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.723 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.551 HG22 ' CD1' ' A' ' 32' ' ' PHE . 2.9 pt -49.11 -41.54 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -46.08 -32.66 3.0 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.514 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.45 -27.64 62.64 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.4 -62.27 1.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.333 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.2 p 51.36 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.724 ' N ' ' HZ2' ' A' ' 153' ' ' LYS . 56.5 m-20 -145.14 -43.92 0.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -155.41 120.52 4.86 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 135' ' ' LEU . 60.9 t -122.52 137.33 56.41 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.3 mt -122.92 124.37 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.7 p -134.3 133.61 40.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -69.89 -38.22 76.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.631 0.253 . . . . 1.0 110.788 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.47 19.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.326 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.67 100.6 0.44 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.6 m -56.72 -41.46 77.48 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.478 -0.425 . . . . 1.0 110.48 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.74 -48.77 26.68 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.3 m -56.52 -42.77 78.99 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.842 -0.211 . . . . 1.0 111.309 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 92.6 mt -66.35 -26.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 1.0 110.852 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 209' ' ' SER . 0.2 OUTLIER -57.35 -46.9 82.84 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.663 -176.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -70.42 -53.55 16.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.097 0.475 . . . . 1.0 109.826 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.9 m -53.19 -25.21 13.04 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 49.8 tp -74.86 -45.77 40.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.859 0.362 . . . . 1.0 111.438 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -76.56 -18.99 58.37 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.279 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.9 mt -85.03 4.03 35.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 41.56 47.89 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.389 0.43 . . . . 1.0 111.688 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.724 ' HZ2' ' N ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -105.68 147.1 34.11 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 119.205 -0.426 . . . . 1.0 111.569 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.63 85.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.46 1.44 . . . . 1.0 111.542 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 153' ' ' LYS . 66.9 tp -89.94 137.49 32.29 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.816 -0.553 . . . . 1.0 111.324 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.3 134.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.084 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.63 128.69 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 120.788 0.328 . . . . 1.0 110.652 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 12.3 m -83.6 102.47 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.88 146.84 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.746 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.9 t30 86.44 103.78 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.887 0.742 . . . . 1.0 110.065 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -167.59 66.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.203 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -64.65 86.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.215 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 165' ' ' ASP . 34.8 tp -168.41 77.03 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 ttt 67.19 -36.74 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.707 0.629 . . . . 1.0 110.984 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 163' ' ' LEU . 66.7 m-20 -77.17 -3.02 37.4 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.077 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -52.86 -37.92 60.87 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.766 0.317 . . . . 1.0 110.369 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.12 -38.17 87.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.135 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -68.11 -38.97 82.87 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.367 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.53 -31.31 64.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.133 0.492 . . . . 1.0 110.692 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.37 -49.09 67.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.51 -27.41 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.79 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.77 -61.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.097 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -51.94 -31.98 31.14 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -60.79 -52.71 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.015 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.26 -42.66 81.97 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.22 -52.84 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -51.96 -44.32 63.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.701 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.33 17.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.134 -0.321 . . . . 1.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 39.29 89.8 0.01 OUTLIER Glycine 0 C--N 1.352 1.423 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.646 ' O ' HD22 ' A' ' 203' ' ' LEU . 49.9 t80 -155.48 -22.39 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.51 152.64 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.83 0.348 . . . . 1.0 110.495 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -71.39 130.63 41.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.6 p -98.11 138.67 35.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.586 -0.734 . . . . 1.0 109.541 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 185' ' ' ALA . 35.7 t -157.77 177.32 11.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 184' ' ' CYS . . . -136.93 155.99 76.07 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 110.164 -0.31 . . . . 1.0 110.164 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.469 ' HG2' HD12 ' A' ' 44' ' ' LEU . 94.3 Cg_endo -69.58 65.62 1.68 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.089 1.86 . . . . 1.0 112.404 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 m -134.06 145.5 49.46 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.014 0.435 . . . . 1.0 109.898 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -55.13 -29.34 57.49 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -84.03 -41.03 17.66 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.089 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.14 93.86 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.978 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.35 -39.54 90.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 119.711 -0.185 . . . . 1.0 111.314 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.73 -45.84 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.61 82.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.53 -36.61 91.74 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.08 -54.63 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.94 0.4 . . . . 1.0 110.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -59.66 -21.29 60.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.432 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.85 3.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.774 0.321 . . . . 1.0 110.46 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.6 p -67.46 -22.53 65.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.769 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.53 -43.72 69.01 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.075 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 21.7 m -79.1 -43.66 23.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.842 0.353 . . . . 1.0 110.698 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.53 125.25 40.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.266 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -120.82 108.59 14.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 180' ' ' TYR . 4.8 tp -63.24 135.8 57.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -52.67 146.88 16.43 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.778 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.45 103.77 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.357 1.371 . . . . 1.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -141.1 96.5 7.21 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.74 114.03 3.86 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 121.13 1.22 . . . . 1.0 111.345 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 209' ' ' SER . 14.8 p -57.75 -43.41 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.531 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.481 ' N ' HG13 ' A' ' 208' ' ' VAL . 37.4 m . . . . . 0 N--CA 1.463 0.221 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.242 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -144.79 -36.34 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -71.16 92.74 1.01 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.95 111.94 24.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.73 117.98 21.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE2' ' NE2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -102.69 124.3 47.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 67' ' ' ILE . 9.4 p -126.18 128.4 71.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.2 p -129.1 129.82 45.7 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' CE1' ' A' ' 69' ' ' PHE . 97.2 m -88.69 164.26 15.39 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.89 37.67 0.75 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.69 -0.564 . . . . 1.0 111.69 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 35' ' ' CYS . . . 67.64 -61.51 0.36 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.386 0.274 . . . . 1.0 110.602 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -64.96 147.41 53.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 1.0 109.978 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.6 81.36 24.09 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.88 -59.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.953 1.768 . . . . 1.0 111.505 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 92.14 18.29 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -74.05 8.32 2.12 Favored 'Trans proline' 0 N--CA 1.508 2.339 0 CA-C-N 120.831 1.333 . . . . 1.0 112.442 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.0 110.555 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.9 mm? -70.02 -35.02 74.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.546 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.37 -40.5 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 78.3 p -50.52 -45.33 56.59 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.839 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -51.57 -39.99 58.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.05 0.452 . . . . 1.0 110.301 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 41.8 t -79.67 -16.21 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.057 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 tp -130.96 39.74 3.55 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.826 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.5 t -132.61 -157.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 50' ' ' SER . 22.6 p-10 -60.28 -44.27 95.48 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.98 -51.58 65.75 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.592 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 5.9 t80 -67.8 -36.79 81.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.972 0.415 . . . . 1.0 109.905 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 t -57.64 -47.96 80.79 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.429 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -63.07 -46.47 87.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.66 -28.39 69.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.406 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.25 -51.24 70.4 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.945 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.7 mp -58.35 -44.9 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.06 -37.6 77.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.33 -21.58 64.74 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.661 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 104.3 35.94 3.24 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 118.016 -1.435 . . . . 1.0 111.355 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' O ' ' A' ' 61' ' ' GLY . 49.8 p90 13.61 130.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 124.86 1.264 . . . . 1.0 112.719 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -145.3 -81.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 122.007 -0.433 . . . . 1.0 110.448 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -169.33 111.24 0.48 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.221 -0.445 . . . . 1.0 109.83 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -92.35 121.59 33.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 66' ' ' ILE . 2.3 mp -102.88 133.02 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.434 -1.321 . . . . 1.0 107.434 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.418 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.7 mm -114.6 132.76 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.509 ' NE2' ' CE2' ' A' ' 32' ' ' PHE . 15.6 mp0 -131.78 163.09 29.0 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.582 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE1' ' SG ' ' A' ' 35' ' ' CYS . 17.7 m-85 -157.22 -179.64 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.183 0.516 . . . . 1.0 109.735 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 72' ' ' ASN . . . -59.1 -29.89 66.16 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.292 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 68.01 -38.32 0.36 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.98 0.459 . . . . 1.0 111.256 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 70' ' ' GLY . 19.0 m120 -62.16 -43.93 97.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.781 0.324 . . . . 1.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.26 -45.76 86.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 p 56.31 166.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.841 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.2 t 52.36 68.88 0.75 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.821 0.343 . . . . 1.0 111.138 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -170.95 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.602 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -166.77 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.613 -0.267 . . . . 1.0 110.609 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.26 -44.62 95.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.832 0.349 . . . . 1.0 110.073 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.08 -28.78 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.733 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -63.74 -48.36 77.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.155 0.503 . . . . 1.0 110.161 -178.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.28 -45.44 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -64.37 -36.4 84.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -52.23 -46.65 65.79 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.581 0.229 . . . . 1.0 110.441 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.19 -17.43 64.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.092 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.02 52.64 35.61 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.12 -1.192 . . . . 1.0 110.12 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.38 -167.76 25.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -128.33 126.95 41.78 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -55.38 145.42 22.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.616 0.246 . . . . 1.0 110.624 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -145.6 179.18 7.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.211 -179.303 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.626 ' CB ' ' H ' ' A' ' 119' ' ' PHE . . . . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.562 0.22 . . . . 1.0 110.411 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -141.41 169.2 18.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -158.79 132.48 7.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.333 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -136.39 151.06 49.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.764 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.7 t -100.83 96.07 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.527 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 109' ' ' LEU . 10.4 mp -87.57 159.77 18.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 tpt 57.03 -88.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.402 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -172.47 62.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.763 0.316 . . . . 1.0 110.686 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.55 27.09 63.96 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.627 -0.589 . . . . 1.0 111.627 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -114.19 -50.36 2.81 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.597 0.359 . . . . 1.0 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mt -95.36 111.86 23.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.855 0.359 . . . . 1.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -105.83 101.24 10.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 p -105.53 111.64 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.709 0.766 . . . . 1.0 109.641 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 pt -125.86 122.77 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.388 -1.278 . . . . 1.0 109.167 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.59 -82.01 0.04 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.548 -0.834 . . . . 1.0 111.453 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.626 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 3.6 m-85 47.72 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.941 0.4 . . . . 1.0 110.005 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -163.19 154.24 16.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 122' ' ' SER . 63.8 t80 -160.11 172.95 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.654 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 44.3 t -52.99 -17.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.26 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.8 m -164.19 103.56 0.86 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.606 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -171.03 -26.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.772 0.32 . . . . 1.0 110.555 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.1 -49.96 75.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.861 0.362 . . . . 1.0 110.71 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -61.82 -25.55 67.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.358 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p -76.41 -44.69 34.97 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.971 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.06 -44.48 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.627 -0.261 . . . . 1.0 110.617 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 133' ' ' SER . 79.4 mt -59.04 -51.94 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -39.14 10.25 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.053 0.454 . . . . 1.0 110.905 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -63.54 -32.17 73.55 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.141 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -112.57 -67.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.784 0.434 . . . . 1.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' ILE . 26.0 t 54.32 89.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.757 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -134.38 -50.1 0.79 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.335 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 29.9 tp -165.7 146.32 6.83 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.38 140.03 44.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.7 pt -123.02 127.89 74.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.6 m -88.85 -161.88 0.8 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -169.99 -36.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.6 48.21 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.809 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.88 112.5 0.53 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.521 ' H ' HE22 ' A' ' 168' ' ' GLN . 35.2 m -74.2 -25.19 59.55 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.698 0.285 . . . . 1.0 110.685 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.94 86.04 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.0 m -72.91 -35.77 67.13 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.841 -0.211 . . . . 1.0 110.756 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 53.6 mt -61.37 -30.37 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.771 0.32 . . . . 1.0 110.989 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 tp -52.35 -52.74 51.72 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.137 0.421 . . . . 1.0 112.137 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -65.69 -46.95 77.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.285 0.564 . . . . 1.0 111.074 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 m -53.01 -26.92 17.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.121 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.4 mt -79.7 -49.26 12.35 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.356 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -62.51 -37.95 88.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.682 -0.236 . . . . 1.0 110.923 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.28 4.77 4.18 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 58.8 t30 53.72 23.28 3.6 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.71 -0.223 . . . . 1.0 111.123 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.66 122.84 46.24 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -45.9 171.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.659 1.572 . . . . 1.0 112.6 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.609 ' C ' HD13 ' A' ' 156' ' ' ILE . 4.0 tt -156.92 151.75 25.86 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.514 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 155' ' ' LEU . 3.1 mm -123.35 128.23 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.9 137.16 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.36 115.38 27.35 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.37 97.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.654 0.264 . . . . 1.0 111.667 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.449 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 20.2 p-10 -148.46 -58.47 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.255 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 163' ' ' LEU . 73.2 m-20 -102.3 14.01 33.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.083 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 27.9 t -69.79 36.9 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.889 0.376 . . . . 1.0 110.837 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 161' ' ' ASP . 52.7 mt -63.42 -39.59 94.9 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 166' ' ' ASN . 23.8 ptt? -52.28 141.45 19.2 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.229 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 167' ' ' HIS . 4.8 m-20 69.24 -37.07 0.36 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.202 0.314 . . . . 1.0 110.749 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 164' ' ' MET . 20.2 t-20 58.97 -0.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.612 0.365 . . . . 1.0 111.336 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 165' ' ' ASP . 24.6 m170 -73.48 -43.42 60.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.866 0.365 . . . . 1.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.521 HE22 ' H ' ' A' ' 142' ' ' THR . 91.4 mm-40 -64.92 -49.47 70.31 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.937 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -59.58 -29.68 68.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.92 0.39 . . . . 1.0 110.013 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.49 -54.67 8.59 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.009 -0.542 . . . . 1.0 110.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.39 -41.39 73.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.45 -64.15 0.96 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 120.466 -0.494 . . . . 1.0 110.196 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.4 -27.76 2.81 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.337 0.589 . . . . 1.0 111.089 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -82.96 -40.48 20.02 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.055 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.04 -45.45 93.52 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.696 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 177' ' ' GLU . 27.1 m -57.14 -52.71 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 176' ' ' VAL . 77.3 mt-10 -52.34 -38.88 59.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.348 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.13 6.31 49.13 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.63 89.77 0.07 OUTLIER Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.291 -1.124 . . . . 1.0 110.291 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -40.65 79.35 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.135 0.974 . . . . 1.0 111.156 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 181' ' ' VAL . 3.2 p -73.8 65.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.531 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TRP . . . . . 0.485 ' C ' ' O ' ' A' ' 181' ' ' VAL . 6.0 m-90 30.4 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 99.9 p -108.6 131.45 54.85 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 30.5 p -162.58 130.17 3.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.861 -1.063 . . . . 1.0 108.387 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.92 157.09 74.34 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 118.92 -0.562 . . . . 1.0 110.851 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.76 69.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.516 2.833 0 C-N-CA 123.253 2.635 . . . . 1.0 114.393 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 185' ' ' ALA . 43.7 m -132.2 146.67 52.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 24.7 mp0 -49.34 -51.69 32.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.494 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.7 p -67.15 -43.04 83.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.66 -0.245 . . . . 1.0 110.578 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -52.6 -53.36 32.85 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 121.427 -0.416 . . . . 1.0 112.145 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.83 -40.98 99.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.926 0.363 . . . . 1.0 110.71 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.45 -44.54 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -58.85 -49.35 78.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 1.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.5 98.81 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 42.6 mt -63.82 -43.47 96.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.713 0.292 . . . . 1.0 110.546 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -66.91 -40.02 87.56 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -64.41 -49.58 70.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.698 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 m -61.13 -22.39 64.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.308 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -74.56 10.46 1.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.017 0.437 . . . . 1.0 110.194 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.4 m -164.09 -54.66 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.816 0.341 . . . . 1.0 110.844 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.7 mt-10 -66.89 116.17 7.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.026 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -103.05 165.59 10.93 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 tp -110.45 -164.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.52 137.54 22.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -79.2 44.47 1.7 Allowed 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.812 1.675 . . . . 1.0 111.915 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.39 84.8 15.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.41 166.03 5.1 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.113 1.876 . . . . 1.0 112.186 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 209' ' ' SER . 12.0 p -57.06 -46.81 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.337 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.501 ' N ' HG13 ' A' ' 208' ' ' VAL . 51.6 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.852 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -168.79 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.826 0.346 . . . . 1.0 110.544 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -74.3 139.47 44.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . -142.9 165.1 28.29 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 137' ' ' ILE . 11.8 mt -109.27 122.51 47.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.489 ' CE1' HG21 ' A' ' 128' ' ' ILE . 12.3 t80 -108.62 141.6 40.32 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.15 148.15 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.955 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -144.78 139.84 28.08 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.735 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.83 8.34 5.73 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.19 108.71 0.23 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.66 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.966 -0.138 . . . . 1.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.0 p 48.85 -167.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.751 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 39' ' ' VAL . 24.4 m -97.69 113.57 63.75 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 123.186 0.304 . . . . 1.0 110.657 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.12 -13.78 17.03 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.05 1.833 . . . . 1.0 111.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -124.92 85.16 57.9 Favored Pre-proline 0 N--CA 1.477 0.899 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.32 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.17 -23.06 27.9 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.145 1.897 . . . . 1.0 111.698 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -80.98 -46.66 14.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.64 -49.88 74.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.861 0.362 . . . . 1.0 111.046 -176.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.47 -39.14 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.19 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 17.0 p -50.01 -57.88 6.64 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 46' ' ' SER . 77.4 m -51.71 -41.41 61.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.971 0.415 . . . . 1.0 110.342 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.5 t -71.2 -17.89 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.038 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 tp -140.65 44.19 1.84 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.039 0.447 . . . . 1.0 110.862 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.6 t -123.59 -167.59 1.64 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.5 ' N ' ' OG ' ' A' ' 50' ' ' SER . 41.2 m-20 -50.73 -40.07 53.47 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.912 -1.04 . . . . 1.0 111.175 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -60.45 -55.22 36.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.79 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -67.28 -39.86 86.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.998 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 91.0 m -48.36 -53.7 16.57 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -77.47 -46.75 21.53 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.45 -30.27 68.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.867 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.69 -45.04 93.31 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.482 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.7 mp -63.59 -30.32 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 119.946 -0.702 . . . . 1.0 109.608 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -63.01 -16.4 59.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.0 111.087 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.74 -18.83 14.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.09 35.37 5.8 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 121.39 -0.433 . . . . 1.0 112.1 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -93.15 154.4 18.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.21 0.529 . . . . 1.0 109.652 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 m -137.77 -6.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.031 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -143.0 144.98 32.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.436 0.636 . . . . 1.0 110.69 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -138.68 122.98 18.21 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.712 -1.131 . . . . 1.0 109.28 178.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 65' ' ' LEU . 4.3 mp -120.66 142.94 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.529 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.05 137.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.006 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -62.51 144.1 56.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.23 120.26 16.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' ASN . . . -64.21 -11.01 44.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 63.41 -68.51 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.888 0.405 . . . . 1.0 110.877 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' GLY . 77.7 m-20 -61.28 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -65.87 -50.19 65.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.98 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t 51.16 -147.79 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.803 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t 55.93 -161.1 0.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.592 0.234 . . . . 1.0 110.699 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 54.7 -166.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.466 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.2 t80 53.3 98.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.652 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -59.4 166.67 2.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.019 -0.363 . . . . 1.0 110.019 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -73.21 54.51 0.41 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.752 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -59.15 -43.44 92.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.285 0.564 . . . . 1.0 110.405 -177.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 82' ' ' GLN . 22.3 m -58.2 -43.66 86.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.571 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.472 ' N ' HG23 ' A' ' 81' ' ' VAL . 2.6 tm0? -68.85 -42.78 76.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.262 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.91 -48.17 67.43 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.693 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.572 ' HD2' HD12 ' A' ' 109' ' ' LEU . 57.9 ttm-85 -76.13 -16.68 59.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.756 -0.377 . . . . 1.0 110.368 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.55 54.21 1.36 Allowed Glycine 0 N--CA 1.474 1.192 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . -80.36 169.31 52.53 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.736 -1.345 . . . . 1.0 109.736 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -132.4 129.36 39.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 90' ' ' SER . 56.8 ttp180 -57.61 151.15 17.69 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 40.46 -86.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.794 0.684 . . . . 1.0 111.286 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' ARG . 93.1 p . . . . . 0 CA--C 1.527 0.089 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.435 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.45 HH12 ' CG1' ' A' ' 116' ' ' VAL . 50.9 ptt85 -141.01 163.5 32.81 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.94 129.63 8.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.492 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.16 161.38 38.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 109' ' ' LEU . 38.8 t -123.35 128.73 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.572 HD12 ' HD2' ' A' ' 84' ' ' ARG . 4.1 mm? -104.79 157.66 17.05 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.173 0.511 . . . . 1.0 109.646 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.9 mmt 54.84 -87.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.819 -1.082 . . . . 1.0 110.282 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LEU . 7.7 p-10 -169.3 72.36 0.08 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.21 -0.19 59.9 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.411 ' C ' HD22 ' A' ' 114' ' ' LEU . 34.2 tptt -73.41 -57.26 4.13 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.901 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.411 HD22 ' C ' ' A' ' 113' ' ' LYS . 4.1 mm? -117.88 120.23 37.26 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.858 0.724 . . . . 1.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.5 126.06 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.177 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.45 ' CG1' HH12 ' A' ' 105' ' ' ARG . 57.6 t -101.56 114.25 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.143 -1.428 . . . . 1.0 107.143 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.05 140.78 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.839 0.712 . . . . 1.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.54 -40.88 66.98 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 110.011 -1.235 . . . . 1.0 110.011 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.0 t80 61.68 135.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.297 0.239 . . . . 1.0 110.508 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -170.08 128.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -161.25 142.99 11.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.169 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 123' ' ' THR . 99.3 p 46.85 -114.53 0.54 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.198 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.491 ' N ' ' HG ' ' A' ' 122' ' ' SER . 60.6 p -61.36 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.161 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 125' ' ' MET . 16.3 pttt -170.64 -73.09 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.546 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 64.4 mtt -71.79 -55.96 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.578 0.228 . . . . 1.0 111.469 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.96 -33.04 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.34 . . . . 1.0 111.276 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.2 m -72.44 -43.93 63.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.489 HG21 ' CE1' ' A' ' 32' ' ' PHE . 74.0 mt -64.93 -46.35 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 1.0 112.076 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 130' ' ' ARG . 20.6 pt -62.61 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 121.874 0.845 . . . . 1.0 110.789 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.42 ' N ' HG13 ' A' ' 129' ' ' ILE . 69.1 mtp85 -56.45 -46.04 80.54 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.95 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.75 -55.86 28.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -73.9 -22.69 59.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.345 -176.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 95.6 p 35.67 76.15 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.831 0.852 . . . . 1.0 112.588 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 30' ' ' ALA . 22.5 t70 -164.58 -151.18 0.15 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.041 -0.725 . . . . 1.0 109.041 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 135' ' ' LEU . 4.0 mm? -91.35 126.24 36.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.13 0.491 . . . . 1.0 109.687 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.0 p -97.1 155.36 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.801 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 31' ' ' LEU . 68.9 mt -119.01 96.35 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.995 -1.002 . . . . 1.0 108.52 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 t -96.42 123.44 40.08 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.51 -50.78 19.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.645 0.26 . . . . 1.0 110.796 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 25.11 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.03 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -63.93 -34.13 89.11 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.4 -44.73 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.926 0.393 . . . . 1.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -65.54 -41.58 96.11 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 111.151 -0.779 . . . . 1.0 111.151 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.9 t -69.65 -40.66 76.36 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 122.51 -0.406 . . . . 1.0 111.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.54 -29.75 39.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.369 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.6 tp -50.11 -51.37 43.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.033 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -65.65 -38.99 90.89 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.721 0.772 . . . . 1.0 110.339 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 m -51.08 -25.26 4.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.433 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.47 -55.35 4.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.073 0.768 . . . . 1.0 113.073 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -63.99 -26.61 68.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.909 0.385 . . . . 1.0 110.457 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.26 -0.91 6.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 t30 56.33 37.7 29.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.37 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.95 144.7 42.37 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.086 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.27 -177.41 2.98 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 121.865 1.71 . . . . 1.0 110.877 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.694 ' C ' HD13 ' A' ' 156' ' ' ILE . 2.0 pt? -158.78 171.95 19.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.177 -0.919 . . . . 1.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.694 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.5 OUTLIER -119.32 120.34 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.618 177.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.37 127.76 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.848 0.356 . . . . 1.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 96.8 m -72.77 104.81 4.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.01 147.73 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 83.48 102.49 0.05 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.976 0.798 . . . . 1.0 110.278 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -168.76 -76.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.6 m 49.17 35.92 8.17 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.06 0.457 . . . . 1.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.68 -40.66 97.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.184 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.9 ttm -162.88 52.3 0.18 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.006 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.29 -41.71 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.181 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 71.52 -51.62 0.69 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.701 0.626 . . . . 1.0 110.319 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -60.93 -23.77 65.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.806 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -42.11 -50.71 4.73 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.332 -0.395 . . . . 1.0 111.305 -176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -67.09 -36.27 81.61 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.101 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -66.17 -38.09 87.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.452 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.6 mm -65.06 -43.63 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.99 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.51 -52.26 8.77 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.823 0.344 . . . . 1.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.25 -51.91 30.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.981 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -61.04 -30.31 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 1.0 110.574 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 179' ' ' GLY . 0.7 OUTLIER -63.96 -36.62 84.57 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.024 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.3 t -57.69 -44.5 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.671 0.272 . . . . 1.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -63.41 -50.22 70.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.831 0.348 . . . . 1.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.2 mt -90.76 0.67 57.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.313 0.578 . . . . 1.0 110.212 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . -173.51 87.23 0.08 OUTLIER Glycine 0 C--O 1.223 -0.575 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -48.25 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.457 0.74 . . . . 1.0 110.308 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.4 p -89.96 146.73 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.107 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -66.93 127.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 p -107.14 133.87 51.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.6 m -162.71 124.79 2.66 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.74 154.98 75.95 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.712 -0.661 . . . . 1.0 110.175 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.5 63.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.513 2.638 0 C-N-CA 122.458 2.106 . . . . 1.0 113.547 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 185' ' ' ALA . 79.4 p -128.12 141.95 51.34 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 17.2 mp0 -65.45 -25.36 67.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.276 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 189' ' ' THR . 1.5 t -89.11 -31.57 17.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.897 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.36 -34.3 12.45 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 112.015 -0.434 . . . . 1.0 112.015 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 34.7 mt -62.41 -41.52 98.74 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.449 -0.442 . . . . 1.0 111.364 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.28 -39.33 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.6 79.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.389 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.48 -53.99 25.5 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.415 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.94 -32.98 72.49 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.716 -0.284 . . . . 1.0 110.387 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -59.16 -48.6 81.03 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.503 -0.479 . . . . 1.0 109.99 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.54 -47.79 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.188 -0.32 . . . . 1.0 111.395 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 83.3 p -59.79 -32.95 71.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.21 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.16 28.35 4.97 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.778 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 62.1 m -150.45 -30.74 0.2 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.328 -0.249 . . . . 1.0 110.328 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -150.8 151.94 33.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.174 0.511 . . . . 1.0 109.751 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -130.39 156.78 44.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.344 -0.844 . . . . 1.0 110.089 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.39 164.61 19.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.183 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -61.73 148.35 87.32 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.904 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.99 99.63 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.742 1.628 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -140.61 87.43 11.52 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 107.36 2.46 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.019 1.813 . . . . 1.0 111.685 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.64 84.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.224 -0.444 . . . . 1.0 109.932 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.798 0.333 . . . . 1.0 110.467 179.758 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 120.401 0.143 . . . . 1.0 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -164.04 73.82 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.932 -0.396 . . . . 1.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' H ' HG21 ' A' ' 63' ' ' VAL . 88.6 tttt -128.78 111.32 12.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.45 160.2 14.53 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 137' ' ' ILE . 14.0 tp -130.15 102.73 6.36 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -99.42 127.62 45.48 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.849 0.46 . . . . 1.0 110.018 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.61 145.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 t -144.01 138.63 28.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.523 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.19 -35.57 76.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.852 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.5 -104.12 1.38 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.371 -1.092 . . . . 1.0 110.371 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.46 -159.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -63.42 172.01 2.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 p -162.34 82.81 1.67 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.9 -32.77 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.054 1.836 . . . . 1.0 111.065 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.6 110.45 3.15 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 118.746 -0.645 . . . . 1.0 110.267 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -84.76 -21.68 3.25 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.613 1.542 . . . . 1.0 112.36 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -81.17 -31.89 33.85 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.548 HD23 ' OG ' ' A' ' 162' ' ' SER . 0.3 OUTLIER -75.58 -51.6 12.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.093 0.473 . . . . 1.0 110.472 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 48' ' ' VAL . 11.9 p -56.74 -32.06 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.995 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 98.3 p -62.39 -19.26 63.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.691 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.5 p -51.07 -38.54 52.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 1.0 110.601 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 45' ' ' VAL . 5.4 m -64.61 -18.76 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.112 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mt -143.63 41.19 1.44 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.939 0.496 . . . . 1.0 109.774 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -124.26 -156.13 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.103 -0.702 . . . . 1.0 109.103 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -54.5 -46.81 73.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.747 -0.66 . . . . 1.0 112.033 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.13 -55.41 35.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.536 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -71.0 -45.63 63.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.455 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 47.5 t -56.77 -32.02 65.2 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.46 0.647 . . . . 1.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -78.83 -49.86 12.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.82 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -70.08 -58.29 3.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.888 -0.597 . . . . 1.0 112.606 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 61' ' ' GLY . 3.2 mm? -49.45 -42.01 41.76 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.289 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.7 mm -69.69 -42.33 80.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -50.46 -51.9 42.79 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.122 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.89 -17.81 24.68 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . 75.54 -16.21 4.11 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.562 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 38.09 -115.54 0.15 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.261 -0.4 . . . . 1.0 111.448 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.433 HG21 ' H ' ' A' ' 29' ' ' LYS . 97.0 t -160.43 -59.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -165.64 130.2 2.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.367 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.603 ' C ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -99.44 143.33 29.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.637 0.775 . . . . 1.0 110.533 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.8 mm -123.28 130.46 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 48' ' ' VAL . 12.5 tt -145.29 141.86 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.243 0.544 . . . . 1.0 109.538 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.565 HE21 ' CE ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -160.58 151.79 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.043 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' OE2' ' A' ' 76' ' ' GLU . 95.8 m-85 -99.96 -60.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.315 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.01 -37.62 3.3 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 111.314 -0.715 . . . . 1.0 111.314 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.3 mmt-85 -97.13 122.65 40.39 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.81 -38.07 89.75 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.973 0.416 . . . . 1.0 110.262 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -54.03 -15.91 1.67 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.936 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -55.08 -80.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.242 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.3 m 52.88 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.667 0.27 . . . . 1.0 111.454 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -168.0 -44.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.908 0.385 . . . . 1.0 111.462 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -69.15 103.57 1.94 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.21 -83.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.267 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.08 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.035 0.445 . . . . 1.0 110.272 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.65 -17.59 60.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.32 -36.59 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' GLY . 17.6 mm100 -66.87 -39.64 87.6 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.52 -0.764 . . . . 1.0 110.128 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -51.96 -38.02 55.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.12 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -18.0 62.59 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' GLN . . . 88.53 41.74 6.0 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.34 168.16 54.81 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -137.84 133.83 34.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -62.39 155.94 23.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.894 -0.322 . . . . 1.0 110.848 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.79 -5.83 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.407 0.442 . . . . 1.0 110.888 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.4 m . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.093 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.07 0.462 . . . . 1.0 111.665 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' A' ' 118' ' ' GLY . 22.3 ptt85 -133.47 147.81 51.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -150.05 117.98 6.28 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -137.04 161.28 36.51 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.09 147.94 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.316 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 111' ' ' ASN . 2.0 mp -123.82 123.14 39.8 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.5 tpp 55.83 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.268 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' LEU . 20.6 t-20 -167.39 78.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.793 0.33 . . . . 1.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.41 5.28 77.05 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.011 -0.835 . . . . 1.0 111.011 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -66.51 -23.44 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 tp -174.04 105.68 0.12 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -109.89 115.32 29.59 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.38 108.45 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.87 100.04 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.938 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.41 ' H ' ' HG3' ' A' ' 105' ' ' ARG . . . -84.68 -25.01 43.7 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 109.889 -1.284 . . . . 1.0 109.889 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -58.69 137.4 57.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.898 0.38 . . . . 1.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -166.41 170.54 12.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -81.56 96.06 7.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.226 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.6 p 46.53 -164.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.784 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.54 8.5 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.15 0.5 . . . . 1.0 110.054 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -144.42 44.87 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.565 ' CE ' HE21 ' A' ' 68' ' ' GLN . 18.1 mmt -52.98 -41.67 64.81 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.668 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -54.83 -26.96 38.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.683 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 51.2 p -83.66 -38.85 20.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.836 0.35 . . . . 1.0 111.245 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.02 -44.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.718 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.85 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -55.14 -38.81 68.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.173 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.48 -43.58 84.23 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -96.07 -61.06 1.5 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.03 0.443 . . . . 1.0 110.293 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 m 55.96 79.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -139.99 -49.37 0.47 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.65 0.262 . . . . 1.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.495 HD13 ' H ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -163.39 139.06 6.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.495 ' H ' HD13 ' A' ' 135' ' ' LEU . 1.5 p -133.47 140.44 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.536 HD11 HD11 ' A' ' 31' ' ' LEU . 79.3 mt -119.18 125.9 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 139' ' ' HIS . 27.5 t -87.6 -164.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.435 ' N ' ' OG ' ' A' ' 138' ' ' SER . 79.4 t60 -139.03 -3.38 1.6 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 110.395 -0.224 . . . . 1.0 110.395 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.09 -56.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.099 0.476 . . . . 1.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 136.8 126.14 2.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 1.9 t -174.07 -131.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -73.76 -27.16 67.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -54.75 -44.81 73.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 89.1 mt -65.69 -26.75 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 122.173 -0.329 . . . . 1.0 110.902 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -54.57 34.68 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.25 -44.55 91.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.534 0.683 . . . . 1.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.7 p -49.08 -22.78 0.99 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.125 -0.943 . . . . 1.0 113.3 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.4 mt -82.46 -45.42 14.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.852 0.358 . . . . 1.0 111.611 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -68.8 -21.85 64.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.308 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.03 -3.0 57.72 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 53.06 34.34 16.93 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.593 0.235 . . . . 1.0 110.557 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.81 115.7 48.38 Favored Pre-proline 0 N--CA 1.481 1.11 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -50.94 155.22 6.12 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 CA-C-N 120.658 1.271 . . . . 1.0 112.308 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.14 170.31 19.73 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.274 1.035 . . . . 1.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.43 138.18 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.685 -1.598 . . . . 1.0 109.278 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.7 p -119.89 138.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 120.631 0.253 . . . . 1.0 110.815 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 14.3 t -72.35 125.27 26.97 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 184' ' ' CYS . 25.1 t -123.54 139.81 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.145 -0.687 . . . . 1.0 109.145 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 64.5 t30 57.11 -176.09 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.02 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' A' ' 160' ' ' ASN . 65.5 m-20 59.76 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.838 0.711 . . . . 1.0 111.077 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.548 ' OG ' HD23 ' A' ' 44' ' ' LEU . 68.8 m 53.59 -90.94 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.847 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 66.5 mt -3.79 78.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.104 1.362 . . . . 1.0 113.14 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 62.1 mmm -60.83 -41.14 95.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.14 -0.937 . . . . 1.0 110.617 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.46 121.58 17.29 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.05 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -64.91 -34.27 78.0 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.77 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -55.63 -39.54 70.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.097 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.7 -52.39 64.49 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -66.88 -28.59 68.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.821 0.343 . . . . 1.0 110.574 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.78 -51.99 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.441 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.9 -27.27 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.41 -58.3 3.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -52.18 -43.88 64.38 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.862 -1.063 . . . . 1.0 112.353 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -64.71 -41.99 95.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.421 -0.512 . . . . 1.0 109.844 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.206 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 179' ' ' GLY . 99.7 t -64.12 -35.32 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -48.09 -43.61 30.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.233 -0.894 . . . . 1.0 109.295 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.64 -29.91 67.49 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 82.47 -5.79 71.89 Favored Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.339 -1.104 . . . . 1.0 110.339 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.538 ' O ' HD22 ' A' ' 203' ' ' LEU . 0.3 OUTLIER -62.53 -4.73 2.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.949 -0.625 . . . . 1.0 111.284 -177.559 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.33 147.47 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.171 0.441 . . . . 1.0 110.156 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 19.6 m-90 -76.71 131.65 38.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m -88.08 138.6 31.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -135.53 149.77 49.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.1 150.34 70.88 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.59 -0.893 . . . . 1.0 108.59 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.17 58.19 5.54 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 122.201 1.934 . . . . 1.0 113.183 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 173.08 6.5 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.88 -57.71 5.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.8 m -88.84 -30.27 19.07 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.585 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -59.19 -47.71 89.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.353 -0.699 . . . . 1.0 111.353 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.42 -43.0 91.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 117.083 0.441 . . . . 1.0 111.155 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.46 -43.65 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.59 -38.51 72.11 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.38 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.24 91.38 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.418 -0.673 . . . . 1.0 111.418 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -52.68 63.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -60.84 -35.33 76.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.141 -0.936 . . . . 1.0 109.432 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.03 -45.23 86.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.885 0.374 . . . . 1.0 110.097 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 84.2 p -67.5 -20.49 65.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.66 -24.73 14.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.01 0.433 . . . . 1.0 109.873 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.1 m -74.63 -40.08 61.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.505 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -120.18 139.7 52.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.794 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -119.18 101.61 8.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.054 0.542 . . . . 1.0 109.977 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 180' ' ' TYR . 5.2 tp -63.83 131.18 46.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -67.99 150.19 97.87 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 106.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.508 2.362 0 C-N-CA 121.891 1.727 . . . . 1.0 113.624 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.81 84.69 9.63 Favored Pre-proline 0 N--CA 1.478 0.953 0 N-CA-C 109.932 -0.395 . . . . 1.0 109.932 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -57.32 127.33 25.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.624 1.55 . . . . 1.0 112.036 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.04 -33.48 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.675 -0.491 . . . . 1.0 109.675 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.537 0.461 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.861 -178.746 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 109.768 -0.456 . . . . 1.0 109.768 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -165.96 -76.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -132.73 101.48 5.3 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.006 0.522 . . . . 1.0 110.019 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.68 119.5 38.95 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -83.07 121.59 27.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.76 0.314 . . . . 1.0 110.22 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CE1' ' CZ ' ' A' ' 132' ' ' TYR . 6.9 m-85 -103.63 122.13 44.37 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.2 t -118.36 99.04 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.5 p -93.23 120.75 33.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.236 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 139' ' ' HIS . 71.5 m -61.25 -27.48 68.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -138.47 31.6 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.721 -0.952 . . . . 1.0 110.721 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.37 -112.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.892 -0.181 . . . . 1.0 110.71 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.5 p -71.3 112.74 7.68 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.5 131.48 95.1 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.874 -0.584 . . . . 1.0 110.358 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.77 -174.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.3 1.333 . . . . 1.0 112.477 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.99 144.96 90.01 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.034 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.78 -33.22 49.38 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.789 1.66 . . . . 1.0 113.086 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.32 -35.39 61.24 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.633 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -66.88 -45.04 79.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.799 0.333 . . . . 1.0 111.531 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 48' ' ' VAL . 16.2 m -60.72 -37.03 74.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.954 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -46.54 -27.53 1.15 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.181 0.515 . . . . 1.0 110.986 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.6 t -53.89 -38.09 64.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.78 . . . . 1.0 110.559 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.5 m -80.53 -4.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.302 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.52 40.18 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.224 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.9 m -135.62 -166.12 1.8 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.898 0.856 . . . . 1.0 109.823 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -54.6 -44.84 73.41 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.95 -1.477 . . . . 1.0 110.327 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 23.4 mp0 -52.27 -52.07 54.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.534 0.207 . . . . 1.0 110.55 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.58 -37.33 76.92 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.432 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.2 t -49.77 -45.98 50.23 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.745 0.307 . . . . 1.0 111.552 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -72.66 -44.59 61.67 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 1.0 111.429 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.35 -36.01 80.53 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.596 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -58.17 -47.23 84.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.619 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.62 HD11 ' HZ3' ' A' ' 113' ' ' LYS . 1.5 mp -68.67 -28.95 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.86 -43.02 59.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.91 -0.587 . . . . 1.0 110.906 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -76.57 -11.05 59.81 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.047 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 83.64 37.83 11.43 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.61 -0.805 . . . . 1.0 111.505 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 63' ' ' VAL . 1.6 p90 -48.43 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 120.936 0.398 . . . . 1.0 111.17 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' N ' ' CD2' ' A' ' 62' ' ' PHE . 8.7 p -172.15 -31.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.001 0.429 . . . . 1.0 109.952 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.504 ' NH1' ' NZ ' ' A' ' 115' ' ' LYS . 56.1 ttt85 -167.02 108.52 0.66 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.5 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.07 130.47 36.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.252 -0.648 . . . . 1.0 109.252 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.09 135.88 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.09 144.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -119.98 124.36 45.74 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.158 -1.052 . . . . 1.0 108.158 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CE1' ' NH2' ' A' ' 105' ' ' ARG . 2.0 t80 -59.04 -169.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.302 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.82 -109.08 0.35 Allowed Glycine 0 N--CA 1.463 0.481 0 N-CA-C 110.664 -0.974 . . . . 1.0 110.664 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -65.17 124.28 21.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.71 0.291 . . . . 1.0 110.723 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.63 -37.99 88.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.775 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.36 -44.49 88.84 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.461 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 99.3 p -63.91 169.73 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.289 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.3 p -153.61 73.37 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.335 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.95 169.39 4.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.83 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 45.8 76.1 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.938 0.399 . . . . 1.0 110.736 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.37 -34.96 77.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.22 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -167.86 22.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.388 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.88 -30.19 66.5 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.839 0.352 . . . . 1.0 110.6 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' GLY . 74.6 t -58.91 -47.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -72.72 -42.15 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.884 0.373 . . . . 1.0 111.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -52.64 -43.37 65.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.954 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -83.1 -16.9 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.93 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.38 -55.86 0.41 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . 46.06 78.02 0.09 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 112.686 -0.166 . . . . 1.0 112.686 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.21 109.96 19.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -59.64 150.48 27.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.925 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.5 16.92 3.37 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.479 0.657 . . . . 1.0 109.549 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.469 0.5 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.441 179.881 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.958 0.408 . . . . 1.0 111.493 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.429 ' NH2' ' CE1' ' A' ' 69' ' ' PHE . 10.5 ptp180 -130.12 151.69 50.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.593 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -157.98 109.46 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.52 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -143.14 -172.96 3.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.75 -0.463 . . . . 1.0 109.75 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 109' ' ' LEU . 11.0 p -152.54 162.26 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.427 ' N ' HG22 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -163.84 -174.17 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.2 mtt 53.82 54.09 10.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.496 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 52.49 33.47 13.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.72 25.03 68.35 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 120.894 -0.67 . . . . 1.0 112.499 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.62 ' HZ3' HD11 ' A' ' 58' ' ' ILE . 16.6 tptm -83.21 -49.86 9.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.4 0.6 . . . . 1.0 112.034 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.73 132.84 56.42 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.186 0.517 . . . . 1.0 112.033 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' NZ ' ' NH1' ' A' ' 64' ' ' ARG . 49.3 mtmt -106.23 152.45 23.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -134.23 132.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.6 mt -145.06 123.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.795 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.26 -16.24 76.75 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.15 -1.18 . . . . 1.0 110.15 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.4 t80 54.69 -99.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -169.67 130.17 1.03 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.19 108.64 4.24 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.1 p -168.07 160.64 12.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.123 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.8 t -76.69 5.27 7.86 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.237 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -72.33 -42.73 65.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.293 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.1 ttm -46.14 -34.21 4.09 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.709 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.96 -28.47 57.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.624 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -79.35 -35.18 41.32 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.421 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 128' ' ' ILE . 1.6 mp -64.55 -27.82 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.762 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.2 mt -52.13 -51.45 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 120.316 -0.553 . . . . 1.0 109.739 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -48.47 -30.95 5.67 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.383 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -52.4 -47.23 66.4 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 121.263 -0.175 . . . . 1.0 111.276 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.595 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.2 p90 -117.1 -53.68 2.45 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.341 0.401 . . . . 1.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 47.4 m 50.25 79.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.869 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -120.14 -53.45 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 154' ' ' PRO . 3.3 tp -168.8 148.39 4.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.065 -0.654 . . . . 1.0 110.481 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.17 149.76 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.47 100.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 t -116.33 127.14 54.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.487 ' H ' ' CD2' ' A' ' 139' ' ' HIS . 13.2 p80 -80.69 67.86 6.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.226 -0.443 . . . . 1.0 109.875 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.85 34.37 23.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.994 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -62.41 -34.77 90.37 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.402 ' H ' HD12 ' A' ' 145' ' ' ILE . 2.8 m 69.03 -16.75 0.22 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.46 0.304 . . . . 1.0 110.413 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -84.25 -54.18 3.08 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.706 -0.557 . . . . 1.0 111.706 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.0 p -79.54 -32.22 42.15 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.47 0.308 . . . . 1.0 111.365 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 142' ' ' THR . 97.4 mt -54.27 -28.2 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 120.693 0.283 . . . . 1.0 110.86 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.9 mt -56.29 -51.08 69.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.807 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -65.17 -53.1 50.05 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 121.426 0.632 . . . . 1.0 110.865 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 88.0 p -58.32 -24.93 61.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 1.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.2 tp -76.7 -57.34 3.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.633 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 152' ' ' ASN . 39.6 ptt180 -62.36 -28.05 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.171 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.7 4.6 1.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 150' ' ' ARG . 22.7 m120 58.41 11.96 1.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.233 0.333 . . . . 1.0 110.274 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -92.5 142.33 25.77 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.458 ' O ' HD12 ' A' ' 135' ' ' LEU . 62.7 Cg_endo -71.67 167.9 25.22 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.719 1.613 . . . . 1.0 111.481 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 155' ' ' LEU . 1.9 pt? -156.65 156.52 33.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.295 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.412 ' CG2' ' SG ' ' A' ' 184' ' ' CYS . 16.8 mm -110.13 109.72 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.58 118.27 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.11 103.65 2.37 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 85.5 t -90.09 137.88 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.1 170.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.011 0.434 . . . . 1.0 110.769 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 49.82 74.75 0.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.715 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.1 t -171.2 -49.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.13 0.49 . . . . 1.0 110.129 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.0 pp -145.52 142.87 29.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.092 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.2 mmm -90.22 86.65 6.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.573 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 166' ' ' ASN . 15.3 t0 -161.16 -19.52 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.962 -0.385 . . . . 1.0 109.962 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 165' ' ' ASP . 67.4 m-20 58.7 6.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.67 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 165' ' ' ASP . 52.8 t-80 -66.25 -36.63 83.49 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 172' ' ' ALA . 5.3 pt20 -61.57 -41.6 97.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.974 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -53.96 -29.56 43.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.83 0.348 . . . . 1.0 111.024 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -70.45 -53.47 16.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.09 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.5 mt -83.63 -51.3 14.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 110.487 -0.19 . . . . 1.0 110.487 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 168' ' ' GLN . . . -45.05 -52.97 8.39 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 176' ' ' VAL . 30.4 t0 -69.36 -56.13 8.4 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -51.04 -26.98 6.95 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.9 0.381 . . . . 1.0 110.791 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.31 -38.84 66.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.243 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 173' ' ' ASP . 15.7 m -55.53 -29.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 120.918 0.39 . . . . 1.0 111.875 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -59.46 -48.49 81.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.942 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.6 mt -104.48 24.7 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.288 0.566 . . . . 1.0 110.409 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.644 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.3 82.57 0.04 OUTLIER Glycine 0 C--O 1.221 -0.703 0 N-CA-C 108.44 -1.864 . . . . 1.0 108.44 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -46.35 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 O-C-N 125.063 1.096 . . . . 1.0 110.692 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.644 ' N ' ' O ' ' A' ' 179' ' ' GLY . 6.3 p -73.24 139.63 19.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.534 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -63.9 116.85 6.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.2 m -108.75 133.63 52.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.562 -0.744 . . . . 1.0 109.875 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 156' ' ' ILE . 28.5 p -165.1 131.32 2.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.697 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.65 79.47 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.43 79.11 0.24 Allowed 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.704 2.27 . . . . 1.0 113.68 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.5 p -130.62 177.14 7.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 2.2 pm0 -68.64 -63.86 0.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.56 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.5 m -75.13 -43.56 51.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.022 0.439 . . . . 1.0 111.547 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -51.85 -51.24 40.61 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.969 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.97 -41.46 97.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.3 0.55 . . . . 1.0 111.743 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.76 -42.93 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.94 76.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 1.0 110.153 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.71 -46.44 61.26 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.66 -44.41 97.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.043 -0.354 . . . . 1.0 110.043 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -64.63 -37.91 89.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.57 86.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.4 t -60.16 -21.2 61.37 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.01 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -101.28 31.67 3.6 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.668 0.27 . . . . 1.0 110.792 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 18.2 p -143.01 -31.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.12 152.21 12.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.336 -0.546 . . . . 1.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -99.08 144.03 28.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.688 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.571 HD22 ' C ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -54.78 173.91 0.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.519 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.13 116.08 22.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-O 118.991 -0.528 . . . . 1.0 110.739 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.61 118.17 2.82 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 CA-C-N 120.919 1.364 . . . . 1.0 112.749 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -142.06 87.81 9.56 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 85.79 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.347 1.365 . . . . 1.0 112.436 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.74 -26.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.257 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.469 0.525 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.864 -178.908 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -116.96 65.19 0.72 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.06 156.09 39.59 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.7 134.77 51.7 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.772 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.65 119.57 32.2 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.743 -0.598 . . . . 1.0 109.466 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -101.42 129.94 47.54 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.25 138.04 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.73 129.62 42.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.491 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.56 34.75 2.67 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.971 0.415 . . . . 1.0 110.066 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.92 -160.13 53.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 -37.37 86.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.477 0.179 . . . . 1.0 111.059 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.1 p -133.18 150.45 52.0 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 110.067 -0.345 . . . . 1.0 110.067 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 39' ' ' VAL . 14.5 p -83.12 121.01 76.93 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 119.309 -0.377 . . . . 1.0 110.93 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.58 -59.63 1.12 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 CA-C-N 120.562 1.236 . . . . 1.0 112.386 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -144.81 145.31 27.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.906 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.76 -19.8 30.93 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 121.748 1.632 . . . . 1.0 111.813 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -77.23 -33.9 56.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.806 0.336 . . . . 1.0 110.875 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.46 -48.7 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 1.0 110.72 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -63.21 -34.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 1.0 109.76 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 50' ' ' SER . 6.4 m -52.52 -44.31 65.65 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.655 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -49.01 -38.56 23.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.73 0.3 . . . . 1.0 110.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.11 -14.1 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.271 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.59 35.17 4.24 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.993 0.425 . . . . 1.0 110.333 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 46' ' ' SER . 20.9 m -114.05 -167.55 1.23 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.16 -27.17 63.35 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.707 -1.133 . . . . 1.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.75 -47.57 65.93 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.241 -0.583 . . . . 1.0 110.485 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.2 t80 -69.22 -40.83 77.72 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.7 t -49.99 -48.48 52.3 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -66.78 -44.27 81.8 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.817 0.342 . . . . 1.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -73.64 -30.58 63.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.29 0.567 . . . . 1.0 109.833 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' PHE . 5.7 tt -58.78 -50.0 75.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.312 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -66.59 -31.07 51.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.268 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -59.8 -10.55 3.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.713 -0.222 . . . . 1.0 110.634 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -103.6 -10.59 18.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.218 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.53 13.39 55.58 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 121.188 -0.53 . . . . 1.0 112.384 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -84.71 160.61 20.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.56 3.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.769 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -148.75 142.4 25.5 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.544 0.688 . . . . 1.0 110.554 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -141.99 116.41 9.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.341 -0.845 . . . . 1.0 108.899 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mm -100.69 137.88 26.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tt -146.13 141.24 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.029 0.443 . . . . 1.0 109.833 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.09 158.91 5.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -174.82 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.963 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.27 147.44 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -155.73 83.83 1.03 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 1.0 110.282 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -68.28 -22.31 64.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.281 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -57.22 -29.6 63.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 84.4 p -149.97 -105.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.066 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.7 m -140.63 147.87 40.02 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 19.8 mp0 -84.2 -119.66 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.79 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -66.55 109.98 2.99 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.77 -57.42 5.64 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.108 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -173.23 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.06 -45.04 82.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.096 0.474 . . . . 1.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.88 -46.59 96.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.937 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.35 -26.45 68.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.009 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.98 -49.82 76.43 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.244 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -62.53 -17.38 59.69 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.083 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.77 54.9 7.83 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 110.179 -1.168 . . . . 1.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.15 -165.53 41.39 Favored Glycine 0 N--CA 1.466 0.669 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -134.6 135.03 41.91 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.004 0.431 . . . . 1.0 110.095 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -60.55 153.28 23.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.922 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -106.45 0.48 24.81 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 91.8 p . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 120.96 0.41 . . . . 1.0 111.117 -179.373 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -136.25 158.6 44.03 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.47 ' NE2' ' H ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -155.17 126.17 7.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.47 ' H ' ' NE2' ' A' ' 106' ' ' GLN . 2.0 m-85 -132.16 148.32 52.47 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.0 t -104.61 104.98 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.149 -0.932 . . . . 1.0 108.807 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -99.76 123.17 43.75 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 65.9 mtt 42.7 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.538 0.569 . . . . 1.0 112.538 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 54.96 7.8 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.757 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.29 24.02 72.18 Favored Glycine 0 N--CA 1.462 0.427 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -56.99 -39.47 74.72 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.046 -0.353 . . . . 1.0 110.046 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.8 tp -129.78 128.36 42.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -108.65 119.4 39.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.102 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.31 112.63 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.1 pt -115.08 158.66 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-N 115.144 -0.935 . . . . 1.0 108.954 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -115.44 95.05 0.69 Allowed Glycine 0 N--CA 1.474 1.205 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.76 -173.46 4.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -146.42 156.21 43.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.641 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -69.14 127.93 34.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.233 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.6 p -169.35 33.83 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.676 0.274 . . . . 1.0 110.448 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 29.6 p 51.6 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.653 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -179.88 -29.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.671 0.607 . . . . 1.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtm -55.38 -48.43 74.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.916 0.389 . . . . 1.0 110.923 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.402 ' O ' ' NE ' ' A' ' 130' ' ' ARG . 51.6 tt0 -55.29 -30.08 59.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 m -86.15 -51.79 6.08 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.965 0.412 . . . . 1.0 111.937 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.85 -43.33 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.199 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.33 -57.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.739 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 126' ' ' GLN . 18.1 ptp180 -69.2 -33.93 74.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.478 0.548 . . . . 1.0 112.478 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.17 -46.28 86.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.011 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.73 -65.38 1.15 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.78 0.324 . . . . 1.0 111.86 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 p -60.68 172.68 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.706 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -157.69 23.49 0.28 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.2 tp -158.69 138.03 11.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.85 155.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.08 102.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 81.9 p -89.71 113.24 24.72 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.42 0.629 . . . . 1.0 109.667 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.401 ' O ' ' N ' ' A' ' 141' ' ' GLY . 59.7 t-80 -69.69 136.44 51.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.24 -63.87 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.394 0.887 . . . . 1.0 113.394 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 139' ' ' HIS . . . -167.94 -80.44 0.04 OUTLIER Glycine 0 C--N 1.345 1.05 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.0 p 56.55 166.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.741 0.781 . . . . 1.0 110.76 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.35 -15.51 80.85 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 114.542 -1.208 . . . . 1.0 110.966 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 91.5 p -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.053 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.557 HG12 HD21 ' A' ' 155' ' ' LEU . 96.6 mt -59.01 -27.09 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.606 -0.438 . . . . 1.0 112.033 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 209' ' ' SER . 51.1 tp -57.02 -48.0 79.55 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.27 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -68.87 -51.99 34.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.631 . . . . 1.0 110.364 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.548 ' HB2' HD22 ' A' ' 155' ' ' LEU . 16.2 m -51.18 -25.22 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.766 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -77.01 -46.41 23.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.857 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -67.54 -32.83 73.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.54 -0.755 . . . . 1.0 111.24 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.75 -9.67 58.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 61.9 t30 54.88 35.27 23.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -109.46 151.28 42.07 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-O 119.294 -0.384 . . . . 1.0 110.393 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -43.13 143.59 1.96 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.007 1.804 . . . . 1.0 112.017 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 156' ' ' ILE . 52.3 tp -152.88 134.71 14.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.77 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -125.69 129.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.942 0.777 . . . . 1.0 109.013 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.17 130.53 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 117.986 0.357 . . . . 1.0 110.069 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 71.0 m -83.35 103.4 12.69 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.164 0.507 . . . . 1.0 109.663 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.36 143.41 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -147.62 175.32 10.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.936 0.398 . . . . 1.0 110.028 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -61.69 171.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.624 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.6 p -62.3 96.46 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.179 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 tp -66.38 -164.85 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.144 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.8 ttp -62.34 -52.47 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.835 0.35 . . . . 1.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 167' ' ' HIS . 75.9 m-20 -71.05 -42.7 69.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.115 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.71 0.86 0.16 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.287 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.475 ' H ' ' C ' ' A' ' 165' ' ' ASP . 34.6 m170 -73.55 -35.91 65.56 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.93 0.395 . . . . 1.0 110.459 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -65.29 -50.88 64.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.642 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.3 -33.32 74.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.441 . . . . 1.0 110.207 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.04 -52.43 65.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.707 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.85 -36.01 67.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.568 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.102 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 176' ' ' VAL . 27.6 t70 -49.32 -28.58 5.02 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.25 0.548 . . . . 1.0 110.423 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -85.43 -45.74 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.014 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.01 -20.51 60.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.258 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 177' ' ' GLU . 14.3 p -62.17 -52.08 64.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.976 0 C-N-CA 121.02 -0.272 . . . . 1.0 110.532 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 176' ' ' VAL . 57.7 mt-10 -58.79 -19.6 42.4 Favored 'General case' 0 CA--C 1.522 -0.11 0 O-C-N 121.931 -0.481 . . . . 1.0 111.048 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.77 3.2 0.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.676 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 177' ' ' GLU . . . 144.64 10.37 0.33 Allowed Glycine 0 N--CA 1.474 1.201 0 N-CA-C 111.089 -0.805 . . . . 1.0 111.089 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 176' ' ' VAL . 27.5 t80 72.23 100.38 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 1.0 109.237 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 181' ' ' VAL . 11.8 p -92.79 58.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.594 0.235 . . . . 1.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 181' ' ' VAL . 4.3 m-90 33.03 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.044 0.449 . . . . 1.0 110.303 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 93.8 p -88.08 132.75 34.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.95 142.55 46.8 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -111.31 155.86 42.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 119.158 -0.448 . . . . 1.0 110.755 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.32 37.73 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.785 1.656 . . . . 1.0 113.214 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p -131.32 143.09 50.25 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 24.8 mp0 -64.53 -46.33 83.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.474 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.0 m -64.4 -28.57 69.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.581 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.53 -31.89 17.53 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.45 -47.34 79.45 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 111.778 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.0 pt -52.66 -34.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.022 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.96 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.3 98.39 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 49.8 mt -64.66 -35.42 80.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.932 0.396 . . . . 1.0 110.359 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -69.89 -37.36 75.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.421 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -70.28 -44.95 67.32 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.062 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -66.58 -30.09 70.31 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.002 0.371 . . . . 1.0 112.002 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -86.16 11.67 11.39 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.176 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.2 p -146.37 -64.3 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.519 -0.31 . . . . 1.0 110.242 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.6 mt-10 -71.63 129.21 38.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.748 0.308 . . . . 1.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.07 170.84 8.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.83 138.49 54.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -57.49 143.25 75.22 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.11 100.35 1.37 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.719 1.613 . . . . 1.0 111.964 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -142.02 82.87 13.08 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.85 112.64 1.16 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.914 1.742 . . . . 1.0 111.873 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.34 -73.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.515 -0.474 . . . . 1.0 110.073 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.52 ' H ' HD13 ' A' ' 146' ' ' LEU . 47.1 m . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.015 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.691 0.282 . . . . 1.0 110.938 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -167.58 -61.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' O ' HG21 ' A' ' 63' ' ' VAL . 68.1 mttm -128.42 142.23 51.17 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.076 0.465 . . . . 1.0 110.167 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.28 167.4 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.85 120.19 19.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -118.73 133.56 55.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.403 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.7 140.29 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 t -143.96 141.24 30.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.034 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.8 m -83.19 143.51 30.43 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.452 ' N ' ' NE2' ' A' ' 139' ' ' HIS . . . -71.01 62.12 0.97 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.36 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.791 0.348 . . . . 1.0 110.775 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.4 p 53.18 100.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -59.68 125.36 79.76 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.035 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.71 -54.68 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.021 1.147 . . . . 1.0 111.927 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.417 ' CE2' ' OD1' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -142.76 144.54 30.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.92 -7.71 15.48 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.968 1.778 . . . . 1.0 111.545 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -66.99 -46.09 75.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.781 0.324 . . . . 1.0 111.083 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.67 -40.98 98.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.78 0.324 . . . . 1.0 110.617 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.23 -44.63 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.6 t -54.82 -48.2 73.11 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.166 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.3 m -51.65 -49.8 61.58 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.272 -0.267 . . . . 1.0 111.369 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 30.0 m -78.94 5.79 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.672 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.04 30.96 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 46' ' ' SER . 14.3 t -119.23 -164.12 1.03 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.548 ' N ' ' OG ' ' A' ' 50' ' ' SER . 76.1 m-20 -50.83 -42.42 58.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.922 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -62.76 -53.82 48.5 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 121.171 0.51 . . . . 1.0 110.218 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CE2' HD13 ' A' ' 57' ' ' LEU . 54.6 t80 -61.99 -45.43 93.66 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.244 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 89.4 m -51.94 -49.62 62.77 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.32 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 78.0 mt-30 -73.14 -52.3 14.72 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.077 0.465 . . . . 1.0 110.593 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -57.02 -24.94 57.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.694 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 ' CE2' ' A' ' 53' ' ' PHE . 48.8 tp -61.15 -45.32 95.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 1.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.7 mp -62.42 -43.39 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.747 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.418 ' OE1' ' N ' ' A' ' 59' ' ' GLN . 1.1 mp0 -55.56 -16.83 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.469 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.71 ' CD1' HD12 ' A' ' 195' ' ' LEU . 74.3 t80 -98.5 -19.06 17.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 102.65 40.52 2.52 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 118.111 -1.383 . . . . 1.0 111.676 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 61' ' ' GLY . 13.3 p90 -13.22 146.57 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 124.33 1.052 . . . . 1.0 112.143 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 29' ' ' LYS . 84.8 t -146.86 -78.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.777 0.717 . . . . 1.0 109.583 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -151.82 110.68 3.84 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.4 tp -92.25 127.6 37.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.03 146.31 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.6 tt -138.75 141.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.473 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 9.8 tp-100 -70.18 -86.38 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.528 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 t80 50.89 -174.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.249 0.219 . . . . 1.0 110.491 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.56 76.03 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -67.18 175.99 2.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.894 0.378 . . . . 1.0 110.039 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -61.61 -29.86 70.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.392 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -60.09 -21.58 61.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.255 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m 53.3 -95.8 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.055 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 t 56.83 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.159 0.504 . . . . 1.0 111.166 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -79.4 132.45 36.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.116 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 54.5 t80 -78.07 12.51 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.211 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 80' ' ' LEU . 78.8 tt0 62.58 137.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.74 0.65 . . . . 1.0 109.745 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -67.83 66.1 0.09 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.928 0.394 . . . . 1.0 110.05 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.14 -57.53 3.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.323 0.582 . . . . 1.0 111.618 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 107' ' ' TYR . 28.7 m -57.43 -43.3 82.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.538 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.479 ' N ' HG23 ' A' ' 81' ' ' VAL . 58.0 tt0 -63.31 -39.83 95.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.298 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -52.45 -46.03 66.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.998 0.428 . . . . 1.0 110.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.44 ' NH2' ' OG ' ' A' ' 50' ' ' SER . 30.3 mmt180 -71.66 -16.44 62.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.06 59.65 1.94 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.61 -168.02 39.61 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 110.087 -1.205 . . . . 1.0 110.087 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -133.35 127.72 34.11 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 113.1 24.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.728 0.299 . . . . 1.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -84.2 -76.51 0.3 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.095 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.531 0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.405 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -141.35 154.15 45.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.682 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -156.18 131.62 9.48 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.349 -0.611 . . . . 1.0 109.349 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.508 ' CD2' HG21 ' A' ' 81' ' ' VAL . 9.9 m-85 -132.1 143.77 50.24 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.465 -0.569 . . . . 1.0 109.465 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 112' ' ' GLY . 9.1 p -127.88 140.57 48.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 111' ' ' ASN . 10.9 mp -101.61 147.96 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.2 mtp 46.66 -89.74 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.442 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 109' ' ' LEU . 16.9 m120 -155.86 81.5 1.01 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.804 0.335 . . . . 1.0 110.476 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.472 ' H ' ' CG2' ' A' ' 108' ' ' VAL . . . 74.74 23.3 75.39 Favored Glycine 0 N--CA 1.469 0.853 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -73.14 -75.05 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.571 -0.37 . . . . 1.0 110.671 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.92 126.96 53.63 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.476 0.485 . . . . 1.0 109.947 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -105.64 101.25 10.78 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.473 -0.195 . . . . 1.0 110.473 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.05 109.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -117.53 139.6 15.03 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 109.914 -1.275 . . . . 1.0 109.914 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -170.11 140.82 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -160.52 155.97 25.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.013 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 123' ' ' THR . 82.7 t80 -161.16 98.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.289 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 64.35 -67.52 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.525 0.516 . . . . 1.0 110.819 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 121' ' ' PHE . 30.3 m -154.78 121.65 5.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -148.6 5.48 0.7 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 125' ' ' MET . 3.9 mpp? -59.22 -57.25 13.86 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.17 -29.01 65.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.951 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.3 m -70.85 -43.4 68.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.435 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.8 -50.05 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 1.0 112.367 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 133' ' ' SER . 1.2 pp -63.78 -54.02 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.926 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -47.03 -37.36 9.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.072 -0.393 . . . . 1.0 111.068 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.94 -48.22 78.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.12 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -100.22 -64.25 1.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.811 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 129' ' ' ILE . 34.2 p 57.09 74.26 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -134.8 -44.87 0.73 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.956 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.9 tp -169.13 151.03 4.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.68 146.51 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.18 105.73 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 138.13 40.34 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.452 ' NE2' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -60.11 -169.65 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.042 0.449 . . . . 1.0 110.176 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.17 45.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.431 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.38 -128.11 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.7 m -163.44 -50.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.576 -0.367 . . . . 1.0 110.771 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.73 -52.51 5.86 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 92.1 p -55.15 -42.69 73.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.743 0.306 . . . . 1.0 110.88 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.74 -49.69 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.6 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.59 -31.24 6.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.001 0.188 . . . . 1.0 111.403 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.27 -50.79 29.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.999 0.428 . . . . 1.0 110.287 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.888 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.36 -46.64 31.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.764 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.98 -37.39 86.94 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.876 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.07 -11.61 59.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.61 36.51 26.83 Favored 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 123.473 0.483 . . . . 1.0 110.049 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -122.95 147.16 50.55 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.925 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -45.19 165.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.205 1.936 . . . . 1.0 112.47 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 59.9 tp -152.03 140.73 20.86 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.039 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.09 123.83 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -116.0 133.3 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 117.801 0.273 . . . . 1.0 111.169 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 77.4 m -72.66 105.13 4.15 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.28 141.52 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.874 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.56 -157.16 0.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.064 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 t70 58.34 21.29 8.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.451 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.5 m -85.75 90.15 7.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.687 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 163' ' ' LEU . 10.0 mp -63.55 -41.19 98.44 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.897 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' ASN . 43.3 ttp -130.1 -53.05 1.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.506 0.322 . . . . 1.0 110.755 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.417 ' OD1' ' CE2' ' A' ' 41' ' ' PHE . 4.0 p-10 -66.72 69.61 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.138 0.494 . . . . 1.0 110.635 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 164' ' ' MET . 76.7 m-20 -65.45 -25.82 67.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.383 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -51.18 -32.3 22.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.839 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -60.7 -47.79 84.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.529 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -69.1 -30.14 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.487 0.184 . . . . 1.0 111.013 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.14 -54.16 45.08 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.02 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 175' ' ' PHE . 17.0 tt -68.61 -34.85 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.25 -65.04 0.63 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.294 0.569 . . . . 1.0 110.623 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.02 -34.26 28.71 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.065 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.04 -31.44 56.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.407 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' ILE . 3.5 t80 -63.19 -47.13 83.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.849 0.357 . . . . 1.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.53 -44.64 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -54.75 -46.85 74.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.113 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 178' ' ' LEU . 10.5 mp -98.33 9.47 42.99 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.071 0.462 . . . . 1.0 110.365 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 173.66 91.11 0.08 OUTLIER Glycine 0 C--O 1.212 -1.239 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -49.51 70.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.086 0.954 . . . . 1.0 111.174 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.6 p -73.8 141.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.889 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -59.25 114.04 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.263 0.554 . . . . 1.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.5 t -87.0 135.96 33.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.443 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.62 170.79 17.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.23 74.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.622 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.62 57.49 1.42 Allowed 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.558 2.172 . . . . 1.0 112.882 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.9 p -131.65 147.05 52.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -59.48 -51.91 67.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.616 0.245 . . . . 1.0 111.19 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 26.1 m -65.27 -24.86 67.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.925 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.04 -36.02 8.61 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 116.183 -0.462 . . . . 1.0 112.087 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -40.97 85.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 117.235 0.518 . . . . 1.0 111.556 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.0 pt -55.58 -34.66 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 1.0 110.833 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.7 78.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.189 0.518 . . . . 1.0 109.775 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.78 -46.16 94.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.236 -0.746 . . . . 1.0 111.236 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.71 HD12 ' CD1' ' A' ' 60' ' ' TYR . 4.4 mm? -61.92 -44.13 97.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.912 0.356 . . . . 1.0 110.312 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -63.32 -52.14 63.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.623 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.56 71.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.177 -0.305 . . . . 1.0 110.177 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 97.1 p -60.48 -34.05 73.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.965 -0.294 . . . . 1.0 111.304 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -102.64 32.8 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 1.0 111.135 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 19.6 m -159.84 -29.17 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.159 -0.338 . . . . 1.0 110.607 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -108.75 152.13 25.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -122.21 170.82 9.51 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.6 tp -119.73 136.24 54.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -62.61 152.25 81.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.196 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -37.9 109.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.826 2.35 . . . . 1.0 112.554 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 206' ' ' PHE . 0.1 OUTLIER -61.53 151.75 76.62 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.332 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.03 -8.01 18.59 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.961 1.774 . . . . 1.0 111.705 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.7 p -49.96 132.57 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.608 0.242 . . . . 1.0 111.06 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.467 0.405 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.449 179.82 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' ' 115' ' ' LYS . 67.8 mt-10 . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.64 0.257 . . . . 1.0 110.613 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -92.39 -73.4 0.55 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.3 110.87 7.03 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.4 125.11 52.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.844 0.458 . . . . 1.0 109.991 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 31' ' ' LEU . 9.2 mp -91.73 107.19 19.04 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.188 0.518 . . . . 1.0 109.63 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -85.07 125.81 33.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.081 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.91 130.09 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -145.52 136.68 24.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.74 -26.6 31.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.451 . . . . 1.0 109.835 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.25 -112.09 3.93 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.95 -156.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.571 0.224 . . . . 1.0 110.627 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 t -53.6 170.53 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.7 t -139.67 82.75 17.65 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.62 16.37 1.97 Allowed 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.481 2.121 . . . . 1.0 111.702 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.08 65.0 28.28 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.98 -17.55 41.09 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.028 1.818 . . . . 1.0 111.941 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -79.99 -30.85 39.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.499 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.47 -44.92 56.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.797 0.332 . . . . 1.0 110.645 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 -29.41 46.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.029 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.5 p -51.31 -38.47 53.15 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.118 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -47.33 -28.34 1.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 1.0 110.605 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -92.23 -23.91 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.839 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 46' ' ' SER . 0.7 OUTLIER -120.67 24.79 10.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.968 0.507 . . . . 1.0 110.194 -177.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 46' ' ' SER . 40.3 t -104.72 -161.76 0.84 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.459 ' N ' ' OG ' ' A' ' 50' ' ' SER . 63.0 m-20 -71.27 -28.52 64.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.28 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.59 -51.51 69.51 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.855 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.7 t80 -70.14 -39.15 75.56 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.185 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.7 t -52.67 -46.2 67.12 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.678 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -71.66 -44.14 64.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.113 0.482 . . . . 1.0 110.586 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -68.41 -26.45 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' PHE . 56.1 tp -57.19 -44.64 83.78 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.7 mp -55.11 -33.63 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -34.56 75.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.43 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -72.31 -18.89 61.75 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.71 34.38 2.85 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 37.33 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.862 0.465 . . . . 1.0 111.462 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -115.86 -95.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 122.618 0.367 . . . . 1.0 110.36 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.463 ' H ' HG23 ' A' ' 63' ' ' VAL . 42.5 ttm180 -168.42 149.87 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -130.29 118.07 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 66' ' ' ILE . 5.2 mp -108.98 132.01 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 tp -114.56 141.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -166.51 -166.98 0.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.03 164.49 32.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.38 -35.35 90.86 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.53 147.65 51.61 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.993 0.425 . . . . 1.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -62.96 -35.18 79.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.274 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -60.95 -49.18 78.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 96.5 p -77.27 102.05 6.53 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.186 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.4 p -169.98 88.91 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.992 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.28 -87.11 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 47.24 94.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.819 0.343 . . . . 1.0 110.145 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.87 -70.83 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.161 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.66 66.0 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.837 0.351 . . . . 1.0 110.318 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 80' ' ' LEU . 9.6 mp -63.34 -41.39 98.87 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.829 0.347 . . . . 1.0 110.339 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 82' ' ' GLN . 20.0 m -60.23 -45.86 95.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.863 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.475 ' N ' HG23 ' A' ' 81' ' ' VAL . 2.6 tm0? -66.53 -46.89 74.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.794 0.33 . . . . 1.0 110.84 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -55.52 -45.66 77.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.932 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.427 ' HA ' ' HE ' ' A' ' 84' ' ' ARG . 0.4 OUTLIER -74.16 -17.16 60.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.475 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.96 50.32 3.96 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.12 177.49 54.3 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 109.487 -1.445 . . . . 1.0 109.487 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -124.44 121.98 36.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -63.45 159.81 17.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.881 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -131.27 -178.8 5.0 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.563 -179.706 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.016 0.436 . . . . 1.0 110.196 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -131.36 161.72 31.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.821 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -155.95 119.61 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.75 159.84 40.06 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.52 143.61 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.8 mm? -95.88 137.42 34.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.9 mmm 47.12 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.014 0.821 . . . . 1.0 111.272 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 109' ' ' LEU . 19.8 p-10 -156.83 70.46 0.64 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.973 0.416 . . . . 1.0 110.551 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.2 27.13 64.63 Favored Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.576 -0.61 . . . . 1.0 111.576 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -91.9 -7.14 50.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.826 0.313 . . . . 1.0 110.728 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.65 131.55 0.89 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 99.3 mttt -98.73 141.66 31.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.83 112.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.87 130.82 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.139 0.576 . . . . 1.0 109.82 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -22.97 68.87 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -117.71 169.52 9.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.875 0.47 . . . . 1.0 110.438 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -168.6 173.71 7.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.112 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 122' ' ' SER . 88.2 t80 -65.62 166.98 9.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.43 . . . . 1.0 109.843 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.478 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 40.7 t 53.15 96.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.807 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 124' ' ' LYS . 89.9 m -58.71 164.86 2.52 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.509 ' N ' HG22 ' A' ' 123' ' ' THR . 14.5 tptm 68.86 108.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.431 0.457 . . . . 1.0 110.263 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 126' ' ' GLN . 0.0 OUTLIER -49.77 -36.74 27.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.122 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.471 ' N ' ' SD ' ' A' ' 125' ' ' MET . 57.8 tt0 -57.3 -32.37 66.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.2 m -78.72 -34.84 45.59 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.835 0.35 . . . . 1.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.379 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -58.29 -48.97 83.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -59.45 -44.9 92.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.59 -0.277 . . . . 1.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -53.26 -42.9 66.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.504 -0.317 . . . . 1.0 111.411 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -98.43 -68.45 0.8 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p 71.52 33.37 1.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.03 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.74 -66.4 0.91 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.198 -0.668 . . . . 1.0 109.198 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 44.3 tp -165.95 142.84 5.3 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.818 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.38 147.24 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.01 125.51 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.145 -1.058 . . . . 1.0 108.145 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.7 p -137.57 134.58 35.78 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.7 -34.53 58.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.65 34.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.669 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 143' ' ' GLY . . . -61.67 -37.01 93.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.5 m 65.19 -65.49 0.16 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.099 0.476 . . . . 1.0 111.021 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' GLY . . . -66.52 -32.68 82.38 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 44.8 m -73.92 -33.89 64.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.769 0.319 . . . . 1.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.4 -28.74 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 120.974 0.416 . . . . 1.0 110.769 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -47.91 -51.11 24.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.618 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -63.18 -44.47 95.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.314 0.578 . . . . 1.0 110.859 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.0 m -59.88 -24.62 64.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.479 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.36 -48.4 23.21 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.3 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -75.08 -22.47 58.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.832 -0.622 . . . . 1.0 111.35 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.87 -6.75 50.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 51.41 31.07 6.8 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.171 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 78.9 mttt -108.8 155.86 39.95 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 123.326 0.391 . . . . 1.0 110.026 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -42.66 139.27 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.683 1.589 . . . . 1.0 111.91 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.757 ' C ' HD13 ' A' ' 156' ' ' ILE . 3.0 tm? -153.82 122.91 6.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.757 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -117.52 120.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.71 0.631 . . . . 1.0 109.731 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.08 115.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 94.7 m -72.33 102.5 3.15 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.29 137.07 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -130.48 171.98 12.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 29.0 p-10 -97.02 14.55 25.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.512 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 t -156.67 -136.49 0.05 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.563 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt 64.88 114.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 tpt 67.82 173.19 0.27 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.317 -0.402 . . . . 1.0 109.927 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.61 -65.6 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -154.22 9.41 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.814 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -62.97 -33.43 75.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.009 -0.367 . . . . 1.0 110.009 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.32 -38.52 77.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 1.0 110.412 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -78.45 -32.52 48.48 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.633 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.07 -50.2 67.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.707 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.88 -38.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.34 -56.33 4.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.196 0.998 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -49.84 -52.36 33.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.882 -1.053 . . . . 1.0 110.922 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.63 -30.88 70.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 1.0 110.478 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 181' ' ' VAL . 2.8 m-85 -74.89 -55.21 6.03 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.783 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.22 -25.89 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.692 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -48.55 -52.03 24.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.485 -0.932 . . . . 1.0 108.485 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.24 -29.96 70.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.701 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 129.75 81.53 0.27 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 112.106 -0.398 . . . . 1.0 112.106 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 36.6 46.88 0.48 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.62 0.724 . . . . 1.0 111.505 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.688 HG13 ' H ' ' A' ' 182' ' ' TRP . 2.5 p -48.12 -61.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.671 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TRP . . . . . 0.688 ' H ' HG13 ' A' ' 181' ' ' VAL . 10.4 m0 -156.73 62.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.991 0.807 . . . . 1.0 110.377 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -111.93 130.43 55.85 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.363 -0.835 . . . . 1.0 108.99 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 49.2 t -164.26 127.44 2.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.071 -0.715 . . . . 1.0 109.071 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 153.14 70.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 110.686 -0.116 . . . . 1.0 110.686 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 84.26 0.45 Allowed 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.077 1.851 . . . . 1.0 112.588 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.9 m -132.19 148.82 52.48 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -48.19 -54.83 12.09 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.185 -0.206 . . . . 1.0 111.37 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.6 m -73.25 -44.98 58.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.986 0.422 . . . . 1.0 111.049 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -55.9 -44.81 87.47 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.029 -0.532 . . . . 1.0 112.427 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -40.98 71.36 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.93 0.365 . . . . 1.0 110.172 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.99 -45.44 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.29 66.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.017 0.437 . . . . 1.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -54.56 -40.19 69.06 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -47.94 71.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.454 0.645 . . . . 1.0 109.928 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -59.99 -45.65 92.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.859 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.13 -52.0 66.71 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.035 0.445 . . . . 1.0 110.946 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 155' ' ' LEU . 39.9 p -65.09 -21.52 66.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.02 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -110.18 31.3 6.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.727 0.411 . . . . 1.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 56.3 m -145.88 -27.05 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.37 151.36 35.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.29 142.99 50.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.918 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.18 -161.24 0.79 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.938 -0.574 . . . . 1.0 109.569 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -73.2 144.91 85.17 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.886 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.84 -47.19 27.7 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.527 1.485 . . . . 1.0 113.374 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -139.73 86.4 13.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.241 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.4 -64.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.039 1.826 . . . . 1.0 111.721 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.17 145.59 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.075 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -133.51 -117.39 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -76.53 94.8 3.77 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.707 0.289 . . . . 1.0 110.913 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.33 166.26 12.17 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.2 mt -132.26 101.0 5.19 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.626 ' CZ ' HD13 ' A' ' 66' ' ' ILE . 6.1 m-85 -95.0 127.12 40.81 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.023 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 137' ' ' ILE . 5.5 p -127.21 125.68 66.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.7 p -143.52 137.38 28.43 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.254 -0.884 . . . . 1.0 109.46 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.8 m -103.45 140.32 37.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.0 -89.48 0.03 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.263 -0.735 . . . . 1.0 111.263 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.56 -78.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.867 0.365 . . . . 1.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -167.12 160.51 13.96 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.297 -0.41 . . . . 1.0 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.16 144.49 87.35 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.744 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.78 -46.6 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.966 1.777 . . . . 1.0 111.054 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -139.32 160.72 60.85 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 123.069 0.23 . . . . 1.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.17 -10.62 29.49 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 122.089 1.859 . . . . 1.0 112.011 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -73.96 -29.56 62.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.876 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 44' ' ' LEU . 4.2 mm? -63.15 -53.84 47.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.072 -0.251 . . . . 1.0 110.897 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 46' ' ' SER . 18.2 m -69.92 -42.67 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.711 0.291 . . . . 1.0 110.581 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.2 t -51.95 -53.19 44.23 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.102 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 53' ' ' PHE . 90.9 m -47.21 -36.14 8.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.771 -0.195 . . . . 1.0 111.294 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.9 t -72.8 -26.18 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 120.775 0.321 . . . . 1.0 111.439 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.24 33.28 3.09 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.365 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.2 t -98.35 -173.71 2.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' N ' ' OG ' ' A' ' 50' ' ' SER . 11.5 m-20 -56.38 -27.64 56.83 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.374 -1.284 . . . . 1.0 110.904 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -71.81 -53.56 12.94 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.669 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 47' ' ' CYS . 3.3 m-85 -68.55 -37.67 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.146 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 93.7 m -53.2 -45.9 68.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.639 0.256 . . . . 1.0 111.039 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.92 -40.96 71.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -67.99 -27.79 66.87 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -60.22 -39.41 86.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.358 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mm -48.89 -41.12 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.564 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -65.97 -40.94 91.72 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.303 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -65.43 -23.28 66.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.027 -0.36 . . . . 1.0 110.027 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' C ' ' CG ' ' A' ' 62' ' ' PHE . . . 93.49 20.3 32.56 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.784 -0.526 . . . . 1.0 111.784 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HA ' HD12 ' A' ' 57' ' ' LEU . 1.4 p90 43.02 78.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 117.801 0.801 . . . . 1.0 111.024 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.7 -85.76 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -168.81 135.05 1.78 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 66' ' ' ILE . 3.6 tt -133.25 131.39 40.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.626 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 1.7 mp -116.47 127.33 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.579 HD13 ' N ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -108.48 132.35 56.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.579 ' N ' HD13 ' A' ' 67' ' ' ILE . 57.2 tt0 -146.65 153.99 40.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.22 -151.33 0.39 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.012 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.94 -114.94 0.01 OUTLIER Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 72' ' ' ASN . 35.6 ttt180 -165.58 -149.96 0.12 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.231 -0.57 . . . . 1.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 71' ' ' ARG . 15.9 p30 -66.14 -25.9 67.19 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -59.51 -41.63 90.34 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.136 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.7 t -140.7 132.45 27.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.195 -0.457 . . . . 1.0 109.99 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 m -157.99 163.12 38.1 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.31 23.67 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.845 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -67.53 85.18 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 80' ' ' LEU . 70.8 mm-40 -61.91 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.657 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -73.89 33.6 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.741 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 78' ' ' GLU . 1.9 pp -62.46 -32.47 73.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 1.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.2 t -62.81 -51.55 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.859 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -72.85 -32.51 65.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.279 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -50.96 -43.98 60.5 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.22 -0.445 . . . . 1.0 109.819 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.437 ' NE ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -79.37 -16.23 56.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.051 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.84 28.87 5.76 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.97 158.17 53.47 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -134.63 128.93 34.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.841 0.353 . . . . 1.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -52.82 159.93 1.03 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.99 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.43 152.07 37.47 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.145 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.456 0.169 . . . . 1.0 111.321 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.426 ' CB ' ' H ' ' A' ' 118' ' ' GLY . 75.4 mmt-85 -123.42 119.19 29.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -160.69 119.44 2.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.275 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.44 161.42 27.12 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.31 135.77 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -95.35 133.88 38.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.439 . . . . 1.0 109.964 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.4 mmm 50.01 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.924 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -148.94 48.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.383 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 27.45 29.14 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 111.955 -0.458 . . . . 1.0 111.955 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.4 -12.27 54.74 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.3 tp -168.0 137.34 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -102.98 140.39 37.31 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.62 142.19 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.078 -1.082 . . . . 1.0 108.078 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' ILE . 18.9 pt -142.53 131.14 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.426 ' H ' ' CB ' ' A' ' 105' ' ' ARG . . . -65.99 -139.72 0.04 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CE2' ' O ' ' A' ' 120' ' ' ASP . 78.5 t80 -57.73 161.31 3.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.921 0.391 . . . . 1.0 110.498 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' CE2' ' A' ' 119' ' ' PHE . 54.3 p-10 -153.64 -177.06 6.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.076 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -65.16 153.97 39.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 123' ' ' THR . 79.5 p -59.3 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.917 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.401 ' N ' ' OG ' ' A' ' 122' ' ' SER . 25.7 m -61.65 106.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -168.01 -54.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.343 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 52.5 mtm -44.99 -45.88 10.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 1.0 111.572 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -59.25 -31.1 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.737 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -80.57 -52.28 7.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.798 0.332 . . . . 1.0 111.813 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 128' ' ' ILE . 1.5 mp -62.69 -43.72 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.876 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -54.06 -53.2 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.23 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -51.1 -30.04 14.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.521 0.201 . . . . 1.0 111.06 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.86 -42.47 58.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.688 -0.233 . . . . 1.0 110.9 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.58 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.1 p90 -123.1 -51.88 1.88 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.58 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 82.8 p 48.65 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.943 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -137.22 -52.39 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.2 tp -167.35 148.14 5.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.6 151.55 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 73.7 mt -117.71 115.63 49.17 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 108.177 -1.046 . . . . 1.0 108.177 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.9 p -85.21 -161.38 0.58 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -159.74 83.97 0.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 52.28 17.61 0.76 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.81 -147.88 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -164.01 -60.6 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 -26.68 73.9 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 123.792 0.683 . . . . 1.0 111.946 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.5 m -70.3 -36.62 74.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.681 0.277 . . . . 1.0 111.313 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.18 -40.61 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.847 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -50.09 -40.84 46.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.798 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -52.11 66.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.512 0.672 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.8 p -70.36 -22.62 62.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.239 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.466 HD11 HD23 ' A' ' 203' ' ' LEU . 17.0 tp -73.23 -53.32 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.157 0.428 . . . . 1.0 112.157 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -67.29 -31.75 72.28 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.583 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 mp -70.04 -1.63 10.42 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 58.53 34.03 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.391 0.432 . . . . 1.0 110.6 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 97.8 mttt -113.2 126.32 28.38 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.44 157.15 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.416 1.41 . . . . 1.0 111.941 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.581 ' C ' HD13 ' A' ' 156' ' ' ILE . 5.4 tt -152.44 144.39 23.73 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.581 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -111.31 116.55 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 157' ' ' VAL . 14.0 p -103.71 117.32 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 57.2 m -74.07 104.35 4.86 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.427 -0.582 . . . . 1.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.01 138.51 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -160.24 -165.51 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.827 0.346 . . . . 1.0 110.174 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -65.34 -168.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.6 m -156.72 81.35 0.95 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.956 0.407 . . . . 1.0 109.927 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -35.36 12.66 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.797 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.1 mmt -82.51 36.15 0.47 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.193 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 167' ' ' HIS . 25.6 t70 54.89 31.23 15.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.663 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.02 74.89 0.08 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.068 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' ASP . 85.2 t60 -57.93 -30.38 65.89 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.995 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -49.72 -40.28 40.11 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.15 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.17 -46.56 86.58 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -45.41 -37.45 5.1 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.09 -42.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.148 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -48.99 -60.58 2.65 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.867 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.74 -25.19 62.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.049 0.452 . . . . 1.0 110.393 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -72.58 -53.69 11.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.472 -0.785 . . . . 1.0 110.446 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 179' ' ' GLY . 58.0 t80 -64.47 -34.91 79.31 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.29 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.6 t -54.86 -56.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.281 0.363 . . . . 1.0 110.189 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.03 -30.63 15.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.149 -0.62 . . . . 1.0 109.939 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.26 21.32 12.77 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.499 -0.773 . . . . 1.0 113.013 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 175' ' ' PHE . . . -151.37 -24.63 0.05 OUTLIER Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 180' ' ' TYR . 73.1 t80 54.42 23.52 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 109.879 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 182' ' ' TRP . 3.2 p -50.18 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.19 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TRP . . . . . 0.56 ' C ' ' O ' ' A' ' 181' ' ' VAL . 7.0 m-90 -9.74 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 124.004 0.815 . . . . 1.0 109.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 88.9 p -86.74 134.83 33.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.829 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -125.02 156.9 37.42 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.24 -0.891 . . . . 1.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.38 154.04 76.73 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.643 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.41 58.34 0.48 Allowed 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.588 2.192 . . . . 1.0 112.358 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 m -135.72 147.16 48.36 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.62 -48.71 28.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.0 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 190' ' ' GLY . 13.3 t -69.68 -44.18 71.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.027 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -51.75 -51.66 37.96 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.245 -0.434 . . . . 1.0 112.134 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.78 -43.63 90.49 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.45 0.147 . . . . 1.0 110.63 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.14 -44.73 80.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.612 0.244 . . . . 1.0 110.46 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -54.1 -56.68 15.81 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.873 0.324 . . . . 1.0 111.873 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -58.53 -30.27 64.97 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -48.07 63.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.983 0.42 . . . . 1.0 110.54 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -64.22 -40.64 96.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.71 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.74 88.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.2 m -71.27 -23.26 61.94 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.967 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -105.0 30.76 5.29 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.899 0.381 . . . . 1.0 110.753 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.1 p -141.7 -21.25 0.73 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.29 153.23 27.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.07 0.462 . . . . 1.0 109.771 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.75 153.92 32.6 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.178 -0.919 . . . . 1.0 109.219 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.466 HD23 HD11 ' A' ' 149' ' ' LEU . 5.2 tp -94.86 136.97 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.8 153.02 8.9 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.711 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.2 106.57 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.391 1.394 . . . . 1.0 111.148 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -140.82 87.16 11.35 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.46 111.58 3.29 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.562 1.508 . . . . 1.0 111.763 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.24 98.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.057 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.465 0.288 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.561 -179.825 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mp -65.43 -44.54 94.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.5 mt 57.12 79.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.939 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -58.92 136.06 57.76 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.231 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -167.65 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -130.17 133.86 46.89 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.828 0.451 . . . . 1.0 110.659 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.21 166.99 10.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -133.85 109.02 8.79 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -103.1 130.47 50.26 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.93 137.18 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 t -142.63 137.91 30.33 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.849 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.604 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 63.4 m -92.65 -14.15 28.52 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.55 -93.63 0.05 OUTLIER Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -179.55 0.78 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -62.12 132.22 52.1 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.955 -0.387 . . . . 1.0 109.955 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -62.54 149.54 88.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.71 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.8 -62.6 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.719 1.613 . . . . 1.0 112.037 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -142.45 138.82 16.76 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 119.117 -0.468 . . . . 1.0 110.621 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.43 -31.17 46.81 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 121.781 1.654 . . . . 1.0 113.52 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.92 -36.95 67.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.969 0.414 . . . . 1.0 111.28 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.89 -41.97 97.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.858 0.361 . . . . 1.0 110.758 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.3 t -61.44 -38.29 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' SER . 14.8 m -51.6 -42.86 62.27 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.0 t -51.81 -41.4 61.71 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.558 0.218 . . . . 1.0 110.538 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.8 t -75.38 -12.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.453 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.25 40.23 2.09 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.65 0.262 . . . . 1.0 110.432 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' SER . 44.4 m -129.71 -164.6 1.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.731 0.777 . . . . 1.0 109.512 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -53.14 -46.15 68.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.995 -1.457 . . . . 1.0 110.42 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -57.97 -53.49 57.66 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 122.059 -0.4 . . . . 1.0 111.196 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 73.7 t80 -63.42 -44.69 93.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.697 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.425 ' SG ' ' NZ ' ' A' ' 113' ' ' LYS . 45.5 t -57.84 -51.48 69.41 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -55.95 -47.9 76.74 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 121.487 0.66 . . . . 1.0 110.266 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -64.81 -29.54 70.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.084 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tp -65.86 -54.16 30.37 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.54 0.525 . . . . 1.0 111.36 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -32.32 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.294 -0.867 . . . . 1.0 109.093 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -75.38 -13.08 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.881 -1.054 . . . . 1.0 109.173 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 199' ' ' GLN . 0.1 OUTLIER -101.4 -1.14 34.04 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.707 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 82.71 41.68 8.76 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.911 -1.137 . . . . 1.0 111.259 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 10.2 p90 -27.02 159.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 123.548 0.739 . . . . 1.0 112.241 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -149.19 -73.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 121.382 -0.824 . . . . 1.0 108.956 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -149.02 106.14 3.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -89.14 130.24 35.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.012 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 65' ' ' LEU . 4.2 mp -131.1 133.7 62.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.4 tt -142.71 140.93 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.44 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -170.26 137.13 1.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.726 178.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -168.56 -172.06 1.58 Allowed 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.426 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.07 168.85 3.61 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.502 -1.039 . . . . 1.0 110.502 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.633 ' NH2' HD21 ' A' ' 72' ' ' ASN . 71.1 ttp85 -168.71 -74.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.633 HD21 ' NH2' ' A' ' 71' ' ' ARG . 89.8 m-20 -63.73 -46.44 85.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 1.0 110.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.73 -17.13 61.15 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 m 59.07 18.59 6.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.713 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 m 50.46 -163.85 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.192 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' PHE . 67.9 mt-10 -145.2 -44.74 0.22 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.545 ' CZ ' ' CE1' ' A' ' 98' ' ' PHE . 33.4 m-85 54.36 108.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -70.44 44.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.8 0.334 . . . . 1.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 77' ' ' PHE . 93.9 m-70 44.97 48.65 9.4 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.228 0.537 . . . . 1.0 111.146 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.37 -38.61 90.23 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.65 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.21 -50.35 80.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.617 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -71.78 -37.53 70.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -57.21 -48.07 79.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -77.65 -13.34 59.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.383 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.37 54.07 3.44 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 110.966 -0.853 . . . . 1.0 110.966 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.43 -178.76 51.44 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 109.831 -1.308 . . . . 1.0 109.831 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -129.85 121.04 25.94 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -80.49 111.46 16.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.342 -0.244 . . . . 1.0 110.342 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' NE2' ' A' ' 91' ' ' GLN . 94.4 mt-10 -72.38 -108.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.2 t -32.04 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.661 0.6 . . . . 1.0 111.653 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.494 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 25.8 mp0 -58.93 94.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.645 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -168.53 98.65 0.41 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.26 83.19 22.27 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.97 -76.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.16 1.907 . . . . 1.0 112.943 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.9 pt -87.71 8.78 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.273 0.629 . . . . 1.0 111.243 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 98' ' ' PHE . 1.1 m-20 58.25 -119.93 1.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 119.195 -0.431 . . . . 1.0 110.421 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 36.91 -93.04 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.626 0.37 . . . . 1.0 111.54 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CE1' ' CZ ' ' A' ' 77' ' ' PHE . 84.5 t80 -128.26 -8.14 5.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.208 0.603 . . . . 1.0 109.938 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.18 65.12 3.6 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.307 -0.717 . . . . 1.0 111.307 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.09 -44.82 95.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.962 0.411 . . . . 1.0 110.459 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.86 36.97 2.1 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.564 -1.015 . . . . 1.0 110.564 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.442 ' OD1' ' NH1' ' A' ' 105' ' ' ARG . 16.0 t70 -145.9 131.19 18.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.173 -0.306 . . . . 1.0 110.173 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.9 p -99.26 6.16 46.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.971 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -108.4 62.07 0.61 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.196 0.522 . . . . 1.0 110.485 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 117' ' ' ILE . 9.8 mmp_? -111.56 114.73 27.99 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.09 122.75 9.21 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.426 ' OH ' ' NE ' ' A' ' 105' ' ' ARG . 5.3 m-85 -133.63 151.78 51.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.4 ' C ' HD22 ' A' ' 109' ' ' LEU . 23.0 m -129.18 147.66 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -108.0 143.95 35.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.449 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 39.9 tpp 56.76 -79.55 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 O-C-N 124.136 0.898 . . . . 1.0 110.287 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 109' ' ' LEU . 54.3 t30 -168.09 78.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.39 8.51 80.31 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.425 ' NZ ' ' SG ' ' A' ' 54' ' ' CYS . 64.1 tttm -64.59 -75.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.25 128.9 50.13 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.204 -1.036 . . . . 1.0 108.204 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -108.02 103.77 13.06 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 119.442 -0.313 . . . . 1.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.56 116.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 105' ' ' ARG . 6.8 mt -137.1 144.16 32.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.815 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.93 120.55 2.05 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -155.17 52.83 0.62 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.228 0.537 . . . . 1.0 110.749 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 18.1 p-10 -169.29 129.72 1.08 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE2' ' OE1' ' A' ' 68' ' ' GLN . 58.4 m-85 -128.03 90.99 3.18 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.2 p 42.12 31.25 0.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.712 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.6 t -149.61 27.87 0.8 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.325 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 127' ' ' SER . 16.1 mttt -170.35 -5.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 71.0 mtp -43.08 -54.88 4.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.855 0.36 . . . . 1.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -59.43 -29.13 67.54 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.74 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.428 ' OG ' ' NH2' ' A' ' 130' ' ' ARG . 1.9 t -65.59 -38.96 90.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 16.0 mm -72.6 -46.04 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.126 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' SER . 64.4 mt -60.1 -57.86 9.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.456 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.428 ' NH2' ' OG ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -48.78 -41.07 31.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 111.392 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.22 -48.25 79.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.155 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -100.64 -66.67 0.89 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.119 0.485 . . . . 1.0 110.281 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' ILE . 53.6 p 55.51 84.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -149.23 -47.8 0.14 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.311 -0.404 . . . . 1.0 109.928 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.532 HD13 ' H ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -163.16 139.3 7.04 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.532 ' H ' HD13 ' A' ' 135' ' ' LEU . 4.3 m -138.22 145.52 28.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.37 96.5 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.2 p -104.89 122.15 45.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 35' ' ' CYS . 4.7 p-80 -64.0 -36.05 82.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.265 . . . . 1.0 111.139 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.14 10.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.591 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.97 108.77 1.04 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.0 -43.98 94.84 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 1.0 110.331 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.67 -50.81 34.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.4 m -52.09 -50.46 61.55 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.539 -0.33 . . . . 1.0 111.791 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -29.07 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.182 -0.303 . . . . 1.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.505 HD21 ' O ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -54.63 -53.91 48.48 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.905 -177.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.17 -51.13 65.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 1.0 110.132 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.8 t -52.83 -28.24 21.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.444 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.467 HD21 HD23 ' A' ' 203' ' ' LEU . 0.2 OUTLIER -71.15 -51.86 22.52 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.879 0.371 . . . . 1.0 110.982 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.6 ttp-105 -64.77 -26.1 68.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.764 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.7 mt -90.8 17.08 8.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.972 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.5 p30 42.34 26.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.501 0.501 . . . . 1.0 111.472 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 133' ' ' SER . 30.9 mtpt -79.38 121.08 82.44 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.306 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.41 ' O ' HD21 ' A' ' 135' ' ' LEU . 77.9 Cg_endo -79.62 113.93 3.15 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.367 1.378 . . . . 1.0 110.712 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 156' ' ' ILE . 0.4 OUTLIER -115.29 171.87 7.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.591 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 156' ' ' ILE . 3.2 mp -118.4 120.01 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.78 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 76.2 t -90.89 117.11 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 O-C-N 122.518 -0.114 . . . . 1.0 110.713 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 13.3 m -85.17 100.57 11.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.08 140.22 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.9 84.67 2.73 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 30.7 p-10 -64.03 -32.18 73.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.018 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 t -60.84 -46.08 91.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.025 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 163' ' ' LEU . 10.8 mp -90.21 -178.91 5.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 28.0 ttt -165.31 -27.76 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.461 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -66.2 -22.14 66.33 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -61.59 113.61 2.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.117 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.01 -32.56 74.15 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.836 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.04 -47.07 75.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.32 -42.01 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.342 0.592 . . . . 1.0 109.922 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -50.59 -45.56 57.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.539 -0.912 . . . . 1.0 108.539 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.68 -26.4 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.877 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -68.06 -58.88 3.78 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 120.01 -0.676 . . . . 1.0 109.409 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -43.52 -24.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.72 0.295 . . . . 1.0 111.774 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.41 -40.26 81.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.145 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -55.74 -45.49 77.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.52 -46.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.98 0.419 . . . . 1.0 109.896 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -46.07 -43.01 14.27 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.439 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.6 mt -70.55 -32.25 69.61 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.832 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.15 -107.43 0.24 Allowed Glycine 0 N--CA 1.468 0.781 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.527 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 180' ' ' TYR . 66.5 t80 -169.95 42.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 180' ' ' TYR . 14.8 p -31.91 137.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 123.663 0.602 . . . . 1.0 109.479 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -54.43 101.7 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.319 0.963 . . . . 1.0 110.661 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 77.2 p -114.76 133.2 56.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.798 -1.092 . . . . 1.0 109.088 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.33 138.7 6.56 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 157.09 70.52 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 122.304 -0.248 . . . . 1.0 110.515 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -56.89 82.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 122.307 2.005 . . . . 1.0 112.991 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 m -134.86 148.9 50.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.95 -25.88 63.86 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.124 -0.36 . . . . 1.0 111.016 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.3 p -89.91 -35.61 15.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.541 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.74 -41.81 5.9 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.94 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.93 -36.24 82.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.808 0.304 . . . . 1.0 111.483 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 pt -66.0 -33.91 66.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.348 . . . . 1.0 111.023 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.56 91.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.639 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -71.66 -38.19 61.4 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.428 -0.669 . . . . 1.0 111.428 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.408 ' O ' ' OH ' ' A' ' 60' ' ' TYR . 7.7 mt -63.28 -54.85 30.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.848 0.356 . . . . 1.0 111.255 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -61.68 -36.39 80.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.1 -39.21 82.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 14.9 m -65.59 -17.96 64.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.854 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 93.9 mt-30 -104.14 29.97 5.57 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.047 -0.408 . . . . 1.0 110.624 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 22.6 p -141.37 -33.02 0.52 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -141.58 154.1 45.23 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -118.07 157.51 26.72 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.584 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 149' ' ' LEU . 8.4 tp -84.32 136.29 33.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -52.76 135.24 46.03 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.289 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -45.39 101.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.511 1.474 . . . . 1.0 113.015 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -142.12 82.78 13.02 Favored Pre-proline 0 N--CA 1.471 0.625 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.54 93.04 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.963 1.775 . . . . 1.0 111.464 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.505 ' O ' HD21 ' A' ' 146' ' ' LEU . 7.1 p -60.73 150.37 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.654 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 211' ' ' ASN . 24.7 m 55.88 109.75 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.715 0.634 . . . . 1.0 110.665 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -67.53 66.93 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.802 0.334 . . . . 1.0 110.551 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.445 ' ND2' ' OE1' ' A' ' 215' ' ' GLU . 0.6 OUTLIER -169.81 142.9 2.05 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 110.241 -0.281 . . . . 1.0 110.241 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 214' ' ' PHE . 71.7 Cg_endo -73.64 177.43 8.03 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.779 1.653 . . . . 1.0 111.297 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.0 m -49.44 -11.54 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.721 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 212' ' ' PRO . 63.5 t80 -54.61 -43.2 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.445 ' OE1' ' ND2' ' A' ' 211' ' ' ASN . 70.8 tt0 -46.98 -39.24 12.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.458 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -60.33 -39.94 88.87 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.8 tp -44.81 -34.11 2.19 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.609 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.8 mm? -65.92 -33.99 77.11 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.055 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.44 -52.23 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -64.98 -40.97 95.77 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.086 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 25.0 m -68.66 -25.44 64.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.291 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 77.0 mt 56.63 -88.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.051 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -84.5 122.88 29.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.964 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 91.0 p . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.191 -0.909 . . . . 1.0 110.399 179.536 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.256 -1.538 . . . . 1.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.3 -50.08 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.162 0.506 . . . . 1.0 109.828 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.1 mt 56.31 74.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.427 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -72.48 179.38 3.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.534 -0.543 . . . . 1.0 109.534 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -103.4 6.5 37.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 63' ' ' VAL . 67.9 mttm -71.25 106.55 3.87 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.13 121.01 43.66 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.384 0.427 . . . . 1.0 110.197 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 mt -87.61 110.97 20.78 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CD1' HG22 ' A' ' 129' ' ' ILE . 85.6 m-85 -96.07 128.62 43.14 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -123.3 122.52 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 t -146.48 137.65 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.2 m -105.36 -24.97 12.57 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.3 20.57 67.55 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.42 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 p -139.7 155.9 47.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.475 0.31 . . . . 1.0 110.218 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' PRO . 16.8 m -94.16 148.64 35.49 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 118.727 -0.654 . . . . 1.0 110.817 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' VAL . 87.2 Cg_exo -46.22 -178.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 121.629 1.553 . . . . 1.0 112.395 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -56.57 144.42 64.27 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-O 119.234 -0.412 . . . . 1.0 110.632 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.55 -30.6 6.2 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.793 1.662 . . . . 1.0 113.497 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -73.26 -39.55 65.32 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.81 0.3 . . . . 1.0 111.81 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 186' ' ' PRO . 4.2 mm? -71.74 -40.86 69.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.97 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.6 -41.61 93.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 50' ' ' SER . 30.0 m -52.15 -45.89 65.2 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.139 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.98 -33.13 10.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 1.0 110.556 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.78 -22.09 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.996 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.98 33.44 4.39 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 120.809 0.337 . . . . 1.0 110.254 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 46' ' ' SER . 22.4 p -110.59 -167.71 1.22 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -60.74 -28.83 68.98 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.66 -50.68 71.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.493 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -35.91 73.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 71.1 m -51.63 -51.0 59.2 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.775 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -73.07 -43.76 61.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.684 0.278 . . . . 1.0 111.654 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -65.91 -28.95 69.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.971 0.415 . . . . 1.0 110.535 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.2 mt -61.35 -52.42 64.73 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.6 mp -57.42 -36.67 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 120.305 -0.558 . . . . 1.0 109.874 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -72.52 -33.78 67.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.695 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 70.1 t80 -77.87 0.57 23.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.997 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 42.08 22.23 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.751 -1.214 . . . . 1.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -49.3 -176.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.534 0.667 . . . . 1.0 111.825 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 64' ' ' ARG . 10.5 p -172.48 -42.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' HG13 ' A' ' 63' ' ' VAL . 47.5 ttm-85 -168.38 105.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.1 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.04 135.83 33.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.31 136.41 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -138.99 141.82 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -143.64 149.37 37.2 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 77' ' ' PHE . 47.5 p90 -163.14 126.29 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.02 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.78 -171.17 44.71 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 109.774 -1.33 . . . . 1.0 109.774 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.564 ' H ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 55.54 118.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.377 0.608 . . . . 1.0 110.914 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -61.85 -20.49 63.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.111 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 75' ' ' SER . 48.3 t80 -56.5 -14.97 3.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.384 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 m -60.59 3.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.391 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 73' ' ' TYR . 3.5 m 63.54 139.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.861 0.363 . . . . 1.0 110.264 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.44 137.17 57.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 69' ' ' PHE . 3.7 m-85 -64.41 -93.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 49.69 45.97 24.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.023 0.439 . . . . 1.0 110.859 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.402 ' ND1' ' O ' ' A' ' 77' ' ' PHE . 35.1 m80 -157.26 -53.87 0.08 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.648 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.47 -48.87 75.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.098 0.475 . . . . 1.0 111.043 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.39 -44.12 77.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.196 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.93 -31.56 72.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.27 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -70.91 -44.31 66.49 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.027 0.442 . . . . 1.0 110.437 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLY . 1.1 mmp_? -99.1 30.03 3.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' ARG . . . 21.15 73.71 0.01 OUTLIER Glycine 0 N--CA 1.486 1.98 0 N-CA-C 111.531 -0.627 . . . . 1.0 111.531 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.74 -179.1 52.01 Favored Glycine 0 C--N 1.322 -0.222 0 N-CA-C 109.846 -1.302 . . . . 1.0 109.846 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -138.34 135.96 35.9 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -54.43 149.6 10.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.442 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -107.0 -155.36 0.55 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.49 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 85.4 p 51.52 12.66 0.17 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.849 0.356 . . . . 1.0 111.252 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 55.23 11.57 0.57 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.82 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.69 166.83 21.12 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.102 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.09 121.68 42.94 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.006 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.61 109.59 1.66 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 CA-C-N 120.658 1.271 . . . . 1.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' GLN . 32.3 pt -85.72 -7.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.232 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.8 t0 64.18 -69.61 0.08 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.08 0.862 . . . . 1.0 110.191 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ILE . 86.3 mt-30 -58.37 152.09 18.43 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.303 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -67.77 1.27 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.836 0.35 . . . . 1.0 110.369 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.17 6.82 87.68 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.3 -0.72 . . . . 1.0 111.3 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 27.0 p 37.06 60.73 0.97 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.164 0.507 . . . . 1.0 112.229 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' CA ' HH21 ' A' ' 105' ' ' ARG . . . -178.62 -156.89 18.09 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 18.5 p-10 -159.22 75.77 0.68 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.703 0.287 . . . . 1.0 110.293 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.0 p -136.58 -27.35 1.05 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.688 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.544 ' H ' ' NH1' ' A' ' 105' ' ' ARG . . . -174.59 103.4 0.1 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.25 0.344 . . . . 1.0 110.208 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.544 ' NH1' ' H ' ' A' ' 104' ' ' ALA . 1.5 mpt_? -135.37 145.75 47.66 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.159 0.504 . . . . 1.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.83 129.05 7.38 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.8 -0.636 . . . . 1.0 109.694 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -147.21 169.11 20.04 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.69 148.27 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 114' ' ' LEU . 19.2 mt -114.39 -178.83 3.46 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.585 0.553 . . . . 1.0 109.562 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 tpt 53.21 -134.67 1.63 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.664 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.86 35.9 0.9 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.013 0.435 . . . . 1.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.59 71.54 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.518 -0.633 . . . . 1.0 111.518 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -96.21 -15.92 21.75 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.392 0.277 . . . . 1.0 111.635 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' A' ' 109' ' ' LEU . 4.4 mm? -96.91 133.57 41.39 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -116.88 93.73 4.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.8 p -106.89 116.59 50.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 CA-C-O 122.219 1.009 . . . . 1.0 109.053 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.2 pt -117.81 146.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 114.076 -1.42 . . . . 1.0 108.658 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -122.94 131.83 8.39 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 109.63 -1.388 . . . . 1.0 109.63 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 120' ' ' ASP . 45.0 t80 59.01 152.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 1.0 110.768 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 38.8 t70 -168.24 163.66 13.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.353 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.446 ' O ' ' CD2' ' A' ' 121' ' ' PHE . 40.4 p90 -70.77 119.27 14.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 124' ' ' LYS . 18.1 m 56.88 135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.421 0.629 . . . . 1.0 111.558 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 t -74.87 38.43 0.12 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.263 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 122' ' ' SER . 36.9 ttpt -64.45 -29.56 70.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.477 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -45.18 -32.0 1.69 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.132 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -58.23 -28.72 65.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.676 -0.693 . . . . 1.0 111.044 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.1 t -80.54 -33.17 36.49 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.742 0.306 . . . . 1.0 110.803 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 128' ' ' ILE . 1.6 mp -63.63 -39.93 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.723 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.551 HG22 ' CD1' ' A' ' 32' ' ' PHE . 2.9 pt -49.11 -41.54 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -46.08 -32.66 3.0 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.514 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.45 -27.64 62.64 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.4 -62.27 1.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.333 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.2 p 51.36 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.724 ' N ' ' HZ2' ' A' ' 153' ' ' LYS . 56.5 m-20 -145.14 -43.92 0.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -155.41 120.52 4.86 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 135' ' ' LEU . 60.9 t -122.52 137.33 56.41 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.3 mt -122.92 124.37 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.7 p -134.3 133.61 40.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -69.89 -38.22 76.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.631 0.253 . . . . 1.0 110.788 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.47 19.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.326 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.67 100.6 0.44 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.662 ' H ' HH21 ' A' ' 216' ' ' ARG . 19.6 m -56.72 -41.46 77.48 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.478 -0.425 . . . . 1.0 110.48 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.74 -48.77 26.68 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.3 m -56.52 -42.77 78.99 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.842 -0.211 . . . . 1.0 111.309 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 92.6 mt -66.35 -26.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 1.0 110.852 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 209' ' ' SER . 0.2 OUTLIER -57.35 -46.9 82.84 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.663 -176.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -70.42 -53.55 16.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.097 0.475 . . . . 1.0 109.826 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.9 m -53.19 -25.21 13.04 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 49.8 tp -74.86 -45.77 40.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.859 0.362 . . . . 1.0 111.438 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -76.56 -18.99 58.37 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.279 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.9 mt -85.03 4.03 35.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 41.56 47.89 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.389 0.43 . . . . 1.0 111.688 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.724 ' HZ2' ' N ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -105.68 147.1 34.11 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 119.205 -0.426 . . . . 1.0 111.569 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.63 85.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.46 1.44 . . . . 1.0 111.542 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 153' ' ' LYS . 66.9 tp -89.94 137.49 32.29 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.816 -0.553 . . . . 1.0 111.324 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.3 134.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.084 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.63 128.69 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 120.788 0.328 . . . . 1.0 110.652 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 12.3 m -83.6 102.47 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.88 146.84 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.746 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.9 t30 86.44 103.78 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.887 0.742 . . . . 1.0 110.065 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -167.59 66.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.203 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -64.65 86.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.215 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 165' ' ' ASP . 34.8 tp -168.41 77.03 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 ttt 67.19 -36.74 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.707 0.629 . . . . 1.0 110.984 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 163' ' ' LEU . 66.7 m-20 -77.17 -3.02 37.4 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.077 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -52.86 -37.92 60.87 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.766 0.317 . . . . 1.0 110.369 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.12 -38.17 87.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.135 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -68.11 -38.97 82.87 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.367 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.53 -31.31 64.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.133 0.492 . . . . 1.0 110.692 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.37 -49.09 67.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.51 -27.41 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.79 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.77 -61.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.097 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -51.94 -31.98 31.14 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -60.79 -52.71 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.015 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.26 -42.66 81.97 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.22 -52.84 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -51.96 -44.32 63.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.701 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.33 17.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.134 -0.321 . . . . 1.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 39.29 89.8 0.01 OUTLIER Glycine 0 C--N 1.352 1.423 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.646 ' O ' HD22 ' A' ' 203' ' ' LEU . 49.9 t80 -155.48 -22.39 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.51 152.64 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.83 0.348 . . . . 1.0 110.495 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -71.39 130.63 41.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.6 p -98.11 138.67 35.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.586 -0.734 . . . . 1.0 109.541 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 185' ' ' ALA . 35.7 t -157.77 177.32 11.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 184' ' ' CYS . . . -136.93 155.99 76.07 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 110.164 -0.31 . . . . 1.0 110.164 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.469 ' HG2' HD12 ' A' ' 44' ' ' LEU . 94.3 Cg_endo -69.58 65.62 1.68 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.089 1.86 . . . . 1.0 112.404 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 m -134.06 145.5 49.46 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.014 0.435 . . . . 1.0 109.898 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -55.13 -29.34 57.49 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -84.03 -41.03 17.66 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.089 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.14 93.86 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.978 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.35 -39.54 90.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 119.711 -0.185 . . . . 1.0 111.314 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.73 -45.84 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.61 82.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.53 -36.61 91.74 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.08 -54.63 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.94 0.4 . . . . 1.0 110.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -59.66 -21.29 60.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.432 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.85 3.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.774 0.321 . . . . 1.0 110.46 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.6 p -67.46 -22.53 65.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.769 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.53 -43.72 69.01 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.075 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 21.7 m -79.1 -43.66 23.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.842 0.353 . . . . 1.0 110.698 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.53 125.25 40.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.266 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -120.82 108.59 14.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 180' ' ' TYR . 4.8 tp -63.24 135.8 57.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -52.67 146.88 16.43 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.778 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.45 103.77 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.357 1.371 . . . . 1.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -141.1 96.5 7.21 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.74 114.03 3.86 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 121.13 1.22 . . . . 1.0 111.345 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 209' ' ' SER . 14.8 p -57.75 -43.41 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.531 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.481 ' N ' HG13 ' A' ' 208' ' ' VAL . 37.4 m -162.51 166.1 25.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.242 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -100.4 104.38 15.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -167.4 60.56 0.53 Allowed Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.411 ' C ' ' N ' ' A' ' 214' ' ' PHE . 74.2 Cg_endo -67.18 -158.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.505 2.152 0 C-N-CA 122.256 1.971 . . . . 1.0 112.141 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 45.6 t -48.52 -12.58 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.845 0.355 . . . . 1.0 111.604 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.411 ' N ' ' C ' ' A' ' 212' ' ' PRO . 70.4 t80 -59.42 -45.29 91.96 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -54.39 -43.16 71.2 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.895 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.662 HH21 ' H ' ' A' ' 142' ' ' THR . 1.5 mpt_? -60.24 -38.15 82.57 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.565 -0.531 . . . . 1.0 109.565 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 tp -53.11 -34.73 57.98 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.139 0.495 . . . . 1.0 110.206 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.03 -40.49 97.9 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.552 -0.749 . . . . 1.0 109.94 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.8 -49.66 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.798 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -59.69 -31.43 69.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.637 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 25.2 m -61.66 -23.04 65.82 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.587 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 41.3 pt -121.55 154.82 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.388 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 60.3 t80 53.43 100.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.373 -179.601 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.466 -1.454 . . . . 1.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.1 pt -66.54 -170.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.919 0.39 . . . . 1.0 110.067 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.6 mp -85.97 97.06 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -153.39 72.12 0.92 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -144.79 -36.34 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -71.16 92.74 1.01 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.95 111.94 24.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.73 117.98 21.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE2' ' NE2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -102.69 124.3 47.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 67' ' ' ILE . 9.4 p -126.18 128.4 71.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.2 p -129.1 129.82 45.7 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' CE1' ' A' ' 69' ' ' PHE . 97.2 m -88.69 164.26 15.39 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.89 37.67 0.75 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.69 -0.564 . . . . 1.0 111.69 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 35' ' ' CYS . . . 67.64 -61.51 0.36 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.386 0.274 . . . . 1.0 110.602 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -64.96 147.41 53.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 1.0 109.978 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.6 81.36 24.09 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.88 -59.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.953 1.768 . . . . 1.0 111.505 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 92.14 18.29 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -74.05 8.32 2.12 Favored 'Trans proline' 0 N--CA 1.508 2.339 0 CA-C-N 120.831 1.333 . . . . 1.0 112.442 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.0 110.555 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.9 mm? -70.02 -35.02 74.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.546 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.37 -40.5 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 78.3 p -50.52 -45.33 56.59 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.839 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -51.57 -39.99 58.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.05 0.452 . . . . 1.0 110.301 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 41.8 t -79.67 -16.21 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.057 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 tp -130.96 39.74 3.55 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.826 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.5 t -132.61 -157.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 50' ' ' SER . 22.6 p-10 -60.28 -44.27 95.48 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.98 -51.58 65.75 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.592 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 5.9 t80 -67.8 -36.79 81.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.972 0.415 . . . . 1.0 109.905 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 t -57.64 -47.96 80.79 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.429 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -63.07 -46.47 87.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.66 -28.39 69.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.406 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.25 -51.24 70.4 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.945 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.7 mp -58.35 -44.9 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.06 -37.6 77.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.33 -21.58 64.74 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.661 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 104.3 35.94 3.24 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 118.016 -1.435 . . . . 1.0 111.355 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' O ' ' A' ' 61' ' ' GLY . 49.8 p90 13.61 130.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 124.86 1.264 . . . . 1.0 112.719 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -145.3 -81.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 122.007 -0.433 . . . . 1.0 110.448 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -169.33 111.24 0.48 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.221 -0.445 . . . . 1.0 109.83 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -92.35 121.59 33.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 66' ' ' ILE . 2.3 mp -102.88 133.02 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.434 -1.321 . . . . 1.0 107.434 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.418 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.7 mm -114.6 132.76 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.509 ' NE2' ' CE2' ' A' ' 32' ' ' PHE . 15.6 mp0 -131.78 163.09 29.0 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.582 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE1' ' SG ' ' A' ' 35' ' ' CYS . 17.7 m-85 -157.22 -179.64 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.183 0.516 . . . . 1.0 109.735 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 72' ' ' ASN . . . -59.1 -29.89 66.16 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.292 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 68.01 -38.32 0.36 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.98 0.459 . . . . 1.0 111.256 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 70' ' ' GLY . 19.0 m120 -62.16 -43.93 97.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.781 0.324 . . . . 1.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.26 -45.76 86.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 p 56.31 166.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.841 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.2 t 52.36 68.88 0.75 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.821 0.343 . . . . 1.0 111.138 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -170.95 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.602 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -166.77 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.613 -0.267 . . . . 1.0 110.609 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.26 -44.62 95.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.832 0.349 . . . . 1.0 110.073 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.08 -28.78 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.733 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -63.74 -48.36 77.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.155 0.503 . . . . 1.0 110.161 -178.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.28 -45.44 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -64.37 -36.4 84.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -52.23 -46.65 65.79 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.581 0.229 . . . . 1.0 110.441 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.19 -17.43 64.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.092 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.02 52.64 35.61 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.12 -1.192 . . . . 1.0 110.12 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.38 -167.76 25.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -128.33 126.95 41.78 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -55.38 145.42 22.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.616 0.246 . . . . 1.0 110.624 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -145.6 179.18 7.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m 65.82 -152.41 0.25 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.211 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -148.55 169.71 19.69 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 58.58 157.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.665 0.603 . . . . 1.0 110.362 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 93' ' ' ILE . 17.9 tt -158.42 87.97 2.32 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.749 -0.463 . . . . 1.0 109.749 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 93' ' ' ILE . 98.8 Cg_exo -50.02 -127.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.511 2.549 0 C-N-CA 122.591 2.194 . . . . 1.0 112.924 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.5 tt -65.2 4.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 121.56 -0.713 . . . . 1.0 110.733 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 99' ' ' GLY . 2.5 m-20 70.18 -134.71 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 -177.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 42.42 -93.95 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.495 0.589 . . . . 1.0 112.175 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -98.9 -21.8 16.11 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 96' ' ' ASP . . . 81.56 1.44 90.14 Favored Glycine 0 N--CA 1.467 0.723 0 CA-C-N 115.826 -0.624 . . . . 1.0 111.684 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 58.3 m 52.67 -163.93 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.765 0.283 . . . . 1.0 111.13 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.76 176.4 52.77 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.483 -1.047 . . . . 1.0 110.483 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.0 t0 54.62 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.594 0.235 . . . . 1.0 111.045 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.7 m 50.74 88.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.626 ' CB ' ' H ' ' A' ' 119' ' ' PHE . . . -86.75 -109.13 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.411 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -141.41 169.2 18.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -158.79 132.48 7.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.333 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -136.39 151.06 49.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.764 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.7 t -100.83 96.07 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.527 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 109' ' ' LEU . 10.4 mp -87.57 159.77 18.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 tpt 57.03 -88.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.402 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -172.47 62.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.763 0.316 . . . . 1.0 110.686 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.55 27.09 63.96 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.627 -0.589 . . . . 1.0 111.627 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -114.19 -50.36 2.81 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.597 0.359 . . . . 1.0 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mt -95.36 111.86 23.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.855 0.359 . . . . 1.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -105.83 101.24 10.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 p -105.53 111.64 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.709 0.766 . . . . 1.0 109.641 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 pt -125.86 122.77 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.388 -1.278 . . . . 1.0 109.167 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.59 -82.01 0.04 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.548 -0.834 . . . . 1.0 111.453 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.626 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 3.6 m-85 47.72 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.941 0.4 . . . . 1.0 110.005 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -163.19 154.24 16.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 122' ' ' SER . 63.8 t80 -160.11 172.95 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.654 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 44.3 t -52.99 -17.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.26 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.8 m -164.19 103.56 0.86 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.606 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -171.03 -26.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.772 0.32 . . . . 1.0 110.555 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.1 -49.96 75.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.861 0.362 . . . . 1.0 110.71 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -61.82 -25.55 67.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.358 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p -76.41 -44.69 34.97 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.971 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.06 -44.48 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.627 -0.261 . . . . 1.0 110.617 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 133' ' ' SER . 79.4 mt -59.04 -51.94 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -39.14 10.25 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.053 0.454 . . . . 1.0 110.905 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -63.54 -32.17 73.55 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.141 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -112.57 -67.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.784 0.434 . . . . 1.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' ILE . 26.0 t 54.32 89.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.757 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -134.38 -50.1 0.79 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.335 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 29.9 tp -165.7 146.32 6.83 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.38 140.03 44.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.7 pt -123.02 127.89 74.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.6 m -88.85 -161.88 0.8 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -169.99 -36.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.6 48.21 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.809 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.88 112.5 0.53 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.521 ' H ' HE22 ' A' ' 168' ' ' GLN . 35.2 m -74.2 -25.19 59.55 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.698 0.285 . . . . 1.0 110.685 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.94 86.04 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.0 m -72.91 -35.77 67.13 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.841 -0.211 . . . . 1.0 110.756 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 53.6 mt -61.37 -30.37 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.771 0.32 . . . . 1.0 110.989 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 tp -52.35 -52.74 51.72 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.137 0.421 . . . . 1.0 112.137 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -65.69 -46.95 77.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.285 0.564 . . . . 1.0 111.074 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 m -53.01 -26.92 17.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.121 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.4 mt -79.7 -49.26 12.35 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.356 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -62.51 -37.95 88.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.682 -0.236 . . . . 1.0 110.923 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.28 4.77 4.18 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 58.8 t30 53.72 23.28 3.6 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.71 -0.223 . . . . 1.0 111.123 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.66 122.84 46.24 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -45.9 171.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.659 1.572 . . . . 1.0 112.6 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.609 ' C ' HD13 ' A' ' 156' ' ' ILE . 4.0 tt -156.92 151.75 25.86 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.514 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 155' ' ' LEU . 3.1 mm -123.35 128.23 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.9 137.16 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.36 115.38 27.35 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.37 97.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.654 0.264 . . . . 1.0 111.667 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.449 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 20.2 p-10 -148.46 -58.47 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.255 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 163' ' ' LEU . 73.2 m-20 -102.3 14.01 33.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.083 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 27.9 t -69.79 36.9 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.889 0.376 . . . . 1.0 110.837 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 161' ' ' ASP . 52.7 mt -63.42 -39.59 94.9 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 166' ' ' ASN . 23.8 ptt? -52.28 141.45 19.2 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.229 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 167' ' ' HIS . 4.8 m-20 69.24 -37.07 0.36 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.202 0.314 . . . . 1.0 110.749 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 164' ' ' MET . 20.2 t-20 58.97 -0.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.612 0.365 . . . . 1.0 111.336 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 165' ' ' ASP . 24.6 m170 -73.48 -43.42 60.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.866 0.365 . . . . 1.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.521 HE22 ' H ' ' A' ' 142' ' ' THR . 91.4 mm-40 -64.92 -49.47 70.31 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.937 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -59.58 -29.68 68.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.92 0.39 . . . . 1.0 110.013 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.49 -54.67 8.59 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.009 -0.542 . . . . 1.0 110.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.39 -41.39 73.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.45 -64.15 0.96 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 120.466 -0.494 . . . . 1.0 110.196 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.4 -27.76 2.81 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.337 0.589 . . . . 1.0 111.089 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -82.96 -40.48 20.02 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.055 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.04 -45.45 93.52 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.696 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 177' ' ' GLU . 27.1 m -57.14 -52.71 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 176' ' ' VAL . 77.3 mt-10 -52.34 -38.88 59.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.348 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.13 6.31 49.13 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.63 89.77 0.07 OUTLIER Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.291 -1.124 . . . . 1.0 110.291 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -40.65 79.35 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.135 0.974 . . . . 1.0 111.156 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 181' ' ' VAL . 3.2 p -73.8 65.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.531 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TRP . . . . . 0.485 ' C ' ' O ' ' A' ' 181' ' ' VAL . 6.0 m-90 30.4 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 99.9 p -108.6 131.45 54.85 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 30.5 p -162.58 130.17 3.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.861 -1.063 . . . . 1.0 108.387 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.92 157.09 74.34 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 118.92 -0.562 . . . . 1.0 110.851 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.76 69.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.516 2.833 0 C-N-CA 123.253 2.635 . . . . 1.0 114.393 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 185' ' ' ALA . 43.7 m -132.2 146.67 52.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 24.7 mp0 -49.34 -51.69 32.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.494 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.7 p -67.15 -43.04 83.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.66 -0.245 . . . . 1.0 110.578 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -52.6 -53.36 32.85 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 121.427 -0.416 . . . . 1.0 112.145 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.83 -40.98 99.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.926 0.363 . . . . 1.0 110.71 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.45 -44.54 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -58.85 -49.35 78.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 1.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.5 98.81 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 42.6 mt -63.82 -43.47 96.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.713 0.292 . . . . 1.0 110.546 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -66.91 -40.02 87.56 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -64.41 -49.58 70.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.698 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 m -61.13 -22.39 64.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.308 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -74.56 10.46 1.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.017 0.437 . . . . 1.0 110.194 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.4 m -164.09 -54.66 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.816 0.341 . . . . 1.0 110.844 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.7 mt-10 -66.89 116.17 7.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.026 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -103.05 165.59 10.93 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 tp -110.45 -164.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.52 137.54 22.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -79.2 44.47 1.7 Allowed 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.812 1.675 . . . . 1.0 111.915 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.39 84.8 15.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.41 166.03 5.1 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.113 1.876 . . . . 1.0 112.186 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 209' ' ' SER . 12.0 p -57.06 -46.81 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.337 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.501 ' N ' HG13 ' A' ' 208' ' ' VAL . 51.6 p -170.21 164.11 9.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.852 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.84 100.61 3.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.601 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.423 ' ND2' ' OE2' ' A' ' 215' ' ' GLU . 27.6 m120 -142.24 68.11 21.64 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 122.768 0.427 . . . . 1.0 110.622 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 214' ' ' PHE . 31.4 Cg_exo -60.44 165.12 11.72 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.638 1.559 . . . . 1.0 111.169 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 44.4 m -46.33 -18.74 0.06 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.994 0.426 . . . . 1.0 110.731 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.403 ' N ' ' C ' ' A' ' 212' ' ' PRO . 48.3 t80 -60.44 -45.08 94.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.096 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.423 ' OE2' ' ND2' ' A' ' 211' ' ' ASN . 43.6 tt0 -50.92 -45.13 60.27 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 110.195 -0.298 . . . . 1.0 110.195 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -55.86 -40.54 73.05 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.92 -43.31 81.32 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.386 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.53 -32.94 52.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.7 t -68.28 -48.01 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -72.31 -24.12 61.27 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.444 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 25.2 m -60.91 -49.55 77.01 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.576 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 28.3 pt -72.52 147.87 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.145 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -61.38 -44.81 96.53 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.179 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.981 -1.009 . . . . 1.0 110.375 -179.797 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.203 -1.559 . . . . 1.0 109.203 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 61' ' ' GLY . 9.1 tp -160.04 140.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.792 0.33 . . . . 1.0 110.174 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.844 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.6 mp -70.62 -42.9 77.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.264 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 61.99 55.45 2.53 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.192 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -168.79 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.826 0.346 . . . . 1.0 110.544 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -74.3 139.47 44.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . -142.9 165.1 28.29 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 137' ' ' ILE . 11.8 mt -109.27 122.51 47.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.489 ' CE1' HG21 ' A' ' 128' ' ' ILE . 12.3 t80 -108.62 141.6 40.32 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.15 148.15 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.955 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -144.78 139.84 28.08 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.735 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.83 8.34 5.73 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.19 108.71 0.23 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.66 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.966 -0.138 . . . . 1.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.0 p 48.85 -167.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.751 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 39' ' ' VAL . 24.4 m -97.69 113.57 63.75 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 123.186 0.304 . . . . 1.0 110.657 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.12 -13.78 17.03 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.05 1.833 . . . . 1.0 111.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -124.92 85.16 57.9 Favored Pre-proline 0 N--CA 1.477 0.899 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.32 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.17 -23.06 27.9 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.145 1.897 . . . . 1.0 111.698 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -80.98 -46.66 14.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.64 -49.88 74.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.861 0.362 . . . . 1.0 111.046 -176.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.47 -39.14 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.19 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 17.0 p -50.01 -57.88 6.64 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 46' ' ' SER . 77.4 m -51.71 -41.41 61.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.971 0.415 . . . . 1.0 110.342 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.5 t -71.2 -17.89 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.038 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 tp -140.65 44.19 1.84 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.039 0.447 . . . . 1.0 110.862 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.6 t -123.59 -167.59 1.64 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' N ' ' OG ' ' A' ' 50' ' ' SER . 41.2 m-20 -50.73 -40.07 53.47 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.912 -1.04 . . . . 1.0 111.175 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -60.45 -55.22 36.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.79 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -67.28 -39.86 86.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.998 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 91.0 m -48.36 -53.7 16.57 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -77.47 -46.75 21.53 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.45 -30.27 68.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.867 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.69 -45.04 93.31 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.482 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.7 mp -63.59 -30.32 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 119.946 -0.702 . . . . 1.0 109.608 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -63.01 -16.4 59.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.0 111.087 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.74 -18.83 14.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 25' ' ' ILE . . . 95.09 35.37 5.8 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 121.39 -0.433 . . . . 1.0 112.1 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -93.15 154.4 18.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.21 0.529 . . . . 1.0 109.652 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 m -137.77 -6.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.031 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -143.0 144.98 32.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.436 0.636 . . . . 1.0 110.69 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -138.68 122.98 18.21 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.712 -1.131 . . . . 1.0 109.28 178.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 65' ' ' LEU . 4.3 mp -120.66 142.94 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.529 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.05 137.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.006 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -62.51 144.1 56.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.23 120.26 16.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' ASN . . . -64.21 -11.01 44.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 63.41 -68.51 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.888 0.405 . . . . 1.0 110.877 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' GLY . 77.7 m-20 -61.28 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -65.87 -50.19 65.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.98 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t 51.16 -147.79 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.803 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t 55.93 -161.1 0.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.592 0.234 . . . . 1.0 110.699 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 54.7 -166.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.466 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.2 t80 53.3 98.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.652 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -59.4 166.67 2.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.019 -0.363 . . . . 1.0 110.019 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.408 ' ND1' ' CZ ' ' A' ' 98' ' ' PHE . 46.7 m-70 -73.21 54.51 0.41 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.752 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -59.15 -43.44 92.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.285 0.564 . . . . 1.0 110.405 -177.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 82' ' ' GLN . 22.3 m -58.2 -43.66 86.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.571 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.472 ' N ' HG23 ' A' ' 81' ' ' VAL . 2.6 tm0? -68.85 -42.78 76.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.262 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.91 -48.17 67.43 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.693 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.572 ' HD2' HD12 ' A' ' 109' ' ' LEU . 57.9 ttm-85 -76.13 -16.68 59.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.756 -0.377 . . . . 1.0 110.368 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.55 54.21 1.36 Allowed Glycine 0 N--CA 1.474 1.192 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . -80.36 169.31 52.53 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.736 -1.345 . . . . 1.0 109.736 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -132.4 129.36 39.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 90' ' ' SER . 56.8 ttp180 -57.61 151.15 17.69 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 40.46 -86.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.794 0.684 . . . . 1.0 111.286 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' ARG . 93.1 p -160.06 97.7 1.28 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.435 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 55.2 67.62 0.99 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.246 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -145.28 162.74 36.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.097 0.475 . . . . 1.0 109.853 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.78 118.74 21.31 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.281 -0.872 . . . . 1.0 111.157 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.02 149.12 36.15 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.132 1.221 . . . . 1.0 111.026 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 97' ' ' GLN . 35.6 pt -93.35 9.02 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.2 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 66.31 -65.57 0.19 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.201 0.938 . . . . 1.0 109.6 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 95' ' ' ILE . 23.8 tp60 -63.88 -146.7 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.57 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.408 ' CZ ' ' ND1' ' A' ' 79' ' ' HIS . 56.5 m-85 -126.4 9.93 7.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.958 0.503 . . . . 1.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.55 66.55 2.39 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.7 m 53.89 -96.83 0.06 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.487 0.184 . . . . 1.0 110.584 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.444 ' H ' ' H ' ' A' ' 102' ' ' ASP . . . 170.54 9.01 0.02 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.444 ' H ' ' H ' ' A' ' 101' ' ' GLY . 29.4 t70 -61.44 -70.05 0.21 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.833 0.349 . . . . 1.0 110.407 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.7 p -91.91 34.91 0.98 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.155 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 54.3 -148.6 0.46 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.36 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.45 HH12 ' CG1' ' A' ' 116' ' ' VAL . 50.9 ptt85 -141.01 163.5 32.81 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.94 129.63 8.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.492 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.16 161.38 38.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 109' ' ' LEU . 38.8 t -123.35 128.73 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.572 HD12 ' HD2' ' A' ' 84' ' ' ARG . 4.1 mm? -104.79 157.66 17.05 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.173 0.511 . . . . 1.0 109.646 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.9 mmt 54.84 -87.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.819 -1.082 . . . . 1.0 110.282 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LEU . 7.7 p-10 -169.3 72.36 0.08 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.21 -0.19 59.9 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.411 ' C ' HD22 ' A' ' 114' ' ' LEU . 34.2 tptt -73.41 -57.26 4.13 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.901 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.411 HD22 ' C ' ' A' ' 113' ' ' LYS . 4.1 mm? -117.88 120.23 37.26 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.858 0.724 . . . . 1.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.5 126.06 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.177 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.45 ' CG1' HH12 ' A' ' 105' ' ' ARG . 57.6 t -101.56 114.25 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.143 -1.428 . . . . 1.0 107.143 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.05 140.78 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.839 0.712 . . . . 1.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.54 -40.88 66.98 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 110.011 -1.235 . . . . 1.0 110.011 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.0 t80 61.68 135.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.297 0.239 . . . . 1.0 110.508 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -170.08 128.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -161.25 142.99 11.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.169 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 123' ' ' THR . 99.3 p 46.85 -114.53 0.54 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.198 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.491 ' N ' ' HG ' ' A' ' 122' ' ' SER . 60.6 p -61.36 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.161 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 125' ' ' MET . 16.3 pttt -170.64 -73.09 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.546 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 64.4 mtt -71.79 -55.96 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.578 0.228 . . . . 1.0 111.469 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.96 -33.04 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.34 . . . . 1.0 111.276 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.2 m -72.44 -43.93 63.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.489 HG21 ' CE1' ' A' ' 32' ' ' PHE . 74.0 mt -64.93 -46.35 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 1.0 112.076 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 130' ' ' ARG . 20.6 pt -62.61 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 121.874 0.845 . . . . 1.0 110.789 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.42 ' N ' HG13 ' A' ' 129' ' ' ILE . 69.1 mtp85 -56.45 -46.04 80.54 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.95 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.75 -55.86 28.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -73.9 -22.69 59.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.345 -176.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 95.6 p 35.67 76.15 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.831 0.852 . . . . 1.0 112.588 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 30' ' ' ALA . 22.5 t70 -164.58 -151.18 0.15 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.041 -0.725 . . . . 1.0 109.041 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 135' ' ' LEU . 4.0 mm? -91.35 126.24 36.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.13 0.491 . . . . 1.0 109.687 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.0 p -97.1 155.36 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.801 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 31' ' ' LEU . 68.9 mt -119.01 96.35 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.995 -1.002 . . . . 1.0 108.52 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 t -96.42 123.44 40.08 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.51 -50.78 19.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.645 0.26 . . . . 1.0 110.796 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 25.11 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.03 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -63.93 -34.13 89.11 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.4 -44.73 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.926 0.393 . . . . 1.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -65.54 -41.58 96.11 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 111.151 -0.779 . . . . 1.0 111.151 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.9 t -69.65 -40.66 76.36 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 122.51 -0.406 . . . . 1.0 111.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.54 -29.75 39.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.369 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.6 tp -50.11 -51.37 43.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.033 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -65.65 -38.99 90.89 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.721 0.772 . . . . 1.0 110.339 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 m -51.08 -25.26 4.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.433 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.47 -55.35 4.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.073 0.768 . . . . 1.0 113.073 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -63.99 -26.61 68.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.909 0.385 . . . . 1.0 110.457 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.26 -0.91 6.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 t30 56.33 37.7 29.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.37 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.95 144.7 42.37 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.086 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.27 -177.41 2.98 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 121.865 1.71 . . . . 1.0 110.877 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.694 ' C ' HD13 ' A' ' 156' ' ' ILE . 2.0 pt? -158.78 171.95 19.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.177 -0.919 . . . . 1.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.694 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.5 OUTLIER -119.32 120.34 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.618 177.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.37 127.76 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.848 0.356 . . . . 1.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 96.8 m -72.77 104.81 4.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.01 147.73 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 83.48 102.49 0.05 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.976 0.798 . . . . 1.0 110.278 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -168.76 -76.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.6 m 49.17 35.92 8.17 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.06 0.457 . . . . 1.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.68 -40.66 97.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.184 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.9 ttm -162.88 52.3 0.18 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.006 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.29 -41.71 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.181 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 71.52 -51.62 0.69 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.701 0.626 . . . . 1.0 110.319 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -60.93 -23.77 65.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.806 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -42.11 -50.71 4.73 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.332 -0.395 . . . . 1.0 111.305 -176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -67.09 -36.27 81.61 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.101 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -66.17 -38.09 87.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.452 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.6 mm -65.06 -43.63 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.99 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.51 -52.26 8.77 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.823 0.344 . . . . 1.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.25 -51.91 30.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.981 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -61.04 -30.31 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 1.0 110.574 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 179' ' ' GLY . 0.7 OUTLIER -63.96 -36.62 84.57 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.024 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.3 t -57.69 -44.5 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.671 0.272 . . . . 1.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -63.41 -50.22 70.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.831 0.348 . . . . 1.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.2 mt -90.76 0.67 57.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.313 0.578 . . . . 1.0 110.212 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . -173.51 87.23 0.08 OUTLIER Glycine 0 C--O 1.223 -0.575 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -48.25 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.457 0.74 . . . . 1.0 110.308 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.4 p -89.96 146.73 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.107 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -66.93 127.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 p -107.14 133.87 51.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.6 m -162.71 124.79 2.66 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.74 154.98 75.95 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.712 -0.661 . . . . 1.0 110.175 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.5 63.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.513 2.638 0 C-N-CA 122.458 2.106 . . . . 1.0 113.547 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 185' ' ' ALA . 79.4 p -128.12 141.95 51.34 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 17.2 mp0 -65.45 -25.36 67.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.276 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 189' ' ' THR . 1.5 t -89.11 -31.57 17.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.897 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.36 -34.3 12.45 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 112.015 -0.434 . . . . 1.0 112.015 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 34.7 mt -62.41 -41.52 98.74 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.449 -0.442 . . . . 1.0 111.364 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.28 -39.33 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.6 79.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.389 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.48 -53.99 25.5 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.415 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.94 -32.98 72.49 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.716 -0.284 . . . . 1.0 110.387 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -59.16 -48.6 81.03 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.503 -0.479 . . . . 1.0 109.99 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.54 -47.79 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.188 -0.32 . . . . 1.0 111.395 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 83.3 p -59.79 -32.95 71.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.21 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.16 28.35 4.97 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.778 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 62.1 m -150.45 -30.74 0.2 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.328 -0.249 . . . . 1.0 110.328 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -150.8 151.94 33.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.174 0.511 . . . . 1.0 109.751 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -130.39 156.78 44.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.344 -0.844 . . . . 1.0 110.089 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.39 164.61 19.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.183 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -61.73 148.35 87.32 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.904 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.99 99.63 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.742 1.628 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -140.61 87.43 11.52 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 107.36 2.46 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.019 1.813 . . . . 1.0 111.685 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.64 84.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.224 -0.444 . . . . 1.0 109.932 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 78.2 p -68.84 -32.75 72.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.798 0.333 . . . . 1.0 110.467 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -83.09 21.2 1.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.988 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.427 HD22 ' H ' ' A' ' 213' ' ' SER . 0.5 OUTLIER -57.59 146.15 66.29 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.902 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.95 13.37 0.62 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.051 1.834 . . . . 1.0 111.855 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.427 ' H ' HD22 ' A' ' 211' ' ' ASN . 4.7 t -65.8 -58.62 5.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.949 0.404 . . . . 1.0 111.111 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -53.33 -39.31 63.98 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.12 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -59.56 -32.23 70.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.214 -0.448 . . . . 1.0 109.939 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -76.69 -49.74 15.36 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.787 0.327 . . . . 1.0 111.434 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 63.2 mt -64.34 -52.69 57.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.524 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.03 -50.88 65.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.459 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.08 -41.56 92.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.326 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.79 -33.93 76.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.573 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 27.6 m -60.91 -46.92 88.73 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.947 0.404 . . . . 1.0 110.465 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.4 tp -82.29 142.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.837 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -165.59 139.21 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.112 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.066 -0.968 . . . . 1.0 110.336 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.39 -21.07 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 26' ' ' ILE . 8.5 tp -73.31 76.83 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.844 0.831 . . . . 1.0 110.387 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -159.09 -30.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -164.04 73.82 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.932 -0.396 . . . . 1.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' H ' HG21 ' A' ' 63' ' ' VAL . 88.6 tttt -128.78 111.32 12.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.45 160.2 14.53 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 137' ' ' ILE . 14.0 tp -130.15 102.73 6.36 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -99.42 127.62 45.48 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.849 0.46 . . . . 1.0 110.018 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.61 145.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 t -144.01 138.63 28.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.523 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.19 -35.57 76.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.852 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.5 -104.12 1.38 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.371 -1.092 . . . . 1.0 110.371 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.46 -159.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -63.42 172.01 2.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 p -162.34 82.81 1.67 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.9 -32.77 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.054 1.836 . . . . 1.0 111.065 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.6 110.45 3.15 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 118.746 -0.645 . . . . 1.0 110.267 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -84.76 -21.68 3.25 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.613 1.542 . . . . 1.0 112.36 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -81.17 -31.89 33.85 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.548 HD23 ' OG ' ' A' ' 162' ' ' SER . 0.3 OUTLIER -75.58 -51.6 12.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.093 0.473 . . . . 1.0 110.472 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 48' ' ' VAL . 11.9 p -56.74 -32.06 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.995 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 98.3 p -62.39 -19.26 63.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.691 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.5 p -51.07 -38.54 52.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 1.0 110.601 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 45' ' ' VAL . 5.4 m -64.61 -18.76 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.112 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mt -143.63 41.19 1.44 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.939 0.496 . . . . 1.0 109.774 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -124.26 -156.13 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.103 -0.702 . . . . 1.0 109.103 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -54.5 -46.81 73.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.747 -0.66 . . . . 1.0 112.033 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.13 -55.41 35.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.536 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -71.0 -45.63 63.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.455 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 47.5 t -56.77 -32.02 65.2 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.46 0.647 . . . . 1.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -78.83 -49.86 12.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.82 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -70.08 -58.29 3.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.888 -0.597 . . . . 1.0 112.606 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 61' ' ' GLY . 3.2 mm? -49.45 -42.01 41.76 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.289 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.7 mm -69.69 -42.33 80.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -50.46 -51.9 42.79 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.122 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.89 -17.81 24.68 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . 75.54 -16.21 4.11 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.562 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 38.09 -115.54 0.15 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.261 -0.4 . . . . 1.0 111.448 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.433 HG21 ' H ' ' A' ' 29' ' ' LYS . 97.0 t -160.43 -59.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -165.64 130.2 2.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.367 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.603 ' C ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -99.44 143.33 29.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.637 0.775 . . . . 1.0 110.533 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.8 mm -123.28 130.46 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 48' ' ' VAL . 12.5 tt -145.29 141.86 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.243 0.544 . . . . 1.0 109.538 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.565 HE21 ' CE ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -160.58 151.79 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.043 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' OE2' ' A' ' 76' ' ' GLU . 95.8 m-85 -99.96 -60.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.315 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.514 ' H ' ' CG2' ' A' ' 103' ' ' THR . . . 89.01 -37.62 3.3 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 111.314 -0.715 . . . . 1.0 111.314 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.638 ' NH2' ' HE ' ' A' ' 216' ' ' ARG . 62.3 mmt-85 -97.13 122.65 40.39 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.81 -38.07 89.75 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.973 0.416 . . . . 1.0 110.262 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -54.03 -15.91 1.67 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.936 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -55.08 -80.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.242 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.3 m 52.88 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.667 0.27 . . . . 1.0 111.454 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -168.0 -44.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.908 0.385 . . . . 1.0 111.462 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -69.15 103.57 1.94 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.21 -83.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.267 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.08 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.035 0.445 . . . . 1.0 110.272 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.65 -17.59 60.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.32 -36.59 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' GLY . 17.6 mm100 -66.87 -39.64 87.6 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.52 -0.764 . . . . 1.0 110.128 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -51.96 -38.02 55.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.12 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -18.0 62.59 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' GLN . . . 88.53 41.74 6.0 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.34 168.16 54.81 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -137.84 133.83 34.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -62.39 155.94 23.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.894 -0.322 . . . . 1.0 110.848 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.79 -5.83 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.407 0.442 . . . . 1.0 110.888 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.4 m -70.31 143.52 52.01 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 92' ' ' LYS . 16.8 mm100 -64.24 128.51 36.09 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 91' ' ' GLN . 61.3 mttp 60.17 127.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.99 -0.745 . . . . 1.0 108.99 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 93' ' ' ILE . 17.1 tt -51.75 102.57 0.32 Allowed Pre-proline 0 CA--C 1.552 1.022 0 CA-C-N 117.666 0.212 . . . . 1.0 111.45 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 96' ' ' ASP . 33.0 Cg_exo -63.27 -141.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.221 0 CA-C-N 120.357 1.163 . . . . 1.0 111.601 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.44 7.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.226 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 94' ' ' PRO . 66.2 t0 63.28 -116.64 0.49 Allowed 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -56.9 -168.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.846 0.355 . . . . 1.0 110.62 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 100' ' ' CYS . 0.1 OUTLIER -67.37 -20.93 65.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' SG ' ' A' ' 100' ' ' CYS . . . 66.35 -11.82 0.51 Allowed Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.96 -0.563 . . . . 1.0 111.872 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.484 ' H ' ' C ' ' A' ' 98' ' ' PHE . 1.2 m 171.95 -86.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.404 -0.961 . . . . 1.0 108.404 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 173.74 120.91 0.59 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.283 -1.127 . . . . 1.0 110.283 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -171.41 -120.76 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.514 ' CG2' ' H ' ' A' ' 70' ' ' GLY . 46.8 p -152.0 71.47 0.97 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -155.22 62.66 0.63 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.07 0.462 . . . . 1.0 111.665 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' A' ' 118' ' ' GLY . 22.3 ptt85 -133.47 147.81 51.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -150.05 117.98 6.28 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -137.04 161.28 36.51 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.09 147.94 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.316 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 111' ' ' ASN . 2.0 mp -123.82 123.14 39.8 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.5 tpp 55.83 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.268 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' LEU . 20.6 t-20 -167.39 78.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.793 0.33 . . . . 1.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.41 5.28 77.05 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.011 -0.835 . . . . 1.0 111.011 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -66.51 -23.44 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 tp -174.04 105.68 0.12 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -109.89 115.32 29.59 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.38 108.45 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.87 100.04 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.938 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.41 ' H ' ' HG3' ' A' ' 105' ' ' ARG . . . -84.68 -25.01 43.7 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 109.889 -1.284 . . . . 1.0 109.889 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -58.69 137.4 57.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.898 0.38 . . . . 1.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -166.41 170.54 12.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -81.56 96.06 7.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.226 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.6 p 46.53 -164.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.784 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.54 8.5 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.15 0.5 . . . . 1.0 110.054 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -144.42 44.87 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.565 ' CE ' HE21 ' A' ' 68' ' ' GLN . 18.1 mmt -52.98 -41.67 64.81 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.668 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -54.83 -26.96 38.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.683 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 51.2 p -83.66 -38.85 20.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.836 0.35 . . . . 1.0 111.245 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.02 -44.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.718 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.85 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -55.14 -38.81 68.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.173 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.48 -43.58 84.23 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -96.07 -61.06 1.5 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.03 0.443 . . . . 1.0 110.293 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 m 55.96 79.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -139.99 -49.37 0.47 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.65 0.262 . . . . 1.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.495 HD13 ' H ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -163.39 139.06 6.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.495 ' H ' HD13 ' A' ' 135' ' ' LEU . 1.5 p -133.47 140.44 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.536 HD11 HD11 ' A' ' 31' ' ' LEU . 79.3 mt -119.18 125.9 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 139' ' ' HIS . 27.5 t -87.6 -164.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.435 ' N ' ' OG ' ' A' ' 138' ' ' SER . 79.4 t60 -139.03 -3.38 1.6 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 110.395 -0.224 . . . . 1.0 110.395 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.09 -56.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.099 0.476 . . . . 1.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 136.8 126.14 2.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 1.9 t -174.07 -131.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -73.76 -27.16 67.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -54.75 -44.81 73.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 89.1 mt -65.69 -26.75 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 122.173 -0.329 . . . . 1.0 110.902 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -54.57 34.68 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.25 -44.55 91.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.534 0.683 . . . . 1.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.7 p -49.08 -22.78 0.99 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.125 -0.943 . . . . 1.0 113.3 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.4 mt -82.46 -45.42 14.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.852 0.358 . . . . 1.0 111.611 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -68.8 -21.85 64.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.308 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.03 -3.0 57.72 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 53.06 34.34 16.93 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.593 0.235 . . . . 1.0 110.557 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.81 115.7 48.38 Favored Pre-proline 0 N--CA 1.481 1.11 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -50.94 155.22 6.12 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 CA-C-N 120.658 1.271 . . . . 1.0 112.308 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.14 170.31 19.73 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.274 1.035 . . . . 1.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.43 138.18 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.685 -1.598 . . . . 1.0 109.278 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.7 p -119.89 138.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 120.631 0.253 . . . . 1.0 110.815 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 14.3 t -72.35 125.27 26.97 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 184' ' ' CYS . 25.1 t -123.54 139.81 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.145 -0.687 . . . . 1.0 109.145 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 64.5 t30 57.11 -176.09 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.02 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' A' ' 160' ' ' ASN . 65.5 m-20 59.76 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.838 0.711 . . . . 1.0 111.077 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.548 ' OG ' HD23 ' A' ' 44' ' ' LEU . 68.8 m 53.59 -90.94 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.847 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 66.5 mt -3.79 78.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.104 1.362 . . . . 1.0 113.14 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 62.1 mmm -60.83 -41.14 95.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.14 -0.937 . . . . 1.0 110.617 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.46 121.58 17.29 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.05 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -64.91 -34.27 78.0 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.77 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -55.63 -39.54 70.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.097 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.7 -52.39 64.49 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -66.88 -28.59 68.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.821 0.343 . . . . 1.0 110.574 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.78 -51.99 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.441 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.9 -27.27 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.41 -58.3 3.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -52.18 -43.88 64.38 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.862 -1.063 . . . . 1.0 112.353 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -64.71 -41.99 95.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.421 -0.512 . . . . 1.0 109.844 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.206 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 179' ' ' GLY . 99.7 t -64.12 -35.32 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -48.09 -43.61 30.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.233 -0.894 . . . . 1.0 109.295 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.64 -29.91 67.49 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 82.47 -5.79 71.89 Favored Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.339 -1.104 . . . . 1.0 110.339 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.538 ' O ' HD22 ' A' ' 203' ' ' LEU . 0.3 OUTLIER -62.53 -4.73 2.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.949 -0.625 . . . . 1.0 111.284 -177.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.33 147.47 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.171 0.441 . . . . 1.0 110.156 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 19.6 m-90 -76.71 131.65 38.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m -88.08 138.6 31.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -135.53 149.77 49.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.1 150.34 70.88 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.59 -0.893 . . . . 1.0 108.59 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.17 58.19 5.54 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 122.201 1.934 . . . . 1.0 113.183 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 173.08 6.5 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.88 -57.71 5.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.8 m -88.84 -30.27 19.07 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.585 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -59.19 -47.71 89.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.353 -0.699 . . . . 1.0 111.353 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.42 -43.0 91.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 117.083 0.441 . . . . 1.0 111.155 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.46 -43.65 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.59 -38.51 72.11 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.38 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.24 91.38 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.418 -0.673 . . . . 1.0 111.418 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -52.68 63.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -60.84 -35.33 76.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.141 -0.936 . . . . 1.0 109.432 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.03 -45.23 86.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.885 0.374 . . . . 1.0 110.097 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 84.2 p -67.5 -20.49 65.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.66 -24.73 14.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.01 0.433 . . . . 1.0 109.873 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.1 m -74.63 -40.08 61.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.505 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -120.18 139.7 52.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.794 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -119.18 101.61 8.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.054 0.542 . . . . 1.0 109.977 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 180' ' ' TYR . 5.2 tp -63.83 131.18 46.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -67.99 150.19 97.87 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 106.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.508 2.362 0 C-N-CA 121.891 1.727 . . . . 1.0 113.624 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.81 84.69 9.63 Favored Pre-proline 0 N--CA 1.478 0.953 0 N-CA-C 109.932 -0.395 . . . . 1.0 109.932 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -57.32 127.33 25.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.624 1.55 . . . . 1.0 112.036 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.04 -33.48 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.675 -0.491 . . . . 1.0 109.675 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 211' ' ' ASN . 50.6 m 55.38 -111.09 0.6 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.861 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.32 -79.34 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 209' ' ' SER . 8.1 p-10 -133.42 78.1 63.95 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 122.943 0.497 . . . . 1.0 110.22 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 214' ' ' PHE . 71.8 Cg_exo -55.32 -136.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.67 0 C-N-CA 123.019 2.48 . . . . 1.0 112.521 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 96.4 p -68.35 8.04 0.51 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.853 0.358 . . . . 1.0 110.212 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 212' ' ' PRO . 65.1 t80 -60.85 -45.1 95.84 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.154 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.88 -54.78 25.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.815 0.34 . . . . 1.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.638 ' HE ' ' NH2' ' A' ' 71' ' ' ARG . 84.9 mtp180 -62.22 -39.54 93.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.889 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 tp -48.95 -47.64 43.67 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.098 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 76.2 mt -58.05 -42.12 84.75 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.468 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.58 -50.55 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -61.46 -36.97 81.9 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.788 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 32.3 m -61.36 -44.58 96.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.759 0.314 . . . . 1.0 110.432 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 84.4 mt -80.35 129.3 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.479 ' CD2' ' N ' ' A' ' 224' ' ' SER . 59.4 t80 57.33 162.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.012 0.434 . . . . 1.0 111.176 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.479 ' N ' ' CD2' ' A' ' 223' ' ' TYR . 46.9 t . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.259 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.435 -1.466 . . . . 1.0 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 27' ' ' GLU . 9.5 tt -169.7 -37.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.2 mm -61.73 69.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 123.605 0.566 . . . . 1.0 110.406 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 25' ' ' ILE . 76.8 tt0 -176.78 95.13 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.822 -0.626 . . . . 1.0 109.768 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -165.96 -76.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -132.73 101.48 5.3 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.006 0.522 . . . . 1.0 110.019 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.68 119.5 38.95 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -83.07 121.59 27.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.76 0.314 . . . . 1.0 110.22 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CE1' ' CZ ' ' A' ' 132' ' ' TYR . 6.9 m-85 -103.63 122.13 44.37 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.2 t -118.36 99.04 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.5 p -93.23 120.75 33.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.236 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 139' ' ' HIS . 71.5 m -61.25 -27.48 68.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -138.47 31.6 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.721 -0.952 . . . . 1.0 110.721 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.37 -112.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.892 -0.181 . . . . 1.0 110.71 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.5 p -71.3 112.74 7.68 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.5 131.48 95.1 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.874 -0.584 . . . . 1.0 110.358 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.77 -174.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.3 1.333 . . . . 1.0 112.477 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.99 144.96 90.01 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.034 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.78 -33.22 49.38 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.789 1.66 . . . . 1.0 113.086 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.32 -35.39 61.24 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.633 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -66.88 -45.04 79.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.799 0.333 . . . . 1.0 111.531 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 48' ' ' VAL . 16.2 m -60.72 -37.03 74.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.954 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -46.54 -27.53 1.15 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.181 0.515 . . . . 1.0 110.986 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.6 t -53.89 -38.09 64.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.78 . . . . 1.0 110.559 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.5 m -80.53 -4.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.302 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.52 40.18 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.224 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.9 m -135.62 -166.12 1.8 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.898 0.856 . . . . 1.0 109.823 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -54.6 -44.84 73.41 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.95 -1.477 . . . . 1.0 110.327 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 23.4 mp0 -52.27 -52.07 54.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.534 0.207 . . . . 1.0 110.55 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.58 -37.33 76.92 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.432 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.2 t -49.77 -45.98 50.23 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.745 0.307 . . . . 1.0 111.552 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -72.66 -44.59 61.67 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 1.0 111.429 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.35 -36.01 80.53 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.596 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -58.17 -47.23 84.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.619 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.62 HD11 ' HZ3' ' A' ' 113' ' ' LYS . 1.5 mp -68.67 -28.95 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.86 -43.02 59.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.91 -0.587 . . . . 1.0 110.906 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -76.57 -11.05 59.81 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.047 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 83.64 37.83 11.43 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.61 -0.805 . . . . 1.0 111.505 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 63' ' ' VAL . 1.6 p90 -48.43 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 120.936 0.398 . . . . 1.0 111.17 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' N ' ' CD2' ' A' ' 62' ' ' PHE . 8.7 p -172.15 -31.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.001 0.429 . . . . 1.0 109.952 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.504 ' NH1' ' NZ ' ' A' ' 115' ' ' LYS . 56.1 ttt85 -167.02 108.52 0.66 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.5 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.07 130.47 36.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.252 -0.648 . . . . 1.0 109.252 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.09 135.88 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.09 144.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -119.98 124.36 45.74 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.158 -1.052 . . . . 1.0 108.158 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CE1' ' NH2' ' A' ' 105' ' ' ARG . 2.0 t80 -59.04 -169.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.302 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.82 -109.08 0.35 Allowed Glycine 0 N--CA 1.463 0.481 0 N-CA-C 110.664 -0.974 . . . . 1.0 110.664 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -65.17 124.28 21.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.71 0.291 . . . . 1.0 110.723 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.63 -37.99 88.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.775 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.36 -44.49 88.84 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.461 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 99.3 p -63.91 169.73 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.289 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.3 p -153.61 73.37 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.335 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.95 169.39 4.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.83 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 45.8 76.1 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.938 0.399 . . . . 1.0 110.736 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.37 -34.96 77.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.22 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -167.86 22.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.388 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.88 -30.19 66.5 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.839 0.352 . . . . 1.0 110.6 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' GLY . 74.6 t -58.91 -47.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -72.72 -42.15 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.884 0.373 . . . . 1.0 111.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -52.64 -43.37 65.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.954 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -83.1 -16.9 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.93 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.38 -55.86 0.41 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . 46.06 78.02 0.09 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 112.686 -0.166 . . . . 1.0 112.686 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.21 109.96 19.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' NH1' ' O ' ' A' ' 97' ' ' GLN . 26.6 mmm180 -59.64 150.48 27.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.925 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.5 16.92 3.37 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.479 0.657 . . . . 1.0 109.549 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t -168.6 -173.79 2.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.441 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -151.78 54.83 0.84 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.506 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.59 -45.37 87.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.444 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.2 pt -109.63 145.03 31.1 Favored Pre-proline 0 CA--C 1.554 1.129 0 O-C-N 123.354 0.409 . . . . 1.0 110.741 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.81 -55.54 3.75 Favored 'Trans proline' 0 N--CA 1.509 2.433 0 C-N-CA 122.053 1.835 . . . . 1.0 113.203 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.5 tt -48.3 -40.95 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.807 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.4 t70 47.42 66.14 1.09 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.18 -0.463 . . . . 1.0 111.47 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.429 ' O ' ' NH1' ' A' ' 88' ' ' ARG . 58.1 tt0 -150.12 -84.24 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.486 ' CE1' ' NH1' ' A' ' 105' ' ' ARG . 81.4 t80 -128.29 -17.41 4.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.8 0.44 . . . . 1.0 110.62 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.22 66.97 2.14 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 101' ' ' GLY . 28.1 p -53.94 -44.62 70.81 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.716 0.294 . . . . 1.0 110.97 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.45 ' N ' ' SG ' ' A' ' 100' ' ' CYS . . . -62.15 -82.78 0.07 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.43 -109.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 t -173.18 -29.4 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.027 -0.36 . . . . 1.0 110.027 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -32.35 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.824 0.703 . . . . 1.0 111.493 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' CE1' ' A' ' 98' ' ' PHE . 10.5 ptp180 -130.12 151.69 50.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.593 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -157.98 109.46 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.52 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -143.14 -172.96 3.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.75 -0.463 . . . . 1.0 109.75 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 109' ' ' LEU . 11.0 p -152.54 162.26 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.427 ' N ' HG22 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -163.84 -174.17 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.2 mtt 53.82 54.09 10.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.496 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 52.49 33.47 13.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.72 25.03 68.35 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 120.894 -0.67 . . . . 1.0 112.499 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.62 ' HZ3' HD11 ' A' ' 58' ' ' ILE . 16.6 tptm -83.21 -49.86 9.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.4 0.6 . . . . 1.0 112.034 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.73 132.84 56.42 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.186 0.517 . . . . 1.0 112.033 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' NZ ' ' NH1' ' A' ' 64' ' ' ARG . 49.3 mtmt -106.23 152.45 23.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -134.23 132.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.6 mt -145.06 123.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.795 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.26 -16.24 76.75 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.15 -1.18 . . . . 1.0 110.15 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.4 t80 54.69 -99.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -169.67 130.17 1.03 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.19 108.64 4.24 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.1 p -168.07 160.64 12.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.123 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.8 t -76.69 5.27 7.86 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.237 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -72.33 -42.73 65.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.293 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.1 ttm -46.14 -34.21 4.09 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.709 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.96 -28.47 57.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.624 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -79.35 -35.18 41.32 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.421 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 128' ' ' ILE . 1.6 mp -64.55 -27.82 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.762 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.2 mt -52.13 -51.45 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 120.316 -0.553 . . . . 1.0 109.739 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -48.47 -30.95 5.67 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.383 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -52.4 -47.23 66.4 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 121.263 -0.175 . . . . 1.0 111.276 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.595 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.2 p90 -117.1 -53.68 2.45 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.341 0.401 . . . . 1.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 47.4 m 50.25 79.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.869 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -120.14 -53.45 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 154' ' ' PRO . 3.3 tp -168.8 148.39 4.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.065 -0.654 . . . . 1.0 110.481 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.17 149.76 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.47 100.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 t -116.33 127.14 54.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.487 ' H ' ' CD2' ' A' ' 139' ' ' HIS . 13.2 p80 -80.69 67.86 6.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.226 -0.443 . . . . 1.0 109.875 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.85 34.37 23.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.994 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -62.41 -34.77 90.37 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.402 ' H ' HD12 ' A' ' 145' ' ' ILE . 2.8 m 69.03 -16.75 0.22 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.46 0.304 . . . . 1.0 110.413 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -84.25 -54.18 3.08 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.706 -0.557 . . . . 1.0 111.706 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.0 p -79.54 -32.22 42.15 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.47 0.308 . . . . 1.0 111.365 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 142' ' ' THR . 97.4 mt -54.27 -28.2 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 120.693 0.283 . . . . 1.0 110.86 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.9 mt -56.29 -51.08 69.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.807 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -65.17 -53.1 50.05 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 121.426 0.632 . . . . 1.0 110.865 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 88.0 p -58.32 -24.93 61.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 1.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.2 tp -76.7 -57.34 3.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.633 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.497 ' NH1' ' ND1' ' A' ' 210' ' ' HIS . 39.6 ptt180 -62.36 -28.05 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.171 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.7 4.6 1.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 150' ' ' ARG . 22.7 m120 58.41 11.96 1.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.233 0.333 . . . . 1.0 110.274 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -92.5 142.33 25.77 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.458 ' O ' HD12 ' A' ' 135' ' ' LEU . 62.7 Cg_endo -71.67 167.9 25.22 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.719 1.613 . . . . 1.0 111.481 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 155' ' ' LEU . 1.9 pt? -156.65 156.52 33.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.295 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.412 ' CG2' ' SG ' ' A' ' 184' ' ' CYS . 16.8 mm -110.13 109.72 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.58 118.27 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.11 103.65 2.37 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 85.5 t -90.09 137.88 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.1 170.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.011 0.434 . . . . 1.0 110.769 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 49.82 74.75 0.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.715 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.1 t -171.2 -49.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.13 0.49 . . . . 1.0 110.129 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.0 pp -145.52 142.87 29.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.092 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.2 mmm -90.22 86.65 6.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.573 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 166' ' ' ASN . 15.3 t0 -161.16 -19.52 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.962 -0.385 . . . . 1.0 109.962 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 165' ' ' ASP . 67.4 m-20 58.7 6.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.67 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 165' ' ' ASP . 52.8 t-80 -66.25 -36.63 83.49 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 172' ' ' ALA . 5.3 pt20 -61.57 -41.6 97.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.974 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -53.96 -29.56 43.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.83 0.348 . . . . 1.0 111.024 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -70.45 -53.47 16.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.09 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.5 mt -83.63 -51.3 14.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 110.487 -0.19 . . . . 1.0 110.487 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 168' ' ' GLN . . . -45.05 -52.97 8.39 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 176' ' ' VAL . 30.4 t0 -69.36 -56.13 8.4 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -51.04 -26.98 6.95 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.9 0.381 . . . . 1.0 110.791 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.31 -38.84 66.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.243 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 173' ' ' ASP . 15.7 m -55.53 -29.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 120.918 0.39 . . . . 1.0 111.875 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -59.46 -48.49 81.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.942 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.6 mt -104.48 24.7 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.288 0.566 . . . . 1.0 110.409 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.644 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.3 82.57 0.04 OUTLIER Glycine 0 C--O 1.221 -0.703 0 N-CA-C 108.44 -1.864 . . . . 1.0 108.44 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -46.35 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 O-C-N 125.063 1.096 . . . . 1.0 110.692 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.644 ' N ' ' O ' ' A' ' 179' ' ' GLY . 6.3 p -73.24 139.63 19.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.534 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -63.9 116.85 6.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.2 m -108.75 133.63 52.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.562 -0.744 . . . . 1.0 109.875 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 156' ' ' ILE . 28.5 p -165.1 131.32 2.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.697 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.65 79.47 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.43 79.11 0.24 Allowed 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.704 2.27 . . . . 1.0 113.68 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.5 p -130.62 177.14 7.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 2.2 pm0 -68.64 -63.86 0.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.56 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.5 m -75.13 -43.56 51.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.022 0.439 . . . . 1.0 111.547 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -51.85 -51.24 40.61 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.969 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.97 -41.46 97.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.3 0.55 . . . . 1.0 111.743 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.76 -42.93 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.94 76.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 1.0 110.153 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.71 -46.44 61.26 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.66 -44.41 97.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.043 -0.354 . . . . 1.0 110.043 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -64.63 -37.91 89.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.57 86.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.4 t -60.16 -21.2 61.37 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.01 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -101.28 31.67 3.6 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.668 0.27 . . . . 1.0 110.792 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 18.2 p -143.01 -31.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.12 152.21 12.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.336 -0.546 . . . . 1.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -99.08 144.03 28.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.688 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.571 HD22 ' C ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -54.78 173.91 0.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.519 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.13 116.08 22.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-O 118.991 -0.528 . . . . 1.0 110.739 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.61 118.17 2.82 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 CA-C-N 120.919 1.364 . . . . 1.0 112.749 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -142.06 87.81 9.56 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 85.79 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.347 1.365 . . . . 1.0 112.436 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.74 -26.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.257 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.4 p 75.78 132.17 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.864 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.497 ' ND1' ' NH1' ' A' ' 150' ' ' ARG . 3.7 p-80 -62.33 -171.36 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.974 -0.38 . . . . 1.0 109.974 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.37 160.09 30.98 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.05 -98.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 122.304 2.003 . . . . 1.0 111.906 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.7 m -66.82 -36.35 82.16 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.832 0.349 . . . . 1.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.07 -33.56 52.58 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.659 0.266 . . . . 1.0 110.294 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -61.83 -24.22 66.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.416 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -82.01 -45.75 14.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.586 -0.279 . . . . 1.0 110.99 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 217' ' ' LEU . 10.2 mp -64.04 -42.87 96.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.647 -0.252 . . . . 1.0 110.536 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.2 mt -55.43 -44.75 76.59 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 55.1 t -74.29 -46.59 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -69.37 -6.94 33.12 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.757 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 26.0 m -46.85 -42.17 16.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.67 0.271 . . . . 1.0 110.972 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.16 143.69 15.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.507 . . . . 1.0 109.843 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 62.7 t80 52.32 97.95 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.028 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.09 -0.957 . . . . 1.0 110.305 -179.831 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.536 -1.426 . . . . 1.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.71 -46.09 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.2 pt -132.68 -36.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.353 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -146.55 173.11 12.61 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -116.96 65.19 0.72 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.06 156.09 39.59 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.7 134.77 51.7 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.772 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.65 119.57 32.2 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.743 -0.598 . . . . 1.0 109.466 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -101.42 129.94 47.54 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.25 138.04 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.73 129.62 42.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.491 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.56 34.75 2.67 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.971 0.415 . . . . 1.0 110.066 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.92 -160.13 53.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 -37.37 86.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.477 0.179 . . . . 1.0 111.059 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.1 p -133.18 150.45 52.0 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 110.067 -0.345 . . . . 1.0 110.067 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 39' ' ' VAL . 14.5 p -83.12 121.01 76.93 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 119.309 -0.377 . . . . 1.0 110.93 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.58 -59.63 1.12 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 CA-C-N 120.562 1.236 . . . . 1.0 112.386 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -144.81 145.31 27.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.906 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.76 -19.8 30.93 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 121.748 1.632 . . . . 1.0 111.813 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -77.23 -33.9 56.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.806 0.336 . . . . 1.0 110.875 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.46 -48.7 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 1.0 110.72 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -63.21 -34.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 1.0 109.76 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 50' ' ' SER . 6.4 m -52.52 -44.31 65.65 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.655 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -49.01 -38.56 23.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.73 0.3 . . . . 1.0 110.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.11 -14.1 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.271 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.59 35.17 4.24 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.993 0.425 . . . . 1.0 110.333 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 46' ' ' SER . 20.9 m -114.05 -167.55 1.23 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.16 -27.17 63.35 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.707 -1.133 . . . . 1.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.75 -47.57 65.93 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.241 -0.583 . . . . 1.0 110.485 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.2 t80 -69.22 -40.83 77.72 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.7 t -49.99 -48.48 52.3 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -66.78 -44.27 81.8 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.817 0.342 . . . . 1.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -73.64 -30.58 63.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.29 0.567 . . . . 1.0 109.833 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' PHE . 5.7 tt -58.78 -50.0 75.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.312 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -66.59 -31.07 51.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.268 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -59.8 -10.55 3.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.713 -0.222 . . . . 1.0 110.634 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -103.6 -10.59 18.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.218 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.53 13.39 55.58 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 121.188 -0.53 . . . . 1.0 112.384 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -84.71 160.61 20.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.56 3.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.769 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -148.75 142.4 25.5 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.544 0.688 . . . . 1.0 110.554 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -141.99 116.41 9.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.341 -0.845 . . . . 1.0 108.899 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mm -100.69 137.88 26.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tt -146.13 141.24 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.029 0.443 . . . . 1.0 109.833 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.09 158.91 5.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -174.82 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.963 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.27 147.44 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -155.73 83.83 1.03 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 1.0 110.282 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -68.28 -22.31 64.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.281 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -57.22 -29.6 63.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 84.4 p -149.97 -105.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.066 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.7 m -140.63 147.87 40.02 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 19.8 mp0 -84.2 -119.66 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.79 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -66.55 109.98 2.99 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.77 -57.42 5.64 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.108 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -173.23 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.06 -45.04 82.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.096 0.474 . . . . 1.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.88 -46.59 96.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.937 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.35 -26.45 68.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.009 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.98 -49.82 76.43 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.244 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -62.53 -17.38 59.69 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.083 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.77 54.9 7.83 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 110.179 -1.168 . . . . 1.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.15 -165.53 41.39 Favored Glycine 0 N--CA 1.466 0.669 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -134.6 135.03 41.91 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.004 0.431 . . . . 1.0 110.095 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' NH1' ' OD1' ' A' ' 96' ' ' ASP . 88.8 mtt-85 -60.55 153.28 23.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.922 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -106.45 0.48 24.81 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 92' ' ' LYS . 91.8 p 50.09 178.03 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.96 0.41 . . . . 1.0 111.117 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 57.72 2.01 0.15 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.198 -0.314 . . . . 1.0 111.59 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 90' ' ' SER . 68.5 mttm -139.68 16.02 2.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.343 0.257 . . . . 1.0 110.487 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.4 pt -144.89 82.43 10.08 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -81.98 -46.76 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.994 1.796 . . . . 1.0 110.534 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.8 pt -94.01 -3.36 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.934 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 97' ' ' GLN . 16.7 t70 62.73 -160.85 0.3 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.457 ' H ' ' CG ' ' A' ' 96' ' ' ASP . 11.4 mm100 59.53 -145.51 0.52 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -67.64 -19.81 65.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.794 -0.185 . . . . 1.0 110.643 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.79 68.08 1.7 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 102' ' ' ASP . 56.3 m -56.95 -156.41 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.782 0.325 . . . . 1.0 110.851 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.19 83.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.476 -0.65 . . . . 1.0 111.476 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 100' ' ' CYS . 7.0 m-20 -155.47 -64.57 0.12 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.07 20.23 0.19 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 110.275 -0.268 . . . . 1.0 110.275 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 58.33 -152.8 0.39 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.068 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -136.25 158.6 44.03 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.47 ' NE2' ' H ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -155.17 126.17 7.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.47 ' H ' ' NE2' ' A' ' 106' ' ' GLN . 2.0 m-85 -132.16 148.32 52.47 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.0 t -104.61 104.98 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.149 -0.932 . . . . 1.0 108.807 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -99.76 123.17 43.75 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 65.9 mtt 42.7 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.538 0.569 . . . . 1.0 112.538 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 54.96 7.8 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.757 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.29 24.02 72.18 Favored Glycine 0 N--CA 1.462 0.427 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -56.99 -39.47 74.72 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.046 -0.353 . . . . 1.0 110.046 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.8 tp -129.78 128.36 42.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -108.65 119.4 39.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.102 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.31 112.63 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.1 pt -115.08 158.66 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-N 115.144 -0.935 . . . . 1.0 108.954 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -115.44 95.05 0.69 Allowed Glycine 0 N--CA 1.474 1.205 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.76 -173.46 4.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -146.42 156.21 43.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.641 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -69.14 127.93 34.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.233 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.6 p -169.35 33.83 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.676 0.274 . . . . 1.0 110.448 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 29.6 p 51.6 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.653 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -179.88 -29.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.671 0.607 . . . . 1.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtm -55.38 -48.43 74.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.916 0.389 . . . . 1.0 110.923 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.402 ' O ' ' NE ' ' A' ' 130' ' ' ARG . 51.6 tt0 -55.29 -30.08 59.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 m -86.15 -51.79 6.08 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.965 0.412 . . . . 1.0 111.937 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.85 -43.33 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.199 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.33 -57.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.739 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 126' ' ' GLN . 18.1 ptp180 -69.2 -33.93 74.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.478 0.548 . . . . 1.0 112.478 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.17 -46.28 86.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.011 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.73 -65.38 1.15 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.78 0.324 . . . . 1.0 111.86 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 p -60.68 172.68 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.706 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -157.69 23.49 0.28 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.2 tp -158.69 138.03 11.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.85 155.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.08 102.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 81.9 p -89.71 113.24 24.72 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.42 0.629 . . . . 1.0 109.667 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.401 ' O ' ' N ' ' A' ' 141' ' ' GLY . 59.7 t-80 -69.69 136.44 51.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.24 -63.87 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.394 0.887 . . . . 1.0 113.394 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 139' ' ' HIS . . . -167.94 -80.44 0.04 OUTLIER Glycine 0 C--N 1.345 1.05 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.0 p 56.55 166.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.741 0.781 . . . . 1.0 110.76 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.35 -15.51 80.85 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 114.542 -1.208 . . . . 1.0 110.966 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 91.5 p -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.053 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.557 HG12 HD21 ' A' ' 155' ' ' LEU . 96.6 mt -59.01 -27.09 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.606 -0.438 . . . . 1.0 112.033 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 209' ' ' SER . 51.1 tp -57.02 -48.0 79.55 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.27 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -68.87 -51.99 34.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.631 . . . . 1.0 110.364 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.548 ' HB2' HD22 ' A' ' 155' ' ' LEU . 16.2 m -51.18 -25.22 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.766 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -77.01 -46.41 23.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.857 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -67.54 -32.83 73.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.54 -0.755 . . . . 1.0 111.24 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.75 -9.67 58.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 61.9 t30 54.88 35.27 23.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -109.46 151.28 42.07 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-O 119.294 -0.384 . . . . 1.0 110.393 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -43.13 143.59 1.96 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.007 1.804 . . . . 1.0 112.017 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 156' ' ' ILE . 52.3 tp -152.88 134.71 14.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.77 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -125.69 129.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.942 0.777 . . . . 1.0 109.013 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.17 130.53 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 117.986 0.357 . . . . 1.0 110.069 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 71.0 m -83.35 103.4 12.69 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.164 0.507 . . . . 1.0 109.663 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.36 143.41 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -147.62 175.32 10.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.936 0.398 . . . . 1.0 110.028 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -61.69 171.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.624 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.6 p -62.3 96.46 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.179 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 tp -66.38 -164.85 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.144 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.8 ttp -62.34 -52.47 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.835 0.35 . . . . 1.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 167' ' ' HIS . 75.9 m-20 -71.05 -42.7 69.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.115 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.71 0.86 0.16 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.287 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.475 ' H ' ' C ' ' A' ' 165' ' ' ASP . 34.6 m170 -73.55 -35.91 65.56 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.93 0.395 . . . . 1.0 110.459 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -65.29 -50.88 64.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.642 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.3 -33.32 74.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.441 . . . . 1.0 110.207 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.04 -52.43 65.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.707 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.85 -36.01 67.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.568 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.102 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 176' ' ' VAL . 27.6 t70 -49.32 -28.58 5.02 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.25 0.548 . . . . 1.0 110.423 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -85.43 -45.74 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.014 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.01 -20.51 60.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.258 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 177' ' ' GLU . 14.3 p -62.17 -52.08 64.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.976 0 C-N-CA 121.02 -0.272 . . . . 1.0 110.532 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 176' ' ' VAL . 57.7 mt-10 -58.79 -19.6 42.4 Favored 'General case' 0 CA--C 1.522 -0.11 0 O-C-N 121.931 -0.481 . . . . 1.0 111.048 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.77 3.2 0.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.676 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 177' ' ' GLU . . . 144.64 10.37 0.33 Allowed Glycine 0 N--CA 1.474 1.201 0 N-CA-C 111.089 -0.805 . . . . 1.0 111.089 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 176' ' ' VAL . 27.5 t80 72.23 100.38 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 1.0 109.237 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 181' ' ' VAL . 11.8 p -92.79 58.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.594 0.235 . . . . 1.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 181' ' ' VAL . 4.3 m-90 33.03 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.044 0.449 . . . . 1.0 110.303 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 93.8 p -88.08 132.75 34.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.95 142.55 46.8 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -111.31 155.86 42.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 119.158 -0.448 . . . . 1.0 110.755 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.32 37.73 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.785 1.656 . . . . 1.0 113.214 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p -131.32 143.09 50.25 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 188' ' ' GLU . 24.8 mp0 -64.53 -46.33 83.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.474 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.0 m -64.4 -28.57 69.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.581 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.53 -31.89 17.53 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.45 -47.34 79.45 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 111.778 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.0 pt -52.66 -34.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.022 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.96 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.3 98.39 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 49.8 mt -64.66 -35.42 80.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.932 0.396 . . . . 1.0 110.359 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -69.89 -37.36 75.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.421 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -70.28 -44.95 67.32 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.062 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -66.58 -30.09 70.31 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.002 0.371 . . . . 1.0 112.002 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -86.16 11.67 11.39 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.176 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.2 p -146.37 -64.3 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.519 -0.31 . . . . 1.0 110.242 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.6 mt-10 -71.63 129.21 38.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.748 0.308 . . . . 1.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.07 170.84 8.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.83 138.49 54.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -57.49 143.25 75.22 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.11 100.35 1.37 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.719 1.613 . . . . 1.0 111.964 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -142.02 82.87 13.08 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.85 112.64 1.16 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.914 1.742 . . . . 1.0 111.873 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.34 -73.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.515 -0.474 . . . . 1.0 110.073 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.52 ' H ' HD13 ' A' ' 146' ' ' LEU . 47.1 m 51.96 97.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.015 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -163.51 -36.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.619 0.247 . . . . 1.0 111.107 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.471 ' N ' ' ND1' ' A' ' 210' ' ' HIS . 1.5 p-10 -173.46 61.76 0.26 Allowed Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.67 -89.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 121.647 1.565 . . . . 1.0 111.688 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 93.4 p -76.25 -1.24 25.53 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.116 0.484 . . . . 1.0 110.495 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -64.47 -32.6 74.3 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.591 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.458 ' CG ' ' H ' ' A' ' 216' ' ' ARG . 7.0 pt-20 -62.33 -58.51 7.42 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.646 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.458 ' H ' ' CG ' ' A' ' 215' ' ' GLU . 17.2 ptm180 -63.52 -34.89 78.77 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.068 0.461 . . . . 1.0 110.245 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 59.9 tp -51.21 -47.1 62.38 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.5 mt -59.3 -38.66 80.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.146 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.76 -51.51 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.14 -30.34 70.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.556 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 28.2 m -60.65 -49.6 76.87 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.767 0.318 . . . . 1.0 110.6 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 39.8 pt -78.9 149.85 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.249 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -66.1 134.09 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.926 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 118.153 -0.927 . . . . 1.0 110.425 179.736 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.573 -1.411 . . . . 1.0 109.573 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.492 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.6 mp -64.1 -43.33 97.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.86 0.362 . . . . 1.0 110.318 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.9 mt -61.4 -43.51 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.191 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -142.32 143.19 32.67 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.938 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -167.58 -61.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' O ' HG21 ' A' ' 63' ' ' VAL . 68.1 mttm -128.42 142.23 51.17 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.076 0.465 . . . . 1.0 110.167 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.28 167.4 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.85 120.19 19.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -118.73 133.56 55.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.403 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.7 140.29 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 t -143.96 141.24 30.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.034 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.8 m -83.19 143.51 30.43 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' N ' ' NE2' ' A' ' 139' ' ' HIS . . . -71.01 62.12 0.97 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.36 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.791 0.348 . . . . 1.0 110.775 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.4 p 53.18 100.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -59.68 125.36 79.76 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.035 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.71 -54.68 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.021 1.147 . . . . 1.0 111.927 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.417 ' CE2' ' OD1' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -142.76 144.54 30.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.92 -7.71 15.48 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.968 1.778 . . . . 1.0 111.545 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -66.99 -46.09 75.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.781 0.324 . . . . 1.0 111.083 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.67 -40.98 98.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.78 0.324 . . . . 1.0 110.617 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.23 -44.63 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.6 t -54.82 -48.2 73.11 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.166 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.3 m -51.65 -49.8 61.58 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.272 -0.267 . . . . 1.0 111.369 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 30.0 m -78.94 5.79 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.672 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.04 30.96 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 46' ' ' SER . 14.3 t -119.23 -164.12 1.03 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.548 ' N ' ' OG ' ' A' ' 50' ' ' SER . 76.1 m-20 -50.83 -42.42 58.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.922 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -62.76 -53.82 48.5 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 121.171 0.51 . . . . 1.0 110.218 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CE2' HD13 ' A' ' 57' ' ' LEU . 54.6 t80 -61.99 -45.43 93.66 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.244 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 89.4 m -51.94 -49.62 62.77 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.32 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 78.0 mt-30 -73.14 -52.3 14.72 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.077 0.465 . . . . 1.0 110.593 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -57.02 -24.94 57.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.694 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 ' CE2' ' A' ' 53' ' ' PHE . 48.8 tp -61.15 -45.32 95.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 1.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.7 mp -62.42 -43.39 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.747 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.418 ' OE1' ' N ' ' A' ' 59' ' ' GLN . 1.1 mp0 -55.56 -16.83 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.469 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.71 ' CD1' HD12 ' A' ' 195' ' ' LEU . 74.3 t80 -98.5 -19.06 17.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 102.65 40.52 2.52 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 118.111 -1.383 . . . . 1.0 111.676 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 61' ' ' GLY . 13.3 p90 -13.22 146.57 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 124.33 1.052 . . . . 1.0 112.143 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 29' ' ' LYS . 84.8 t -146.86 -78.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.777 0.717 . . . . 1.0 109.583 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -151.82 110.68 3.84 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.4 tp -92.25 127.6 37.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.03 146.31 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.6 tt -138.75 141.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.473 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 9.8 tp-100 -70.18 -86.38 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.528 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 t80 50.89 -174.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.249 0.219 . . . . 1.0 110.491 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.56 76.03 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -67.18 175.99 2.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.894 0.378 . . . . 1.0 110.039 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -61.61 -29.86 70.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.392 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -60.09 -21.58 61.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.255 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m 53.3 -95.8 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.055 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 t 56.83 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.159 0.504 . . . . 1.0 111.166 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -79.4 132.45 36.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.116 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD2' ' CZ ' ' A' ' 98' ' ' PHE . 54.5 t80 -78.07 12.51 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.211 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 80' ' ' LEU . 78.8 tt0 62.58 137.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.74 0.65 . . . . 1.0 109.745 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -67.83 66.1 0.09 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.928 0.394 . . . . 1.0 110.05 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.14 -57.53 3.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.323 0.582 . . . . 1.0 111.618 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 107' ' ' TYR . 28.7 m -57.43 -43.3 82.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.538 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.479 ' N ' HG23 ' A' ' 81' ' ' VAL . 58.0 tt0 -63.31 -39.83 95.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.298 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -52.45 -46.03 66.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.998 0.428 . . . . 1.0 110.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' NH2' ' OG ' ' A' ' 50' ' ' SER . 30.3 mmt180 -71.66 -16.44 62.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.06 59.65 1.94 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.61 -168.02 39.61 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 110.087 -1.205 . . . . 1.0 110.087 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -133.35 127.72 34.11 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 113.1 24.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.728 0.299 . . . . 1.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -84.2 -76.51 0.3 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.095 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.3 m -70.74 140.97 51.52 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.405 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -170.6 132.26 0.94 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -138.82 -91.85 0.19 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.403 0.281 . . . . 1.0 110.375 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.93 156.45 25.66 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-O 118.796 -0.621 . . . . 1.0 109.502 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -35.26 159.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.645 2.23 . . . . 1.0 113.785 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 tt -58.14 -24.49 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.678 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -51.53 179.85 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.7 -0.227 . . . . 1.0 110.45 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 80.02 -40.85 0.21 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.905 -0.406 . . . . 1.0 109.905 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.47 ' CZ ' ' CD2' ' A' ' 77' ' ' PHE . 61.6 t80 -126.44 -18.61 4.83 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.483 0.313 . . . . 1.0 110.991 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.23 3.16 60.58 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.221 -0.751 . . . . 1.0 111.221 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.71 -10.14 0.21 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 110.009 -0.367 . . . . 1.0 110.009 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.45 -130.91 1.53 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.651 -0.979 . . . . 1.0 110.651 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' O ' ' NE ' ' A' ' 105' ' ' ARG . 22.1 p-10 -164.02 -175.57 4.1 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -38.24 -33.82 0.11 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.543 0.527 . . . . 1.0 111.233 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.85 93.76 4.58 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 98' ' ' PHE . 7.2 ptp85 -141.35 154.15 45.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.682 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -156.18 131.62 9.48 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.349 -0.611 . . . . 1.0 109.349 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.508 ' CD2' HG21 ' A' ' 81' ' ' VAL . 9.9 m-85 -132.1 143.77 50.24 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.465 -0.569 . . . . 1.0 109.465 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 112' ' ' GLY . 9.1 p -127.88 140.57 48.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 111' ' ' ASN . 10.9 mp -101.61 147.96 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.2 mtp 46.66 -89.74 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.442 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 109' ' ' LEU . 16.9 m120 -155.86 81.5 1.01 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.804 0.335 . . . . 1.0 110.476 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.472 ' H ' ' CG2' ' A' ' 108' ' ' VAL . . . 74.74 23.3 75.39 Favored Glycine 0 N--CA 1.469 0.853 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -73.14 -75.05 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.571 -0.37 . . . . 1.0 110.671 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.92 126.96 53.63 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.476 0.485 . . . . 1.0 109.947 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -105.64 101.25 10.78 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.473 -0.195 . . . . 1.0 110.473 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.05 109.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -117.53 139.6 15.03 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 109.914 -1.275 . . . . 1.0 109.914 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -170.11 140.82 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -160.52 155.97 25.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.013 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 123' ' ' THR . 82.7 t80 -161.16 98.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.289 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 64.35 -67.52 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.525 0.516 . . . . 1.0 110.819 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 121' ' ' PHE . 30.3 m -154.78 121.65 5.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -148.6 5.48 0.7 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 125' ' ' MET . 3.9 mpp? -59.22 -57.25 13.86 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.17 -29.01 65.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.951 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.3 m -70.85 -43.4 68.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.435 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.8 -50.05 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 1.0 112.367 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 133' ' ' SER . 1.2 pp -63.78 -54.02 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.926 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -47.03 -37.36 9.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.072 -0.393 . . . . 1.0 111.068 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.94 -48.22 78.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.12 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -100.22 -64.25 1.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.811 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 129' ' ' ILE . 34.2 p 57.09 74.26 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -134.8 -44.87 0.73 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.956 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.9 tp -169.13 151.03 4.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.68 146.51 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.18 105.73 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 138.13 40.34 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.452 ' NE2' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -60.11 -169.65 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.042 0.449 . . . . 1.0 110.176 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.17 45.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.431 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.38 -128.11 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.7 m -163.44 -50.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.576 -0.367 . . . . 1.0 110.771 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.73 -52.51 5.86 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 92.1 p -55.15 -42.69 73.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.743 0.306 . . . . 1.0 110.88 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.74 -49.69 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.6 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.59 -31.24 6.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.001 0.188 . . . . 1.0 111.403 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.27 -50.79 29.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.999 0.428 . . . . 1.0 110.287 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.888 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.36 -46.64 31.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.764 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.98 -37.39 86.94 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.876 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.07 -11.61 59.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.61 36.51 26.83 Favored 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 123.473 0.483 . . . . 1.0 110.049 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -122.95 147.16 50.55 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.925 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -45.19 165.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.205 1.936 . . . . 1.0 112.47 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 59.9 tp -152.03 140.73 20.86 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.039 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.09 123.83 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -116.0 133.3 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 117.801 0.273 . . . . 1.0 111.169 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 77.4 m -72.66 105.13 4.15 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.28 141.52 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.874 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.56 -157.16 0.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.064 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 t70 58.34 21.29 8.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.451 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.5 m -85.75 90.15 7.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.687 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 163' ' ' LEU . 10.0 mp -63.55 -41.19 98.44 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.897 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' ASN . 43.3 ttp -130.1 -53.05 1.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.506 0.322 . . . . 1.0 110.755 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.417 ' OD1' ' CE2' ' A' ' 41' ' ' PHE . 4.0 p-10 -66.72 69.61 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.138 0.494 . . . . 1.0 110.635 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 164' ' ' MET . 76.7 m-20 -65.45 -25.82 67.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.383 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -51.18 -32.3 22.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.839 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -60.7 -47.79 84.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.529 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -69.1 -30.14 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.487 0.184 . . . . 1.0 111.013 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.14 -54.16 45.08 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.02 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 175' ' ' PHE . 17.0 tt -68.61 -34.85 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.25 -65.04 0.63 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.294 0.569 . . . . 1.0 110.623 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.02 -34.26 28.71 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.065 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.04 -31.44 56.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.407 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' ILE . 3.5 t80 -63.19 -47.13 83.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.849 0.357 . . . . 1.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.53 -44.64 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -54.75 -46.85 74.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.113 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 178' ' ' LEU . 10.5 mp -98.33 9.47 42.99 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.071 0.462 . . . . 1.0 110.365 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 173.66 91.11 0.08 OUTLIER Glycine 0 C--O 1.212 -1.239 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -49.51 70.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.086 0.954 . . . . 1.0 111.174 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.6 p -73.8 141.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.889 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -59.25 114.04 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.263 0.554 . . . . 1.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.5 t -87.0 135.96 33.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.443 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.62 170.79 17.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.23 74.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.622 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.62 57.49 1.42 Allowed 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.558 2.172 . . . . 1.0 112.882 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.9 p -131.65 147.05 52.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -59.48 -51.91 67.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.616 0.245 . . . . 1.0 111.19 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 26.1 m -65.27 -24.86 67.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.925 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.04 -36.02 8.61 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 116.183 -0.462 . . . . 1.0 112.087 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -40.97 85.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 117.235 0.518 . . . . 1.0 111.556 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.0 pt -55.58 -34.66 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 1.0 110.833 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.7 78.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.189 0.518 . . . . 1.0 109.775 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.78 -46.16 94.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.236 -0.746 . . . . 1.0 111.236 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.71 HD12 ' CD1' ' A' ' 60' ' ' TYR . 4.4 mm? -61.92 -44.13 97.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.912 0.356 . . . . 1.0 110.312 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -63.32 -52.14 63.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.623 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.56 71.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.177 -0.305 . . . . 1.0 110.177 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 97.1 p -60.48 -34.05 73.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.965 -0.294 . . . . 1.0 111.304 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -102.64 32.8 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 1.0 111.135 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 19.6 m -159.84 -29.17 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.159 -0.338 . . . . 1.0 110.607 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -108.75 152.13 25.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -122.21 170.82 9.51 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.6 tp -119.73 136.24 54.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -62.61 152.25 81.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.196 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -37.9 109.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.826 2.35 . . . . 1.0 112.554 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 206' ' ' PHE . 0.1 OUTLIER -61.53 151.75 76.62 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.332 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.03 -8.01 18.59 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.961 1.774 . . . . 1.0 111.705 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.7 p -49.96 132.57 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.608 0.242 . . . . 1.0 111.06 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.9 t -78.54 -74.73 0.26 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.449 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 211' ' ' ASN . 6.6 t-80 -163.87 -150.87 0.16 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.606 ' H ' ' CG ' ' A' ' 210' ' ' HIS . 0.6 OUTLIER 34.62 63.46 1.92 Allowed Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 123.111 0.564 . . . . 1.0 111.072 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.79 -79.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.489 2.126 . . . . 1.0 112.032 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.4 m -60.0 -15.63 24.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.546 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.0 -51.99 65.8 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -51.24 -35.25 36.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.759 0.314 . . . . 1.0 110.689 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -59.81 -43.18 94.61 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 120.933 0.397 . . . . 1.0 110.191 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.1 tt -50.14 -37.32 33.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.875 0.369 . . . . 1.0 111.275 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 48.2 mt -60.88 -30.22 70.02 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.473 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.86 -47.42 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.49 -31.46 72.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.458 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 223' ' ' TYR . 19.9 m -60.75 -43.24 98.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.613 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.9 mt 58.77 -83.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.95 -0.568 . . . . 1.0 109.735 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 221' ' ' THR . 74.8 t80 -67.09 102.69 1.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.284 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.959 -1.02 . . . . 1.0 110.513 179.701 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 mt -63.59 -47.64 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.5 mt -131.86 -23.01 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' ' 115' ' ' LYS . 67.8 mt-10 -66.82 88.68 0.15 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.613 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -92.39 -73.4 0.55 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.3 110.87 7.03 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.4 125.11 52.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.844 0.458 . . . . 1.0 109.991 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 31' ' ' LEU . 9.2 mp -91.73 107.19 19.04 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.188 0.518 . . . . 1.0 109.63 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -85.07 125.81 33.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.081 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.91 130.09 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -145.52 136.68 24.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.74 -26.6 31.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.451 . . . . 1.0 109.835 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.25 -112.09 3.93 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.95 -156.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.571 0.224 . . . . 1.0 110.627 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 t -53.6 170.53 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.7 t -139.67 82.75 17.65 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.62 16.37 1.97 Allowed 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.481 2.121 . . . . 1.0 111.702 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.08 65.0 28.28 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.98 -17.55 41.09 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.028 1.818 . . . . 1.0 111.941 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -79.99 -30.85 39.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.499 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.47 -44.92 56.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.797 0.332 . . . . 1.0 110.645 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 -29.41 46.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.029 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.5 p -51.31 -38.47 53.15 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.118 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -47.33 -28.34 1.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 1.0 110.605 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -92.23 -23.91 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.839 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 46' ' ' SER . 0.7 OUTLIER -120.67 24.79 10.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.968 0.507 . . . . 1.0 110.194 -177.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 46' ' ' SER . 40.3 t -104.72 -161.76 0.84 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.459 ' N ' ' OG ' ' A' ' 50' ' ' SER . 63.0 m-20 -71.27 -28.52 64.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.28 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.59 -51.51 69.51 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.855 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.7 t80 -70.14 -39.15 75.56 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.185 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.7 t -52.67 -46.2 67.12 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.678 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -71.66 -44.14 64.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.113 0.482 . . . . 1.0 110.586 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -68.41 -26.45 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' PHE . 56.1 tp -57.19 -44.64 83.78 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.7 mp -55.11 -33.63 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -34.56 75.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.43 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -72.31 -18.89 61.75 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.71 34.38 2.85 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 37.33 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.862 0.465 . . . . 1.0 111.462 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -115.86 -95.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 122.618 0.367 . . . . 1.0 110.36 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.463 ' H ' HG23 ' A' ' 63' ' ' VAL . 42.5 ttm180 -168.42 149.87 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -130.29 118.07 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 66' ' ' ILE . 5.2 mp -108.98 132.01 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 tp -114.56 141.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -166.51 -166.98 0.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.03 164.49 32.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.38 -35.35 90.86 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.53 147.65 51.61 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.993 0.425 . . . . 1.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -62.96 -35.18 79.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.274 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -60.95 -49.18 78.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 96.5 p -77.27 102.05 6.53 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.186 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.4 p -169.98 88.91 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.992 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.28 -87.11 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 47.24 94.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.819 0.343 . . . . 1.0 110.145 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.87 -70.83 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.161 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.66 66.0 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.837 0.351 . . . . 1.0 110.318 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 80' ' ' LEU . 9.6 mp -63.34 -41.39 98.87 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.829 0.347 . . . . 1.0 110.339 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 82' ' ' GLN . 20.0 m -60.23 -45.86 95.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.863 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.475 ' N ' HG23 ' A' ' 81' ' ' VAL . 2.6 tm0? -66.53 -46.89 74.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.794 0.33 . . . . 1.0 110.84 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -55.52 -45.66 77.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.932 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.427 ' HA ' ' HE ' ' A' ' 84' ' ' ARG . 0.4 OUTLIER -74.16 -17.16 60.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.475 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.96 50.32 3.96 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.12 177.49 54.3 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 109.487 -1.445 . . . . 1.0 109.487 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -124.44 121.98 36.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -63.45 159.81 17.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.881 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -131.27 -178.8 5.0 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t -58.89 141.89 52.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.563 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -151.91 143.11 23.27 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -80.5 -73.8 0.35 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.629 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 94' ' ' PRO . 1.7 pp -59.67 151.56 61.64 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.95 -0.548 . . . . 1.0 110.221 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.464 ' O ' HD12 ' A' ' 93' ' ' ILE . 91.3 Cg_exo -42.26 174.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.42 2.08 . . . . 1.0 113.311 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.6 tp -64.53 -39.71 86.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.28 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 98' ' ' PHE . 88.5 m-20 48.94 55.38 9.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 50.52 -90.09 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.128 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.53 ' CE2' ' NE ' ' A' ' 105' ' ' ARG . 59.4 t80 -127.38 28.93 5.62 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.322 0.649 . . . . 1.0 110.133 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 22.3 74.63 Favored Glycine 0 N--CA 1.469 0.839 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 28.2 p -61.13 133.54 56.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.636 0.255 . . . . 1.0 110.463 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.07 -4.25 11.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -153.65 87.55 1.24 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.87 0.367 . . . . 1.0 110.058 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.8 p -61.04 103.4 0.27 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.333 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -171.02 67.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.016 0.436 . . . . 1.0 110.196 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.53 ' NE ' ' CE2' ' A' ' 98' ' ' PHE . 27.9 ptt-85 -131.36 161.72 31.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.821 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -155.95 119.61 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.75 159.84 40.06 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.52 143.61 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.8 mm? -95.88 137.42 34.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.9 mmm 47.12 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.014 0.821 . . . . 1.0 111.272 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 109' ' ' LEU . 19.8 p-10 -156.83 70.46 0.64 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.973 0.416 . . . . 1.0 110.551 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.2 27.13 64.63 Favored Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.576 -0.61 . . . . 1.0 111.576 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -91.9 -7.14 50.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.826 0.313 . . . . 1.0 110.728 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.65 131.55 0.89 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 99.3 mttt -98.73 141.66 31.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.83 112.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.87 130.82 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.139 0.576 . . . . 1.0 109.82 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -22.97 68.87 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -117.71 169.52 9.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.875 0.47 . . . . 1.0 110.438 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -168.6 173.71 7.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.112 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 122' ' ' SER . 88.2 t80 -65.62 166.98 9.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.43 . . . . 1.0 109.843 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.478 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 40.7 t 53.15 96.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.807 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 124' ' ' LYS . 89.9 m -58.71 164.86 2.52 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.509 ' N ' HG22 ' A' ' 123' ' ' THR . 14.5 tptm 68.86 108.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.431 0.457 . . . . 1.0 110.263 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 126' ' ' GLN . 0.0 OUTLIER -49.77 -36.74 27.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.122 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.471 ' N ' ' SD ' ' A' ' 125' ' ' MET . 57.8 tt0 -57.3 -32.37 66.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.2 m -78.72 -34.84 45.59 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.835 0.35 . . . . 1.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.379 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -58.29 -48.97 83.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -59.45 -44.9 92.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.59 -0.277 . . . . 1.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -53.26 -42.9 66.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.504 -0.317 . . . . 1.0 111.411 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -98.43 -68.45 0.8 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p 71.52 33.37 1.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.03 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.74 -66.4 0.91 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.198 -0.668 . . . . 1.0 109.198 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 44.3 tp -165.95 142.84 5.3 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.818 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.38 147.24 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.01 125.51 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.145 -1.058 . . . . 1.0 108.145 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.7 p -137.57 134.58 35.78 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.7 -34.53 58.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.65 34.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.669 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 143' ' ' GLY . . . -61.67 -37.01 93.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.412 ' OG1' ' NH1' ' A' ' 216' ' ' ARG . 3.5 m 65.19 -65.49 0.16 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.099 0.476 . . . . 1.0 111.021 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' GLY . . . -66.52 -32.68 82.38 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 44.8 m -73.92 -33.89 64.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.769 0.319 . . . . 1.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.4 -28.74 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 120.974 0.416 . . . . 1.0 110.769 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -47.91 -51.11 24.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.618 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -63.18 -44.47 95.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.314 0.578 . . . . 1.0 110.859 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.0 m -59.88 -24.62 64.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.479 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.36 -48.4 23.21 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.3 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -75.08 -22.47 58.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.832 -0.622 . . . . 1.0 111.35 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.87 -6.75 50.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 51.41 31.07 6.8 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.171 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 78.9 mttt -108.8 155.86 39.95 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 123.326 0.391 . . . . 1.0 110.026 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -42.66 139.27 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.683 1.589 . . . . 1.0 111.91 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.757 ' C ' HD13 ' A' ' 156' ' ' ILE . 3.0 tm? -153.82 122.91 6.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.757 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -117.52 120.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.71 0.631 . . . . 1.0 109.731 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.08 115.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 94.7 m -72.33 102.5 3.15 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.29 137.07 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -130.48 171.98 12.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 29.0 p-10 -97.02 14.55 25.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.512 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 t -156.67 -136.49 0.05 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.563 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt 64.88 114.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 tpt 67.82 173.19 0.27 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.317 -0.402 . . . . 1.0 109.927 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.61 -65.6 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -154.22 9.41 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.814 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -62.97 -33.43 75.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.009 -0.367 . . . . 1.0 110.009 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.32 -38.52 77.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 1.0 110.412 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -78.45 -32.52 48.48 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.633 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.07 -50.2 67.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.707 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.88 -38.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.34 -56.33 4.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.196 0.998 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -49.84 -52.36 33.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.882 -1.053 . . . . 1.0 110.922 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.63 -30.88 70.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 1.0 110.478 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 181' ' ' VAL . 2.8 m-85 -74.89 -55.21 6.03 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.783 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.22 -25.89 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.692 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -48.55 -52.03 24.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.485 -0.932 . . . . 1.0 108.485 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.24 -29.96 70.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.701 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 129.75 81.53 0.27 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 112.106 -0.398 . . . . 1.0 112.106 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 36.6 46.88 0.48 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.62 0.724 . . . . 1.0 111.505 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.688 HG13 ' H ' ' A' ' 182' ' ' TRP . 2.5 p -48.12 -61.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.671 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TRP . . . . . 0.688 ' H ' HG13 ' A' ' 181' ' ' VAL . 10.4 m0 -156.73 62.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.991 0.807 . . . . 1.0 110.377 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -111.93 130.43 55.85 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.363 -0.835 . . . . 1.0 108.99 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 49.2 t -164.26 127.44 2.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.071 -0.715 . . . . 1.0 109.071 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 153.14 70.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 110.686 -0.116 . . . . 1.0 110.686 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 84.26 0.45 Allowed 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.077 1.851 . . . . 1.0 112.588 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.9 m -132.19 148.82 52.48 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -48.19 -54.83 12.09 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.185 -0.206 . . . . 1.0 111.37 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.6 m -73.25 -44.98 58.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.986 0.422 . . . . 1.0 111.049 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -55.9 -44.81 87.47 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.029 -0.532 . . . . 1.0 112.427 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -40.98 71.36 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.93 0.365 . . . . 1.0 110.172 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.99 -45.44 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.29 66.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.017 0.437 . . . . 1.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -54.56 -40.19 69.06 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -47.94 71.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.454 0.645 . . . . 1.0 109.928 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -59.99 -45.65 92.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.859 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.13 -52.0 66.71 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.035 0.445 . . . . 1.0 110.946 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 155' ' ' LEU . 39.9 p -65.09 -21.52 66.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.02 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -110.18 31.3 6.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.727 0.411 . . . . 1.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 56.3 m -145.88 -27.05 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.37 151.36 35.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.29 142.99 50.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.918 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.18 -161.24 0.79 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.938 -0.574 . . . . 1.0 109.569 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -73.2 144.91 85.17 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.886 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.84 -47.19 27.7 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.527 1.485 . . . . 1.0 113.374 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -139.73 86.4 13.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.241 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.4 -64.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.039 1.826 . . . . 1.0 111.721 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.17 145.59 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m -80.06 27.08 0.32 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.075 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 210' ' ' HIS . 14.0 t-80 53.89 57.14 6.28 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.806 0.336 . . . . 1.0 111.485 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.526 ' H ' ' CD ' ' A' ' 212' ' ' PRO . 19.6 m120 -106.59 -37.41 0.17 Allowed Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.968 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.526 ' CD ' ' H ' ' A' ' 211' ' ' ASN . 51.4 Cg_exo -56.75 -49.83 13.47 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 121.818 1.679 . . . . 1.0 113.162 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 50.2 m -65.34 -47.79 75.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.994 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.74 -51.45 64.9 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 120.772 0.32 . . . . 1.0 110.357 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -48.52 -43.25 35.11 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.86 0.362 . . . . 1.0 110.844 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.412 ' NH1' ' OG1' ' A' ' 142' ' ' THR . 41.8 mmm-85 -64.96 -39.27 93.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.855 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.6 tp -53.68 -41.71 67.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.941 0.401 . . . . 1.0 110.293 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.02 -28.77 68.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.505 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.4 t -75.34 -49.4 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.845 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -67.51 -12.49 60.46 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.198 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 26.0 m -63.22 -41.01 99.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.359 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 45.0 pt 38.71 32.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.071 0.548 . . . . 1.0 111.449 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -159.71 159.22 32.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.248 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.7 t . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.022 -0.99 . . . . 1.0 111.565 179.695 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 109.099 -1.6 . . . . 1.0 109.099 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 tp -65.12 140.77 19.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.952 0.406 . . . . 1.0 110.002 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.65 49.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.667 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -65.4 115.07 5.28 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -133.51 -117.39 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -76.53 94.8 3.77 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.707 0.289 . . . . 1.0 110.913 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.33 166.26 12.17 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.2 mt -132.26 101.0 5.19 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.626 ' CZ ' HD13 ' A' ' 66' ' ' ILE . 6.1 m-85 -95.0 127.12 40.81 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.023 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 137' ' ' ILE . 5.5 p -127.21 125.68 66.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.7 p -143.52 137.38 28.43 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.254 -0.884 . . . . 1.0 109.46 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.8 m -103.45 140.32 37.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.0 -89.48 0.03 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.263 -0.735 . . . . 1.0 111.263 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.56 -78.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.867 0.365 . . . . 1.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -167.12 160.51 13.96 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.297 -0.41 . . . . 1.0 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.16 144.49 87.35 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.744 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.78 -46.6 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.966 1.777 . . . . 1.0 111.054 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -139.32 160.72 60.85 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 123.069 0.23 . . . . 1.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.17 -10.62 29.49 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 122.089 1.859 . . . . 1.0 112.011 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -73.96 -29.56 62.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.876 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 44' ' ' LEU . 4.2 mm? -63.15 -53.84 47.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.072 -0.251 . . . . 1.0 110.897 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 46' ' ' SER . 18.2 m -69.92 -42.67 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.711 0.291 . . . . 1.0 110.581 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.2 t -51.95 -53.19 44.23 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.102 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 53' ' ' PHE . 90.9 m -47.21 -36.14 8.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.771 -0.195 . . . . 1.0 111.294 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.9 t -72.8 -26.18 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 120.775 0.321 . . . . 1.0 111.439 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.24 33.28 3.09 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.365 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.2 t -98.35 -173.71 2.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' N ' ' OG ' ' A' ' 50' ' ' SER . 11.5 m-20 -56.38 -27.64 56.83 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.374 -1.284 . . . . 1.0 110.904 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -71.81 -53.56 12.94 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.669 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 47' ' ' CYS . 3.3 m-85 -68.55 -37.67 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.146 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 93.7 m -53.2 -45.9 68.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.639 0.256 . . . . 1.0 111.039 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.92 -40.96 71.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -67.99 -27.79 66.87 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -60.22 -39.41 86.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.358 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mm -48.89 -41.12 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.564 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -65.97 -40.94 91.72 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.303 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -65.43 -23.28 66.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.027 -0.36 . . . . 1.0 110.027 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' C ' ' CG ' ' A' ' 62' ' ' PHE . . . 93.49 20.3 32.56 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.784 -0.526 . . . . 1.0 111.784 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HA ' HD12 ' A' ' 57' ' ' LEU . 1.4 p90 43.02 78.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 117.801 0.801 . . . . 1.0 111.024 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.7 -85.76 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -168.81 135.05 1.78 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 66' ' ' ILE . 3.6 tt -133.25 131.39 40.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.626 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 1.7 mp -116.47 127.33 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.579 HD13 ' N ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -108.48 132.35 56.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.579 ' N ' HD13 ' A' ' 67' ' ' ILE . 57.2 tt0 -146.65 153.99 40.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.22 -151.33 0.39 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.012 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.94 -114.94 0.01 OUTLIER Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 72' ' ' ASN . 35.6 ttt180 -165.58 -149.96 0.12 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.231 -0.57 . . . . 1.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 71' ' ' ARG . 15.9 p30 -66.14 -25.9 67.19 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -59.51 -41.63 90.34 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.136 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.7 t -140.7 132.45 27.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.195 -0.457 . . . . 1.0 109.99 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 m -157.99 163.12 38.1 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.31 23.67 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.845 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -67.53 85.18 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 80' ' ' LEU . 70.8 mm-40 -61.91 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.657 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -73.89 33.6 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.741 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 78' ' ' GLU . 1.9 pp -62.46 -32.47 73.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 1.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.2 t -62.81 -51.55 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.859 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -72.85 -32.51 65.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.279 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -50.96 -43.98 60.5 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.22 -0.445 . . . . 1.0 109.819 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.437 ' NE ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -79.37 -16.23 56.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.051 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.84 28.87 5.76 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.97 158.17 53.47 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -134.63 128.93 34.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.841 0.353 . . . . 1.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -52.82 159.93 1.03 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.99 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.43 152.07 37.47 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m 57.55 -130.95 1.48 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.145 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -61.79 115.86 4.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -89.06 99.37 12.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -155.34 98.41 2.34 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 110.162 -0.311 . . . . 1.0 110.162 178.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.74 116.02 1.57 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.607 1.538 . . . . 1.0 110.173 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.3 pt -92.89 -18.13 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.347 0.594 . . . . 1.0 109.933 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 98' ' ' PHE . 65.3 m-20 -156.29 41.05 0.37 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.914 -1.039 . . . . 1.0 111.299 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 63.39 -1.52 0.56 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.533 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -72.98 -22.04 60.75 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.106 -0.331 . . . . 1.0 110.106 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.09 48.06 12.02 Favored Glycine 0 N--CA 1.465 0.597 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 47.2 t -55.69 129.61 39.88 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.736 0.303 . . . . 1.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.21 164.71 36.65 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.701 -0.96 . . . . 1.0 110.701 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 103' ' ' THR . 53.6 t0 54.54 -129.85 2.15 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.801 -0.199 . . . . 1.0 110.497 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.418 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 82.0 p -66.78 -39.05 87.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.699 0.285 . . . . 1.0 110.322 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -170.27 -74.38 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.321 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.426 ' CB ' ' H ' ' A' ' 118' ' ' GLY . 75.4 mmt-85 -123.42 119.19 29.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -160.69 119.44 2.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.275 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.44 161.42 27.12 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.31 135.77 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -95.35 133.88 38.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.439 . . . . 1.0 109.964 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.4 mmm 50.01 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.924 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -148.94 48.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.383 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 27.45 29.14 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 111.955 -0.458 . . . . 1.0 111.955 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.4 -12.27 54.74 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.3 tp -168.0 137.34 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -102.98 140.39 37.31 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.62 142.19 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.078 -1.082 . . . . 1.0 108.078 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' ILE . 18.9 pt -142.53 131.14 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.426 ' H ' ' CB ' ' A' ' 105' ' ' ARG . . . -65.99 -139.72 0.04 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CE2' ' O ' ' A' ' 120' ' ' ASP . 78.5 t80 -57.73 161.31 3.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.921 0.391 . . . . 1.0 110.498 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' CE2' ' A' ' 119' ' ' PHE . 54.3 p-10 -153.64 -177.06 6.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.076 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -65.16 153.97 39.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 123' ' ' THR . 79.5 p -59.3 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.917 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.401 ' N ' ' OG ' ' A' ' 122' ' ' SER . 25.7 m -61.65 106.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -168.01 -54.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.343 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 52.5 mtm -44.99 -45.88 10.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 1.0 111.572 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -59.25 -31.1 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.737 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -80.57 -52.28 7.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.798 0.332 . . . . 1.0 111.813 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 128' ' ' ILE . 1.5 mp -62.69 -43.72 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.876 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -54.06 -53.2 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.23 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -51.1 -30.04 14.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.521 0.201 . . . . 1.0 111.06 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.86 -42.47 58.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.688 -0.233 . . . . 1.0 110.9 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.58 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.1 p90 -123.1 -51.88 1.88 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.58 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 82.8 p 48.65 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.943 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -137.22 -52.39 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.2 tp -167.35 148.14 5.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.6 151.55 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 73.7 mt -117.71 115.63 49.17 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 108.177 -1.046 . . . . 1.0 108.177 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.9 p -85.21 -161.38 0.58 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -159.74 83.97 0.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 52.28 17.61 0.76 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.81 -147.88 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -164.01 -60.6 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 -26.68 73.9 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 123.792 0.683 . . . . 1.0 111.946 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.5 m -70.3 -36.62 74.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.681 0.277 . . . . 1.0 111.313 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.18 -40.61 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.847 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -50.09 -40.84 46.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.798 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -52.11 66.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.512 0.672 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.8 p -70.36 -22.62 62.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.239 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.466 HD11 HD23 ' A' ' 203' ' ' LEU . 17.0 tp -73.23 -53.32 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.157 0.428 . . . . 1.0 112.157 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -67.29 -31.75 72.28 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.583 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 mp -70.04 -1.63 10.42 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 58.53 34.03 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.391 0.432 . . . . 1.0 110.6 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 97.8 mttt -113.2 126.32 28.38 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.44 157.15 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.416 1.41 . . . . 1.0 111.941 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.581 ' C ' HD13 ' A' ' 156' ' ' ILE . 5.4 tt -152.44 144.39 23.73 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.581 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -111.31 116.55 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 157' ' ' VAL . 14.0 p -103.71 117.32 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 57.2 m -74.07 104.35 4.86 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.427 -0.582 . . . . 1.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.01 138.51 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -160.24 -165.51 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.827 0.346 . . . . 1.0 110.174 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -65.34 -168.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.6 m -156.72 81.35 0.95 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.956 0.407 . . . . 1.0 109.927 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -35.36 12.66 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.797 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.1 mmt -82.51 36.15 0.47 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.193 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 167' ' ' HIS . 25.6 t70 54.89 31.23 15.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.663 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.02 74.89 0.08 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.068 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' ASP . 85.2 t60 -57.93 -30.38 65.89 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.995 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -49.72 -40.28 40.11 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.15 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.17 -46.56 86.58 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -45.41 -37.45 5.1 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.09 -42.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.148 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -48.99 -60.58 2.65 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.867 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.74 -25.19 62.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.049 0.452 . . . . 1.0 110.393 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -72.58 -53.69 11.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.472 -0.785 . . . . 1.0 110.446 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 179' ' ' GLY . 58.0 t80 -64.47 -34.91 79.31 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.29 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.6 t -54.86 -56.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.281 0.363 . . . . 1.0 110.189 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.03 -30.63 15.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.149 -0.62 . . . . 1.0 109.939 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.26 21.32 12.77 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.499 -0.773 . . . . 1.0 113.013 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 175' ' ' PHE . . . -151.37 -24.63 0.05 OUTLIER Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 180' ' ' TYR . 73.1 t80 54.42 23.52 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 109.879 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 182' ' ' TRP . 3.2 p -50.18 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.19 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TRP . . . . . 0.56 ' C ' ' O ' ' A' ' 181' ' ' VAL . 7.0 m-90 -9.74 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 124.004 0.815 . . . . 1.0 109.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 88.9 p -86.74 134.83 33.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.829 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -125.02 156.9 37.42 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.24 -0.891 . . . . 1.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.38 154.04 76.73 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.643 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.41 58.34 0.48 Allowed 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.588 2.192 . . . . 1.0 112.358 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 m -135.72 147.16 48.36 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.62 -48.71 28.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.0 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 190' ' ' GLY . 13.3 t -69.68 -44.18 71.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.027 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -51.75 -51.66 37.96 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.245 -0.434 . . . . 1.0 112.134 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.78 -43.63 90.49 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.45 0.147 . . . . 1.0 110.63 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.14 -44.73 80.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.612 0.244 . . . . 1.0 110.46 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -54.1 -56.68 15.81 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.873 0.324 . . . . 1.0 111.873 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -58.53 -30.27 64.97 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -48.07 63.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.983 0.42 . . . . 1.0 110.54 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -64.22 -40.64 96.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.71 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.74 88.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.2 m -71.27 -23.26 61.94 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.967 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -105.0 30.76 5.29 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.899 0.381 . . . . 1.0 110.753 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.1 p -141.7 -21.25 0.73 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.29 153.23 27.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.07 0.462 . . . . 1.0 109.771 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.75 153.92 32.6 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.178 -0.919 . . . . 1.0 109.219 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.466 HD23 HD11 ' A' ' 149' ' ' LEU . 5.2 tp -94.86 136.97 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.8 153.02 8.9 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.711 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.2 106.57 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.391 1.394 . . . . 1.0 111.148 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -140.82 87.16 11.35 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.46 111.58 3.29 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.562 1.508 . . . . 1.0 111.763 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 210' ' ' HIS . 22.0 t -63.24 98.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.057 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t 56.06 5.12 0.15 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.561 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 208' ' ' VAL . 85.4 t60 49.47 93.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.716 0.293 . . . . 1.0 110.632 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 212' ' ' PRO . 7.3 p-10 -144.84 73.69 14.93 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 211' ' ' ASN . 83.1 Cg_exo -49.56 -121.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.433 0 C-N-CA 123.077 2.518 . . . . 1.0 112.548 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.2 t -85.05 4.15 35.35 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.911 -0.493 . . . . 1.0 109.932 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -57.63 -49.73 75.49 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -46.44 -50.34 16.92 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.116 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -58.29 -40.88 83.13 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.751 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.5 tt -52.74 -49.7 64.92 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 62.8 mt -51.02 -36.19 38.19 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.231 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.77 -46.97 87.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -56.41 -45.5 80.65 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.73 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 81.3 p -63.1 -45.24 93.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.694 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.5 mt -84.28 115.54 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.29 -0.634 . . . . 1.0 109.29 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -80.38 106.15 12.17 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.749 -0.463 . . . . 1.0 109.749 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.096 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 110.231 -0.285 . . . . 1.0 110.231 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -167.65 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -130.17 133.86 46.89 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.828 0.451 . . . . 1.0 110.659 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.21 166.99 10.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -133.85 109.02 8.79 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -103.1 130.47 50.26 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.93 137.18 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 t -142.63 137.91 30.33 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.849 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 63.4 m -92.65 -14.15 28.52 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.55 -93.63 0.05 OUTLIER Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -179.55 0.78 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -62.12 132.22 52.1 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.955 -0.387 . . . . 1.0 109.955 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -62.54 149.54 88.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.71 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.8 -62.6 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.719 1.613 . . . . 1.0 112.037 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -142.45 138.82 16.76 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 119.117 -0.468 . . . . 1.0 110.621 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.43 -31.17 46.81 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 121.781 1.654 . . . . 1.0 113.52 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.92 -36.95 67.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.969 0.414 . . . . 1.0 111.28 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.89 -41.97 97.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.858 0.361 . . . . 1.0 110.758 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.3 t -61.44 -38.29 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' SER . 14.8 m -51.6 -42.86 62.27 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.0 t -51.81 -41.4 61.71 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.558 0.218 . . . . 1.0 110.538 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.8 t -75.38 -12.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.453 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.25 40.23 2.09 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.65 0.262 . . . . 1.0 110.432 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' SER . 44.4 m -129.71 -164.6 1.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.731 0.777 . . . . 1.0 109.512 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -53.14 -46.15 68.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.995 -1.457 . . . . 1.0 110.42 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -57.97 -53.49 57.66 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 122.059 -0.4 . . . . 1.0 111.196 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 73.7 t80 -63.42 -44.69 93.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.697 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.425 ' SG ' ' NZ ' ' A' ' 113' ' ' LYS . 45.5 t -57.84 -51.48 69.41 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -55.95 -47.9 76.74 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 121.487 0.66 . . . . 1.0 110.266 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -64.81 -29.54 70.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.084 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tp -65.86 -54.16 30.37 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.54 0.525 . . . . 1.0 111.36 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -32.32 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.294 -0.867 . . . . 1.0 109.093 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -75.38 -13.08 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.881 -1.054 . . . . 1.0 109.173 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 199' ' ' GLN . 0.1 OUTLIER -101.4 -1.14 34.04 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.707 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 82.71 41.68 8.76 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.911 -1.137 . . . . 1.0 111.259 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 10.2 p90 -27.02 159.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 123.548 0.739 . . . . 1.0 112.241 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -149.19 -73.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 121.382 -0.824 . . . . 1.0 108.956 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -149.02 106.14 3.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -89.14 130.24 35.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.012 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 65' ' ' LEU . 4.2 mp -131.1 133.7 62.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.4 tt -142.71 140.93 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.44 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -170.26 137.13 1.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.726 178.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -168.56 -172.06 1.58 Allowed 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.426 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.07 168.85 3.61 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.502 -1.039 . . . . 1.0 110.502 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.633 ' NH2' HD21 ' A' ' 72' ' ' ASN . 71.1 ttp85 -168.71 -74.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.633 HD21 ' NH2' ' A' ' 71' ' ' ARG . 89.8 m-20 -63.73 -46.44 85.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 1.0 110.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.73 -17.13 61.15 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 m 59.07 18.59 6.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.713 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 m 50.46 -163.85 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.192 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' PHE . 67.9 mt-10 -145.2 -44.74 0.22 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.411 ' C ' ' H ' ' A' ' 79' ' ' HIS . 33.4 m-85 54.36 108.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -70.44 44.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.8 0.334 . . . . 1.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 77' ' ' PHE . 93.9 m-70 44.97 48.65 9.4 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.228 0.537 . . . . 1.0 111.146 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.37 -38.61 90.23 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.65 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.21 -50.35 80.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.617 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -71.78 -37.53 70.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -57.21 -48.07 79.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -77.65 -13.34 59.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.383 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.37 54.07 3.44 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 110.966 -0.853 . . . . 1.0 110.966 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.43 -178.76 51.44 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 109.831 -1.308 . . . . 1.0 109.831 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -129.85 121.04 25.94 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -80.49 111.46 16.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.342 -0.244 . . . . 1.0 110.342 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -72.38 -108.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.48 1.067 0 O-C-N 123.661 0.6 . . . . 1.0 111.653 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.196 0.522 . . . . 1.0 110.485 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 117' ' ' ILE . 9.8 mmp_? -111.56 114.73 27.99 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.09 122.75 9.21 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.426 ' OH ' ' NE ' ' A' ' 105' ' ' ARG . 5.3 m-85 -133.63 151.78 51.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.4 ' C ' HD22 ' A' ' 109' ' ' LEU . 23.0 m -129.18 147.66 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -108.0 143.95 35.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.449 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 39.9 tpp 56.76 -79.55 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 O-C-N 124.136 0.898 . . . . 1.0 110.287 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 109' ' ' LEU . 54.3 t30 -168.09 78.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.39 8.51 80.31 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.425 ' NZ ' ' SG ' ' A' ' 54' ' ' CYS . 64.1 tttm -64.59 -75.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.25 128.9 50.13 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.204 -1.036 . . . . 1.0 108.204 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -108.02 103.77 13.06 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 119.442 -0.313 . . . . 1.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.56 116.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 105' ' ' ARG . 6.8 mt -137.1 144.16 32.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.815 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.93 120.55 2.05 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -155.17 52.83 0.62 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.228 0.537 . . . . 1.0 110.749 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 18.1 p-10 -169.29 129.72 1.08 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE2' ' OE1' ' A' ' 68' ' ' GLN . 58.4 m-85 -128.03 90.99 3.18 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.2 p 42.12 31.25 0.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.712 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.6 t -149.61 27.87 0.8 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.325 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 127' ' ' SER . 16.1 mttt -170.35 -5.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 71.0 mtp -43.08 -54.88 4.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.855 0.36 . . . . 1.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -59.43 -29.13 67.54 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.74 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.428 ' OG ' ' NH2' ' A' ' 130' ' ' ARG . 1.9 t -65.59 -38.96 90.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 16.0 mm -72.6 -46.04 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.126 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' SER . 64.4 mt -60.1 -57.86 9.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.456 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.428 ' NH2' ' OG ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -48.78 -41.07 31.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 111.392 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.22 -48.25 79.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.155 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -100.64 -66.67 0.89 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.119 0.485 . . . . 1.0 110.281 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' ILE . 53.6 p 55.51 84.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -149.23 -47.8 0.14 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.311 -0.404 . . . . 1.0 109.928 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.532 HD13 ' H ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -163.16 139.3 7.04 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.532 ' H ' HD13 ' A' ' 135' ' ' LEU . 4.3 m -138.22 145.52 28.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.37 96.5 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.2 p -104.89 122.15 45.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.484 ' CD2' ' H ' ' A' ' 140' ' ' ALA . 1.3 p80 -64.0 -36.05 82.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.265 . . . . 1.0 111.139 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.484 ' H ' ' CD2' ' A' ' 139' ' ' HIS . . . -173.14 10.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.591 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.97 108.77 1.04 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.0 -43.98 94.84 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 1.0 110.331 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.67 -50.81 34.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.4 m -52.09 -50.46 61.55 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.539 -0.33 . . . . 1.0 111.791 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -29.07 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.182 -0.303 . . . . 1.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.505 HD21 ' O ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -54.63 -53.91 48.48 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.905 -177.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.17 -51.13 65.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 1.0 110.132 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.8 t -52.83 -28.24 21.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.444 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.467 HD21 HD23 ' A' ' 203' ' ' LEU . 0.2 OUTLIER -71.15 -51.86 22.52 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.879 0.371 . . . . 1.0 110.982 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.6 ttp-105 -64.77 -26.1 68.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.764 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.7 mt -90.8 17.08 8.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.972 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.5 p30 42.34 26.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.501 0.501 . . . . 1.0 111.472 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 133' ' ' SER . 30.9 mtpt -79.38 121.08 82.44 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.306 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.41 ' O ' HD21 ' A' ' 135' ' ' LEU . 77.9 Cg_endo -79.62 113.93 3.15 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.367 1.378 . . . . 1.0 110.712 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 156' ' ' ILE . 0.4 OUTLIER -115.29 171.87 7.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.591 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 156' ' ' ILE . 3.2 mp -118.4 120.01 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.78 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 76.2 t -90.89 117.11 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 O-C-N 122.518 -0.114 . . . . 1.0 110.713 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 13.3 m -85.17 100.57 11.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.08 140.22 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -100.9 84.67 2.73 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 30.7 p-10 -64.03 -32.18 73.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.018 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 t -60.84 -46.08 91.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.025 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.451 ' CD2' HD21 ' A' ' 166' ' ' ASN . 10.8 mp -90.21 -178.91 5.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 28.0 ttt -165.31 -27.76 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.461 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -66.2 -22.14 66.33 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.451 HD21 ' CD2' ' A' ' 163' ' ' LEU . 84.1 m-20 -61.59 113.61 2.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.117 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.01 -32.56 74.15 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.836 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.04 -47.07 75.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.32 -42.01 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.342 0.592 . . . . 1.0 109.922 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -50.59 -45.56 57.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.539 -0.912 . . . . 1.0 108.539 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.68 -26.4 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.877 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -68.06 -58.88 3.78 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 120.01 -0.676 . . . . 1.0 109.409 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -43.52 -24.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.72 0.295 . . . . 1.0 111.774 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.41 -40.26 81.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.145 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -55.74 -45.49 77.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.52 -46.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.98 0.419 . . . . 1.0 109.896 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -46.07 -43.01 14.27 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.439 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.6 mt -70.55 -32.25 69.61 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.832 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.15 -107.43 0.24 Allowed Glycine 0 N--CA 1.468 0.781 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.527 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 180' ' ' TYR . 66.5 t80 -169.95 42.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 180' ' ' TYR . 14.8 p -31.91 137.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 123.663 0.602 . . . . 1.0 109.479 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -54.43 101.7 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.319 0.963 . . . . 1.0 110.661 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 77.2 p -114.76 133.2 56.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.798 -1.092 . . . . 1.0 109.088 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.33 138.7 6.56 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 157.09 70.52 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 122.304 -0.248 . . . . 1.0 110.515 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -56.89 82.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 122.307 2.005 . . . . 1.0 112.991 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 m -134.86 148.9 50.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.95 -25.88 63.86 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.124 -0.36 . . . . 1.0 111.016 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.3 p -89.91 -35.61 15.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.541 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.74 -41.81 5.9 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.94 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.93 -36.24 82.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.808 0.304 . . . . 1.0 111.483 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 pt -66.0 -33.91 66.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.348 . . . . 1.0 111.023 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.56 91.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.639 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -71.66 -38.19 61.4 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.428 -0.669 . . . . 1.0 111.428 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.408 ' O ' ' OH ' ' A' ' 60' ' ' TYR . 7.7 mt -63.28 -54.85 30.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.848 0.356 . . . . 1.0 111.255 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -61.68 -36.39 80.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.1 -39.21 82.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 14.9 m -65.59 -17.96 64.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.854 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 93.9 mt-30 -104.14 29.97 5.57 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.047 -0.408 . . . . 1.0 110.624 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 22.6 p -141.37 -33.02 0.52 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -141.58 154.1 45.23 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -118.07 157.51 26.72 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.584 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 149' ' ' LEU . 8.4 tp -84.32 136.29 33.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -52.76 135.24 46.03 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.289 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -45.39 101.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.511 1.474 . . . . 1.0 113.015 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -142.12 82.78 13.02 Favored Pre-proline 0 N--CA 1.471 0.625 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.54 93.04 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.963 1.775 . . . . 1.0 111.464 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.505 ' O ' HD21 ' A' ' 146' ' ' LEU . 7.1 p -60.73 150.37 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.654 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 CA--C 1.532 0.266 0 O-C-N 123.715 0.634 . . . . 1.0 110.665 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.534 -0.543 . . . . 1.0 109.534 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -103.4 6.5 37.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 63' ' ' VAL . 67.9 mttm -71.25 106.55 3.87 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.13 121.01 43.66 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.384 0.427 . . . . 1.0 110.197 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 mt -87.61 110.97 20.78 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CD1' HG22 ' A' ' 129' ' ' ILE . 85.6 m-85 -96.07 128.62 43.14 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -123.3 122.52 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 t -146.48 137.65 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 139' ' ' HIS . 77.2 m -105.36 -24.97 12.57 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.3 20.57 67.55 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.42 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 p -139.7 155.9 47.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.475 0.31 . . . . 1.0 110.218 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' PRO . 16.8 m -94.16 148.64 35.49 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 118.727 -0.654 . . . . 1.0 110.817 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' VAL . 87.2 Cg_exo -46.22 -178.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 121.629 1.553 . . . . 1.0 112.395 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -56.57 144.42 64.27 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-O 119.234 -0.412 . . . . 1.0 110.632 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.55 -30.6 6.2 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.793 1.662 . . . . 1.0 113.497 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -73.26 -39.55 65.32 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.81 0.3 . . . . 1.0 111.81 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 186' ' ' PRO . 4.2 mm? -71.74 -40.86 69.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.97 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.6 -41.61 93.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 50' ' ' SER . 30.0 m -52.15 -45.89 65.2 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.139 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.98 -33.13 10.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 1.0 110.556 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.78 -22.09 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.996 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.98 33.44 4.39 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 120.809 0.337 . . . . 1.0 110.254 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 46' ' ' SER . 22.4 p -110.59 -167.71 1.22 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -60.74 -28.83 68.98 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.66 -50.68 71.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.493 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -35.91 73.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 71.1 m -51.63 -51.0 59.2 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.775 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -73.07 -43.76 61.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.684 0.278 . . . . 1.0 111.654 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -65.91 -28.95 69.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.971 0.415 . . . . 1.0 110.535 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.2 mt -61.35 -52.42 64.73 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.6 mp -57.42 -36.67 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 120.305 -0.558 . . . . 1.0 109.874 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -72.52 -33.78 67.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.695 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 60' ' ' TYR . 70.1 t80 -77.87 0.57 23.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.997 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 42.08 22.23 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.751 -1.214 . . . . 1.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -49.3 -176.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.534 0.667 . . . . 1.0 111.825 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 64' ' ' ARG . 10.5 p -172.48 -42.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' HG13 ' A' ' 63' ' ' VAL . 47.5 ttm-85 -168.38 105.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.1 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.04 135.83 33.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.31 136.41 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -138.99 141.82 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -143.64 149.37 37.2 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 77' ' ' PHE . 47.5 p90 -163.14 126.29 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.02 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.78 -171.17 44.71 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 109.774 -1.33 . . . . 1.0 109.774 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.564 ' NE ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 55.54 118.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.377 0.608 . . . . 1.0 110.914 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -61.85 -20.49 63.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.111 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 75' ' ' SER . 48.3 t80 -56.5 -14.97 3.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.384 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 m -60.59 3.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.391 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 73' ' ' TYR . 3.5 m 63.54 139.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.861 0.363 . . . . 1.0 110.264 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.44 137.17 57.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 69' ' ' PHE . 3.7 m-85 -64.41 -93.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 49.69 45.97 24.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.023 0.439 . . . . 1.0 110.859 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.402 ' ND1' ' O ' ' A' ' 77' ' ' PHE . 35.1 m80 -157.26 -53.87 0.08 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.648 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.47 -48.87 75.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.098 0.475 . . . . 1.0 111.043 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.39 -44.12 77.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.196 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.93 -31.56 72.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.27 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -70.91 -44.31 66.49 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.027 0.442 . . . . 1.0 110.437 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLY . 1.1 mmp_? -99.1 30.03 3.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' ARG . . . 21.15 73.71 0.01 OUTLIER Glycine 0 N--CA 1.486 1.98 0 N-CA-C 111.531 -0.627 . . . . 1.0 111.531 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.74 -179.1 52.01 Favored Glycine 0 C--N 1.322 -0.222 0 N-CA-C 109.846 -1.302 . . . . 1.0 109.846 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -138.34 135.96 35.9 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.517 ' CZ ' HE21 ' A' ' 106' ' ' GLN . 53.0 ttt85 -54.43 149.6 10.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.442 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -107.0 -155.36 0.55 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.49 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 85.4 p . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.849 0.356 . . . . 1.0 111.252 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' C ' HH11 ' A' ' 105' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 110.208 -0.293 . . . . 1.0 110.208 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.479 HH11 ' C ' ' A' ' 104' ' ' ALA . 1.5 mpt_? -135.37 145.75 47.66 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.159 0.504 . . . . 1.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.517 HE21 ' CZ ' ' A' ' 88' ' ' ARG . 1.8 pm0 -156.83 129.05 7.38 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.8 -0.636 . . . . 1.0 109.694 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -147.21 169.11 20.04 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.69 148.27 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 114' ' ' LEU . 19.2 mt -114.39 -178.83 3.46 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.585 0.553 . . . . 1.0 109.562 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 tpt 53.21 -134.67 1.63 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.664 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.86 35.9 0.9 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.013 0.435 . . . . 1.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.59 71.54 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.518 -0.633 . . . . 1.0 111.518 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -96.21 -15.92 21.75 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.392 0.277 . . . . 1.0 111.635 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' A' ' 109' ' ' LEU . 4.4 mm? -96.91 133.57 41.39 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -116.88 93.73 4.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.8 p -106.89 116.59 50.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 CA-C-O 122.219 1.009 . . . . 1.0 109.053 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.2 pt -117.81 146.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 114.076 -1.42 . . . . 1.0 108.658 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -122.94 131.83 8.39 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 109.63 -1.388 . . . . 1.0 109.63 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 120' ' ' ASP . 45.0 t80 59.01 152.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 1.0 110.768 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 38.8 t70 -168.24 163.66 13.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.353 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.446 ' CD2' ' O ' ' A' ' 121' ' ' PHE . 40.4 p90 -70.77 119.27 14.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 124' ' ' LYS . 18.1 m 56.88 135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.421 0.629 . . . . 1.0 111.558 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 t -74.87 38.43 0.12 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.263 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 122' ' ' SER . 36.9 ttpt -64.45 -29.56 70.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.477 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.49 ' SD ' ' NE2' ' A' ' 126' ' ' GLN . 3.6 ppp? -45.18 -32.0 1.69 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.49 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 88.5 mm-40 -58.23 -28.72 65.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.676 -0.693 . . . . 1.0 111.044 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.1 t -80.54 -33.17 36.49 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.742 0.306 . . . . 1.0 110.803 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 128' ' ' ILE . 1.6 mp -63.63 -39.93 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.723 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.551 HG22 ' CD1' ' A' ' 32' ' ' PHE . 2.9 pt -49.11 -41.54 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -46.08 -32.66 3.0 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.514 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.45 -27.64 62.64 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.4 -62.27 1.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.333 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.2 p 51.36 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.724 ' N ' ' HZ2' ' A' ' 153' ' ' LYS . 56.5 m-20 -145.14 -43.92 0.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -155.41 120.52 4.86 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 135' ' ' LEU . 60.9 t -122.52 137.33 56.41 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.3 mt -122.92 124.37 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.7 p -134.3 133.61 40.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.427 ' CD2' ' SG ' ' A' ' 35' ' ' CYS . 37.8 m-70 -69.89 -38.22 76.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.631 0.253 . . . . 1.0 110.788 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.47 19.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.326 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.67 100.6 0.44 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.6 m -56.72 -41.46 77.48 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.478 -0.425 . . . . 1.0 110.48 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.74 -48.77 26.68 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.3 m -56.52 -42.77 78.99 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.842 -0.211 . . . . 1.0 111.309 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 92.6 mt -66.35 -26.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 1.0 110.852 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 209' ' ' SER . 0.2 OUTLIER -57.35 -46.9 82.84 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.663 -176.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -70.42 -53.55 16.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.097 0.475 . . . . 1.0 109.826 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.9 m -53.19 -25.21 13.04 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 49.8 tp -74.86 -45.77 40.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.859 0.362 . . . . 1.0 111.438 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -76.56 -18.99 58.37 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.279 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.9 mt -85.03 4.03 35.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.9 p30 41.56 47.89 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.389 0.43 . . . . 1.0 111.688 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.724 ' HZ2' ' N ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -105.68 147.1 34.11 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 119.205 -0.426 . . . . 1.0 111.569 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.63 85.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.46 1.44 . . . . 1.0 111.542 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 153' ' ' LYS . 66.9 tp -89.94 137.49 32.29 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.816 -0.553 . . . . 1.0 111.324 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.3 134.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.084 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.63 128.69 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 120.788 0.328 . . . . 1.0 110.652 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 12.3 m -83.6 102.47 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.88 146.84 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.746 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.9 t30 86.44 103.78 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.887 0.742 . . . . 1.0 110.065 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -167.59 66.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.203 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -64.65 86.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.215 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 165' ' ' ASP . 34.8 tp -168.41 77.03 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 ttt 67.19 -36.74 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.707 0.629 . . . . 1.0 110.984 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 163' ' ' LEU . 66.7 m-20 -77.17 -3.02 37.4 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.077 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -52.86 -37.92 60.87 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.766 0.317 . . . . 1.0 110.369 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.12 -38.17 87.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.135 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -68.11 -38.97 82.87 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.367 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.53 -31.31 64.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.133 0.492 . . . . 1.0 110.692 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.37 -49.09 67.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.51 -27.41 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.79 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.77 -61.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.097 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -51.94 -31.98 31.14 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -60.79 -52.71 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.015 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.26 -42.66 81.97 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.22 -52.84 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -51.96 -44.32 63.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.701 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.33 17.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.134 -0.321 . . . . 1.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 39.29 89.8 0.01 OUTLIER Glycine 0 C--N 1.352 1.423 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.646 ' O ' HD22 ' A' ' 203' ' ' LEU . 49.9 t80 -155.48 -22.39 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.51 152.64 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.83 0.348 . . . . 1.0 110.495 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -71.39 130.63 41.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.6 p -98.11 138.67 35.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.586 -0.734 . . . . 1.0 109.541 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 185' ' ' ALA . 35.7 t -157.77 177.32 11.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 184' ' ' CYS . . . -136.93 155.99 76.07 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 110.164 -0.31 . . . . 1.0 110.164 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.469 ' HG2' HD12 ' A' ' 44' ' ' LEU . 94.3 Cg_endo -69.58 65.62 1.68 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.089 1.86 . . . . 1.0 112.404 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 m -134.06 145.5 49.46 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.014 0.435 . . . . 1.0 109.898 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -55.13 -29.34 57.49 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -84.03 -41.03 17.66 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.089 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.14 93.86 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.978 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.35 -39.54 90.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 119.711 -0.185 . . . . 1.0 111.314 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.73 -45.84 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.61 82.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.53 -36.61 91.74 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.08 -54.63 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.94 0.4 . . . . 1.0 110.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -59.66 -21.29 60.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.432 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.85 3.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.774 0.321 . . . . 1.0 110.46 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.6 p -67.46 -22.53 65.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.769 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.53 -43.72 69.01 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.075 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 21.7 m -79.1 -43.66 23.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.842 0.353 . . . . 1.0 110.698 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.53 125.25 40.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.266 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -120.82 108.59 14.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 180' ' ' TYR . 4.8 tp -63.24 135.8 57.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -52.67 146.88 16.43 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.778 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.45 103.77 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.357 1.371 . . . . 1.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -141.1 96.5 7.21 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.74 114.03 3.86 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 121.13 1.22 . . . . 1.0 111.345 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 209' ' ' SER . 14.8 p -57.75 -43.41 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.531 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.481 ' N ' HG13 ' A' ' 208' ' ' VAL . 37.4 m . . . . . 0 N--CA 1.463 0.221 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.242 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -144.79 -36.34 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -71.16 92.74 1.01 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.95 111.94 24.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.73 117.98 21.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE2' ' NE2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -102.69 124.3 47.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 67' ' ' ILE . 9.4 p -126.18 128.4 71.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.2 p -129.1 129.82 45.7 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' CE1' ' A' ' 69' ' ' PHE . 97.2 m -88.69 164.26 15.39 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.89 37.67 0.75 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.69 -0.564 . . . . 1.0 111.69 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 35' ' ' CYS . . . 67.64 -61.51 0.36 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.386 0.274 . . . . 1.0 110.602 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -64.96 147.41 53.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 1.0 109.978 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.6 81.36 24.09 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.88 -59.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.953 1.768 . . . . 1.0 111.505 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 92.14 18.29 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -74.05 8.32 2.12 Favored 'Trans proline' 0 N--CA 1.508 2.339 0 CA-C-N 120.831 1.333 . . . . 1.0 112.442 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.0 110.555 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.9 mm? -70.02 -35.02 74.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.546 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.37 -40.5 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 78.3 p -50.52 -45.33 56.59 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.839 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -51.57 -39.99 58.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.05 0.452 . . . . 1.0 110.301 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 41.8 t -79.67 -16.21 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.057 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 tp -130.96 39.74 3.55 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.826 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.5 t -132.61 -157.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 50' ' ' SER . 22.6 p-10 -60.28 -44.27 95.48 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.98 -51.58 65.75 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.592 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 5.9 t80 -67.8 -36.79 81.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.972 0.415 . . . . 1.0 109.905 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 t -57.64 -47.96 80.79 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.429 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -63.07 -46.47 87.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.66 -28.39 69.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.406 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.25 -51.24 70.4 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.945 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -58.35 -44.9 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.06 -37.6 77.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.33 -21.58 64.74 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.661 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 104.3 35.94 3.24 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 118.016 -1.435 . . . . 1.0 111.355 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' O ' ' A' ' 61' ' ' GLY . 49.8 p90 13.61 130.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 124.86 1.264 . . . . 1.0 112.719 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -145.3 -81.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 122.007 -0.433 . . . . 1.0 110.448 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -169.33 111.24 0.48 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.221 -0.445 . . . . 1.0 109.83 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -92.35 121.59 33.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 66' ' ' ILE . 2.3 mp -102.88 133.02 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.434 -1.321 . . . . 1.0 107.434 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.418 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.7 mm -114.6 132.76 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.509 ' NE2' ' CE2' ' A' ' 32' ' ' PHE . 15.6 mp0 -131.78 163.09 29.0 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.582 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE1' ' SG ' ' A' ' 35' ' ' CYS . 17.7 m-85 -157.22 -179.64 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.183 0.516 . . . . 1.0 109.735 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 72' ' ' ASN . . . -59.1 -29.89 66.16 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.292 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 68.01 -38.32 0.36 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.98 0.459 . . . . 1.0 111.256 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 70' ' ' GLY . 19.0 m120 -62.16 -43.93 97.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.781 0.324 . . . . 1.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.26 -45.76 86.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 p 56.31 166.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.841 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.2 t 52.36 68.88 0.75 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.821 0.343 . . . . 1.0 111.138 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -170.95 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.602 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -166.77 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.613 -0.267 . . . . 1.0 110.609 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.26 -44.62 95.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.832 0.349 . . . . 1.0 110.073 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.08 -28.78 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.733 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -63.74 -48.36 77.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.155 0.503 . . . . 1.0 110.161 -178.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.28 -45.44 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -64.37 -36.4 84.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -52.23 -46.65 65.79 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.581 0.229 . . . . 1.0 110.441 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.19 -17.43 64.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.092 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.02 52.64 35.61 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.12 -1.192 . . . . 1.0 110.12 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.38 -167.76 25.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -128.33 126.95 41.78 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -55.38 145.42 22.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.616 0.246 . . . . 1.0 110.624 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -145.6 179.18 7.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.211 -179.303 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.626 ' CB ' ' H ' ' A' ' 119' ' ' PHE . . . . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.562 0.22 . . . . 1.0 110.411 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -141.41 169.2 18.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -158.79 132.48 7.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.333 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -136.39 151.06 49.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.764 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.7 t -100.83 96.07 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.527 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 109' ' ' LEU . 10.4 mp -87.57 159.77 18.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 tpt 57.03 -88.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.402 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -172.47 62.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.763 0.316 . . . . 1.0 110.686 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.55 27.09 63.96 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.627 -0.589 . . . . 1.0 111.627 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -114.19 -50.36 2.81 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.597 0.359 . . . . 1.0 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mt -95.36 111.86 23.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.855 0.359 . . . . 1.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -105.83 101.24 10.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 p -105.53 111.64 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.709 0.766 . . . . 1.0 109.641 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 pt -125.86 122.77 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.388 -1.278 . . . . 1.0 109.167 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.59 -82.01 0.04 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.548 -0.834 . . . . 1.0 111.453 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.626 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 3.6 m-85 47.72 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.941 0.4 . . . . 1.0 110.005 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -163.19 154.24 16.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 122' ' ' SER . 63.8 t80 -160.11 172.95 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.654 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 44.3 t -52.99 -17.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.26 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.8 m -164.19 103.56 0.86 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.606 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -171.03 -26.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.772 0.32 . . . . 1.0 110.555 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.1 -49.96 75.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.861 0.362 . . . . 1.0 110.71 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -61.82 -25.55 67.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.358 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p -76.41 -44.69 34.97 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.971 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.06 -44.48 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.627 -0.261 . . . . 1.0 110.617 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 133' ' ' SER . 79.4 mt -59.04 -51.94 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -39.14 10.25 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.053 0.454 . . . . 1.0 110.905 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -63.54 -32.17 73.55 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.141 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -112.57 -67.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.784 0.434 . . . . 1.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' ILE . 26.0 t 54.32 89.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.757 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -134.38 -50.1 0.79 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.335 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 29.9 tp -165.7 146.32 6.83 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.38 140.03 44.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.7 pt -123.02 127.89 74.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.6 m -88.85 -161.88 0.8 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -169.99 -36.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.6 48.21 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.809 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.88 112.5 0.53 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.668 ' N ' HE22 ' A' ' 168' ' ' GLN . 35.2 m -74.2 -25.19 59.55 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.698 0.285 . . . . 1.0 110.685 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.94 86.04 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.0 m -72.91 -35.77 67.13 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.841 -0.211 . . . . 1.0 110.756 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 53.6 mt -61.37 -30.37 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.771 0.32 . . . . 1.0 110.989 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 tp -52.35 -52.74 51.72 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.137 0.421 . . . . 1.0 112.137 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -65.69 -46.95 77.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.285 0.564 . . . . 1.0 111.074 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 m -53.01 -26.92 17.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.121 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.4 mt -79.7 -49.26 12.35 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.356 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -62.51 -37.95 88.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.682 -0.236 . . . . 1.0 110.923 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.28 4.77 4.18 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 58.8 t30 53.72 23.28 3.6 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.71 -0.223 . . . . 1.0 111.123 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.66 122.84 46.24 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -45.9 171.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.659 1.572 . . . . 1.0 112.6 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.609 ' C ' HD13 ' A' ' 156' ' ' ILE . 4.0 tt -156.92 151.75 25.86 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.514 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 155' ' ' LEU . 3.1 mm -123.35 128.23 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.9 137.16 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.36 115.38 27.35 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.37 97.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.654 0.264 . . . . 1.0 111.667 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.449 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 20.2 p-10 -148.46 -58.47 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.255 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 163' ' ' LEU . 73.2 m-20 -102.3 14.01 33.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.083 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 27.9 t -69.79 36.9 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.889 0.376 . . . . 1.0 110.837 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 161' ' ' ASP . 52.7 mt -63.42 -39.59 94.9 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 166' ' ' ASN . 23.8 ptt? -52.28 141.45 19.2 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.229 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 167' ' ' HIS . 4.8 m-20 69.24 -37.07 0.36 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.202 0.314 . . . . 1.0 110.749 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 164' ' ' MET . 20.2 t-20 58.97 -0.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.612 0.365 . . . . 1.0 111.336 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 165' ' ' ASP . 24.6 m170 -73.48 -43.42 60.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.866 0.365 . . . . 1.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.668 HE22 ' N ' ' A' ' 142' ' ' THR . 22.6 mm100 -64.92 -49.47 70.31 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.937 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -59.58 -29.68 68.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.92 0.39 . . . . 1.0 110.013 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.49 -54.67 8.59 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.009 -0.542 . . . . 1.0 110.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.39 -41.39 73.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.45 -64.15 0.96 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 120.466 -0.494 . . . . 1.0 110.196 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.4 -27.76 2.81 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.337 0.589 . . . . 1.0 111.089 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -82.96 -40.48 20.02 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.055 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.04 -45.45 93.52 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.696 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 177' ' ' GLU . 27.1 m -57.14 -52.71 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 176' ' ' VAL . 77.3 mt-10 -52.34 -38.88 59.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.348 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.13 6.31 49.13 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.63 89.77 0.07 OUTLIER Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.291 -1.124 . . . . 1.0 110.291 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -40.65 79.35 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.135 0.974 . . . . 1.0 111.156 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.594 ' O ' HG22 ' A' ' 181' ' ' VAL . 3.2 p -73.8 65.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.531 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . 0.485 ' C ' ' O ' ' A' ' 181' ' ' VAL . 6.0 m-90 30.4 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 99.9 p -108.6 131.45 54.85 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 30.5 p -162.58 130.17 3.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.861 -1.063 . . . . 1.0 108.387 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.92 157.09 74.34 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 118.92 -0.562 . . . . 1.0 110.851 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.76 69.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.516 2.833 0 C-N-CA 123.253 2.635 . . . . 1.0 114.393 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 185' ' ' ALA . 43.7 m -132.2 146.67 52.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 24.7 mp0 -49.34 -51.69 32.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.494 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.7 p -67.15 -43.04 83.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.66 -0.245 . . . . 1.0 110.578 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -52.6 -53.36 32.85 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 121.427 -0.416 . . . . 1.0 112.145 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.83 -40.98 99.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.926 0.363 . . . . 1.0 110.71 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.45 -44.54 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -58.85 -49.35 78.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 1.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.5 98.81 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 42.6 mt -63.82 -43.47 96.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.713 0.292 . . . . 1.0 110.546 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -66.91 -40.02 87.56 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -64.41 -49.58 70.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.698 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 m -61.13 -22.39 64.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.308 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -74.56 10.46 1.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.017 0.437 . . . . 1.0 110.194 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.4 m -164.09 -54.66 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.816 0.341 . . . . 1.0 110.844 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.7 mt-10 -66.89 116.17 7.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.026 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -103.05 165.59 10.93 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 tp -110.45 -164.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.52 137.54 22.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -79.2 44.47 1.7 Allowed 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.812 1.675 . . . . 1.0 111.915 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.39 84.8 15.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.41 166.03 5.1 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.113 1.876 . . . . 1.0 112.186 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 209' ' ' SER . 12.0 p -57.06 -46.81 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.337 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.501 ' N ' HG13 ' A' ' 208' ' ' VAL . 51.6 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.852 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -168.79 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.826 0.346 . . . . 1.0 110.544 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -74.3 139.47 44.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . -142.9 165.1 28.29 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 137' ' ' ILE . 11.8 mt -109.27 122.51 47.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.489 ' CE1' HG21 ' A' ' 128' ' ' ILE . 12.3 t80 -108.62 141.6 40.32 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.15 148.15 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.955 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -144.78 139.84 28.08 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.735 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.83 8.34 5.73 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.19 108.71 0.23 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.66 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.966 -0.138 . . . . 1.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.0 p 48.85 -167.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.751 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 39' ' ' VAL . 24.4 m -97.69 113.57 63.75 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 123.186 0.304 . . . . 1.0 110.657 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.12 -13.78 17.03 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.05 1.833 . . . . 1.0 111.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -124.92 85.16 57.9 Favored Pre-proline 0 N--CA 1.477 0.899 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.32 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.17 -23.06 27.9 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.145 1.897 . . . . 1.0 111.698 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -80.98 -46.66 14.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.64 -49.88 74.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.861 0.362 . . . . 1.0 111.046 -176.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.47 -39.14 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.19 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 17.0 p -50.01 -57.88 6.64 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 46' ' ' SER . 77.4 m -51.71 -41.41 61.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.971 0.415 . . . . 1.0 110.342 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.5 t -71.2 -17.89 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.038 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 tp -140.65 44.19 1.84 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.039 0.447 . . . . 1.0 110.862 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.6 t -123.59 -167.59 1.64 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.5 ' N ' ' OG ' ' A' ' 50' ' ' SER . 41.2 m-20 -50.73 -40.07 53.47 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.912 -1.04 . . . . 1.0 111.175 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -60.45 -55.22 36.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.79 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -67.28 -39.86 86.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.998 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 91.0 m -48.36 -53.7 16.57 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -77.47 -46.75 21.53 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.45 -30.27 68.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.867 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.69 -45.04 93.31 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.482 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -63.59 -30.32 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 119.946 -0.702 . . . . 1.0 109.608 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -63.01 -16.4 59.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.0 111.087 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.74 -18.83 14.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.09 35.37 5.8 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 121.39 -0.433 . . . . 1.0 112.1 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -93.15 154.4 18.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.21 0.529 . . . . 1.0 109.652 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 m -137.77 -6.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.031 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -143.0 144.98 32.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.436 0.636 . . . . 1.0 110.69 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -138.68 122.98 18.21 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.712 -1.131 . . . . 1.0 109.28 178.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 65' ' ' LEU . 4.3 mp -120.66 142.94 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.529 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.05 137.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.006 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -62.51 144.1 56.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.23 120.26 16.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' ASN . . . -64.21 -11.01 44.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 63.41 -68.51 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.888 0.405 . . . . 1.0 110.877 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' GLY . 77.7 m-20 -61.28 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -65.87 -50.19 65.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.98 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t 51.16 -147.79 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.803 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t 55.93 -161.1 0.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.592 0.234 . . . . 1.0 110.699 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 54.7 -166.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.466 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.2 t80 53.3 98.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.652 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -59.4 166.67 2.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.019 -0.363 . . . . 1.0 110.019 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -73.21 54.51 0.41 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.752 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -59.15 -43.44 92.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.285 0.564 . . . . 1.0 110.405 -177.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 82' ' ' GLN . 22.3 m -58.2 -43.66 86.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.571 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.472 ' N ' HG23 ' A' ' 81' ' ' VAL . 2.6 tm0? -68.85 -42.78 76.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.262 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.91 -48.17 67.43 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.693 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.572 ' HD2' HD12 ' A' ' 109' ' ' LEU . 57.9 ttm-85 -76.13 -16.68 59.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.756 -0.377 . . . . 1.0 110.368 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.55 54.21 1.36 Allowed Glycine 0 N--CA 1.474 1.192 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . -80.36 169.31 52.53 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.736 -1.345 . . . . 1.0 109.736 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -132.4 129.36 39.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 90' ' ' SER . 56.8 ttp180 -57.61 151.15 17.69 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 40.46 -86.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.794 0.684 . . . . 1.0 111.286 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' ARG . 93.1 p . . . . . 0 CA--C 1.527 0.089 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.435 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.45 HH12 ' CG1' ' A' ' 116' ' ' VAL . 50.9 ptt85 -141.01 163.5 32.81 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.94 129.63 8.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.492 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.16 161.38 38.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 109' ' ' LEU . 38.8 t -123.35 128.73 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.572 HD12 ' HD2' ' A' ' 84' ' ' ARG . 4.1 mm? -104.79 157.66 17.05 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.173 0.511 . . . . 1.0 109.646 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.9 mmt 54.84 -87.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.819 -1.082 . . . . 1.0 110.282 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LEU . 2.6 p30 -169.3 72.36 0.08 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.21 -0.19 59.9 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.411 ' C ' HD22 ' A' ' 114' ' ' LEU . 34.2 tptt -73.41 -57.26 4.13 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.901 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.411 HD22 ' C ' ' A' ' 113' ' ' LYS . 4.1 mm? -117.88 120.23 37.26 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.858 0.724 . . . . 1.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.5 126.06 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.177 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.45 ' CG1' HH12 ' A' ' 105' ' ' ARG . 57.6 t -101.56 114.25 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.143 -1.428 . . . . 1.0 107.143 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.05 140.78 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.839 0.712 . . . . 1.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.54 -40.88 66.98 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 110.011 -1.235 . . . . 1.0 110.011 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.0 t80 61.68 135.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.297 0.239 . . . . 1.0 110.508 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -170.08 128.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -161.25 142.99 11.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.169 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 123' ' ' THR . 99.3 p 46.85 -114.53 0.54 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.198 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.491 ' N ' ' HG ' ' A' ' 122' ' ' SER . 60.6 p -61.36 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.161 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 125' ' ' MET . 16.3 pttt -170.64 -73.09 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.546 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 64.4 mtt -71.79 -55.96 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.578 0.228 . . . . 1.0 111.469 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.96 -33.04 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.34 . . . . 1.0 111.276 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.2 m -72.44 -43.93 63.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.489 HG21 ' CE1' ' A' ' 32' ' ' PHE . 74.0 mt -64.93 -46.35 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 1.0 112.076 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 130' ' ' ARG . 20.6 pt -62.61 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 121.874 0.845 . . . . 1.0 110.789 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.42 ' N ' HG13 ' A' ' 129' ' ' ILE . 69.1 mtp85 -56.45 -46.04 80.54 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.95 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.75 -55.86 28.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -73.9 -22.69 59.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.345 -176.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 95.6 p 35.67 76.15 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.831 0.852 . . . . 1.0 112.588 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 30' ' ' ALA . 22.5 t70 -164.58 -151.18 0.15 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.041 -0.725 . . . . 1.0 109.041 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 135' ' ' LEU . 4.0 mm? -91.35 126.24 36.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.13 0.491 . . . . 1.0 109.687 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.0 p -97.1 155.36 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.801 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 31' ' ' LEU . 68.9 mt -119.01 96.35 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.995 -1.002 . . . . 1.0 108.52 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 t -96.42 123.44 40.08 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.426 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 1.8 t60 -73.51 -50.78 19.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.645 0.26 . . . . 1.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 25.11 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.03 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -63.93 -34.13 89.11 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.4 -44.73 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.926 0.393 . . . . 1.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -65.54 -41.58 96.11 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 111.151 -0.779 . . . . 1.0 111.151 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.9 t -69.65 -40.66 76.36 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 122.51 -0.406 . . . . 1.0 111.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.54 -29.75 39.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.369 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.6 tp -50.11 -51.37 43.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.033 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -65.65 -38.99 90.89 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.721 0.772 . . . . 1.0 110.339 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 m -51.08 -25.26 4.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.433 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.47 -55.35 4.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.073 0.768 . . . . 1.0 113.073 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -63.99 -26.61 68.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.909 0.385 . . . . 1.0 110.457 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.26 -0.91 6.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 t30 56.33 37.7 29.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.37 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.95 144.7 42.37 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.086 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.27 -177.41 2.98 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 121.865 1.71 . . . . 1.0 110.877 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.694 ' C ' HD13 ' A' ' 156' ' ' ILE . 2.0 pt? -158.78 171.95 19.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.177 -0.919 . . . . 1.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.694 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.5 OUTLIER -119.32 120.34 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.618 177.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.37 127.76 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.848 0.356 . . . . 1.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 96.8 m -72.77 104.81 4.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.01 147.73 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 83.48 102.49 0.05 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.976 0.798 . . . . 1.0 110.278 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -168.76 -76.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.6 m 49.17 35.92 8.17 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.06 0.457 . . . . 1.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.68 -40.66 97.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.184 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.9 ttm -162.88 52.3 0.18 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.006 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.29 -41.71 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.181 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 71.52 -51.62 0.69 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.701 0.626 . . . . 1.0 110.319 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -60.93 -23.77 65.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.806 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.426 ' NE2' ' CE1' ' A' ' 139' ' ' HIS . 11.6 tm0? -42.11 -50.71 4.73 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.332 -0.395 . . . . 1.0 111.305 -176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -67.09 -36.27 81.61 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.101 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -66.17 -38.09 87.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.452 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.6 mm -65.06 -43.63 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.99 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.51 -52.26 8.77 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.823 0.344 . . . . 1.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.25 -51.91 30.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.981 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -61.04 -30.31 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 1.0 110.574 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 179' ' ' GLY . 0.7 OUTLIER -63.96 -36.62 84.57 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.024 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.3 t -57.69 -44.5 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.671 0.272 . . . . 1.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -63.41 -50.22 70.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.831 0.348 . . . . 1.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.2 mt -90.76 0.67 57.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.313 0.578 . . . . 1.0 110.212 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . -173.51 87.23 0.08 OUTLIER Glycine 0 C--O 1.223 -0.575 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -48.25 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.457 0.74 . . . . 1.0 110.308 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.4 p -89.96 146.73 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.107 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -66.93 127.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 p -107.14 133.87 51.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.6 m -162.71 124.79 2.66 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.74 154.98 75.95 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.712 -0.661 . . . . 1.0 110.175 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.5 63.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.513 2.638 0 C-N-CA 122.458 2.106 . . . . 1.0 113.547 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 185' ' ' ALA . 79.4 p -128.12 141.95 51.34 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 17.2 mp0 -65.45 -25.36 67.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.276 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 189' ' ' THR . 1.5 t -89.11 -31.57 17.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.897 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.36 -34.3 12.45 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 112.015 -0.434 . . . . 1.0 112.015 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 34.7 mt -62.41 -41.52 98.74 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.449 -0.442 . . . . 1.0 111.364 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.28 -39.33 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.6 79.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.389 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.48 -53.99 25.5 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.415 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.94 -32.98 72.49 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.716 -0.284 . . . . 1.0 110.387 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -59.16 -48.6 81.03 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.503 -0.479 . . . . 1.0 109.99 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.54 -47.79 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.188 -0.32 . . . . 1.0 111.395 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 83.3 p -59.79 -32.95 71.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.21 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.16 28.35 4.97 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.778 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 62.1 m -150.45 -30.74 0.2 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.328 -0.249 . . . . 1.0 110.328 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -150.8 151.94 33.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.174 0.511 . . . . 1.0 109.751 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -130.39 156.78 44.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.344 -0.844 . . . . 1.0 110.089 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.39 164.61 19.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.183 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -61.73 148.35 87.32 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.904 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.99 99.63 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.742 1.628 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -140.61 87.43 11.52 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 107.36 2.46 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.019 1.813 . . . . 1.0 111.685 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.64 84.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.224 -0.444 . . . . 1.0 109.932 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.798 0.333 . . . . 1.0 110.467 179.758 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 120.401 0.143 . . . . 1.0 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -164.04 73.82 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.932 -0.396 . . . . 1.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' H ' HG21 ' A' ' 63' ' ' VAL . 88.6 tttt -128.78 111.32 12.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.45 160.2 14.53 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 137' ' ' ILE . 14.0 tp -130.15 102.73 6.36 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -99.42 127.62 45.48 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.849 0.46 . . . . 1.0 110.018 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.61 145.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 t -144.01 138.63 28.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.523 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.19 -35.57 76.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.852 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.5 -104.12 1.38 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.371 -1.092 . . . . 1.0 110.371 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.46 -159.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -63.42 172.01 2.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 p -162.34 82.81 1.67 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.9 -32.77 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.054 1.836 . . . . 1.0 111.065 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.6 110.45 3.15 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 118.746 -0.645 . . . . 1.0 110.267 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -84.76 -21.68 3.25 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.613 1.542 . . . . 1.0 112.36 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -81.17 -31.89 33.85 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.548 HD23 ' OG ' ' A' ' 162' ' ' SER . 0.3 OUTLIER -75.58 -51.6 12.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.093 0.473 . . . . 1.0 110.472 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 48' ' ' VAL . 11.9 p -56.74 -32.06 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.995 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 98.3 p -62.39 -19.26 63.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.691 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.5 p -51.07 -38.54 52.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 1.0 110.601 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 45' ' ' VAL . 5.4 m -64.61 -18.76 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.112 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mt -143.63 41.19 1.44 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.939 0.496 . . . . 1.0 109.774 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -124.26 -156.13 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.103 -0.702 . . . . 1.0 109.103 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -54.5 -46.81 73.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.747 -0.66 . . . . 1.0 112.033 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.13 -55.41 35.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.536 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -71.0 -45.63 63.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.455 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 47.5 t -56.77 -32.02 65.2 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.46 0.647 . . . . 1.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -78.83 -49.86 12.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.82 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -70.08 -58.29 3.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.888 -0.597 . . . . 1.0 112.606 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 61' ' ' GLY . 3.2 mm? -49.45 -42.01 41.76 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.289 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.7 mm -69.69 -42.33 80.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -50.46 -51.9 42.79 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.122 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.89 -17.81 24.68 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . 75.54 -16.21 4.11 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.562 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 38.09 -115.54 0.15 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.261 -0.4 . . . . 1.0 111.448 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.433 HG21 ' H ' ' A' ' 29' ' ' LYS . 97.0 t -160.43 -59.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -165.64 130.2 2.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.367 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.603 ' C ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -99.44 143.33 29.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.637 0.775 . . . . 1.0 110.533 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.8 mm -123.28 130.46 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 48' ' ' VAL . 12.5 tt -145.29 141.86 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.243 0.544 . . . . 1.0 109.538 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.565 HE21 ' CE ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -160.58 151.79 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.043 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' OE2' ' A' ' 76' ' ' GLU . 95.8 m-85 -99.96 -60.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.315 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.01 -37.62 3.3 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 111.314 -0.715 . . . . 1.0 111.314 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.3 mmt-85 -97.13 122.65 40.39 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.81 -38.07 89.75 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.973 0.416 . . . . 1.0 110.262 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -54.03 -15.91 1.67 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.936 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -55.08 -80.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.242 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.3 m 52.88 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.667 0.27 . . . . 1.0 111.454 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -168.0 -44.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.908 0.385 . . . . 1.0 111.462 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -69.15 103.57 1.94 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.21 -83.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.267 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -169.08 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.035 0.445 . . . . 1.0 110.272 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.65 -17.59 60.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.32 -36.59 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' GLY . 41.4 mm-40 -66.87 -39.64 87.6 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.52 -0.764 . . . . 1.0 110.128 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -51.96 -38.02 55.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.12 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -18.0 62.59 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' GLN . . . 88.53 41.74 6.0 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.34 168.16 54.81 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -137.84 133.83 34.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -62.39 155.94 23.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.894 -0.322 . . . . 1.0 110.848 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.79 -5.83 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.407 0.442 . . . . 1.0 110.888 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.4 m . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.093 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.07 0.462 . . . . 1.0 111.665 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' A' ' 118' ' ' GLY . 22.3 ptt85 -133.47 147.81 51.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -150.05 117.98 6.28 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -137.04 161.28 36.51 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.09 147.94 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.316 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 111' ' ' ASN . 2.0 mp -123.82 123.14 39.8 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.5 tpp 55.83 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.268 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' LEU . 20.6 t-20 -167.39 78.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.793 0.33 . . . . 1.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.41 5.28 77.05 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.011 -0.835 . . . . 1.0 111.011 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -66.51 -23.44 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 tp -174.04 105.68 0.12 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -109.89 115.32 29.59 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.38 108.45 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.87 100.04 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.938 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.41 ' H ' ' HG3' ' A' ' 105' ' ' ARG . . . -84.68 -25.01 43.7 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 109.889 -1.284 . . . . 1.0 109.889 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -58.69 137.4 57.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.898 0.38 . . . . 1.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -166.41 170.54 12.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -81.56 96.06 7.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.226 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.6 p 46.53 -164.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.784 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.54 8.5 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.15 0.5 . . . . 1.0 110.054 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -144.42 44.87 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.565 ' CE ' HE21 ' A' ' 68' ' ' GLN . 18.1 mmt -52.98 -41.67 64.81 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.668 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -54.83 -26.96 38.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.683 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 51.2 p -83.66 -38.85 20.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.836 0.35 . . . . 1.0 111.245 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.02 -44.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.718 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.85 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -55.14 -38.81 68.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.173 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.48 -43.58 84.23 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -96.07 -61.06 1.5 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.03 0.443 . . . . 1.0 110.293 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 m 55.96 79.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -139.99 -49.37 0.47 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.65 0.262 . . . . 1.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.495 HD13 ' H ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -163.39 139.06 6.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.495 ' H ' HD13 ' A' ' 135' ' ' LEU . 1.5 p -133.47 140.44 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.536 HD11 HD11 ' A' ' 31' ' ' LEU . 79.3 mt -119.18 125.9 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 139' ' ' HIS . 27.5 t -87.6 -164.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.435 ' N ' ' OG ' ' A' ' 138' ' ' SER . 79.4 t60 -139.03 -3.38 1.6 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 110.395 -0.224 . . . . 1.0 110.395 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.09 -56.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.099 0.476 . . . . 1.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 136.8 126.14 2.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 1.9 t -174.07 -131.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -73.76 -27.16 67.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -54.75 -44.81 73.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 89.1 mt -65.69 -26.75 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 122.173 -0.329 . . . . 1.0 110.902 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -54.57 34.68 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.25 -44.55 91.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.534 0.683 . . . . 1.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.7 p -49.08 -22.78 0.99 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.125 -0.943 . . . . 1.0 113.3 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.4 mt -82.46 -45.42 14.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.852 0.358 . . . . 1.0 111.611 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -68.8 -21.85 64.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.308 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.03 -3.0 57.72 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 53.06 34.34 16.93 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.593 0.235 . . . . 1.0 110.557 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.81 115.7 48.38 Favored Pre-proline 0 N--CA 1.481 1.11 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -50.94 155.22 6.12 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 CA-C-N 120.658 1.271 . . . . 1.0 112.308 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.14 170.31 19.73 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.274 1.035 . . . . 1.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.43 138.18 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.685 -1.598 . . . . 1.0 109.278 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.7 p -119.89 138.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 120.631 0.253 . . . . 1.0 110.815 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 14.3 t -72.35 125.27 26.97 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 184' ' ' CYS . 25.1 t -123.54 139.81 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.145 -0.687 . . . . 1.0 109.145 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 64.5 t30 57.11 -176.09 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.02 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' A' ' 160' ' ' ASN . 65.5 m-20 59.76 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.838 0.711 . . . . 1.0 111.077 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.548 ' OG ' HD23 ' A' ' 44' ' ' LEU . 68.8 m 53.59 -90.94 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.847 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 66.5 mt -3.79 78.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.104 1.362 . . . . 1.0 113.14 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 62.1 mmm -60.83 -41.14 95.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.14 -0.937 . . . . 1.0 110.617 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.46 121.58 17.29 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.05 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -64.91 -34.27 78.0 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.77 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -55.63 -39.54 70.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.097 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.7 -52.39 64.49 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -66.88 -28.59 68.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.821 0.343 . . . . 1.0 110.574 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.78 -51.99 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.441 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.9 -27.27 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.41 -58.3 3.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -52.18 -43.88 64.38 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.862 -1.063 . . . . 1.0 112.353 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -64.71 -41.99 95.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.421 -0.512 . . . . 1.0 109.844 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.206 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 179' ' ' GLY . 99.7 t -64.12 -35.32 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -48.09 -43.61 30.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.233 -0.894 . . . . 1.0 109.295 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.64 -29.91 67.49 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 82.47 -5.79 71.89 Favored Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.339 -1.104 . . . . 1.0 110.339 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.538 ' O ' HD22 ' A' ' 203' ' ' LEU . 0.3 OUTLIER -62.53 -4.73 2.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.949 -0.625 . . . . 1.0 111.284 -177.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.33 147.47 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.171 0.441 . . . . 1.0 110.156 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 19.6 m-90 -76.71 131.65 38.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m -88.08 138.6 31.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -135.53 149.77 49.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.1 150.34 70.88 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.59 -0.893 . . . . 1.0 108.59 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.17 58.19 5.54 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 122.201 1.934 . . . . 1.0 113.183 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 173.08 6.5 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.88 -57.71 5.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.8 m -88.84 -30.27 19.07 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.585 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -59.19 -47.71 89.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.353 -0.699 . . . . 1.0 111.353 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.42 -43.0 91.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 117.083 0.441 . . . . 1.0 111.155 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.46 -43.65 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.59 -38.51 72.11 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.38 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.24 91.38 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.418 -0.673 . . . . 1.0 111.418 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -52.68 63.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -60.84 -35.33 76.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.141 -0.936 . . . . 1.0 109.432 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.03 -45.23 86.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.885 0.374 . . . . 1.0 110.097 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 84.2 p -67.5 -20.49 65.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.66 -24.73 14.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.01 0.433 . . . . 1.0 109.873 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.1 m -74.63 -40.08 61.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.505 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -120.18 139.7 52.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.794 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -119.18 101.61 8.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.054 0.542 . . . . 1.0 109.977 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 180' ' ' TYR . 5.2 tp -63.83 131.18 46.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -67.99 150.19 97.87 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 106.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.508 2.362 0 C-N-CA 121.891 1.727 . . . . 1.0 113.624 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.81 84.69 9.63 Favored Pre-proline 0 N--CA 1.478 0.953 0 N-CA-C 109.932 -0.395 . . . . 1.0 109.932 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -57.32 127.33 25.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.624 1.55 . . . . 1.0 112.036 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.04 -33.48 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.675 -0.491 . . . . 1.0 109.675 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.537 0.461 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.861 -178.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 109.768 -0.456 . . . . 1.0 109.768 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -165.96 -76.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -132.73 101.48 5.3 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.006 0.522 . . . . 1.0 110.019 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.68 119.5 38.95 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -83.07 121.59 27.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.76 0.314 . . . . 1.0 110.22 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CE1' ' CZ ' ' A' ' 132' ' ' TYR . 6.9 m-85 -103.63 122.13 44.37 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.2 t -118.36 99.04 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.5 p -93.23 120.75 33.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.236 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 139' ' ' HIS . 71.5 m -61.25 -27.48 68.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -138.47 31.6 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.721 -0.952 . . . . 1.0 110.721 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.37 -112.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.892 -0.181 . . . . 1.0 110.71 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.5 p -71.3 112.74 7.68 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.5 131.48 95.1 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.874 -0.584 . . . . 1.0 110.358 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.77 -174.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.3 1.333 . . . . 1.0 112.477 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.99 144.96 90.01 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.034 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.78 -33.22 49.38 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.789 1.66 . . . . 1.0 113.086 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.32 -35.39 61.24 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.633 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -66.88 -45.04 79.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.799 0.333 . . . . 1.0 111.531 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 48' ' ' VAL . 16.2 m -60.72 -37.03 74.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.954 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -46.54 -27.53 1.15 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.181 0.515 . . . . 1.0 110.986 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.6 t -53.89 -38.09 64.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.78 . . . . 1.0 110.559 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.5 m -80.53 -4.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.302 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.52 40.18 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.224 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.9 m -135.62 -166.12 1.8 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.898 0.856 . . . . 1.0 109.823 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -54.6 -44.84 73.41 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.95 -1.477 . . . . 1.0 110.327 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.489 ' H ' ' CD ' ' A' ' 52' ' ' GLU . 23.4 mp0 -52.27 -52.07 54.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.534 0.207 . . . . 1.0 110.55 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.58 -37.33 76.92 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.432 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.2 t -49.77 -45.98 50.23 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.745 0.307 . . . . 1.0 111.552 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -72.66 -44.59 61.67 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 1.0 111.429 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.35 -36.01 80.53 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.596 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -58.17 -47.23 84.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.619 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.62 HD11 ' HZ3' ' A' ' 113' ' ' LYS . 1.5 mp -68.67 -28.95 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.86 -43.02 59.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.91 -0.587 . . . . 1.0 110.906 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -76.57 -11.05 59.81 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.047 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 83.64 37.83 11.43 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.61 -0.805 . . . . 1.0 111.505 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 63' ' ' VAL . 1.6 p90 -48.43 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 120.936 0.398 . . . . 1.0 111.17 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' N ' ' CD2' ' A' ' 62' ' ' PHE . 8.7 p -172.15 -31.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.001 0.429 . . . . 1.0 109.952 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.504 ' NH1' ' NZ ' ' A' ' 115' ' ' LYS . 56.1 ttt85 -167.02 108.52 0.66 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.5 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.07 130.47 36.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.252 -0.648 . . . . 1.0 109.252 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.09 135.88 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.09 144.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -119.98 124.36 45.74 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.158 -1.052 . . . . 1.0 108.158 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CE1' ' NH2' ' A' ' 105' ' ' ARG . 2.0 t80 -59.04 -169.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.302 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.82 -109.08 0.35 Allowed Glycine 0 N--CA 1.463 0.481 0 N-CA-C 110.664 -0.974 . . . . 1.0 110.664 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -65.17 124.28 21.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.71 0.291 . . . . 1.0 110.723 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.63 -37.99 88.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.775 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.36 -44.49 88.84 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.461 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 99.3 p -63.91 169.73 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.289 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.3 p -153.61 73.37 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.335 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.95 169.39 4.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.83 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 45.8 76.1 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.938 0.399 . . . . 1.0 110.736 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.37 -34.96 77.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.22 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -167.86 22.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.388 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.88 -30.19 66.5 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.839 0.352 . . . . 1.0 110.6 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' GLY . 74.6 t -58.91 -47.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -72.72 -42.15 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.884 0.373 . . . . 1.0 111.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -52.64 -43.37 65.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.954 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -83.1 -16.9 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.93 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.38 -55.86 0.41 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . 46.06 78.02 0.09 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 112.686 -0.166 . . . . 1.0 112.686 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.21 109.96 19.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -59.64 150.48 27.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.925 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.5 16.92 3.37 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.479 0.657 . . . . 1.0 109.549 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.469 0.5 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.441 179.881 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.958 0.408 . . . . 1.0 111.493 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.429 ' NH2' ' CE1' ' A' ' 69' ' ' PHE . 10.5 ptp180 -130.12 151.69 50.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.593 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -157.98 109.46 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.52 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -143.14 -172.96 3.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.75 -0.463 . . . . 1.0 109.75 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 109' ' ' LEU . 11.0 p -152.54 162.26 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.427 ' N ' HG22 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -163.84 -174.17 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.2 mtt 53.82 54.09 10.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.496 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 52.49 33.47 13.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.72 25.03 68.35 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 120.894 -0.67 . . . . 1.0 112.499 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.62 ' HZ3' HD11 ' A' ' 58' ' ' ILE . 16.6 tptm -83.21 -49.86 9.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.4 0.6 . . . . 1.0 112.034 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.73 132.84 56.42 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.186 0.517 . . . . 1.0 112.033 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' NZ ' ' NH1' ' A' ' 64' ' ' ARG . 49.3 mtmt -106.23 152.45 23.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -134.23 132.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.6 mt -145.06 123.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.795 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.26 -16.24 76.75 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.15 -1.18 . . . . 1.0 110.15 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.4 t80 54.69 -99.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -169.67 130.17 1.03 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.19 108.64 4.24 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.1 p -168.07 160.64 12.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.123 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.8 t -76.69 5.27 7.86 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.237 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -72.33 -42.73 65.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.293 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.1 ttm -46.14 -34.21 4.09 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.709 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.96 -28.47 57.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.624 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -79.35 -35.18 41.32 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.421 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 128' ' ' ILE . 1.6 mp -64.55 -27.82 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.762 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.2 mt -52.13 -51.45 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 120.316 -0.553 . . . . 1.0 109.739 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -48.47 -30.95 5.67 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.383 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -52.4 -47.23 66.4 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 121.263 -0.175 . . . . 1.0 111.276 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.595 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.2 p90 -117.1 -53.68 2.45 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.341 0.401 . . . . 1.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 47.4 m 50.25 79.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.869 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -120.14 -53.45 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 154' ' ' PRO . 3.3 tp -168.8 148.39 4.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.065 -0.654 . . . . 1.0 110.481 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.17 149.76 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.47 100.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 t -116.33 127.14 54.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.487 ' CD2' ' H ' ' A' ' 139' ' ' HIS . 13.2 p80 -80.69 67.86 6.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.226 -0.443 . . . . 1.0 109.875 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.85 34.37 23.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.994 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -62.41 -34.77 90.37 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.402 ' H ' HD12 ' A' ' 145' ' ' ILE . 2.8 m 69.03 -16.75 0.22 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.46 0.304 . . . . 1.0 110.413 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -84.25 -54.18 3.08 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.706 -0.557 . . . . 1.0 111.706 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.0 p -79.54 -32.22 42.15 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.47 0.308 . . . . 1.0 111.365 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 142' ' ' THR . 97.4 mt -54.27 -28.2 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 120.693 0.283 . . . . 1.0 110.86 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.9 mt -56.29 -51.08 69.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.807 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -65.17 -53.1 50.05 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 121.426 0.632 . . . . 1.0 110.865 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 88.0 p -58.32 -24.93 61.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 1.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.2 tp -76.7 -57.34 3.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.633 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 152' ' ' ASN . 39.6 ptt180 -62.36 -28.05 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.171 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.7 4.6 1.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 150' ' ' ARG . 22.7 m120 58.41 11.96 1.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.233 0.333 . . . . 1.0 110.274 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -92.5 142.33 25.77 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.458 ' O ' HD12 ' A' ' 135' ' ' LEU . 62.7 Cg_endo -71.67 167.9 25.22 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.719 1.613 . . . . 1.0 111.481 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 155' ' ' LEU . 1.9 pt? -156.65 156.52 33.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.295 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.412 ' CG2' ' SG ' ' A' ' 184' ' ' CYS . 16.8 mm -110.13 109.72 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.58 118.27 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.11 103.65 2.37 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 85.5 t -90.09 137.88 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.1 170.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.011 0.434 . . . . 1.0 110.769 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 49.82 74.75 0.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.715 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.1 t -171.2 -49.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.13 0.49 . . . . 1.0 110.129 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.0 pp -145.52 142.87 29.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.092 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.2 mmm -90.22 86.65 6.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.573 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 166' ' ' ASN . 15.3 t0 -161.16 -19.52 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.962 -0.385 . . . . 1.0 109.962 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 165' ' ' ASP . 67.4 m-20 58.7 6.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.67 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 165' ' ' ASP . 52.8 t-80 -66.25 -36.63 83.49 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 172' ' ' ALA . 5.3 pt20 -61.57 -41.6 97.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.974 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -53.96 -29.56 43.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.83 0.348 . . . . 1.0 111.024 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -70.45 -53.47 16.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.09 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.5 mt -83.63 -51.3 14.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 110.487 -0.19 . . . . 1.0 110.487 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 168' ' ' GLN . . . -45.05 -52.97 8.39 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 176' ' ' VAL . 30.4 t0 -69.36 -56.13 8.4 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -51.04 -26.98 6.95 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.9 0.381 . . . . 1.0 110.791 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.31 -38.84 66.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.243 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 173' ' ' ASP . 15.7 m -55.53 -29.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 120.918 0.39 . . . . 1.0 111.875 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -59.46 -48.49 81.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.942 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.6 mt -104.48 24.7 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.288 0.566 . . . . 1.0 110.409 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.644 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.3 82.57 0.04 OUTLIER Glycine 0 C--O 1.221 -0.703 0 N-CA-C 108.44 -1.864 . . . . 1.0 108.44 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -46.35 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 O-C-N 125.063 1.096 . . . . 1.0 110.692 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.644 ' N ' ' O ' ' A' ' 179' ' ' GLY . 6.3 p -73.24 139.63 19.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.534 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -63.9 116.85 6.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.2 m -108.75 133.63 52.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.562 -0.744 . . . . 1.0 109.875 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 156' ' ' ILE . 28.5 p -165.1 131.32 2.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.697 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.65 79.47 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.43 79.11 0.24 Allowed 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.704 2.27 . . . . 1.0 113.68 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.5 p -130.62 177.14 7.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 2.2 pm0 -68.64 -63.86 0.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.56 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.5 m -75.13 -43.56 51.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.022 0.439 . . . . 1.0 111.547 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -51.85 -51.24 40.61 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.969 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.97 -41.46 97.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.3 0.55 . . . . 1.0 111.743 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.76 -42.93 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.94 76.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 1.0 110.153 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.71 -46.44 61.26 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.66 -44.41 97.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.043 -0.354 . . . . 1.0 110.043 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -64.63 -37.91 89.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.57 86.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.4 t -60.16 -21.2 61.37 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.01 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -101.28 31.67 3.6 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.668 0.27 . . . . 1.0 110.792 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 18.2 p -143.01 -31.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.12 152.21 12.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.336 -0.546 . . . . 1.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -99.08 144.03 28.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.688 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.571 ' C ' HD22 ' A' ' 203' ' ' LEU . 0.0 OUTLIER -54.78 173.91 0.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.519 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.13 116.08 22.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-O 118.991 -0.528 . . . . 1.0 110.739 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.61 118.17 2.82 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 CA-C-N 120.919 1.364 . . . . 1.0 112.749 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -142.06 87.81 9.56 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 85.79 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.347 1.365 . . . . 1.0 112.436 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.74 -26.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.257 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.469 0.525 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.864 -178.908 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -116.96 65.19 0.72 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.06 156.09 39.59 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.7 134.77 51.7 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.772 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.65 119.57 32.2 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.743 -0.598 . . . . 1.0 109.466 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -101.42 129.94 47.54 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.25 138.04 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.73 129.62 42.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.491 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.56 34.75 2.67 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.971 0.415 . . . . 1.0 110.066 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.92 -160.13 53.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 -37.37 86.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.477 0.179 . . . . 1.0 111.059 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.1 p -133.18 150.45 52.0 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 110.067 -0.345 . . . . 1.0 110.067 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 39' ' ' VAL . 14.5 p -83.12 121.01 76.93 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 119.309 -0.377 . . . . 1.0 110.93 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.58 -59.63 1.12 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 CA-C-N 120.562 1.236 . . . . 1.0 112.386 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -144.81 145.31 27.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.906 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.76 -19.8 30.93 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 121.748 1.632 . . . . 1.0 111.813 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -77.23 -33.9 56.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.806 0.336 . . . . 1.0 110.875 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.46 -48.7 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 1.0 110.72 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -63.21 -34.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 1.0 109.76 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 50' ' ' SER . 6.4 m -52.52 -44.31 65.65 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.655 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -49.01 -38.56 23.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.73 0.3 . . . . 1.0 110.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.11 -14.1 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.271 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.59 35.17 4.24 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.993 0.425 . . . . 1.0 110.333 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 46' ' ' SER . 20.9 m -114.05 -167.55 1.23 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.16 -27.17 63.35 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.707 -1.133 . . . . 1.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.75 -47.57 65.93 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.241 -0.583 . . . . 1.0 110.485 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.2 t80 -69.22 -40.83 77.72 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.7 t -49.99 -48.48 52.3 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -66.78 -44.27 81.8 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.817 0.342 . . . . 1.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -73.64 -30.58 63.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.29 0.567 . . . . 1.0 109.833 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' PHE . 5.7 tt -58.78 -50.0 75.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.312 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -66.59 -31.07 51.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.268 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -59.8 -10.55 3.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.713 -0.222 . . . . 1.0 110.634 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -103.6 -10.59 18.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.218 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.53 13.39 55.58 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 121.188 -0.53 . . . . 1.0 112.384 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -84.71 160.61 20.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.56 3.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.769 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -148.75 142.4 25.5 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.544 0.688 . . . . 1.0 110.554 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -141.99 116.41 9.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.341 -0.845 . . . . 1.0 108.899 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mm -100.69 137.88 26.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tt -146.13 141.24 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.029 0.443 . . . . 1.0 109.833 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.09 158.91 5.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -174.82 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.963 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.27 147.44 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -155.73 83.83 1.03 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 1.0 110.282 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -68.28 -22.31 64.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.281 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -57.22 -29.6 63.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 84.4 p -149.97 -105.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.066 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.7 m -140.63 147.87 40.02 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 19.8 mp0 -84.2 -119.66 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.79 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -66.55 109.98 2.99 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.77 -57.42 5.64 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.108 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -173.23 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.06 -45.04 82.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.096 0.474 . . . . 1.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.88 -46.59 96.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.937 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.35 -26.45 68.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.009 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.98 -49.82 76.43 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.244 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -62.53 -17.38 59.69 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.083 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.77 54.9 7.83 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 110.179 -1.168 . . . . 1.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.15 -165.53 41.39 Favored Glycine 0 N--CA 1.466 0.669 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -134.6 135.03 41.91 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.004 0.431 . . . . 1.0 110.095 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -60.55 153.28 23.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.922 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -106.45 0.48 24.81 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 91.8 p . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 120.96 0.41 . . . . 1.0 111.117 -179.373 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -136.25 158.6 44.03 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.47 ' NE2' ' H ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -155.17 126.17 7.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.47 ' H ' ' NE2' ' A' ' 106' ' ' GLN . 2.0 m-85 -132.16 148.32 52.47 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.0 t -104.61 104.98 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.149 -0.932 . . . . 1.0 108.807 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -99.76 123.17 43.75 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 65.9 mtt 42.7 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.538 0.569 . . . . 1.0 112.538 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 54.96 7.8 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.757 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.29 24.02 72.18 Favored Glycine 0 N--CA 1.462 0.427 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -56.99 -39.47 74.72 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.046 -0.353 . . . . 1.0 110.046 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.8 tp -129.78 128.36 42.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -108.65 119.4 39.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.102 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.31 112.63 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.1 pt -115.08 158.66 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-N 115.144 -0.935 . . . . 1.0 108.954 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -115.44 95.05 0.69 Allowed Glycine 0 N--CA 1.474 1.205 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.76 -173.46 4.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -146.42 156.21 43.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.641 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -69.14 127.93 34.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.233 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.6 p -169.35 33.83 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.676 0.274 . . . . 1.0 110.448 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 29.6 p 51.6 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.653 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -179.88 -29.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.671 0.607 . . . . 1.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtm -55.38 -48.43 74.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.916 0.389 . . . . 1.0 110.923 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.402 ' O ' ' NE ' ' A' ' 130' ' ' ARG . 51.6 tt0 -55.29 -30.08 59.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 m -86.15 -51.79 6.08 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.965 0.412 . . . . 1.0 111.937 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.85 -43.33 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.199 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.33 -57.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.739 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 126' ' ' GLN . 18.1 ptp180 -69.2 -33.93 74.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.478 0.548 . . . . 1.0 112.478 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.17 -46.28 86.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.011 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.73 -65.38 1.15 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.78 0.324 . . . . 1.0 111.86 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 p -60.68 172.68 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.706 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -157.69 23.49 0.28 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.2 tp -158.69 138.03 11.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.85 155.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.08 102.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 81.9 p -89.71 113.24 24.72 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.42 0.629 . . . . 1.0 109.667 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.401 ' O ' ' N ' ' A' ' 141' ' ' GLY . 59.7 t-80 -69.69 136.44 51.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.24 -63.87 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.394 0.887 . . . . 1.0 113.394 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 139' ' ' HIS . . . -167.94 -80.44 0.04 OUTLIER Glycine 0 C--N 1.345 1.05 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.0 p 56.55 166.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.741 0.781 . . . . 1.0 110.76 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.35 -15.51 80.85 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 114.542 -1.208 . . . . 1.0 110.966 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 91.5 p -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.053 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.557 HG12 HD21 ' A' ' 155' ' ' LEU . 96.6 mt -59.01 -27.09 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.606 -0.438 . . . . 1.0 112.033 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 209' ' ' SER . 51.1 tp -57.02 -48.0 79.55 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.27 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -68.87 -51.99 34.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.631 . . . . 1.0 110.364 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.548 ' HB2' HD22 ' A' ' 155' ' ' LEU . 16.2 m -51.18 -25.22 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.766 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -77.01 -46.41 23.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.857 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -67.54 -32.83 73.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.54 -0.755 . . . . 1.0 111.24 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.75 -9.67 58.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 61.9 t30 54.88 35.27 23.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -109.46 151.28 42.07 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-O 119.294 -0.384 . . . . 1.0 110.393 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -43.13 143.59 1.96 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.007 1.804 . . . . 1.0 112.017 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 156' ' ' ILE . 52.3 tp -152.88 134.71 14.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.77 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -125.69 129.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.942 0.777 . . . . 1.0 109.013 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.17 130.53 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 117.986 0.357 . . . . 1.0 110.069 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 71.0 m -83.35 103.4 12.69 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.164 0.507 . . . . 1.0 109.663 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.36 143.41 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 160' ' ' ASN . 0.2 OUTLIER -147.62 175.32 10.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.936 0.398 . . . . 1.0 110.028 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -61.69 171.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.624 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.6 p -62.3 96.46 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.179 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 tp -66.38 -164.85 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.144 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.8 ttp -62.34 -52.47 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.835 0.35 . . . . 1.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 167' ' ' HIS . 75.9 m-20 -71.05 -42.7 69.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.115 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.71 0.86 0.16 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.287 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.475 ' H ' ' C ' ' A' ' 165' ' ' ASP . 34.6 m170 -73.55 -35.91 65.56 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.93 0.395 . . . . 1.0 110.459 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -65.29 -50.88 64.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.642 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.3 -33.32 74.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.441 . . . . 1.0 110.207 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.04 -52.43 65.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.707 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.85 -36.01 67.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.568 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.102 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 176' ' ' VAL . 27.6 t70 -49.32 -28.58 5.02 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.25 0.548 . . . . 1.0 110.423 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -85.43 -45.74 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.014 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.01 -20.51 60.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.258 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 177' ' ' GLU . 14.3 p -62.17 -52.08 64.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.976 0 C-N-CA 121.02 -0.272 . . . . 1.0 110.532 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 176' ' ' VAL . 57.7 mt-10 -58.79 -19.6 42.4 Favored 'General case' 0 CA--C 1.522 -0.11 0 O-C-N 121.931 -0.481 . . . . 1.0 111.048 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.77 3.2 0.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.676 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 177' ' ' GLU . . . 144.64 10.37 0.33 Allowed Glycine 0 N--CA 1.474 1.201 0 N-CA-C 111.089 -0.805 . . . . 1.0 111.089 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 176' ' ' VAL . 27.5 t80 72.23 100.38 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 1.0 109.237 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 181' ' ' VAL . 11.8 p -92.79 58.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.594 0.235 . . . . 1.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 181' ' ' VAL . 4.3 m-90 33.03 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.044 0.449 . . . . 1.0 110.303 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 93.8 p -88.08 132.75 34.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.95 142.55 46.8 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -111.31 155.86 42.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 119.158 -0.448 . . . . 1.0 110.755 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.32 37.73 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.785 1.656 . . . . 1.0 113.214 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p -131.32 143.09 50.25 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 24.8 mp0 -64.53 -46.33 83.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.474 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.0 m -64.4 -28.57 69.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.581 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.53 -31.89 17.53 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.45 -47.34 79.45 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 111.778 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.0 pt -52.66 -34.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.022 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.96 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.3 98.39 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 49.8 mt -64.66 -35.42 80.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.932 0.396 . . . . 1.0 110.359 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -69.89 -37.36 75.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.421 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -70.28 -44.95 67.32 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.062 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -66.58 -30.09 70.31 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.002 0.371 . . . . 1.0 112.002 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -86.16 11.67 11.39 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.176 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.2 p -146.37 -64.3 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.519 -0.31 . . . . 1.0 110.242 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.6 mt-10 -71.63 129.21 38.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.748 0.308 . . . . 1.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.07 170.84 8.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.83 138.49 54.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -57.49 143.25 75.22 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.11 100.35 1.37 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.719 1.613 . . . . 1.0 111.964 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -142.02 82.87 13.08 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.85 112.64 1.16 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.914 1.742 . . . . 1.0 111.873 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.34 -73.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.515 -0.474 . . . . 1.0 110.073 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.52 ' H ' HD13 ' A' ' 146' ' ' LEU . 47.1 m . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.015 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.691 0.282 . . . . 1.0 110.938 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -167.58 -61.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' O ' HG21 ' A' ' 63' ' ' VAL . 68.1 mttm -128.42 142.23 51.17 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.076 0.465 . . . . 1.0 110.167 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.28 167.4 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.85 120.19 19.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -118.73 133.56 55.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.403 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.7 140.29 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 t -143.96 141.24 30.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.034 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.8 m -83.19 143.51 30.43 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.452 ' N ' ' NE2' ' A' ' 139' ' ' HIS . . . -71.01 62.12 0.97 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.36 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.791 0.348 . . . . 1.0 110.775 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.4 p 53.18 100.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -59.68 125.36 79.76 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.035 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.71 -54.68 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.021 1.147 . . . . 1.0 111.927 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.417 ' CE2' ' OD1' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -142.76 144.54 30.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.92 -7.71 15.48 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.968 1.778 . . . . 1.0 111.545 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -66.99 -46.09 75.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.781 0.324 . . . . 1.0 111.083 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.67 -40.98 98.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.78 0.324 . . . . 1.0 110.617 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.23 -44.63 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.6 t -54.82 -48.2 73.11 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.166 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.3 m -51.65 -49.8 61.58 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.272 -0.267 . . . . 1.0 111.369 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 30.0 m -78.94 5.79 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.672 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.04 30.96 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 46' ' ' SER . 14.3 t -119.23 -164.12 1.03 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.548 ' N ' ' OG ' ' A' ' 50' ' ' SER . 76.1 m-20 -50.83 -42.42 58.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.922 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -62.76 -53.82 48.5 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 121.171 0.51 . . . . 1.0 110.218 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CE2' HD13 ' A' ' 57' ' ' LEU . 54.6 t80 -61.99 -45.43 93.66 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.244 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 89.4 m -51.94 -49.62 62.77 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.32 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 78.0 mt-30 -73.14 -52.3 14.72 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.077 0.465 . . . . 1.0 110.593 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -57.02 -24.94 57.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.694 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 ' CE2' ' A' ' 53' ' ' PHE . 48.8 tp -61.15 -45.32 95.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 1.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -62.42 -43.39 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.747 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.418 ' N ' ' OE1' ' A' ' 59' ' ' GLN . 1.1 mp0 -55.56 -16.83 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.469 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.71 ' CD1' HD12 ' A' ' 195' ' ' LEU . 74.3 t80 -98.5 -19.06 17.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 102.65 40.52 2.52 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 118.111 -1.383 . . . . 1.0 111.676 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 61' ' ' GLY . 13.3 p90 -13.22 146.57 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 124.33 1.052 . . . . 1.0 112.143 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 29' ' ' LYS . 84.8 t -146.86 -78.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.777 0.717 . . . . 1.0 109.583 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -151.82 110.68 3.84 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.4 tp -92.25 127.6 37.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.03 146.31 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.6 tt -138.75 141.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.473 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 9.8 tp-100 -70.18 -86.38 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.528 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 t80 50.89 -174.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.249 0.219 . . . . 1.0 110.491 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.56 76.03 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -67.18 175.99 2.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.894 0.378 . . . . 1.0 110.039 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -61.61 -29.86 70.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.392 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -60.09 -21.58 61.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.255 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m 53.3 -95.8 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.055 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 t 56.83 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.159 0.504 . . . . 1.0 111.166 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -79.4 132.45 36.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.116 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.439 ' CD2' ' O ' ' A' ' 77' ' ' PHE . 54.5 t80 -78.07 12.51 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.211 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 80' ' ' LEU . 78.8 tt0 62.58 137.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.74 0.65 . . . . 1.0 109.745 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -67.83 66.1 0.09 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.928 0.394 . . . . 1.0 110.05 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.14 -57.53 3.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.323 0.582 . . . . 1.0 111.618 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 107' ' ' TYR . 28.7 m -57.43 -43.3 82.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.538 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.479 ' N ' HG23 ' A' ' 81' ' ' VAL . 58.0 tt0 -63.31 -39.83 95.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.298 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -52.45 -46.03 66.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.998 0.428 . . . . 1.0 110.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.44 ' NH2' ' OG ' ' A' ' 50' ' ' SER . 30.3 mmt180 -71.66 -16.44 62.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.06 59.65 1.94 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.61 -168.02 39.61 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 110.087 -1.205 . . . . 1.0 110.087 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -133.35 127.72 34.11 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 113.1 24.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.728 0.299 . . . . 1.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -84.2 -76.51 0.3 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.095 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.531 0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.405 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -141.35 154.15 45.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.682 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -156.18 131.62 9.48 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.349 -0.611 . . . . 1.0 109.349 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.508 ' CD2' HG21 ' A' ' 81' ' ' VAL . 9.9 m-85 -132.1 143.77 50.24 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.465 -0.569 . . . . 1.0 109.465 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 112' ' ' GLY . 9.1 p -127.88 140.57 48.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 111' ' ' ASN . 10.9 mp -101.61 147.96 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.2 mtp 46.66 -89.74 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.442 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 109' ' ' LEU . 16.9 m120 -155.86 81.5 1.01 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.804 0.335 . . . . 1.0 110.476 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.472 ' H ' ' CG2' ' A' ' 108' ' ' VAL . . . 74.74 23.3 75.39 Favored Glycine 0 N--CA 1.469 0.853 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -73.14 -75.05 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.571 -0.37 . . . . 1.0 110.671 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.92 126.96 53.63 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.476 0.485 . . . . 1.0 109.947 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -105.64 101.25 10.78 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.473 -0.195 . . . . 1.0 110.473 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.05 109.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -117.53 139.6 15.03 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 109.914 -1.275 . . . . 1.0 109.914 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -170.11 140.82 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -160.52 155.97 25.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.013 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 123' ' ' THR . 82.7 t80 -161.16 98.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.289 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 64.35 -67.52 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.525 0.516 . . . . 1.0 110.819 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 121' ' ' PHE . 30.3 m -154.78 121.65 5.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -148.6 5.48 0.7 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 125' ' ' MET . 3.9 mpp? -59.22 -57.25 13.86 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.17 -29.01 65.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.951 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.3 m -70.85 -43.4 68.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.435 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.8 -50.05 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 1.0 112.367 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 133' ' ' SER . 1.2 pp -63.78 -54.02 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.926 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -47.03 -37.36 9.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.072 -0.393 . . . . 1.0 111.068 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.94 -48.22 78.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.12 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -100.22 -64.25 1.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.811 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 129' ' ' ILE . 34.2 p 57.09 74.26 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -134.8 -44.87 0.73 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.956 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.9 tp -169.13 151.03 4.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.68 146.51 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.18 105.73 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 138.13 40.34 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.509 ' CD2' ' NE2' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -60.11 -169.65 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.042 0.449 . . . . 1.0 110.176 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.17 45.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.431 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.38 -128.11 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.7 m -163.44 -50.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.576 -0.367 . . . . 1.0 110.771 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.73 -52.51 5.86 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 92.1 p -55.15 -42.69 73.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.743 0.306 . . . . 1.0 110.88 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.74 -49.69 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.6 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.59 -31.24 6.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.001 0.188 . . . . 1.0 111.403 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.27 -50.79 29.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.999 0.428 . . . . 1.0 110.287 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.888 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.36 -46.64 31.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.764 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.98 -37.39 86.94 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.876 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.07 -11.61 59.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.61 36.51 26.83 Favored 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 123.473 0.483 . . . . 1.0 110.049 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -122.95 147.16 50.55 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.925 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -45.19 165.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.205 1.936 . . . . 1.0 112.47 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 59.9 tp -152.03 140.73 20.86 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.039 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.09 123.83 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -116.0 133.3 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 117.801 0.273 . . . . 1.0 111.169 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 77.4 m -72.66 105.13 4.15 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.28 141.52 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.874 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.56 -157.16 0.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.064 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 t70 58.34 21.29 8.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.451 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.5 m -85.75 90.15 7.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.687 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 163' ' ' LEU . 10.0 mp -63.55 -41.19 98.44 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.897 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' ASN . 43.3 ttp -130.1 -53.05 1.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.506 0.322 . . . . 1.0 110.755 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.417 ' OD1' ' CE2' ' A' ' 41' ' ' PHE . 4.0 p-10 -66.72 69.61 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.138 0.494 . . . . 1.0 110.635 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 164' ' ' MET . 76.7 m-20 -65.45 -25.82 67.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.383 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -51.18 -32.3 22.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.839 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.509 ' NE2' ' CD2' ' A' ' 139' ' ' HIS . 19.6 mm100 -60.7 -47.79 84.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.529 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -69.1 -30.14 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.487 0.184 . . . . 1.0 111.013 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.14 -54.16 45.08 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.02 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 175' ' ' PHE . 17.0 tt -68.61 -34.85 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.25 -65.04 0.63 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.294 0.569 . . . . 1.0 110.623 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.02 -34.26 28.71 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.065 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.04 -31.44 56.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.407 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' ILE . 3.5 t80 -63.19 -47.13 83.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.849 0.357 . . . . 1.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.53 -44.64 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -54.75 -46.85 74.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.113 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 178' ' ' LEU . 10.5 mp -98.33 9.47 42.99 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.071 0.462 . . . . 1.0 110.365 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 173.66 91.11 0.08 OUTLIER Glycine 0 C--O 1.212 -1.239 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -49.51 70.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.086 0.954 . . . . 1.0 111.174 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.6 p -73.8 141.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.889 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -59.25 114.04 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.263 0.554 . . . . 1.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.5 t -87.0 135.96 33.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.443 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.62 170.79 17.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.23 74.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.622 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.62 57.49 1.42 Allowed 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.558 2.172 . . . . 1.0 112.882 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.9 p -131.65 147.05 52.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -59.48 -51.91 67.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.616 0.245 . . . . 1.0 111.19 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 26.1 m -65.27 -24.86 67.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.925 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.04 -36.02 8.61 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 116.183 -0.462 . . . . 1.0 112.087 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -40.97 85.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 117.235 0.518 . . . . 1.0 111.556 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.0 pt -55.58 -34.66 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 1.0 110.833 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.7 78.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.189 0.518 . . . . 1.0 109.775 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.78 -46.16 94.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.236 -0.746 . . . . 1.0 111.236 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.71 HD12 ' CD1' ' A' ' 60' ' ' TYR . 4.4 mm? -61.92 -44.13 97.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.912 0.356 . . . . 1.0 110.312 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -63.32 -52.14 63.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.623 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.56 71.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.177 -0.305 . . . . 1.0 110.177 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 97.1 p -60.48 -34.05 73.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.965 -0.294 . . . . 1.0 111.304 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -102.64 32.8 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 1.0 111.135 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 19.6 m -159.84 -29.17 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.159 -0.338 . . . . 1.0 110.607 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -108.75 152.13 25.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -122.21 170.82 9.51 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.6 tp -119.73 136.24 54.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -62.61 152.25 81.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.196 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -37.9 109.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.826 2.35 . . . . 1.0 112.554 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 206' ' ' PHE . 0.1 OUTLIER -61.53 151.75 76.62 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.332 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.03 -8.01 18.59 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.961 1.774 . . . . 1.0 111.705 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.7 p -49.96 132.57 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.608 0.242 . . . . 1.0 111.06 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.467 0.405 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.449 179.82 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' ' 115' ' ' LYS . 67.8 mt-10 . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.64 0.257 . . . . 1.0 110.613 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -92.39 -73.4 0.55 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.3 110.87 7.03 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.4 125.11 52.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.844 0.458 . . . . 1.0 109.991 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.2 mp -91.73 107.19 19.04 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.188 0.518 . . . . 1.0 109.63 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -85.07 125.81 33.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.081 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.91 130.09 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -145.52 136.68 24.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.74 -26.6 31.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.451 . . . . 1.0 109.835 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.25 -112.09 3.93 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.95 -156.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.571 0.224 . . . . 1.0 110.627 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 t -53.6 170.53 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.7 t -139.67 82.75 17.65 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.62 16.37 1.97 Allowed 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.481 2.121 . . . . 1.0 111.702 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.08 65.0 28.28 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.98 -17.55 41.09 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.028 1.818 . . . . 1.0 111.941 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -79.99 -30.85 39.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.499 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.47 -44.92 56.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.797 0.332 . . . . 1.0 110.645 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 -29.41 46.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.029 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.5 p -51.31 -38.47 53.15 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.118 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -47.33 -28.34 1.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 1.0 110.605 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -92.23 -23.91 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.839 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 46' ' ' SER . 0.7 OUTLIER -120.67 24.79 10.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.968 0.507 . . . . 1.0 110.194 -177.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 46' ' ' SER . 40.3 t -104.72 -161.76 0.84 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.459 ' N ' ' OG ' ' A' ' 50' ' ' SER . 63.0 m-20 -71.27 -28.52 64.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.28 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.59 -51.51 69.51 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.855 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.7 t80 -70.14 -39.15 75.56 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.185 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.7 t -52.67 -46.2 67.12 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.678 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -71.66 -44.14 64.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.113 0.482 . . . . 1.0 110.586 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -68.41 -26.45 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' PHE . 56.1 tp -57.19 -44.64 83.78 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -55.11 -33.63 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -34.56 75.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.43 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -72.31 -18.89 61.75 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.71 34.38 2.85 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 37.33 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.862 0.465 . . . . 1.0 111.462 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -115.86 -95.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 122.618 0.367 . . . . 1.0 110.36 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.463 ' H ' HG23 ' A' ' 63' ' ' VAL . 42.5 ttm180 -168.42 149.87 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -130.29 118.07 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 66' ' ' ILE . 5.2 mp -108.98 132.01 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 tp -114.56 141.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -166.51 -166.98 0.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.03 164.49 32.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.38 -35.35 90.86 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.53 147.65 51.61 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.993 0.425 . . . . 1.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -62.96 -35.18 79.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.274 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -60.95 -49.18 78.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 96.5 p -77.27 102.05 6.53 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.186 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.4 p -169.98 88.91 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.992 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.28 -87.11 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 47.24 94.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.819 0.343 . . . . 1.0 110.145 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.87 -70.83 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.161 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -174.66 66.0 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.837 0.351 . . . . 1.0 110.318 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 80' ' ' LEU . 9.6 mp -63.34 -41.39 98.87 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.829 0.347 . . . . 1.0 110.339 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 82' ' ' GLN . 20.0 m -60.23 -45.86 95.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.863 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.475 ' N ' HG23 ' A' ' 81' ' ' VAL . 2.6 tm0? -66.53 -46.89 74.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.794 0.33 . . . . 1.0 110.84 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -55.52 -45.66 77.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.932 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.427 ' HA ' ' HE ' ' A' ' 84' ' ' ARG . 0.4 OUTLIER -74.16 -17.16 60.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.475 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.96 50.32 3.96 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.12 177.49 54.3 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 109.487 -1.445 . . . . 1.0 109.487 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -124.44 121.98 36.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -63.45 159.81 17.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.881 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -131.27 -178.8 5.0 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.563 -179.706 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.016 0.436 . . . . 1.0 110.196 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -131.36 161.72 31.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.821 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -155.95 119.61 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.75 159.84 40.06 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.52 143.61 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.8 mm? -95.88 137.42 34.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.9 mmm 47.12 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.014 0.821 . . . . 1.0 111.272 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 109' ' ' LEU . 19.8 p-10 -156.83 70.46 0.64 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.973 0.416 . . . . 1.0 110.551 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.2 27.13 64.63 Favored Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.576 -0.61 . . . . 1.0 111.576 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -91.9 -7.14 50.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.826 0.313 . . . . 1.0 110.728 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.65 131.55 0.89 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 99.3 mttt -98.73 141.66 31.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.83 112.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.87 130.82 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.139 0.576 . . . . 1.0 109.82 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -22.97 68.87 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -117.71 169.52 9.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.875 0.47 . . . . 1.0 110.438 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -168.6 173.71 7.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.112 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 122' ' ' SER . 88.2 t80 -65.62 166.98 9.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.43 . . . . 1.0 109.843 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.478 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 40.7 t 53.15 96.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.807 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 124' ' ' LYS . 89.9 m -58.71 164.86 2.52 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.509 ' N ' HG22 ' A' ' 123' ' ' THR . 14.5 tptm 68.86 108.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.431 0.457 . . . . 1.0 110.263 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 126' ' ' GLN . 0.0 OUTLIER -49.77 -36.74 27.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.122 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.471 ' N ' ' SD ' ' A' ' 125' ' ' MET . 57.8 tt0 -57.3 -32.37 66.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.2 m -78.72 -34.84 45.59 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.835 0.35 . . . . 1.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.379 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -58.29 -48.97 83.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -59.45 -44.9 92.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.59 -0.277 . . . . 1.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -53.26 -42.9 66.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.504 -0.317 . . . . 1.0 111.411 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -98.43 -68.45 0.8 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p 71.52 33.37 1.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.03 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.74 -66.4 0.91 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.198 -0.668 . . . . 1.0 109.198 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 44.3 tp -165.95 142.84 5.3 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.818 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.38 147.24 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.01 125.51 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.145 -1.058 . . . . 1.0 108.145 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.7 p -137.57 134.58 35.78 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.7 -34.53 58.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.65 34.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.669 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 143' ' ' GLY . . . -61.67 -37.01 93.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.5 m 65.19 -65.49 0.16 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.099 0.476 . . . . 1.0 111.021 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' GLY . . . -66.52 -32.68 82.38 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 44.8 m -73.92 -33.89 64.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.769 0.319 . . . . 1.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.4 -28.74 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 120.974 0.416 . . . . 1.0 110.769 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -47.91 -51.11 24.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.618 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -63.18 -44.47 95.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.314 0.578 . . . . 1.0 110.859 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.0 m -59.88 -24.62 64.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.479 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.36 -48.4 23.21 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.3 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -75.08 -22.47 58.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.832 -0.622 . . . . 1.0 111.35 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.87 -6.75 50.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 51.41 31.07 6.8 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.171 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 78.9 mttt -108.8 155.86 39.95 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 123.326 0.391 . . . . 1.0 110.026 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -42.66 139.27 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.683 1.589 . . . . 1.0 111.91 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.757 ' C ' HD13 ' A' ' 156' ' ' ILE . 3.0 tm? -153.82 122.91 6.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.757 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -117.52 120.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.71 0.631 . . . . 1.0 109.731 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.08 115.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 94.7 m -72.33 102.5 3.15 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.29 137.07 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -130.48 171.98 12.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 29.0 p-10 -97.02 14.55 25.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.512 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 t -156.67 -136.49 0.05 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.563 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt 64.88 114.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 tpt 67.82 173.19 0.27 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.317 -0.402 . . . . 1.0 109.927 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.61 -65.6 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -154.22 9.41 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.814 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -62.97 -33.43 75.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.009 -0.367 . . . . 1.0 110.009 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.32 -38.52 77.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 1.0 110.412 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -78.45 -32.52 48.48 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.633 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.07 -50.2 67.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.707 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.88 -38.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.34 -56.33 4.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.196 0.998 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -49.84 -52.36 33.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.882 -1.053 . . . . 1.0 110.922 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.63 -30.88 70.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 1.0 110.478 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 181' ' ' VAL . 2.8 m-85 -74.89 -55.21 6.03 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.783 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.22 -25.89 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.692 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -48.55 -52.03 24.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.485 -0.932 . . . . 1.0 108.485 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.24 -29.96 70.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.701 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 129.75 81.53 0.27 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 112.106 -0.398 . . . . 1.0 112.106 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 36.6 46.88 0.48 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.62 0.724 . . . . 1.0 111.505 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.688 HG13 ' H ' ' A' ' 182' ' ' TRP . 2.5 p -48.12 -61.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.671 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . 0.688 ' H ' HG13 ' A' ' 181' ' ' VAL . 10.4 m0 -156.73 62.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.991 0.807 . . . . 1.0 110.377 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -111.93 130.43 55.85 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.363 -0.835 . . . . 1.0 108.99 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 49.2 t -164.26 127.44 2.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.071 -0.715 . . . . 1.0 109.071 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 153.14 70.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 110.686 -0.116 . . . . 1.0 110.686 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 84.26 0.45 Allowed 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.077 1.851 . . . . 1.0 112.588 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.9 m -132.19 148.82 52.48 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -48.19 -54.83 12.09 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.185 -0.206 . . . . 1.0 111.37 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.6 m -73.25 -44.98 58.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.986 0.422 . . . . 1.0 111.049 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -55.9 -44.81 87.47 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.029 -0.532 . . . . 1.0 112.427 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -40.98 71.36 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.93 0.365 . . . . 1.0 110.172 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.99 -45.44 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.29 66.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.017 0.437 . . . . 1.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -54.56 -40.19 69.06 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -47.94 71.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.454 0.645 . . . . 1.0 109.928 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -59.99 -45.65 92.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.859 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.13 -52.0 66.71 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.035 0.445 . . . . 1.0 110.946 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 155' ' ' LEU . 39.9 p -65.09 -21.52 66.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.02 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -110.18 31.3 6.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.727 0.411 . . . . 1.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 56.3 m -145.88 -27.05 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.37 151.36 35.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.29 142.99 50.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.918 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.18 -161.24 0.79 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.938 -0.574 . . . . 1.0 109.569 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -73.2 144.91 85.17 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.886 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.84 -47.19 27.7 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.527 1.485 . . . . 1.0 113.374 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -139.73 86.4 13.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.241 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.4 -64.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.039 1.826 . . . . 1.0 111.721 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.17 145.59 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.075 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -133.51 -117.39 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -76.53 94.8 3.77 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.707 0.289 . . . . 1.0 110.913 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.33 166.26 12.17 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.2 mt -132.26 101.0 5.19 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.626 ' CZ ' HD13 ' A' ' 66' ' ' ILE . 6.1 m-85 -95.0 127.12 40.81 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.023 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 137' ' ' ILE . 5.5 p -127.21 125.68 66.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.7 p -143.52 137.38 28.43 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.254 -0.884 . . . . 1.0 109.46 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.8 m -103.45 140.32 37.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.0 -89.48 0.03 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.263 -0.735 . . . . 1.0 111.263 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.56 -78.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.867 0.365 . . . . 1.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -167.12 160.51 13.96 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.297 -0.41 . . . . 1.0 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.16 144.49 87.35 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.744 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.78 -46.6 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.966 1.777 . . . . 1.0 111.054 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -139.32 160.72 60.85 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 123.069 0.23 . . . . 1.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.17 -10.62 29.49 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 122.089 1.859 . . . . 1.0 112.011 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -73.96 -29.56 62.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.876 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.441 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.2 mm? -63.15 -53.84 47.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.072 -0.251 . . . . 1.0 110.897 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 46' ' ' SER . 18.2 m -69.92 -42.67 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.711 0.291 . . . . 1.0 110.581 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.2 t -51.95 -53.19 44.23 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.102 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 53' ' ' PHE . 90.9 m -47.21 -36.14 8.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.771 -0.195 . . . . 1.0 111.294 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.9 t -72.8 -26.18 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 120.775 0.321 . . . . 1.0 111.439 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.24 33.28 3.09 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.365 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.2 t -98.35 -173.71 2.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' N ' ' OG ' ' A' ' 50' ' ' SER . 11.5 m-20 -56.38 -27.64 56.83 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.374 -1.284 . . . . 1.0 110.904 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -71.81 -53.56 12.94 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.669 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 47' ' ' CYS . 3.3 m-85 -68.55 -37.67 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.146 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 93.7 m -53.2 -45.9 68.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.639 0.256 . . . . 1.0 111.039 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.92 -40.96 71.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -67.99 -27.79 66.87 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -60.22 -39.41 86.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.358 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mm -48.89 -41.12 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.564 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -65.97 -40.94 91.72 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.303 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -65.43 -23.28 66.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.027 -0.36 . . . . 1.0 110.027 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' C ' ' CG ' ' A' ' 62' ' ' PHE . . . 93.49 20.3 32.56 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.784 -0.526 . . . . 1.0 111.784 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HA ' HD12 ' A' ' 57' ' ' LEU . 1.4 p90 43.02 78.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 117.801 0.801 . . . . 1.0 111.024 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.7 -85.76 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -168.81 135.05 1.78 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 66' ' ' ILE . 3.6 tt -133.25 131.39 40.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.626 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 1.7 mp -116.47 127.33 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.579 HD13 ' N ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -108.48 132.35 56.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.579 ' N ' HD13 ' A' ' 67' ' ' ILE . 57.2 tt0 -146.65 153.99 40.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.22 -151.33 0.39 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.012 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.94 -114.94 0.01 OUTLIER Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 72' ' ' ASN . 35.6 ttt180 -165.58 -149.96 0.12 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.231 -0.57 . . . . 1.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -59.51 -41.63 90.34 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.136 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.7 t -140.7 132.45 27.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.195 -0.457 . . . . 1.0 109.99 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 m -157.99 163.12 38.1 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.31 23.67 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.845 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -67.53 85.18 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 80' ' ' LEU . 70.8 mm-40 -61.91 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.657 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -73.89 33.6 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.741 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 78' ' ' GLU . 1.9 pp -62.46 -32.47 73.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 1.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.2 t -62.81 -51.55 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.859 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -72.85 -32.51 65.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.279 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -50.96 -43.98 60.5 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.22 -0.445 . . . . 1.0 109.819 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.437 ' NE ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -79.37 -16.23 56.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.051 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.84 28.87 5.76 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.97 158.17 53.47 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -134.63 128.93 34.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.841 0.353 . . . . 1.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -52.82 159.93 1.03 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.99 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.43 152.07 37.47 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.145 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.456 0.169 . . . . 1.0 111.321 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.426 ' CB ' ' H ' ' A' ' 118' ' ' GLY . 75.4 mmt-85 -123.42 119.19 29.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -160.69 119.44 2.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.275 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.44 161.42 27.12 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.31 135.77 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -95.35 133.88 38.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.439 . . . . 1.0 109.964 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.4 mmm 50.01 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.924 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -148.94 48.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.383 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 27.45 29.14 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 111.955 -0.458 . . . . 1.0 111.955 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.4 -12.27 54.74 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.3 tp -168.0 137.34 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -102.98 140.39 37.31 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.62 142.19 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.078 -1.082 . . . . 1.0 108.078 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' ILE . 18.9 pt -142.53 131.14 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.426 ' H ' ' CB ' ' A' ' 105' ' ' ARG . . . -65.99 -139.72 0.04 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CE2' ' O ' ' A' ' 120' ' ' ASP . 78.5 t80 -57.73 161.31 3.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.921 0.391 . . . . 1.0 110.498 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' CE2' ' A' ' 119' ' ' PHE . 54.3 p-10 -153.64 -177.06 6.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.076 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -65.16 153.97 39.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 123' ' ' THR . 79.5 p -59.3 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.917 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.401 ' N ' ' OG ' ' A' ' 122' ' ' SER . 25.7 m -61.65 106.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -168.01 -54.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.343 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 52.5 mtm -44.99 -45.88 10.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 1.0 111.572 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -59.25 -31.1 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.737 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -80.57 -52.28 7.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.798 0.332 . . . . 1.0 111.813 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 128' ' ' ILE . 1.5 mp -62.69 -43.72 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.876 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -54.06 -53.2 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.23 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -51.1 -30.04 14.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.521 0.201 . . . . 1.0 111.06 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.86 -42.47 58.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.688 -0.233 . . . . 1.0 110.9 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.58 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.1 p90 -123.1 -51.88 1.88 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.58 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 82.8 p 48.65 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.943 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -137.22 -52.39 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.2 tp -167.35 148.14 5.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.6 151.55 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 73.7 mt -117.71 115.63 49.17 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 108.177 -1.046 . . . . 1.0 108.177 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.9 p -85.21 -161.38 0.58 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -159.74 83.97 0.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 52.28 17.61 0.76 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.81 -147.88 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -164.01 -60.6 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 -26.68 73.9 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 123.792 0.683 . . . . 1.0 111.946 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.5 m -70.3 -36.62 74.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.681 0.277 . . . . 1.0 111.313 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.18 -40.61 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.847 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -50.09 -40.84 46.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.798 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -52.11 66.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.512 0.672 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.8 p -70.36 -22.62 62.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.239 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.466 HD11 HD23 ' A' ' 203' ' ' LEU . 17.0 tp -73.23 -53.32 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.157 0.428 . . . . 1.0 112.157 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -67.29 -31.75 72.28 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.583 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 mp -70.04 -1.63 10.42 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 58.53 34.03 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.391 0.432 . . . . 1.0 110.6 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 97.8 mttt -113.2 126.32 28.38 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.44 157.15 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.416 1.41 . . . . 1.0 111.941 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.581 ' C ' HD13 ' A' ' 156' ' ' ILE . 5.4 tt -152.44 144.39 23.73 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.581 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -111.31 116.55 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 157' ' ' VAL . 14.0 p -103.71 117.32 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 57.2 m -74.07 104.35 4.86 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.427 -0.582 . . . . 1.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.01 138.51 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -160.24 -165.51 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.827 0.346 . . . . 1.0 110.174 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -65.34 -168.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.6 m -156.72 81.35 0.95 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.956 0.407 . . . . 1.0 109.927 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -35.36 12.66 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.797 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.1 mmt -82.51 36.15 0.47 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.193 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 167' ' ' HIS . 25.6 t70 54.89 31.23 15.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.663 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.02 74.89 0.08 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.068 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' ASP . 85.2 t60 -57.93 -30.38 65.89 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.995 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -49.72 -40.28 40.11 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.15 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.17 -46.56 86.58 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -45.41 -37.45 5.1 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.09 -42.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.148 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -48.99 -60.58 2.65 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.867 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.74 -25.19 62.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.049 0.452 . . . . 1.0 110.393 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -72.58 -53.69 11.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.472 -0.785 . . . . 1.0 110.446 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 179' ' ' GLY . 58.0 t80 -64.47 -34.91 79.31 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.29 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.6 t -54.86 -56.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.281 0.363 . . . . 1.0 110.189 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.03 -30.63 15.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.149 -0.62 . . . . 1.0 109.939 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.26 21.32 12.77 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.499 -0.773 . . . . 1.0 113.013 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 175' ' ' PHE . . . -151.37 -24.63 0.05 OUTLIER Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 180' ' ' TYR . 73.1 t80 54.42 23.52 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 109.879 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 182' ' ' TRP . 3.2 p -50.18 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.19 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . 0.56 ' C ' ' O ' ' A' ' 181' ' ' VAL . 7.0 m-90 -9.74 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 124.004 0.815 . . . . 1.0 109.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 88.9 p -86.74 134.83 33.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.829 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -125.02 156.9 37.42 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.24 -0.891 . . . . 1.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.38 154.04 76.73 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.643 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.41 58.34 0.48 Allowed 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.588 2.192 . . . . 1.0 112.358 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 m -135.72 147.16 48.36 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.62 -48.71 28.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.0 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 190' ' ' GLY . 13.3 t -69.68 -44.18 71.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.027 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -51.75 -51.66 37.96 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.245 -0.434 . . . . 1.0 112.134 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.78 -43.63 90.49 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.45 0.147 . . . . 1.0 110.63 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.14 -44.73 80.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.612 0.244 . . . . 1.0 110.46 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -54.1 -56.68 15.81 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.873 0.324 . . . . 1.0 111.873 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -58.53 -30.27 64.97 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -48.07 63.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.983 0.42 . . . . 1.0 110.54 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -64.22 -40.64 96.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.71 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.74 88.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.2 m -71.27 -23.26 61.94 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.967 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -105.0 30.76 5.29 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.899 0.381 . . . . 1.0 110.753 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.1 p -141.7 -21.25 0.73 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.29 153.23 27.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.07 0.462 . . . . 1.0 109.771 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.75 153.92 32.6 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.178 -0.919 . . . . 1.0 109.219 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.466 HD23 HD11 ' A' ' 149' ' ' LEU . 5.2 tp -94.86 136.97 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.8 153.02 8.9 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.711 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.2 106.57 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.391 1.394 . . . . 1.0 111.148 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -140.82 87.16 11.35 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.46 111.58 3.29 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.562 1.508 . . . . 1.0 111.763 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.24 98.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.057 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.465 0.288 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.561 -179.825 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mp -65.43 -44.54 94.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.5 mt 57.12 79.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.939 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -58.92 136.06 57.76 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.231 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -167.65 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -130.17 133.86 46.89 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.828 0.451 . . . . 1.0 110.659 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.21 166.99 10.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -133.85 109.02 8.79 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -103.1 130.47 50.26 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.93 137.18 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 t -142.63 137.91 30.33 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.849 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 63.4 m -92.65 -14.15 28.52 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.55 -93.63 0.05 OUTLIER Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -179.55 0.78 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.3 p -62.12 132.22 52.1 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.955 -0.387 . . . . 1.0 109.955 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -62.54 149.54 88.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.71 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.8 -62.6 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.719 1.613 . . . . 1.0 112.037 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -142.45 138.82 16.76 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 119.117 -0.468 . . . . 1.0 110.621 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.43 -31.17 46.81 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 121.781 1.654 . . . . 1.0 113.52 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.92 -36.95 67.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.969 0.414 . . . . 1.0 111.28 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -63.89 -41.97 97.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.858 0.361 . . . . 1.0 110.758 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.3 t -61.44 -38.29 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' SER . 14.8 m -51.6 -42.86 62.27 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.0 t -51.81 -41.4 61.71 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.558 0.218 . . . . 1.0 110.538 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.8 t -75.38 -12.95 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.453 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.25 40.23 2.09 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.65 0.262 . . . . 1.0 110.432 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' SER . 44.4 m -129.71 -164.6 1.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.731 0.777 . . . . 1.0 109.512 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -53.14 -46.15 68.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.995 -1.457 . . . . 1.0 110.42 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -57.97 -53.49 57.66 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 122.059 -0.4 . . . . 1.0 111.196 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 73.7 t80 -63.42 -44.69 93.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.697 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.425 ' SG ' ' NZ ' ' A' ' 113' ' ' LYS . 45.5 t -57.84 -51.48 69.41 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -55.95 -47.9 76.74 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 121.487 0.66 . . . . 1.0 110.266 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -64.81 -29.54 70.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.084 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tp -65.86 -54.16 30.37 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.54 0.525 . . . . 1.0 111.36 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -32.32 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.294 -0.867 . . . . 1.0 109.093 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -75.38 -13.08 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.881 -1.054 . . . . 1.0 109.173 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 199' ' ' GLN . 0.1 OUTLIER -101.4 -1.14 34.04 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.707 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 82.71 41.68 8.76 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.911 -1.137 . . . . 1.0 111.259 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 61' ' ' GLY . 10.2 p90 -27.02 159.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 123.548 0.739 . . . . 1.0 112.241 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.8 t -149.19 -73.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 121.382 -0.824 . . . . 1.0 108.956 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.7 mtm-85 -149.02 106.14 3.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -89.14 130.24 35.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.012 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 65' ' ' LEU . 4.2 mp -131.1 133.7 62.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.4 tt -142.71 140.93 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.44 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -170.26 137.13 1.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.726 178.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -168.56 -172.06 1.58 Allowed 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.426 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.07 168.85 3.61 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.502 -1.039 . . . . 1.0 110.502 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.633 ' NH2' HD21 ' A' ' 72' ' ' ASN . 71.1 ttp85 -168.71 -74.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.633 HD21 ' NH2' ' A' ' 71' ' ' ARG . 89.8 m-20 -63.73 -46.44 85.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 1.0 110.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.73 -17.13 61.15 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 m 59.07 18.59 6.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.713 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 m 50.46 -163.85 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.192 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 77' ' ' PHE . 67.9 mt-10 -145.2 -44.74 0.22 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.545 ' CZ ' ' CE1' ' A' ' 98' ' ' PHE . 33.4 m-85 54.36 108.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -70.44 44.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.8 0.334 . . . . 1.0 110.203 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 77' ' ' PHE . 93.9 m-70 44.97 48.65 9.4 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.228 0.537 . . . . 1.0 111.146 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.37 -38.61 90.23 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.65 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.21 -50.35 80.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.617 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -71.78 -37.53 70.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -57.21 -48.07 79.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -77.65 -13.34 59.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.383 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.37 54.07 3.44 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 110.966 -0.853 . . . . 1.0 110.966 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.43 -178.76 51.44 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 109.831 -1.308 . . . . 1.0 109.831 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -129.85 121.04 25.94 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -80.49 111.46 16.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.342 -0.244 . . . . 1.0 110.342 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' NE2' ' A' ' 91' ' ' GLN . 94.4 mt-10 -72.38 -108.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.2 t -32.04 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.661 0.6 . . . . 1.0 111.653 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.494 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 25.8 mp0 -58.93 94.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.645 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -168.53 98.65 0.41 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.26 83.19 22.27 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.97 -76.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.16 1.907 . . . . 1.0 112.943 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.9 pt -87.71 8.78 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.273 0.629 . . . . 1.0 111.243 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 98' ' ' PHE . 1.1 m-20 58.25 -119.93 1.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 119.195 -0.431 . . . . 1.0 110.421 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 36.91 -93.04 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.626 0.37 . . . . 1.0 111.54 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CE1' ' CZ ' ' A' ' 77' ' ' PHE . 84.5 t80 -128.26 -8.14 5.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.208 0.603 . . . . 1.0 109.938 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.18 65.12 3.6 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.307 -0.717 . . . . 1.0 111.307 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.09 -44.82 95.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.962 0.411 . . . . 1.0 110.459 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.86 36.97 2.1 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.564 -1.015 . . . . 1.0 110.564 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.442 ' OD1' ' NH1' ' A' ' 105' ' ' ARG . 16.0 t70 -145.9 131.19 18.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.173 -0.306 . . . . 1.0 110.173 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.9 p -99.26 6.16 46.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.971 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -108.4 62.07 0.61 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.196 0.522 . . . . 1.0 110.485 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 117' ' ' ILE . 9.8 mmp_? -111.56 114.73 27.99 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.09 122.75 9.21 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.426 ' OH ' ' NE ' ' A' ' 105' ' ' ARG . 5.3 m-85 -133.63 151.78 51.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.4 ' C ' HD22 ' A' ' 109' ' ' LEU . 23.0 m -129.18 147.66 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -108.0 143.95 35.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.449 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 39.9 tpp 56.76 -79.55 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 O-C-N 124.136 0.898 . . . . 1.0 110.287 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 109' ' ' LEU . 54.3 t30 -168.09 78.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.39 8.51 80.31 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.425 ' NZ ' ' SG ' ' A' ' 54' ' ' CYS . 64.1 tttm -64.59 -75.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.25 128.9 50.13 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.204 -1.036 . . . . 1.0 108.204 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -108.02 103.77 13.06 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 119.442 -0.313 . . . . 1.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.56 116.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 105' ' ' ARG . 6.8 mt -137.1 144.16 32.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.815 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.93 120.55 2.05 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 109.735 -1.346 . . . . 1.0 109.735 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -155.17 52.83 0.62 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.228 0.537 . . . . 1.0 110.749 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 18.1 p-10 -169.29 129.72 1.08 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE2' ' OE1' ' A' ' 68' ' ' GLN . 58.4 m-85 -128.03 90.99 3.18 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.2 p 42.12 31.25 0.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.712 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.6 t -149.61 27.87 0.8 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.473 -0.331 . . . . 1.0 110.325 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 127' ' ' SER . 16.1 mttt -170.35 -5.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.746 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 71.0 mtp -43.08 -54.88 4.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.855 0.36 . . . . 1.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -59.43 -29.13 67.54 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.74 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.428 ' OG ' ' NH2' ' A' ' 130' ' ' ARG . 1.9 t -65.59 -38.96 90.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 16.0 mm -72.6 -46.04 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.126 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' SER . 64.4 mt -60.1 -57.86 9.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.456 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.428 ' NH2' ' OG ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -48.78 -41.07 31.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 111.392 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -57.22 -48.25 79.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.155 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -100.64 -66.67 0.89 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.119 0.485 . . . . 1.0 110.281 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' ILE . 53.6 p 55.51 84.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -149.23 -47.8 0.14 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.311 -0.404 . . . . 1.0 109.928 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.532 HD13 ' H ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -163.16 139.3 7.04 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.532 ' H ' HD13 ' A' ' 135' ' ' LEU . 4.3 m -138.22 145.52 28.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.37 96.5 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.2 p -104.89 122.15 45.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.484 ' CD2' ' H ' ' A' ' 140' ' ' ALA . 1.3 p80 -64.0 -36.05 82.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.265 . . . . 1.0 111.139 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.484 ' H ' ' CD2' ' A' ' 139' ' ' HIS . . . -173.14 10.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.591 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.97 108.77 1.04 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.0 -43.98 94.84 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 1.0 110.331 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.67 -50.81 34.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.4 m -52.09 -50.46 61.55 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.539 -0.33 . . . . 1.0 111.791 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -29.07 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.182 -0.303 . . . . 1.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.505 HD21 ' O ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -54.63 -53.91 48.48 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.905 -177.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -64.17 -51.13 65.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 1.0 110.132 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.8 t -52.83 -28.24 21.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.444 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.467 HD21 HD23 ' A' ' 203' ' ' LEU . 0.2 OUTLIER -71.15 -51.86 22.52 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.879 0.371 . . . . 1.0 110.982 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.6 ttp-105 -64.77 -26.1 68.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.764 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.7 mt -90.8 17.08 8.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.972 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 19.5 p30 42.34 26.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.501 0.501 . . . . 1.0 111.472 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 133' ' ' SER . 30.9 mtpt -79.38 121.08 82.44 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.306 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.41 ' O ' HD21 ' A' ' 135' ' ' LEU . 77.9 Cg_endo -79.62 113.93 3.15 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.367 1.378 . . . . 1.0 110.712 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 156' ' ' ILE . 0.4 OUTLIER -115.29 171.87 7.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.591 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 156' ' ' ILE . 3.2 mp -118.4 120.01 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.78 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 76.2 t -90.89 117.11 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 O-C-N 122.518 -0.114 . . . . 1.0 110.713 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 13.3 m -85.17 100.57 11.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.08 140.22 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -100.9 84.67 2.73 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 30.7 p-10 -64.03 -32.18 73.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.018 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 t -60.84 -46.08 91.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.025 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.451 ' CD2' HD21 ' A' ' 166' ' ' ASN . 10.8 mp -90.21 -178.91 5.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 28.0 ttt -165.31 -27.76 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.461 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -66.2 -22.14 66.33 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.013 -0.366 . . . . 1.0 110.013 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.451 HD21 ' CD2' ' A' ' 163' ' ' LEU . 84.1 m-20 -61.59 113.61 2.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.117 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.01 -32.56 74.15 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.836 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.04 -47.07 75.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.32 -42.01 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.342 0.592 . . . . 1.0 109.922 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -50.59 -45.56 57.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.539 -0.912 . . . . 1.0 108.539 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.68 -26.4 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.877 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -68.06 -58.88 3.78 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 120.01 -0.676 . . . . 1.0 109.409 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -43.52 -24.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.72 0.295 . . . . 1.0 111.774 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.41 -40.26 81.32 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.145 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -55.74 -45.49 77.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.52 -46.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.98 0.419 . . . . 1.0 109.896 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -46.07 -43.01 14.27 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.006 -0.997 . . . . 1.0 108.439 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.6 mt -70.55 -32.25 69.61 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.832 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.15 -107.43 0.24 Allowed Glycine 0 N--CA 1.468 0.781 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.527 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.442 ' O ' ' CD2' ' A' ' 180' ' ' TYR . 66.5 t80 -169.95 42.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 180' ' ' TYR . 14.8 p -31.91 137.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 123.663 0.602 . . . . 1.0 109.479 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -54.43 101.7 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.319 0.963 . . . . 1.0 110.661 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 77.2 p -114.76 133.2 56.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.798 -1.092 . . . . 1.0 109.088 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 25.6 p -163.33 138.7 6.56 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 157.09 70.52 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 122.304 -0.248 . . . . 1.0 110.515 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -56.89 82.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 122.307 2.005 . . . . 1.0 112.991 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.1 m -134.86 148.9 50.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -69.95 -25.88 63.86 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.124 -0.36 . . . . 1.0 111.016 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.3 p -89.91 -35.61 15.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.541 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.74 -41.81 5.9 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.94 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.93 -36.24 82.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.808 0.304 . . . . 1.0 111.483 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 pt -66.0 -33.91 66.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.348 . . . . 1.0 111.023 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.56 91.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.639 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -71.66 -38.19 61.4 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.428 -0.669 . . . . 1.0 111.428 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.408 ' O ' ' OH ' ' A' ' 60' ' ' TYR . 7.7 mt -63.28 -54.85 30.73 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.848 0.356 . . . . 1.0 111.255 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -61.68 -36.39 80.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.1 -39.21 82.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 14.9 m -65.59 -17.96 64.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.854 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 93.9 mt-30 -104.14 29.97 5.57 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.047 -0.408 . . . . 1.0 110.624 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 22.6 p -141.37 -33.02 0.52 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -141.58 154.1 45.23 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -118.07 157.51 26.72 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.584 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 149' ' ' LEU . 8.4 tp -84.32 136.29 33.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -52.76 135.24 46.03 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.289 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -45.39 101.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.511 1.474 . . . . 1.0 113.015 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -142.12 82.78 13.02 Favored Pre-proline 0 N--CA 1.471 0.625 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.54 93.04 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.963 1.775 . . . . 1.0 111.464 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.505 ' O ' HD21 ' A' ' 146' ' ' LEU . 7.1 p -60.73 150.37 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.654 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 211' ' ' ASN . 24.7 m 55.88 109.75 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.715 0.634 . . . . 1.0 110.665 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -67.53 66.93 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.802 0.334 . . . . 1.0 110.551 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.445 ' ND2' ' OE1' ' A' ' 215' ' ' GLU . 0.6 OUTLIER -169.81 142.9 2.05 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 110.241 -0.281 . . . . 1.0 110.241 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 214' ' ' PHE . 71.7 Cg_endo -73.64 177.43 8.03 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.779 1.653 . . . . 1.0 111.297 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 20.0 m -49.44 -11.54 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.721 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 212' ' ' PRO . 63.5 t80 -54.61 -43.2 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.445 ' OE1' ' ND2' ' A' ' 211' ' ' ASN . 70.8 tt0 -46.98 -39.24 12.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.458 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -60.33 -39.94 88.87 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.8 tp -44.81 -34.11 2.19 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.609 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.8 mm? -65.92 -33.99 77.11 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.055 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.44 -52.23 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -64.98 -40.97 95.77 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.086 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 25.0 m -68.66 -25.44 64.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.291 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 77.0 mt 56.63 -88.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.051 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -84.5 122.88 29.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.964 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 91.0 p . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.191 -0.909 . . . . 1.0 110.399 179.536 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.256 -1.538 . . . . 1.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.3 -50.08 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.162 0.506 . . . . 1.0 109.828 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.1 mt 56.31 74.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.427 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -72.48 179.38 3.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.534 -0.543 . . . . 1.0 109.534 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -103.4 6.5 37.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 63' ' ' VAL . 67.9 mttm -71.25 106.55 3.87 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.13 121.01 43.66 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.384 0.427 . . . . 1.0 110.197 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 mt -87.61 110.97 20.78 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CD1' HG22 ' A' ' 129' ' ' ILE . 85.6 m-85 -96.07 128.62 43.14 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -123.3 122.52 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 t -146.48 137.65 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 139' ' ' HIS . 77.2 m -105.36 -24.97 12.57 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.3 20.57 67.55 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.42 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 p -139.7 155.9 47.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.475 0.31 . . . . 1.0 110.218 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' PRO . 16.8 m -94.16 148.64 35.49 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 118.727 -0.654 . . . . 1.0 110.817 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' VAL . 87.2 Cg_exo -46.22 -178.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 121.629 1.553 . . . . 1.0 112.395 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -56.57 144.42 64.27 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-O 119.234 -0.412 . . . . 1.0 110.632 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.55 -30.6 6.2 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.793 1.662 . . . . 1.0 113.497 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -73.26 -39.55 65.32 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.81 0.3 . . . . 1.0 111.81 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 186' ' ' PRO . 4.2 mm? -71.74 -40.86 69.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.97 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.6 -41.61 93.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 50' ' ' SER . 30.0 m -52.15 -45.89 65.2 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.139 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.98 -33.13 10.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 1.0 110.556 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.78 -22.09 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.996 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.98 33.44 4.39 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 120.809 0.337 . . . . 1.0 110.254 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 46' ' ' SER . 22.4 p -110.59 -167.71 1.22 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -60.74 -28.83 68.98 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.66 -50.68 71.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.493 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -35.91 73.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 71.1 m -51.63 -51.0 59.2 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.775 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -73.07 -43.76 61.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.684 0.278 . . . . 1.0 111.654 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -65.91 -28.95 69.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.971 0.415 . . . . 1.0 110.535 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.2 mt -61.35 -52.42 64.73 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.6 mp -57.42 -36.67 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 120.305 -0.558 . . . . 1.0 109.874 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -72.52 -33.78 67.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.695 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 60' ' ' TYR . 70.1 t80 -77.87 0.57 23.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.997 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 42.08 22.23 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.751 -1.214 . . . . 1.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -49.3 -176.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.534 0.667 . . . . 1.0 111.825 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 64' ' ' ARG . 10.5 p -172.48 -42.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' HG13 ' A' ' 63' ' ' VAL . 47.5 ttm-85 -168.38 105.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.1 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.04 135.83 33.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.31 136.41 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -138.99 141.82 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -143.64 149.37 37.2 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 77' ' ' PHE . 47.5 p90 -163.14 126.29 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.02 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.78 -171.17 44.71 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 109.774 -1.33 . . . . 1.0 109.774 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.564 ' NE ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER 55.54 118.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.377 0.608 . . . . 1.0 110.914 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -61.85 -20.49 63.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.111 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 75' ' ' SER . 48.3 t80 -56.5 -14.97 3.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.384 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 m -60.59 3.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.391 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 73' ' ' TYR . 3.5 m 63.54 139.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.861 0.363 . . . . 1.0 110.264 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.44 137.17 57.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 69' ' ' PHE . 3.7 m-85 -64.41 -93.07 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 49.69 45.97 24.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.023 0.439 . . . . 1.0 110.859 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.402 ' ND1' ' O ' ' A' ' 77' ' ' PHE . 35.1 m80 -157.26 -53.87 0.08 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.648 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.47 -48.87 75.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.098 0.475 . . . . 1.0 111.043 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.39 -44.12 77.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.196 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.93 -31.56 72.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.27 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -70.91 -44.31 66.49 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.027 0.442 . . . . 1.0 110.437 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLY . 1.1 mmp_? -99.1 30.03 3.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' ARG . . . 21.15 73.71 0.01 OUTLIER Glycine 0 N--CA 1.486 1.98 0 N-CA-C 111.531 -0.627 . . . . 1.0 111.531 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.74 -179.1 52.01 Favored Glycine 0 C--N 1.322 -0.222 0 N-CA-C 109.846 -1.302 . . . . 1.0 109.846 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -138.34 135.96 35.9 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.517 ' CZ ' HE21 ' A' ' 106' ' ' GLN . 53.0 ttt85 -54.43 149.6 10.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.442 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -107.0 -155.36 0.55 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.49 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 85.4 p 51.52 12.66 0.17 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.849 0.356 . . . . 1.0 111.252 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 55.23 11.57 0.57 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.82 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.69 166.83 21.12 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.102 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.09 121.68 42.94 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.006 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.61 109.59 1.66 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 CA-C-N 120.658 1.271 . . . . 1.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' GLN . 32.3 pt -85.72 -7.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.232 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.8 t0 64.18 -69.61 0.08 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.08 0.862 . . . . 1.0 110.191 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ILE . 86.3 mt-30 -58.37 152.09 18.43 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.303 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -67.77 1.27 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.836 0.35 . . . . 1.0 110.369 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.17 6.82 87.68 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.3 -0.72 . . . . 1.0 111.3 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 27.0 p 37.06 60.73 0.97 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.164 0.507 . . . . 1.0 112.229 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' CA ' HH21 ' A' ' 105' ' ' ARG . . . -178.62 -156.89 18.09 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 18.5 p-10 -159.22 75.77 0.68 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.703 0.287 . . . . 1.0 110.293 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.0 p -136.58 -27.35 1.05 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.688 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.544 ' H ' ' NH1' ' A' ' 105' ' ' ARG . . . -174.59 103.4 0.1 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.25 0.344 . . . . 1.0 110.208 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.544 ' NH1' ' H ' ' A' ' 104' ' ' ALA . 1.5 mpt_? -135.37 145.75 47.66 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.159 0.504 . . . . 1.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.517 HE21 ' CZ ' ' A' ' 88' ' ' ARG . 1.8 pm0 -156.83 129.05 7.38 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 115.8 -0.636 . . . . 1.0 109.694 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -147.21 169.11 20.04 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.69 148.27 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 114' ' ' LEU . 19.2 mt -114.39 -178.83 3.46 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.585 0.553 . . . . 1.0 109.562 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 tpt 53.21 -134.67 1.63 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.664 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.86 35.9 0.9 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.013 0.435 . . . . 1.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.59 71.54 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.518 -0.633 . . . . 1.0 111.518 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -96.21 -15.92 21.75 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.392 0.277 . . . . 1.0 111.635 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' A' ' 109' ' ' LEU . 4.4 mm? -96.91 133.57 41.39 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -116.88 93.73 4.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.8 p -106.89 116.59 50.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 CA-C-O 122.219 1.009 . . . . 1.0 109.053 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.2 pt -117.81 146.49 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 114.076 -1.42 . . . . 1.0 108.658 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -122.94 131.83 8.39 Favored Glycine 0 N--CA 1.465 0.609 0 N-CA-C 109.63 -1.388 . . . . 1.0 109.63 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 120' ' ' ASP . 45.0 t80 59.01 152.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 1.0 110.768 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 38.8 t70 -168.24 163.66 13.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.353 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.446 ' CD2' ' O ' ' A' ' 121' ' ' PHE . 40.4 p90 -70.77 119.27 14.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 124' ' ' LYS . 18.1 m 56.88 135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.421 0.629 . . . . 1.0 111.558 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 t -74.87 38.43 0.12 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.263 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 122' ' ' SER . 36.9 ttpt -64.45 -29.56 70.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.477 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.49 ' SD ' ' NE2' ' A' ' 126' ' ' GLN . 3.6 ppp? -45.18 -32.0 1.69 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.49 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 88.5 mm-40 -58.23 -28.72 65.14 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.676 -0.693 . . . . 1.0 111.044 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.1 t -80.54 -33.17 36.49 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.742 0.306 . . . . 1.0 110.803 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 128' ' ' ILE . 1.6 mp -63.63 -39.93 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.723 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.551 HG22 ' CD1' ' A' ' 32' ' ' PHE . 2.9 pt -49.11 -41.54 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -46.08 -32.66 3.0 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.514 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.45 -27.64 62.64 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.567 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.4 -62.27 1.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.333 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.2 p 51.36 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.724 ' N ' ' HZ2' ' A' ' 153' ' ' LYS . 56.5 m-20 -145.14 -43.92 0.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -155.41 120.52 4.86 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 135' ' ' LEU . 60.9 t -122.52 137.33 56.41 Favored 'Isoleucine or valine' 0 C--N 1.348 0.507 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.3 mt -122.92 124.37 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.7 p -134.3 133.61 40.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.427 ' CD2' ' SG ' ' A' ' 35' ' ' CYS . 37.8 m-70 -69.89 -38.22 76.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.631 0.253 . . . . 1.0 110.788 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.47 19.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.326 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.67 100.6 0.44 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.662 ' H ' HH21 ' A' ' 216' ' ' ARG . 19.6 m -56.72 -41.46 77.48 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.478 -0.425 . . . . 1.0 110.48 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.74 -48.77 26.68 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.3 m -56.52 -42.77 78.99 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.842 -0.211 . . . . 1.0 111.309 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 92.6 mt -66.35 -26.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 1.0 110.852 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 209' ' ' SER . 0.2 OUTLIER -57.35 -46.9 82.84 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.663 -176.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -70.42 -53.55 16.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.097 0.475 . . . . 1.0 109.826 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.9 m -53.19 -25.21 13.04 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 49.8 tp -74.86 -45.77 40.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.859 0.362 . . . . 1.0 111.438 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -76.56 -18.99 58.37 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.279 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.9 mt -85.03 4.03 35.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.9 p30 41.56 47.89 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.389 0.43 . . . . 1.0 111.688 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.724 ' HZ2' ' N ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -105.68 147.1 34.11 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 119.205 -0.426 . . . . 1.0 111.569 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.63 85.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.46 1.44 . . . . 1.0 111.542 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 153' ' ' LYS . 66.9 tp -89.94 137.49 32.29 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.816 -0.553 . . . . 1.0 111.324 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.3 134.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.084 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.63 128.69 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 120.788 0.328 . . . . 1.0 110.652 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 12.3 m -83.6 102.47 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.88 146.84 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.746 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.9 t30 86.44 103.78 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.887 0.742 . . . . 1.0 110.065 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -167.59 66.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.203 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -64.65 86.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.215 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 165' ' ' ASP . 34.8 tp -168.41 77.03 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 ttt 67.19 -36.74 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.707 0.629 . . . . 1.0 110.984 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 163' ' ' LEU . 66.7 m-20 -77.17 -3.02 37.4 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.077 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -52.86 -37.92 60.87 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.766 0.317 . . . . 1.0 110.369 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.12 -38.17 87.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.135 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -68.11 -38.97 82.87 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.367 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.53 -31.31 64.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.133 0.492 . . . . 1.0 110.692 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -53.37 -49.09 67.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.51 -27.41 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.79 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.77 -61.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.097 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -51.94 -31.98 31.14 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -60.79 -52.71 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.015 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.26 -42.66 81.97 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.22 -52.84 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -51.96 -44.32 63.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.701 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.33 17.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.134 -0.321 . . . . 1.0 110.134 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 39.29 89.8 0.01 OUTLIER Glycine 0 C--N 1.352 1.423 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.646 ' O ' HD22 ' A' ' 203' ' ' LEU . 49.9 t80 -155.48 -22.39 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.51 152.64 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.83 0.348 . . . . 1.0 110.495 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -71.39 130.63 41.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.6 p -98.11 138.67 35.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.586 -0.734 . . . . 1.0 109.541 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 185' ' ' ALA . 35.7 t -157.77 177.32 11.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 184' ' ' CYS . . . -136.93 155.99 76.07 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 110.164 -0.31 . . . . 1.0 110.164 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.469 ' HG2' HD12 ' A' ' 44' ' ' LEU . 94.3 Cg_endo -69.58 65.62 1.68 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.089 1.86 . . . . 1.0 112.404 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 m -134.06 145.5 49.46 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.014 0.435 . . . . 1.0 109.898 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -55.13 -29.34 57.49 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -84.03 -41.03 17.66 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.089 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.14 93.86 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.978 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.35 -39.54 90.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 119.711 -0.185 . . . . 1.0 111.314 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.73 -45.84 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.61 82.1 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.541 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.53 -36.61 91.74 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.08 -54.63 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.94 0.4 . . . . 1.0 110.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -59.66 -21.29 60.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.432 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.85 3.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.774 0.321 . . . . 1.0 110.46 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.6 p -67.46 -22.53 65.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.769 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.53 -43.72 69.01 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.075 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 21.7 m -79.1 -43.66 23.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.842 0.353 . . . . 1.0 110.698 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.53 125.25 40.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.266 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -120.82 108.59 14.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 180' ' ' TYR . 4.8 tp -63.24 135.8 57.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -52.67 146.88 16.43 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.778 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.45 103.77 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.357 1.371 . . . . 1.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -141.1 96.5 7.21 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.74 114.03 3.86 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 121.13 1.22 . . . . 1.0 111.345 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 209' ' ' SER . 14.8 p -57.75 -43.41 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.531 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.481 ' N ' HG13 ' A' ' 208' ' ' VAL . 37.4 m -162.51 166.1 25.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.242 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -100.4 104.38 15.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -167.4 60.56 0.53 Allowed Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.411 ' C ' ' N ' ' A' ' 214' ' ' PHE . 74.2 Cg_endo -67.18 -158.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.505 2.152 0 C-N-CA 122.256 1.971 . . . . 1.0 112.141 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 45.6 t -48.52 -12.58 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.845 0.355 . . . . 1.0 111.604 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.411 ' N ' ' C ' ' A' ' 212' ' ' PRO . 70.4 t80 -59.42 -45.29 91.96 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -54.39 -43.16 71.2 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.895 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.662 HH21 ' H ' ' A' ' 142' ' ' THR . 1.5 mpt_? -60.24 -38.15 82.57 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.565 -0.531 . . . . 1.0 109.565 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 tp -53.11 -34.73 57.98 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.139 0.495 . . . . 1.0 110.206 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.03 -40.49 97.9 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.552 -0.749 . . . . 1.0 109.94 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.8 -49.66 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.798 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -59.69 -31.43 69.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.637 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 25.2 m -61.66 -23.04 65.82 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.587 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 41.3 pt -121.55 154.82 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.388 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 60.3 t80 53.43 100.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.373 -179.601 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.466 -1.454 . . . . 1.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.1 pt -66.54 -170.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.919 0.39 . . . . 1.0 110.067 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.6 mp -85.97 97.06 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -153.39 72.12 0.92 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -144.79 -36.34 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -71.16 92.74 1.01 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.95 111.94 24.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.73 117.98 21.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.509 ' CE2' ' NE2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -102.69 124.3 47.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 67' ' ' ILE . 9.4 p -126.18 128.4 71.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.2 p -129.1 129.82 45.7 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' CE1' ' A' ' 69' ' ' PHE . 97.2 m -88.69 164.26 15.39 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.89 37.67 0.75 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.69 -0.564 . . . . 1.0 111.69 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 35' ' ' CYS . . . 67.64 -61.51 0.36 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.386 0.274 . . . . 1.0 110.602 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -64.96 147.41 53.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 1.0 109.978 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -138.6 81.36 24.09 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.88 -59.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.953 1.768 . . . . 1.0 111.505 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 92.14 18.29 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -74.05 8.32 2.12 Favored 'Trans proline' 0 N--CA 1.508 2.339 0 CA-C-N 120.831 1.333 . . . . 1.0 112.442 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.0 110.555 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.9 mm? -70.02 -35.02 74.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.546 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.37 -40.5 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 78.3 p -50.52 -45.33 56.59 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.839 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -51.57 -39.99 58.92 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.05 0.452 . . . . 1.0 110.301 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 41.8 t -79.67 -16.21 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.057 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 tp -130.96 39.74 3.55 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.826 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.5 t -132.61 -157.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 50' ' ' SER . 22.6 p-10 -60.28 -44.27 95.48 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.383 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.98 -51.58 65.75 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.592 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 48' ' ' VAL . 5.9 t80 -67.8 -36.79 81.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.972 0.415 . . . . 1.0 109.905 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.0 t -57.64 -47.96 80.79 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.429 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -63.07 -46.47 87.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.66 -28.39 69.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.406 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.25 -51.24 70.4 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.945 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -58.35 -44.9 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.06 -37.6 77.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.33 -21.58 64.74 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.661 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 104.3 35.94 3.24 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 118.016 -1.435 . . . . 1.0 111.355 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' O ' ' A' ' 61' ' ' GLY . 49.8 p90 13.61 130.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 124.86 1.264 . . . . 1.0 112.719 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -145.3 -81.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 122.007 -0.433 . . . . 1.0 110.448 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -169.33 111.24 0.48 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.221 -0.445 . . . . 1.0 109.83 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -92.35 121.59 33.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 66' ' ' ILE . 2.3 mp -102.88 133.02 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.434 -1.321 . . . . 1.0 107.434 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.418 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.7 mm -114.6 132.76 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.509 ' NE2' ' CE2' ' A' ' 32' ' ' PHE . 15.6 mp0 -131.78 163.09 29.0 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.582 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE1' ' SG ' ' A' ' 35' ' ' CYS . 17.7 m-85 -157.22 -179.64 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.183 0.516 . . . . 1.0 109.735 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 72' ' ' ASN . . . -59.1 -29.89 66.16 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.292 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 68.01 -38.32 0.36 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.98 0.459 . . . . 1.0 111.256 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 70' ' ' GLY . 19.0 m120 -62.16 -43.93 97.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.781 0.324 . . . . 1.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.26 -45.76 86.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 p 56.31 166.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.841 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.2 t 52.36 68.88 0.75 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.821 0.343 . . . . 1.0 111.138 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.611 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 17.8 pt-20 -170.95 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.602 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' H ' HE22 ' A' ' 97' ' ' GLN . 74.9 t80 -166.77 -15.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.613 -0.267 . . . . 1.0 110.609 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.26 -44.62 95.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.832 0.349 . . . . 1.0 110.073 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.08 -28.78 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.733 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -63.74 -48.36 77.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.155 0.503 . . . . 1.0 110.161 -178.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.28 -45.44 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -64.37 -36.4 84.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -52.23 -46.65 65.79 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.581 0.229 . . . . 1.0 110.441 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.19 -17.43 64.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.092 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.02 52.64 35.61 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.12 -1.192 . . . . 1.0 110.12 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.38 -167.76 25.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -128.33 126.95 41.78 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -55.38 145.42 22.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.616 0.246 . . . . 1.0 110.624 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -145.6 179.18 7.6 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 m 65.82 -152.41 0.25 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.211 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -148.55 169.71 19.69 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 58.58 157.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.665 0.603 . . . . 1.0 110.362 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 93' ' ' ILE . 17.9 tt -158.42 87.97 2.32 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.749 -0.463 . . . . 1.0 109.749 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 93' ' ' ILE . 98.8 Cg_exo -50.02 -127.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.511 2.549 0 C-N-CA 122.591 2.194 . . . . 1.0 112.924 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.5 tt -65.2 4.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 121.56 -0.713 . . . . 1.0 110.733 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 99' ' ' GLY . 2.5 m-20 70.18 -134.71 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 -177.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.611 ' NE2' ' H ' ' A' ' 76' ' ' GLU . 47.9 tp60 42.42 -93.95 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.495 0.589 . . . . 1.0 112.175 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -98.9 -21.8 16.11 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 96' ' ' ASP . . . 81.56 1.44 90.14 Favored Glycine 0 N--CA 1.467 0.723 0 CA-C-N 115.826 -0.624 . . . . 1.0 111.684 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 58.3 m 52.67 -163.93 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.765 0.283 . . . . 1.0 111.13 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.76 176.4 52.77 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.483 -1.047 . . . . 1.0 110.483 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.0 t0 54.62 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.594 0.235 . . . . 1.0 111.045 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.7 m 50.74 88.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.626 ' CB ' ' H ' ' A' ' 119' ' ' PHE . . . -86.75 -109.13 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.411 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -141.41 169.2 18.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -158.79 132.48 7.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.333 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -136.39 151.06 49.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.764 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.7 t -100.83 96.07 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.527 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 109' ' ' LEU . 10.4 mp -87.57 159.77 18.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 tpt 57.03 -88.07 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.402 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -172.47 62.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.763 0.316 . . . . 1.0 110.686 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.55 27.09 63.96 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.627 -0.589 . . . . 1.0 111.627 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -114.19 -50.36 2.81 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.597 0.359 . . . . 1.0 110.845 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mt -95.36 111.86 23.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.855 0.359 . . . . 1.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -105.83 101.24 10.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 p -105.53 111.64 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.709 0.766 . . . . 1.0 109.641 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 pt -125.86 122.77 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.388 -1.278 . . . . 1.0 109.167 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.59 -82.01 0.04 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.548 -0.834 . . . . 1.0 111.453 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.626 ' H ' ' CB ' ' A' ' 104' ' ' ALA . 3.6 m-85 47.72 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.941 0.4 . . . . 1.0 110.005 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -163.19 154.24 16.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 122' ' ' SER . 63.8 t80 -160.11 172.95 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.654 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 44.3 t -52.99 -17.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.26 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.8 m -164.19 103.56 0.86 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.606 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -171.03 -26.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.772 0.32 . . . . 1.0 110.555 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.1 -49.96 75.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.861 0.362 . . . . 1.0 110.71 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -61.82 -25.55 67.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.358 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p -76.41 -44.69 34.97 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.971 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.06 -44.48 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.627 -0.261 . . . . 1.0 110.617 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 133' ' ' SER . 79.4 mt -59.04 -51.94 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -39.14 10.25 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.053 0.454 . . . . 1.0 110.905 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -63.54 -32.17 73.55 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.141 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -112.57 -67.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.784 0.434 . . . . 1.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' ILE . 26.0 t 54.32 89.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.757 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -134.38 -50.1 0.79 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.335 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 29.9 tp -165.7 146.32 6.83 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.38 140.03 44.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.7 pt -123.02 127.89 74.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.6 m -88.85 -161.88 0.8 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -169.99 -36.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.6 48.21 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.809 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.88 112.5 0.53 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.668 ' N ' HE22 ' A' ' 168' ' ' GLN . 35.2 m -74.2 -25.19 59.55 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.698 0.285 . . . . 1.0 110.685 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 -33.94 86.04 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.0 m -72.91 -35.77 67.13 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.841 -0.211 . . . . 1.0 110.756 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 53.6 mt -61.37 -30.37 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.771 0.32 . . . . 1.0 110.989 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 tp -52.35 -52.74 51.72 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.137 0.421 . . . . 1.0 112.137 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -65.69 -46.95 77.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.285 0.564 . . . . 1.0 111.074 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 m -53.01 -26.92 17.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.121 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.4 mt -79.7 -49.26 12.35 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.356 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -62.51 -37.95 88.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.682 -0.236 . . . . 1.0 110.923 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.28 4.77 4.18 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 58.8 t30 53.72 23.28 3.6 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.71 -0.223 . . . . 1.0 111.123 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.66 122.84 46.24 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -45.9 171.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.659 1.572 . . . . 1.0 112.6 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.609 ' C ' HD13 ' A' ' 156' ' ' ILE . 4.0 tt -156.92 151.75 25.86 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.514 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 155' ' ' LEU . 3.1 mm -123.35 128.23 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.9 137.16 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.36 115.38 27.35 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.37 97.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.654 0.264 . . . . 1.0 111.667 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.449 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 20.2 p-10 -148.46 -58.47 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.255 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 163' ' ' LEU . 73.2 m-20 -102.3 14.01 33.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.083 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 27.9 t -69.79 36.9 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.889 0.376 . . . . 1.0 110.837 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 161' ' ' ASP . 52.7 mt -63.42 -39.59 94.9 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 166' ' ' ASN . 23.8 ptt? -52.28 141.45 19.2 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.229 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 167' ' ' HIS . 4.8 m-20 69.24 -37.07 0.36 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.202 0.314 . . . . 1.0 110.749 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 164' ' ' MET . 20.2 t-20 58.97 -0.44 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.612 0.365 . . . . 1.0 111.336 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 165' ' ' ASP . 24.6 m170 -73.48 -43.42 60.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.866 0.365 . . . . 1.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.668 HE22 ' N ' ' A' ' 142' ' ' THR . 22.6 mm100 -64.92 -49.47 70.31 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.937 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -59.58 -29.68 68.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.92 0.39 . . . . 1.0 110.013 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.49 -54.67 8.59 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.009 -0.542 . . . . 1.0 110.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 55.8 mt -71.39 -41.39 73.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.45 -64.15 0.96 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 120.466 -0.494 . . . . 1.0 110.196 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.4 -27.76 2.81 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.337 0.589 . . . . 1.0 111.089 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -82.96 -40.48 20.02 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.055 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.04 -45.45 93.52 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.696 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 177' ' ' GLU . 27.1 m -57.14 -52.71 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 176' ' ' VAL . 77.3 mt-10 -52.34 -38.88 59.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.348 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.13 6.31 49.13 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.63 89.77 0.07 OUTLIER Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.291 -1.124 . . . . 1.0 110.291 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -40.65 79.35 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.135 0.974 . . . . 1.0 111.156 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.594 ' O ' HG22 ' A' ' 181' ' ' VAL . 3.2 p -73.8 65.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.531 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . 0.485 ' C ' ' O ' ' A' ' 181' ' ' VAL . 6.0 m-90 30.4 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 99.9 p -108.6 131.45 54.85 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 30.5 p -162.58 130.17 3.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.861 -1.063 . . . . 1.0 108.387 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.92 157.09 74.34 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 118.92 -0.562 . . . . 1.0 110.851 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.76 69.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.516 2.833 0 C-N-CA 123.253 2.635 . . . . 1.0 114.393 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 185' ' ' ALA . 43.7 m -132.2 146.67 52.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 24.7 mp0 -49.34 -51.69 32.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.494 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.7 p -67.15 -43.04 83.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.66 -0.245 . . . . 1.0 110.578 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -52.6 -53.36 32.85 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 121.427 -0.416 . . . . 1.0 112.145 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.83 -40.98 99.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.926 0.363 . . . . 1.0 110.71 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.45 -44.54 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -58.85 -49.35 78.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 1.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.5 98.81 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 42.6 mt -63.82 -43.47 96.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.713 0.292 . . . . 1.0 110.546 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -66.91 -40.02 87.56 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -64.41 -49.58 70.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.698 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 m -61.13 -22.39 64.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.504 -0.316 . . . . 1.0 111.308 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -74.56 10.46 1.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.017 0.437 . . . . 1.0 110.194 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.4 m -164.09 -54.66 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.816 0.341 . . . . 1.0 110.844 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.7 mt-10 -66.89 116.17 7.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.026 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -103.05 165.59 10.93 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 tp -110.45 -164.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.52 137.54 22.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -79.2 44.47 1.7 Allowed 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.812 1.675 . . . . 1.0 111.915 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.39 84.8 15.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.41 166.03 5.1 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.113 1.876 . . . . 1.0 112.186 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 209' ' ' SER . 12.0 p -57.06 -46.81 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.337 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.501 ' N ' HG13 ' A' ' 208' ' ' VAL . 51.6 p -170.21 164.11 9.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.852 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.84 100.61 3.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.601 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.423 ' ND2' ' OE2' ' A' ' 215' ' ' GLU . 27.6 m120 -142.24 68.11 21.64 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 122.768 0.427 . . . . 1.0 110.622 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 214' ' ' PHE . 31.4 Cg_exo -60.44 165.12 11.72 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.638 1.559 . . . . 1.0 111.169 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 44.4 m -46.33 -18.74 0.06 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.994 0.426 . . . . 1.0 110.731 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.403 ' N ' ' C ' ' A' ' 212' ' ' PRO . 48.3 t80 -60.44 -45.08 94.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.096 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.423 ' OE2' ' ND2' ' A' ' 211' ' ' ASN . 43.6 tt0 -50.92 -45.13 60.27 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 110.195 -0.298 . . . . 1.0 110.195 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -55.86 -40.54 73.05 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.92 -43.31 81.32 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.386 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.53 -32.94 52.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.7 t -68.28 -48.01 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -72.31 -24.12 61.27 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.444 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 25.2 m -60.91 -49.55 77.01 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.576 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 28.3 pt -72.52 147.87 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.145 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -61.38 -44.81 96.53 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.179 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.981 -1.009 . . . . 1.0 110.375 -179.797 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.203 -1.559 . . . . 1.0 109.203 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 61' ' ' GLY . 9.1 tp -160.04 140.32 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.792 0.33 . . . . 1.0 110.174 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.844 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.6 mp -70.62 -42.9 77.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.264 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 61.99 55.45 2.53 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.192 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -168.79 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.826 0.346 . . . . 1.0 110.544 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -74.3 139.47 44.24 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . -142.9 165.1 28.29 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 137' ' ' ILE . 11.8 mt -109.27 122.51 47.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.489 ' CE1' HG21 ' A' ' 128' ' ' ILE . 12.3 t80 -108.62 141.6 40.32 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.15 148.15 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.955 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -144.78 139.84 28.08 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.735 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.83 8.34 5.73 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.19 108.71 0.23 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.66 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.966 -0.138 . . . . 1.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.0 p 48.85 -167.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.751 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 39' ' ' VAL . 24.4 m -97.69 113.57 63.75 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 123.186 0.304 . . . . 1.0 110.657 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.12 -13.78 17.03 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.05 1.833 . . . . 1.0 111.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -124.92 85.16 57.9 Favored Pre-proline 0 N--CA 1.477 0.899 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.32 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.17 -23.06 27.9 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.145 1.897 . . . . 1.0 111.698 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -80.98 -46.66 14.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.64 -49.88 74.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.861 0.362 . . . . 1.0 111.046 -176.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.47 -39.14 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.19 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 17.0 p -50.01 -57.88 6.64 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 46' ' ' SER . 77.4 m -51.71 -41.41 61.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.971 0.415 . . . . 1.0 110.342 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.5 t -71.2 -17.89 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.038 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 tp -140.65 44.19 1.84 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.039 0.447 . . . . 1.0 110.862 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.6 t -123.59 -167.59 1.64 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' N ' ' OG ' ' A' ' 50' ' ' SER . 41.2 m-20 -50.73 -40.07 53.47 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.912 -1.04 . . . . 1.0 111.175 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -60.45 -55.22 36.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.79 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -67.28 -39.86 86.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.998 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 91.0 m -48.36 -53.7 16.57 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -77.47 -46.75 21.53 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.45 -30.27 68.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.867 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.69 -45.04 93.31 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.482 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -63.59 -30.32 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 119.946 -0.702 . . . . 1.0 109.608 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -63.01 -16.4 59.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.0 111.087 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.74 -18.83 14.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 25' ' ' ILE . . . 95.09 35.37 5.8 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 121.39 -0.433 . . . . 1.0 112.1 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -93.15 154.4 18.09 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.21 0.529 . . . . 1.0 109.652 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 m -137.77 -6.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.031 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -143.0 144.98 32.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.436 0.636 . . . . 1.0 110.69 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -138.68 122.98 18.21 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.712 -1.131 . . . . 1.0 109.28 178.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 65' ' ' LEU . 4.3 mp -120.66 142.94 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.529 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.05 137.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.006 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -62.51 144.1 56.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.23 120.26 16.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' ASN . . . -64.21 -11.01 44.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 63.41 -68.51 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.888 0.405 . . . . 1.0 110.877 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' GLY . 77.7 m-20 -61.28 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -65.87 -50.19 65.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.98 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t 51.16 -147.79 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.803 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t 55.93 -161.1 0.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.592 0.234 . . . . 1.0 110.699 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 54.7 -166.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.466 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.2 t80 53.3 98.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.652 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -59.4 166.67 2.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.019 -0.363 . . . . 1.0 110.019 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.408 ' ND1' ' CZ ' ' A' ' 98' ' ' PHE . 46.7 m-70 -73.21 54.51 0.41 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.752 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -59.15 -43.44 92.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.285 0.564 . . . . 1.0 110.405 -177.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 82' ' ' GLN . 22.3 m -58.2 -43.66 86.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.571 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.472 ' N ' HG23 ' A' ' 81' ' ' VAL . 2.6 tm0? -68.85 -42.78 76.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.262 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.91 -48.17 67.43 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.693 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.572 ' HD2' HD12 ' A' ' 109' ' ' LEU . 57.9 ttm-85 -76.13 -16.68 59.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.756 -0.377 . . . . 1.0 110.368 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.55 54.21 1.36 Allowed Glycine 0 N--CA 1.474 1.192 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . -80.36 169.31 52.53 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.736 -1.345 . . . . 1.0 109.736 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -132.4 129.36 39.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 90' ' ' SER . 56.8 ttp180 -57.61 151.15 17.69 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 40.46 -86.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.794 0.684 . . . . 1.0 111.286 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' ARG . 93.1 p -160.06 97.7 1.28 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.435 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 55.2 67.62 0.99 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.246 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -145.28 162.74 36.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.097 0.475 . . . . 1.0 109.853 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.78 118.74 21.31 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.281 -0.872 . . . . 1.0 111.157 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.02 149.12 36.15 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.132 1.221 . . . . 1.0 111.026 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 97' ' ' GLN . 35.6 pt -93.35 9.02 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.2 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 66.31 -65.57 0.19 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.201 0.938 . . . . 1.0 109.6 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 95' ' ' ILE . 23.8 tp60 -63.88 -146.7 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.57 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.408 ' CZ ' ' ND1' ' A' ' 79' ' ' HIS . 56.5 m-85 -126.4 9.93 7.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.958 0.503 . . . . 1.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.55 66.55 2.39 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.7 m 53.89 -96.83 0.06 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.487 0.184 . . . . 1.0 110.584 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.444 ' H ' ' H ' ' A' ' 102' ' ' ASP . . . 170.54 9.01 0.02 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.444 ' H ' ' H ' ' A' ' 101' ' ' GLY . 29.4 t70 -61.44 -70.05 0.21 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.833 0.349 . . . . 1.0 110.407 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.7 p -91.91 34.91 0.98 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.155 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 54.3 -148.6 0.46 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.36 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.45 HH12 ' CG1' ' A' ' 116' ' ' VAL . 50.9 ptt85 -141.01 163.5 32.81 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.94 129.63 8.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.492 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.16 161.38 38.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.454 ' C ' HD22 ' A' ' 109' ' ' LEU . 38.8 t -123.35 128.73 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.572 HD12 ' HD2' ' A' ' 84' ' ' ARG . 4.1 mm? -104.79 157.66 17.05 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.173 0.511 . . . . 1.0 109.646 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.9 mmt 54.84 -87.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.819 -1.082 . . . . 1.0 110.282 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LEU . 2.6 p30 -169.3 72.36 0.08 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.21 -0.19 59.9 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.411 ' C ' HD22 ' A' ' 114' ' ' LEU . 34.2 tptt -73.41 -57.26 4.13 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.901 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.411 HD22 ' C ' ' A' ' 113' ' ' LYS . 4.1 mm? -117.88 120.23 37.26 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.858 0.724 . . . . 1.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.5 126.06 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.177 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.45 ' CG1' HH12 ' A' ' 105' ' ' ARG . 57.6 t -101.56 114.25 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.143 -1.428 . . . . 1.0 107.143 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.05 140.78 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.839 0.712 . . . . 1.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.54 -40.88 66.98 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 110.011 -1.235 . . . . 1.0 110.011 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.0 t80 61.68 135.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.297 0.239 . . . . 1.0 110.508 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -170.08 128.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -161.25 142.99 11.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.169 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 123' ' ' THR . 99.3 p 46.85 -114.53 0.54 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.198 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.491 ' N ' ' HG ' ' A' ' 122' ' ' SER . 60.6 p -61.36 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.161 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 125' ' ' MET . 16.3 pttt -170.64 -73.09 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.546 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 64.4 mtt -71.79 -55.96 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.578 0.228 . . . . 1.0 111.469 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.96 -33.04 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.813 0.34 . . . . 1.0 111.276 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.2 m -72.44 -43.93 63.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.762 0.282 . . . . 1.0 111.762 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.489 HG21 ' CE1' ' A' ' 32' ' ' PHE . 74.0 mt -64.93 -46.35 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 1.0 112.076 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 130' ' ' ARG . 20.6 pt -62.61 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 121.874 0.845 . . . . 1.0 110.789 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.42 ' N ' HG13 ' A' ' 129' ' ' ILE . 69.1 mtp85 -56.45 -46.04 80.54 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.95 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.75 -55.86 28.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -73.9 -22.69 59.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.345 -176.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 95.6 p 35.67 76.15 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.831 0.852 . . . . 1.0 112.588 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 30' ' ' ALA . 22.5 t70 -164.58 -151.18 0.15 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.041 -0.725 . . . . 1.0 109.041 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 135' ' ' LEU . 4.0 mm? -91.35 126.24 36.37 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.13 0.491 . . . . 1.0 109.687 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.0 p -97.1 155.36 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.801 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 31' ' ' LEU . 68.9 mt -119.01 96.35 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.995 -1.002 . . . . 1.0 108.52 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 t -96.42 123.44 40.08 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.62 -0.511 . . . . 1.0 109.62 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.426 ' CE1' ' NE2' ' A' ' 168' ' ' GLN . 1.8 t60 -73.51 -50.78 19.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.645 0.26 . . . . 1.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 25.11 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.03 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -63.93 -34.13 89.11 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.4 -44.73 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.926 0.393 . . . . 1.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -65.54 -41.58 96.11 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 111.151 -0.779 . . . . 1.0 111.151 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.9 t -69.65 -40.66 76.36 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 122.51 -0.406 . . . . 1.0 111.21 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.54 -29.75 39.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.369 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.6 tp -50.11 -51.37 43.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.033 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -65.65 -38.99 90.89 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.721 0.772 . . . . 1.0 110.339 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 m -51.08 -25.26 4.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.433 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.47 -55.35 4.93 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.073 0.768 . . . . 1.0 113.073 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -63.99 -26.61 68.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.909 0.385 . . . . 1.0 110.457 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.26 -0.91 6.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 t30 56.33 37.7 29.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.37 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -138.95 144.7 42.37 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.086 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.27 -177.41 2.98 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 121.865 1.71 . . . . 1.0 110.877 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.694 ' C ' HD13 ' A' ' 156' ' ' ILE . 2.0 pt? -158.78 171.95 19.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.177 -0.919 . . . . 1.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.694 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.5 OUTLIER -119.32 120.34 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.618 177.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.7 t -106.37 127.76 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.848 0.356 . . . . 1.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 96.8 m -72.77 104.81 4.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.01 147.73 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 83.48 102.49 0.05 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.976 0.798 . . . . 1.0 110.278 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -168.76 -76.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.6 m 49.17 35.92 8.17 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.06 0.457 . . . . 1.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.68 -40.66 97.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.184 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.9 ttm -162.88 52.3 0.18 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.006 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.29 -41.71 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.181 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 71.52 -51.62 0.69 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.701 0.626 . . . . 1.0 110.319 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -60.93 -23.77 65.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.806 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.426 ' NE2' ' CE1' ' A' ' 139' ' ' HIS . 11.6 tm0? -42.11 -50.71 4.73 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.332 -0.395 . . . . 1.0 111.305 -176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -67.09 -36.27 81.61 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.101 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -66.17 -38.09 87.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.452 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.6 mm -65.06 -43.63 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.99 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.51 -52.26 8.77 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.823 0.344 . . . . 1.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.25 -51.91 30.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.981 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -61.04 -30.31 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 1.0 110.574 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 179' ' ' GLY . 0.7 OUTLIER -63.96 -36.62 84.57 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.024 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.3 t -57.69 -44.5 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.671 0.272 . . . . 1.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -63.41 -50.22 70.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.831 0.348 . . . . 1.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.2 mt -90.76 0.67 57.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.313 0.578 . . . . 1.0 110.212 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . -173.51 87.23 0.08 OUTLIER Glycine 0 C--O 1.223 -0.575 0 N-CA-C 109.727 -1.349 . . . . 1.0 109.727 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -48.25 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.457 0.74 . . . . 1.0 110.308 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.4 p -89.96 146.73 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.107 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -66.93 127.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 p -107.14 133.87 51.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.6 m -162.71 124.79 2.66 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -79.74 154.98 75.95 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.712 -0.661 . . . . 1.0 110.175 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.5 63.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.513 2.638 0 C-N-CA 122.458 2.106 . . . . 1.0 113.547 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 185' ' ' ALA . 79.4 p -128.12 141.95 51.34 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 17.2 mp0 -65.45 -25.36 67.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.276 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 189' ' ' THR . 1.5 t -89.11 -31.57 17.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.897 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.36 -34.3 12.45 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 112.015 -0.434 . . . . 1.0 112.015 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 34.7 mt -62.41 -41.52 98.74 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 122.449 -0.442 . . . . 1.0 111.364 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.28 -39.33 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.6 79.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.389 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.48 -53.99 25.5 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.415 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.94 -32.98 72.49 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.716 -0.284 . . . . 1.0 110.387 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -59.16 -48.6 81.03 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.503 -0.479 . . . . 1.0 109.99 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.54 -47.79 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.188 -0.32 . . . . 1.0 111.395 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 83.3 p -59.79 -32.95 71.09 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.21 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.16 28.35 4.97 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.778 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 62.1 m -150.45 -30.74 0.2 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.328 -0.249 . . . . 1.0 110.328 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -150.8 151.94 33.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.174 0.511 . . . . 1.0 109.751 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -130.39 156.78 44.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.344 -0.844 . . . . 1.0 110.089 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.39 164.61 19.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.183 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -61.73 148.35 87.32 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.904 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.99 99.63 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.742 1.628 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -140.61 87.43 11.52 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 107.36 2.46 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.019 1.813 . . . . 1.0 111.685 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.64 84.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.224 -0.444 . . . . 1.0 109.932 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 78.2 p -68.84 -32.75 72.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.798 0.333 . . . . 1.0 110.467 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -83.09 21.2 1.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.988 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.427 HD22 ' H ' ' A' ' 213' ' ' SER . 0.5 OUTLIER -57.59 146.15 66.29 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.902 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -72.95 13.37 0.62 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.051 1.834 . . . . 1.0 111.855 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.427 ' H ' HD22 ' A' ' 211' ' ' ASN . 4.7 t -65.8 -58.62 5.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.949 0.404 . . . . 1.0 111.111 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -53.33 -39.31 63.98 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.12 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -59.56 -32.23 70.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.214 -0.448 . . . . 1.0 109.939 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -76.69 -49.74 15.36 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.787 0.327 . . . . 1.0 111.434 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 63.2 mt -64.34 -52.69 57.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.524 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.03 -50.88 65.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.459 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.08 -41.56 92.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.326 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.79 -33.93 76.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.573 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 27.6 m -60.91 -46.92 88.73 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.947 0.404 . . . . 1.0 110.465 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.4 tp -82.29 142.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.837 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -165.59 139.21 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.112 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.066 -0.968 . . . . 1.0 110.336 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.39 -21.07 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 26' ' ' ILE . 8.5 tp -73.31 76.83 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.844 0.831 . . . . 1.0 110.387 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -159.09 -30.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -164.04 73.82 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.932 -0.396 . . . . 1.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' H ' HG21 ' A' ' 63' ' ' VAL . 88.6 tttt -128.78 111.32 12.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.45 160.2 14.53 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 137' ' ' ILE . 14.0 tp -130.15 102.73 6.36 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -99.42 127.62 45.48 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.849 0.46 . . . . 1.0 110.018 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.61 145.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 t -144.01 138.63 28.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.523 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.19 -35.57 76.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 1.0 109.852 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.5 -104.12 1.38 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.371 -1.092 . . . . 1.0 110.371 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.46 -159.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -63.42 172.01 2.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 p -162.34 82.81 1.67 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.9 -32.77 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.054 1.836 . . . . 1.0 111.065 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.6 110.45 3.15 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 118.746 -0.645 . . . . 1.0 110.267 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -84.76 -21.68 3.25 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.613 1.542 . . . . 1.0 112.36 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -81.17 -31.89 33.85 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.548 HD23 ' OG ' ' A' ' 162' ' ' SER . 0.3 OUTLIER -75.58 -51.6 12.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.093 0.473 . . . . 1.0 110.472 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 48' ' ' VAL . 11.9 p -56.74 -32.06 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.995 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 98.3 p -62.39 -19.26 63.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.691 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.5 p -51.07 -38.54 52.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 1.0 110.601 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 45' ' ' VAL . 5.4 m -64.61 -18.76 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.112 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mt -143.63 41.19 1.44 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.939 0.496 . . . . 1.0 109.774 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -124.26 -156.13 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.103 -0.702 . . . . 1.0 109.103 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -54.5 -46.81 73.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.747 -0.66 . . . . 1.0 112.033 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.13 -55.41 35.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.536 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -71.0 -45.63 63.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.455 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 47.5 t -56.77 -32.02 65.2 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.46 0.647 . . . . 1.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -78.83 -49.86 12.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.82 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -70.08 -58.29 3.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.888 -0.597 . . . . 1.0 112.606 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 61' ' ' GLY . 3.2 mm? -49.45 -42.01 41.76 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.289 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.7 mm -69.69 -42.33 80.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -50.46 -51.9 42.79 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.122 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.89 -17.81 24.68 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . 75.54 -16.21 4.11 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.562 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 38.09 -115.54 0.15 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.261 -0.4 . . . . 1.0 111.448 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.433 HG21 ' H ' ' A' ' 29' ' ' LYS . 97.0 t -160.43 -59.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -165.64 130.2 2.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.367 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.603 ' C ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -99.44 143.33 29.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.637 0.775 . . . . 1.0 110.533 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.8 mm -123.28 130.46 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 48' ' ' VAL . 12.5 tt -145.29 141.86 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.243 0.544 . . . . 1.0 109.538 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.565 HE21 ' CE ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -160.58 151.79 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.18 -0.918 . . . . 1.0 109.043 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' OE2' ' A' ' 76' ' ' GLU . 95.8 m-85 -99.96 -60.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.315 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.514 ' H ' ' CG2' ' A' ' 103' ' ' THR . . . 89.01 -37.62 3.3 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 111.314 -0.715 . . . . 1.0 111.314 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.638 ' NH2' ' HE ' ' A' ' 216' ' ' ARG . 62.3 mmt-85 -97.13 122.65 40.39 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -64.81 -38.07 89.75 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.973 0.416 . . . . 1.0 110.262 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -54.03 -15.91 1.67 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.936 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -55.08 -80.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.242 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.3 m 52.88 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.667 0.27 . . . . 1.0 111.454 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -168.0 -44.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.908 0.385 . . . . 1.0 111.462 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -69.15 103.57 1.94 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.21 -83.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.267 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -169.08 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.035 0.445 . . . . 1.0 110.272 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.65 -17.59 60.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.32 -36.59 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' GLY . 41.4 mm-40 -66.87 -39.64 87.6 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.52 -0.764 . . . . 1.0 110.128 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -51.96 -38.02 55.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.12 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -18.0 62.59 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' GLN . . . 88.53 41.74 6.0 Favored Glycine 0 N--CA 1.47 0.904 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.34 168.16 54.81 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -137.84 133.83 34.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -62.39 155.94 23.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.894 -0.322 . . . . 1.0 110.848 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.79 -5.83 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.407 0.442 . . . . 1.0 110.888 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.4 m -70.31 143.52 52.01 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 92' ' ' LYS . 16.8 mm100 -64.24 128.51 36.09 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 91' ' ' GLN . 61.3 mttp 60.17 127.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.99 -0.745 . . . . 1.0 108.99 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 93' ' ' ILE . 17.1 tt -51.75 102.57 0.32 Allowed Pre-proline 0 CA--C 1.552 1.022 0 CA-C-N 117.666 0.212 . . . . 1.0 111.45 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 96' ' ' ASP . 33.0 Cg_exo -63.27 -141.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.221 0 CA-C-N 120.357 1.163 . . . . 1.0 111.601 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.44 7.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.226 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 94' ' ' PRO . 66.2 t0 63.28 -116.64 0.49 Allowed 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -56.9 -168.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.846 0.355 . . . . 1.0 110.62 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 100' ' ' CYS . 0.1 OUTLIER -67.37 -20.93 65.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' SG ' ' A' ' 100' ' ' CYS . . . 66.35 -11.82 0.51 Allowed Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.96 -0.563 . . . . 1.0 111.872 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.484 ' H ' ' C ' ' A' ' 98' ' ' PHE . 1.2 m 171.95 -86.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.404 -0.961 . . . . 1.0 108.404 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 173.74 120.91 0.59 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.283 -1.127 . . . . 1.0 110.283 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -171.41 -120.76 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.514 ' CG2' ' H ' ' A' ' 70' ' ' GLY . 46.8 p -152.0 71.47 0.97 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -155.22 62.66 0.63 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.07 0.462 . . . . 1.0 111.665 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' A' ' 118' ' ' GLY . 22.3 ptt85 -133.47 147.81 51.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -150.05 117.98 6.28 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -137.04 161.28 36.51 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.09 147.94 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.316 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 111' ' ' ASN . 2.0 mp -123.82 123.14 39.8 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.5 tpp 55.83 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.268 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' LEU . 20.6 t-20 -167.39 78.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.793 0.33 . . . . 1.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.41 5.28 77.05 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.011 -0.835 . . . . 1.0 111.011 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -66.51 -23.44 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.668 0.247 . . . . 1.0 111.668 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 tp -174.04 105.68 0.12 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -109.89 115.32 29.59 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.38 108.45 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.87 100.04 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.938 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.41 ' H ' ' HG3' ' A' ' 105' ' ' ARG . . . -84.68 -25.01 43.7 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 109.889 -1.284 . . . . 1.0 109.889 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -58.69 137.4 57.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.898 0.38 . . . . 1.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -166.41 170.54 12.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -81.56 96.06 7.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.226 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.6 p 46.53 -164.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.784 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.54 8.5 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.15 0.5 . . . . 1.0 110.054 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -144.42 44.87 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.565 ' CE ' HE21 ' A' ' 68' ' ' GLN . 18.1 mmt -52.98 -41.67 64.81 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.668 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -54.83 -26.96 38.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.683 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 51.2 p -83.66 -38.85 20.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.836 0.35 . . . . 1.0 111.245 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.02 -44.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.718 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.85 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -55.14 -38.81 68.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.173 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.48 -43.58 84.23 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -96.07 -61.06 1.5 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.03 0.443 . . . . 1.0 110.293 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 m 55.96 79.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -139.99 -49.37 0.47 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.65 0.262 . . . . 1.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.495 HD13 ' H ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -163.39 139.06 6.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.495 ' H ' HD13 ' A' ' 135' ' ' LEU . 1.5 p -133.47 140.44 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.536 HD11 HD11 ' A' ' 31' ' ' LEU . 79.3 mt -119.18 125.9 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 139' ' ' HIS . 27.5 t -87.6 -164.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.435 ' N ' ' OG ' ' A' ' 138' ' ' SER . 79.4 t60 -139.03 -3.38 1.6 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 110.395 -0.224 . . . . 1.0 110.395 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.09 -56.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.099 0.476 . . . . 1.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 136.8 126.14 2.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 1.9 t -174.07 -131.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.488 -0.93 . . . . 1.0 108.488 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -73.76 -27.16 67.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -54.75 -44.81 73.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 89.1 mt -65.69 -26.75 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 122.173 -0.329 . . . . 1.0 110.902 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -54.57 34.68 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.25 -44.55 91.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.534 0.683 . . . . 1.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.7 p -49.08 -22.78 0.99 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.125 -0.943 . . . . 1.0 113.3 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.4 mt -82.46 -45.42 14.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.852 0.358 . . . . 1.0 111.611 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -68.8 -21.85 64.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.308 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.03 -3.0 57.72 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 53.06 34.34 16.93 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.593 0.235 . . . . 1.0 110.557 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.81 115.7 48.38 Favored Pre-proline 0 N--CA 1.481 1.11 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -50.94 155.22 6.12 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 CA-C-N 120.658 1.271 . . . . 1.0 112.308 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.14 170.31 19.73 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.274 1.035 . . . . 1.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.43 138.18 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.685 -1.598 . . . . 1.0 109.278 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.7 p -119.89 138.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 120.631 0.253 . . . . 1.0 110.815 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 14.3 t -72.35 125.27 26.97 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 184' ' ' CYS . 25.1 t -123.54 139.81 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 109.145 -0.687 . . . . 1.0 109.145 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 161' ' ' ASP . 64.5 t30 57.11 -176.09 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.02 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' A' ' 160' ' ' ASN . 65.5 m-20 59.76 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.838 0.711 . . . . 1.0 111.077 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.548 ' OG ' HD23 ' A' ' 44' ' ' LEU . 68.8 m 53.59 -90.94 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.847 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 66.5 mt -3.79 78.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.104 1.362 . . . . 1.0 113.14 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 62.1 mmm -60.83 -41.14 95.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.14 -0.937 . . . . 1.0 110.617 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.46 121.58 17.29 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.05 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -64.91 -34.27 78.0 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.77 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -55.63 -39.54 70.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.097 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.7 -52.39 64.49 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -66.88 -28.59 68.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.821 0.343 . . . . 1.0 110.574 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.78 -51.99 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.441 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.9 -27.27 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.41 -58.3 3.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -52.18 -43.88 64.38 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.862 -1.063 . . . . 1.0 112.353 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -64.71 -41.99 95.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.421 -0.512 . . . . 1.0 109.844 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.206 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 179' ' ' GLY . 99.7 t -64.12 -35.32 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -48.09 -43.61 30.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.233 -0.894 . . . . 1.0 109.295 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.64 -29.91 67.49 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 176' ' ' VAL . . . 82.47 -5.79 71.89 Favored Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.339 -1.104 . . . . 1.0 110.339 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.538 ' O ' HD22 ' A' ' 203' ' ' LEU . 0.3 OUTLIER -62.53 -4.73 2.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.949 -0.625 . . . . 1.0 111.284 -177.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.8 p -131.33 147.47 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.171 0.441 . . . . 1.0 110.156 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 19.6 m-90 -76.71 131.65 38.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m -88.08 138.6 31.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -135.53 149.77 49.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.1 150.34 70.88 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 108.59 -0.893 . . . . 1.0 108.59 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.17 58.19 5.54 Favored 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 122.201 1.934 . . . . 1.0 113.183 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 173.08 6.5 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.88 -57.71 5.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.8 m -88.84 -30.27 19.07 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.585 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -59.19 -47.71 89.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.353 -0.699 . . . . 1.0 111.353 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.42 -43.0 91.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 117.083 0.441 . . . . 1.0 111.155 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.46 -43.65 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.59 -38.51 72.11 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.38 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.24 91.38 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.418 -0.673 . . . . 1.0 111.418 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -52.68 63.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -60.84 -35.33 76.28 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.141 -0.936 . . . . 1.0 109.432 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.03 -45.23 86.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.885 0.374 . . . . 1.0 110.097 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 84.2 p -67.5 -20.49 65.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.66 -24.73 14.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.01 0.433 . . . . 1.0 109.873 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.1 m -74.63 -40.08 61.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.505 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -120.18 139.7 52.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.794 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -119.18 101.61 8.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.054 0.542 . . . . 1.0 109.977 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 180' ' ' TYR . 5.2 tp -63.83 131.18 46.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -67.99 150.19 97.87 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 106.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.508 2.362 0 C-N-CA 121.891 1.727 . . . . 1.0 113.624 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.81 84.69 9.63 Favored Pre-proline 0 N--CA 1.478 0.953 0 N-CA-C 109.932 -0.395 . . . . 1.0 109.932 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -57.32 127.33 25.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.624 1.55 . . . . 1.0 112.036 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.04 -33.48 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.675 -0.491 . . . . 1.0 109.675 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 211' ' ' ASN . 50.6 m 55.38 -111.09 0.6 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.861 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.32 -79.34 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 209' ' ' SER . 8.1 p-10 -133.42 78.1 63.95 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 122.943 0.497 . . . . 1.0 110.22 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 214' ' ' PHE . 71.8 Cg_exo -55.32 -136.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.67 0 C-N-CA 123.019 2.48 . . . . 1.0 112.521 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 96.4 p -68.35 8.04 0.51 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.853 0.358 . . . . 1.0 110.212 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 212' ' ' PRO . 65.1 t80 -60.85 -45.1 95.84 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.154 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.88 -54.78 25.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.815 0.34 . . . . 1.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.638 ' HE ' ' NH2' ' A' ' 71' ' ' ARG . 84.9 mtp180 -62.22 -39.54 93.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.889 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 tp -48.95 -47.64 43.67 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.098 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 76.2 mt -58.05 -42.12 84.75 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.468 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.58 -50.55 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -61.46 -36.97 81.9 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.788 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 32.3 m -61.36 -44.58 96.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.759 0.314 . . . . 1.0 110.432 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 84.4 mt -80.35 129.3 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.479 ' CD2' ' N ' ' A' ' 224' ' ' SER . 59.4 t80 57.33 162.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.012 0.434 . . . . 1.0 111.176 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.479 ' N ' ' CD2' ' A' ' 223' ' ' TYR . 46.9 t . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.259 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.435 -1.466 . . . . 1.0 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 27' ' ' GLU . 9.5 tt -169.7 -37.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.2 mm -61.73 69.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 123.605 0.566 . . . . 1.0 110.406 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 25' ' ' ILE . 76.8 tt0 -176.78 95.13 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.822 -0.626 . . . . 1.0 109.768 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -165.96 -76.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -132.73 101.48 5.3 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.006 0.522 . . . . 1.0 110.019 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.68 119.5 38.95 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -83.07 121.59 27.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.76 0.314 . . . . 1.0 110.22 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CE1' ' CZ ' ' A' ' 132' ' ' TYR . 6.9 m-85 -103.63 122.13 44.37 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.2 t -118.36 99.04 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.5 p -93.23 120.75 33.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.236 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 139' ' ' HIS . 71.5 m -61.25 -27.48 68.48 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -138.47 31.6 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.721 -0.952 . . . . 1.0 110.721 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.37 -112.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.892 -0.181 . . . . 1.0 110.71 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.5 p -71.3 112.74 7.68 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.5 131.48 95.1 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.874 -0.584 . . . . 1.0 110.358 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.77 -174.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.3 1.333 . . . . 1.0 112.477 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.99 144.96 90.01 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.034 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.78 -33.22 49.38 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.789 1.66 . . . . 1.0 113.086 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.32 -35.39 61.24 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.633 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tp -66.88 -45.04 79.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.799 0.333 . . . . 1.0 111.531 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 48' ' ' VAL . 16.2 m -60.72 -37.03 74.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.238 -0.437 . . . . 1.0 109.954 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -46.54 -27.53 1.15 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.181 0.515 . . . . 1.0 110.986 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.6 t -53.89 -38.09 64.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.78 . . . . 1.0 110.559 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 45' ' ' VAL . 1.5 m -80.53 -4.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.302 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.52 40.18 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.224 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.9 m -135.62 -166.12 1.8 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.898 0.856 . . . . 1.0 109.823 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -54.6 -44.84 73.41 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.95 -1.477 . . . . 1.0 110.327 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.489 ' H ' ' CD ' ' A' ' 52' ' ' GLU . 23.4 mp0 -52.27 -52.07 54.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.534 0.207 . . . . 1.0 110.55 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.58 -37.33 76.92 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.432 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.2 t -49.77 -45.98 50.23 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 120.745 0.307 . . . . 1.0 111.552 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -72.66 -44.59 61.67 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 1.0 111.429 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.35 -36.01 80.53 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.596 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -58.17 -47.23 84.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.619 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.62 HD11 ' HZ3' ' A' ' 113' ' ' LYS . 1.5 mp -68.67 -28.95 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.86 -43.02 59.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.91 -0.587 . . . . 1.0 110.906 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -76.57 -11.05 59.81 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.047 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 83.64 37.83 11.43 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.61 -0.805 . . . . 1.0 111.505 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 63' ' ' VAL . 1.6 p90 -48.43 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 120.936 0.398 . . . . 1.0 111.17 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' N ' ' CD2' ' A' ' 62' ' ' PHE . 8.7 p -172.15 -31.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.001 0.429 . . . . 1.0 109.952 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.504 ' NH1' ' NZ ' ' A' ' 115' ' ' LYS . 56.1 ttt85 -167.02 108.52 0.66 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.5 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.1 tp -90.07 130.47 36.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.252 -0.648 . . . . 1.0 109.252 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.09 135.88 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.09 144.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -119.98 124.36 45.74 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.158 -1.052 . . . . 1.0 108.158 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CE1' ' NH2' ' A' ' 105' ' ' ARG . 2.0 t80 -59.04 -169.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.302 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.82 -109.08 0.35 Allowed Glycine 0 N--CA 1.463 0.481 0 N-CA-C 110.664 -0.974 . . . . 1.0 110.664 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -65.17 124.28 21.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.71 0.291 . . . . 1.0 110.723 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.63 -37.99 88.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.775 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.36 -44.49 88.84 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.461 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 99.3 p -63.91 169.73 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.289 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.3 p -153.61 73.37 0.96 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.335 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.95 169.39 4.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.83 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 45.8 76.1 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.938 0.399 . . . . 1.0 110.736 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.37 -34.96 77.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.22 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -167.86 22.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.388 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.88 -30.19 66.5 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.839 0.352 . . . . 1.0 110.6 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' GLY . 74.6 t -58.91 -47.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -72.72 -42.15 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.884 0.373 . . . . 1.0 111.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -52.64 -43.37 65.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.954 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -83.1 -16.9 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.93 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.38 -55.86 0.41 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 81' ' ' VAL . . . 46.06 78.02 0.09 OUTLIER Glycine 0 N--CA 1.465 0.593 0 N-CA-C 112.686 -0.166 . . . . 1.0 112.686 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.21 109.96 19.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' NH1' ' O ' ' A' ' 97' ' ' GLN . 26.6 mmm180 -59.64 150.48 27.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.925 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.5 16.92 3.37 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.479 0.657 . . . . 1.0 109.549 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.9 t -168.6 -173.79 2.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.441 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -151.78 54.83 0.84 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.506 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.59 -45.37 87.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.444 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.2 pt -109.63 145.03 31.1 Favored Pre-proline 0 CA--C 1.554 1.129 0 O-C-N 123.354 0.409 . . . . 1.0 110.741 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.81 -55.54 3.75 Favored 'Trans proline' 0 N--CA 1.509 2.433 0 C-N-CA 122.053 1.835 . . . . 1.0 113.203 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.5 tt -48.3 -40.95 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.807 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.4 t70 47.42 66.14 1.09 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.18 -0.463 . . . . 1.0 111.47 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.429 ' O ' ' NH1' ' A' ' 88' ' ' ARG . 58.1 tt0 -150.12 -84.24 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.486 ' CE1' ' NH1' ' A' ' 105' ' ' ARG . 81.4 t80 -128.29 -17.41 4.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.8 0.44 . . . . 1.0 110.62 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.22 66.97 2.14 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 101' ' ' GLY . 28.1 p -53.94 -44.62 70.81 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.716 0.294 . . . . 1.0 110.97 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.45 ' N ' ' SG ' ' A' ' 100' ' ' CYS . . . -62.15 -82.78 0.07 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.43 -109.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 t -173.18 -29.4 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.027 -0.36 . . . . 1.0 110.027 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -32.35 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.824 0.703 . . . . 1.0 111.493 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' CE1' ' A' ' 98' ' ' PHE . 10.5 ptp180 -130.12 151.69 50.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.571 -0.741 . . . . 1.0 109.593 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -157.98 109.46 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.52 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -143.14 -172.96 3.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.75 -0.463 . . . . 1.0 109.75 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 109' ' ' LEU . 11.0 p -152.54 162.26 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.427 ' N ' HG22 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -163.84 -174.17 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -178.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.2 mtt 53.82 54.09 10.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.496 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 52.49 33.47 13.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.72 25.03 68.35 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 120.894 -0.67 . . . . 1.0 112.499 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.62 ' HZ3' HD11 ' A' ' 58' ' ' ILE . 16.6 tptm -83.21 -49.86 9.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.4 0.6 . . . . 1.0 112.034 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.73 132.84 56.42 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.186 0.517 . . . . 1.0 112.033 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' NZ ' ' NH1' ' A' ' 64' ' ' ARG . 49.3 mtmt -106.23 152.45 23.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -134.23 132.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.6 mt -145.06 123.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.795 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.26 -16.24 76.75 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 110.15 -1.18 . . . . 1.0 110.15 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.4 t80 54.69 -99.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -169.67 130.17 1.03 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.19 108.64 4.24 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.1 p -168.07 160.64 12.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.123 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.8 t -76.69 5.27 7.86 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.237 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -72.33 -42.73 65.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.293 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 37.1 ttm -46.14 -34.21 4.09 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.709 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.96 -28.47 57.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.624 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -79.35 -35.18 41.32 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.421 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 128' ' ' ILE . 1.6 mp -64.55 -27.82 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.762 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.2 mt -52.13 -51.45 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 120.316 -0.553 . . . . 1.0 109.739 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -48.47 -30.95 5.67 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.383 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -52.4 -47.23 66.4 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 121.263 -0.175 . . . . 1.0 111.276 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.595 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.2 p90 -117.1 -53.68 2.45 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.341 0.401 . . . . 1.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 47.4 m 50.25 79.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.869 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -120.14 -53.45 2.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 154' ' ' PRO . 3.3 tp -168.8 148.39 4.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.065 -0.654 . . . . 1.0 110.481 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.17 149.76 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.47 100.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 t -116.33 127.14 54.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.487 ' CD2' ' H ' ' A' ' 139' ' ' HIS . 13.2 p80 -80.69 67.86 6.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.226 -0.443 . . . . 1.0 109.875 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.85 34.37 23.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.994 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 143' ' ' GLY . . . -62.41 -34.77 90.37 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.402 ' H ' HD12 ' A' ' 145' ' ' ILE . 2.8 m 69.03 -16.75 0.22 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.46 0.304 . . . . 1.0 110.413 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 141' ' ' GLY . . . -84.25 -54.18 3.08 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.706 -0.557 . . . . 1.0 111.706 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.0 p -79.54 -32.22 42.15 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.47 0.308 . . . . 1.0 111.365 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 142' ' ' THR . 97.4 mt -54.27 -28.2 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 120.693 0.283 . . . . 1.0 110.86 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.9 mt -56.29 -51.08 69.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.807 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -65.17 -53.1 50.05 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 121.426 0.632 . . . . 1.0 110.865 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 88.0 p -58.32 -24.93 61.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 1.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 52.2 tp -76.7 -57.34 3.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.633 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.497 ' NH1' ' ND1' ' A' ' 210' ' ' HIS . 39.6 ptt180 -62.36 -28.05 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.171 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.7 4.6 1.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 150' ' ' ARG . 22.7 m120 58.41 11.96 1.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.233 0.333 . . . . 1.0 110.274 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -92.5 142.33 25.77 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.458 ' O ' HD12 ' A' ' 135' ' ' LEU . 62.7 Cg_endo -71.67 167.9 25.22 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.719 1.613 . . . . 1.0 111.481 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 155' ' ' LEU . 1.9 pt? -156.65 156.52 33.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.295 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.412 ' CG2' ' SG ' ' A' ' 184' ' ' CYS . 16.8 mm -110.13 109.72 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.58 118.27 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.11 103.65 2.37 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 85.5 t -90.09 137.88 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 55.1 170.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.011 0.434 . . . . 1.0 110.769 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 49.82 74.75 0.19 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.715 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.1 t -171.2 -49.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.13 0.49 . . . . 1.0 110.129 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.0 pp -145.52 142.87 29.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.092 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.2 mmm -90.22 86.65 6.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.573 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 166' ' ' ASN . 15.3 t0 -161.16 -19.52 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.962 -0.385 . . . . 1.0 109.962 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 165' ' ' ASP . 67.4 m-20 58.7 6.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.67 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 165' ' ' ASP . 52.8 t-80 -66.25 -36.63 83.49 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 172' ' ' ALA . 5.3 pt20 -61.57 -41.6 97.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.974 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -53.96 -29.56 43.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.83 0.348 . . . . 1.0 111.024 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -70.45 -53.47 16.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.09 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.5 mt -83.63 -51.3 14.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 110.487 -0.19 . . . . 1.0 110.487 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 168' ' ' GLN . . . -45.05 -52.97 8.39 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.335 0.494 . . . . 1.0 112.335 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 176' ' ' VAL . 30.4 t0 -69.36 -56.13 8.4 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -51.04 -26.98 6.95 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.9 0.381 . . . . 1.0 110.791 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -54.31 -38.84 66.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.243 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 173' ' ' ASP . 15.7 m -55.53 -29.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 120.918 0.39 . . . . 1.0 111.875 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -59.46 -48.49 81.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.942 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.6 mt -104.48 24.7 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.288 0.566 . . . . 1.0 110.409 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.644 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 162.3 82.57 0.04 OUTLIER Glycine 0 C--O 1.221 -0.703 0 N-CA-C 108.44 -1.864 . . . . 1.0 108.44 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -46.35 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 O-C-N 125.063 1.096 . . . . 1.0 110.692 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.644 ' N ' ' O ' ' A' ' 179' ' ' GLY . 6.3 p -73.24 139.63 19.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.534 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -63.9 116.85 6.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.2 m -108.75 133.63 52.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.562 -0.744 . . . . 1.0 109.875 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 156' ' ' ILE . 28.5 p -165.1 131.32 2.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.697 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.65 79.47 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.43 79.11 0.24 Allowed 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 122.704 2.27 . . . . 1.0 113.68 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.5 p -130.62 177.14 7.61 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 2.2 pm0 -68.64 -63.86 0.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.56 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.5 m -75.13 -43.56 51.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.022 0.439 . . . . 1.0 111.547 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -51.85 -51.24 40.61 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.969 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.97 -41.46 97.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.3 0.55 . . . . 1.0 111.743 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.76 -42.93 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.94 76.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 1.0 110.153 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.71 -46.44 61.26 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.66 -44.41 97.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 110.043 -0.354 . . . . 1.0 110.043 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -64.63 -37.91 89.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.57 86.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.081 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.4 t -60.16 -21.2 61.37 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.01 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -101.28 31.67 3.6 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.668 0.27 . . . . 1.0 110.792 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 18.2 p -143.01 -31.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.12 152.21 12.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.336 -0.546 . . . . 1.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -99.08 144.03 28.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.688 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.571 ' C ' HD22 ' A' ' 203' ' ' LEU . 0.0 OUTLIER -54.78 173.91 0.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.519 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.13 116.08 22.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-O 118.991 -0.528 . . . . 1.0 110.739 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.61 118.17 2.82 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 CA-C-N 120.919 1.364 . . . . 1.0 112.749 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -142.06 87.81 9.56 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 85.79 1.4 Allowed 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.347 1.365 . . . . 1.0 112.436 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 p -63.74 -26.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.257 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.4 p 75.78 132.17 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.864 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.497 ' ND1' ' NH1' ' A' ' 150' ' ' ARG . 3.7 p-80 -62.33 -171.36 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.974 -0.38 . . . . 1.0 109.974 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.37 160.09 30.98 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.05 -98.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 122.304 2.003 . . . . 1.0 111.906 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.7 m -66.82 -36.35 82.16 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.832 0.349 . . . . 1.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.07 -33.56 52.58 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.659 0.266 . . . . 1.0 110.294 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -61.83 -24.22 66.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.416 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -82.01 -45.75 14.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.586 -0.279 . . . . 1.0 110.99 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 217' ' ' LEU . 10.2 mp -64.04 -42.87 96.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.647 -0.252 . . . . 1.0 110.536 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.2 mt -55.43 -44.75 76.59 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 55.1 t -74.29 -46.59 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -69.37 -6.94 33.12 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.757 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 26.0 m -46.85 -42.17 16.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.67 0.271 . . . . 1.0 110.972 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.16 143.69 15.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.507 . . . . 1.0 109.843 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 62.7 t80 52.32 97.95 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.028 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.09 -0.957 . . . . 1.0 110.305 -179.831 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.536 -1.426 . . . . 1.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.71 -46.09 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.2 pt -132.68 -36.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.353 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -146.55 173.11 12.61 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -116.96 65.19 0.72 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.06 156.09 39.59 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.7 134.77 51.7 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.772 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.65 119.57 32.2 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.743 -0.598 . . . . 1.0 109.466 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -101.42 129.94 47.54 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.25 138.04 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.73 129.62 42.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.685 -0.689 . . . . 1.0 109.491 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.56 34.75 2.67 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.971 0.415 . . . . 1.0 110.066 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.92 -160.13 53.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.78 -37.37 86.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.477 0.179 . . . . 1.0 111.059 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.1 p -133.18 150.45 52.0 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 110.067 -0.345 . . . . 1.0 110.067 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 39' ' ' VAL . 14.5 p -83.12 121.01 76.93 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 119.309 -0.377 . . . . 1.0 110.93 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.58 -59.63 1.12 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 CA-C-N 120.562 1.236 . . . . 1.0 112.386 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -144.81 145.31 27.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.906 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.76 -19.8 30.93 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 121.748 1.632 . . . . 1.0 111.813 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -77.23 -33.9 56.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.806 0.336 . . . . 1.0 110.875 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.46 -48.7 79.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 1.0 110.72 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -63.21 -34.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 1.0 109.76 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 50' ' ' SER . 6.4 m -52.52 -44.31 65.65 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.655 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -49.01 -38.56 23.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.73 0.3 . . . . 1.0 110.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.11 -14.1 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.271 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.59 35.17 4.24 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.993 0.425 . . . . 1.0 110.333 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 46' ' ' SER . 20.9 m -114.05 -167.55 1.23 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.16 -27.17 63.35 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.707 -1.133 . . . . 1.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.75 -47.57 65.93 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.241 -0.583 . . . . 1.0 110.485 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.2 t80 -69.22 -40.83 77.72 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.7 t -49.99 -48.48 52.3 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.293 0.479 . . . . 1.0 112.293 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -66.78 -44.27 81.8 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.817 0.342 . . . . 1.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -73.64 -30.58 63.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.29 0.567 . . . . 1.0 109.833 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' PHE . 5.7 tt -58.78 -50.0 75.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.312 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -66.59 -31.07 51.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.268 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -59.8 -10.55 3.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.713 -0.222 . . . . 1.0 110.634 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -103.6 -10.59 18.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.218 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.53 13.39 55.58 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 121.188 -0.53 . . . . 1.0 112.384 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -84.71 160.61 20.29 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.56 3.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.769 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -148.75 142.4 25.5 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.544 0.688 . . . . 1.0 110.554 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -141.99 116.41 9.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.341 -0.845 . . . . 1.0 108.899 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mm -100.69 137.88 26.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.6 tt -146.13 141.24 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.029 0.443 . . . . 1.0 109.833 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.09 158.91 5.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -174.82 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.963 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.27 147.44 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -155.73 83.83 1.03 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 1.0 110.282 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -68.28 -22.31 64.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.281 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -57.22 -29.6 63.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 84.4 p -149.97 -105.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.066 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.7 m -140.63 147.87 40.02 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 76' ' ' GLU . 19.8 mp0 -84.2 -119.66 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.79 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -66.55 109.98 2.99 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.77 -57.42 5.64 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.108 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -173.23 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 tp -66.06 -45.04 82.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.096 0.474 . . . . 1.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.88 -46.59 96.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.937 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.35 -26.45 68.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.009 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.98 -49.82 76.43 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.244 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -62.53 -17.38 59.69 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.083 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.77 54.9 7.83 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 110.179 -1.168 . . . . 1.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.15 -165.53 41.39 Favored Glycine 0 N--CA 1.466 0.669 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -134.6 135.03 41.91 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.004 0.431 . . . . 1.0 110.095 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' NH1' ' OD1' ' A' ' 96' ' ' ASP . 88.8 mtt-85 -60.55 153.28 23.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.922 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -106.45 0.48 24.81 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 92' ' ' LYS . 91.8 p 50.09 178.03 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.96 0.41 . . . . 1.0 111.117 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 57.72 2.01 0.15 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.198 -0.314 . . . . 1.0 111.59 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 90' ' ' SER . 68.5 mttm -139.68 16.02 2.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.343 0.257 . . . . 1.0 110.487 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.4 pt -144.89 82.43 10.08 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -81.98 -46.76 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.994 1.796 . . . . 1.0 110.534 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.8 pt -94.01 -3.36 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.934 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 97' ' ' GLN . 16.7 t70 62.73 -160.85 0.3 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.457 ' H ' ' CG ' ' A' ' 96' ' ' ASP . 11.4 mm100 59.53 -145.51 0.52 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -67.64 -19.81 65.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.794 -0.185 . . . . 1.0 110.643 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.79 68.08 1.7 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 102' ' ' ASP . 56.3 m -56.95 -156.41 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.782 0.325 . . . . 1.0 110.851 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.19 83.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.476 -0.65 . . . . 1.0 111.476 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 100' ' ' CYS . 7.0 m-20 -155.47 -64.57 0.12 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.07 20.23 0.19 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 110.275 -0.268 . . . . 1.0 110.275 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 58.33 -152.8 0.39 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.068 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -136.25 158.6 44.03 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.47 ' NE2' ' H ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -155.17 126.17 7.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 179.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.47 ' H ' ' NE2' ' A' ' 106' ' ' GLN . 2.0 m-85 -132.16 148.32 52.47 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.522 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.0 t -104.61 104.98 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.149 -0.932 . . . . 1.0 108.807 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -99.76 123.17 43.75 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 65.9 mtt 42.7 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.538 0.569 . . . . 1.0 112.538 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 54.96 7.8 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.757 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.29 24.02 72.18 Favored Glycine 0 N--CA 1.462 0.427 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -56.99 -39.47 74.72 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.046 -0.353 . . . . 1.0 110.046 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.8 tp -129.78 128.36 42.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -108.65 119.4 39.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.102 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.31 112.63 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.1 pt -115.08 158.66 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-N 115.144 -0.935 . . . . 1.0 108.954 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -115.44 95.05 0.69 Allowed Glycine 0 N--CA 1.474 1.205 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.76 -173.46 4.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -146.42 156.21 43.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.978 -0.555 . . . . 1.0 109.641 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -69.14 127.93 34.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.233 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.6 p -169.35 33.83 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.676 0.274 . . . . 1.0 110.448 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 29.6 p 51.6 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.653 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -179.88 -29.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.671 0.607 . . . . 1.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 59.6 mtm -55.38 -48.43 74.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.916 0.389 . . . . 1.0 110.923 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.402 ' O ' ' NE ' ' A' ' 130' ' ' ARG . 51.6 tt0 -55.29 -30.08 59.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.066 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 m -86.15 -51.79 6.08 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.965 0.412 . . . . 1.0 111.937 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.85 -43.33 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.199 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.33 -57.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.739 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 126' ' ' GLN . 18.1 ptp180 -69.2 -33.93 74.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.478 0.548 . . . . 1.0 112.478 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.17 -46.28 86.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.011 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.73 -65.38 1.15 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.78 0.324 . . . . 1.0 111.86 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 p -60.68 172.68 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.706 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -157.69 23.49 0.28 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.2 tp -158.69 138.03 11.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.85 155.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.08 102.06 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 81.9 p -89.71 113.24 24.72 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.42 0.629 . . . . 1.0 109.667 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.401 ' O ' ' N ' ' A' ' 141' ' ' GLY . 59.7 t-80 -69.69 136.44 51.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.24 -63.87 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.394 0.887 . . . . 1.0 113.394 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 139' ' ' HIS . . . -167.94 -80.44 0.04 OUTLIER Glycine 0 C--N 1.345 1.05 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.0 p 56.55 166.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.741 0.781 . . . . 1.0 110.76 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.35 -15.51 80.85 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 114.542 -1.208 . . . . 1.0 110.966 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 91.5 p -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.053 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.557 HG12 HD21 ' A' ' 155' ' ' LEU . 96.6 mt -59.01 -27.09 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.606 -0.438 . . . . 1.0 112.033 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 209' ' ' SER . 51.1 tp -57.02 -48.0 79.55 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.27 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -68.87 -51.99 34.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.631 . . . . 1.0 110.364 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.548 ' HB2' HD22 ' A' ' 155' ' ' LEU . 16.2 m -51.18 -25.22 5.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.766 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -77.01 -46.41 23.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.857 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -67.54 -32.83 73.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.54 -0.755 . . . . 1.0 111.24 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.75 -9.67 58.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 61.9 t30 54.88 35.27 23.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -109.46 151.28 42.07 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-O 119.294 -0.384 . . . . 1.0 110.393 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -43.13 143.59 1.96 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.007 1.804 . . . . 1.0 112.017 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 156' ' ' ILE . 52.3 tp -152.88 134.71 14.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.77 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -125.69 129.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.942 0.777 . . . . 1.0 109.013 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.17 130.53 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 117.986 0.357 . . . . 1.0 110.069 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 71.0 m -83.35 103.4 12.69 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.164 0.507 . . . . 1.0 109.663 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.36 143.41 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 160' ' ' ASN . 0.2 OUTLIER -147.62 175.32 10.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.936 0.398 . . . . 1.0 110.028 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -61.69 171.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.624 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.6 p -62.3 96.46 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.179 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 tp -66.38 -164.85 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.144 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.8 ttp -62.34 -52.47 63.52 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.835 0.35 . . . . 1.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 167' ' ' HIS . 75.9 m-20 -71.05 -42.7 69.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.115 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.71 0.86 0.16 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.287 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.475 ' H ' ' C ' ' A' ' 165' ' ' ASP . 34.6 m170 -73.55 -35.91 65.56 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.93 0.395 . . . . 1.0 110.459 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -65.29 -50.88 64.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.642 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.3 -33.32 74.42 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.441 . . . . 1.0 110.207 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -57.04 -52.43 65.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.707 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.85 -36.01 67.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.568 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.102 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 176' ' ' VAL . 27.6 t70 -49.32 -28.58 5.02 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.25 0.548 . . . . 1.0 110.423 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -85.43 -45.74 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.392 -0.822 . . . . 1.0 112.014 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.01 -20.51 60.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.258 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 177' ' ' GLU . 14.3 p -62.17 -52.08 64.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.976 0 C-N-CA 121.02 -0.272 . . . . 1.0 110.532 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 176' ' ' VAL . 57.7 mt-10 -58.79 -19.6 42.4 Favored 'General case' 0 CA--C 1.522 -0.11 0 O-C-N 121.931 -0.481 . . . . 1.0 111.048 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.77 3.2 0.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.676 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 177' ' ' GLU . . . 144.64 10.37 0.33 Allowed Glycine 0 N--CA 1.474 1.201 0 N-CA-C 111.089 -0.805 . . . . 1.0 111.089 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 176' ' ' VAL . 27.5 t80 72.23 100.38 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 1.0 109.237 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 181' ' ' VAL . 11.8 p -92.79 58.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.594 0.235 . . . . 1.0 110.821 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 181' ' ' VAL . 4.3 m-90 33.03 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.044 0.449 . . . . 1.0 110.303 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 93.8 p -88.08 132.75 34.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.95 142.55 46.8 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -111.31 155.86 42.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 119.158 -0.448 . . . . 1.0 110.755 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.32 37.73 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.785 1.656 . . . . 1.0 113.214 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p -131.32 143.09 50.25 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 24.8 mp0 -64.53 -46.33 83.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.474 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.0 m -64.4 -28.57 69.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.581 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.53 -31.89 17.53 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.45 -47.34 79.45 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 111.778 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.0 pt -52.66 -34.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.022 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -62.12 -37.96 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.741 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.3 98.39 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 49.8 mt -64.66 -35.42 80.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.932 0.396 . . . . 1.0 110.359 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -69.89 -37.36 75.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.421 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 201' ' ' GLU . . . -70.28 -44.95 67.32 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.062 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -66.58 -30.09 70.31 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.002 0.371 . . . . 1.0 112.002 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -86.16 11.67 11.39 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.176 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.2 p -146.37 -64.3 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.519 -0.31 . . . . 1.0 110.242 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 197' ' ' ALA . 92.6 mt-10 -71.63 129.21 38.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.748 0.308 . . . . 1.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.07 170.84 8.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.83 138.49 54.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -57.49 143.25 75.22 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.484 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.11 100.35 1.37 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.719 1.613 . . . . 1.0 111.964 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -142.02 82.87 13.08 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.85 112.64 1.16 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.914 1.742 . . . . 1.0 111.873 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.34 -73.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.515 -0.474 . . . . 1.0 110.073 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.52 ' H ' HD13 ' A' ' 146' ' ' LEU . 47.1 m 51.96 97.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.015 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.48 ' N ' ' ND1' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -163.51 -36.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.619 0.247 . . . . 1.0 111.107 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.471 ' N ' ' ND1' ' A' ' 210' ' ' HIS . 1.5 p-10 -173.46 61.76 0.26 Allowed Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.67 -89.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 121.647 1.565 . . . . 1.0 111.688 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 93.4 p -76.25 -1.24 25.53 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.116 0.484 . . . . 1.0 110.495 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -64.47 -32.6 74.3 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.591 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.458 ' CG ' ' H ' ' A' ' 216' ' ' ARG . 7.0 pt-20 -62.33 -58.51 7.42 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.646 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.458 ' H ' ' CG ' ' A' ' 215' ' ' GLU . 17.2 ptm180 -63.52 -34.89 78.77 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.068 0.461 . . . . 1.0 110.245 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 59.9 tp -51.21 -47.1 62.38 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.5 mt -59.3 -38.66 80.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.146 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.76 -51.51 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.14 -30.34 70.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.556 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 28.2 m -60.65 -49.6 76.87 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.767 0.318 . . . . 1.0 110.6 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 39.8 pt -78.9 149.85 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.249 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -66.1 134.09 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.926 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 118.153 -0.927 . . . . 1.0 110.425 179.736 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.573 -1.411 . . . . 1.0 109.573 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.492 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.6 mp -64.1 -43.33 97.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.86 0.362 . . . . 1.0 110.318 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.9 mt -61.4 -43.51 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.191 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -142.32 143.19 32.67 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.938 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -167.58 -61.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' O ' HG21 ' A' ' 63' ' ' VAL . 68.1 mttm -128.42 142.23 51.17 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.076 0.465 . . . . 1.0 110.167 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.28 167.4 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.85 120.19 19.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -118.73 133.56 55.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.403 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.7 140.29 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 t -143.96 141.24 30.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.034 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.8 m -83.19 143.51 30.43 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' N ' ' NE2' ' A' ' 139' ' ' HIS . . . -71.01 62.12 0.97 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.36 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.791 0.348 . . . . 1.0 110.775 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.4 p 53.18 100.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -59.68 125.36 79.76 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.035 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.71 -54.68 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.021 1.147 . . . . 1.0 111.927 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.417 ' CE2' ' OD1' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -142.76 144.54 30.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.92 -7.71 15.48 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.968 1.778 . . . . 1.0 111.545 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -66.99 -46.09 75.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.781 0.324 . . . . 1.0 111.083 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.67 -40.98 98.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.78 0.324 . . . . 1.0 110.617 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.23 -44.63 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.6 t -54.82 -48.2 73.11 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.166 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.3 m -51.65 -49.8 61.58 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.272 -0.267 . . . . 1.0 111.369 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 30.0 m -78.94 5.79 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.672 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.04 30.96 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 46' ' ' SER . 14.3 t -119.23 -164.12 1.03 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.548 ' N ' ' OG ' ' A' ' 50' ' ' SER . 76.1 m-20 -50.83 -42.42 58.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.922 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -62.76 -53.82 48.5 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 121.171 0.51 . . . . 1.0 110.218 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CE2' HD13 ' A' ' 57' ' ' LEU . 54.6 t80 -61.99 -45.43 93.66 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.244 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 89.4 m -51.94 -49.62 62.77 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.32 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 78.0 mt-30 -73.14 -52.3 14.72 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.077 0.465 . . . . 1.0 110.593 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -57.02 -24.94 57.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.694 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 ' CE2' ' A' ' 53' ' ' PHE . 48.8 tp -61.15 -45.32 95.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.905 0.383 . . . . 1.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -62.42 -43.39 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.747 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.418 ' N ' ' OE1' ' A' ' 59' ' ' GLN . 1.1 mp0 -55.56 -16.83 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.469 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.71 ' CD1' HD12 ' A' ' 195' ' ' LEU . 74.3 t80 -98.5 -19.06 17.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 102.65 40.52 2.52 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 118.111 -1.383 . . . . 1.0 111.676 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 61' ' ' GLY . 13.3 p90 -13.22 146.57 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 C-N-CA 124.33 1.052 . . . . 1.0 112.143 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 29' ' ' LYS . 84.8 t -146.86 -78.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 118.777 0.717 . . . . 1.0 109.583 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -151.82 110.68 3.84 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.4 tp -92.25 127.6 37.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.03 146.31 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.6 tt -138.75 141.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.473 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' NE2' ' SD ' ' A' ' 125' ' ' MET . 9.8 tp-100 -70.18 -86.38 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.528 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 t80 50.89 -174.12 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.249 0.219 . . . . 1.0 110.491 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.56 76.03 Favored Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -67.18 175.99 2.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.894 0.378 . . . . 1.0 110.039 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -61.61 -29.86 70.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.392 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -60.09 -21.58 61.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.255 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m 53.3 -95.8 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.055 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 t 56.83 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.159 0.504 . . . . 1.0 111.166 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -79.4 132.45 36.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.116 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD2' ' CZ ' ' A' ' 98' ' ' PHE . 54.5 t80 -78.07 12.51 1.79 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.211 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 80' ' ' LEU . 78.8 tt0 62.58 137.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.74 0.65 . . . . 1.0 109.745 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -67.83 66.1 0.09 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.928 0.394 . . . . 1.0 110.05 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.14 -57.53 3.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.323 0.582 . . . . 1.0 111.618 -178.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 107' ' ' TYR . 28.7 m -57.43 -43.3 82.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.538 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.479 ' N ' HG23 ' A' ' 81' ' ' VAL . 58.0 tt0 -63.31 -39.83 95.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.298 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -52.45 -46.03 66.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.998 0.428 . . . . 1.0 110.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' NH2' ' OG ' ' A' ' 50' ' ' SER . 30.3 mmt180 -71.66 -16.44 62.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.06 59.65 1.94 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.61 -168.02 39.61 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 110.087 -1.205 . . . . 1.0 110.087 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -133.35 127.72 34.11 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 113.1 24.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.728 0.299 . . . . 1.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -84.2 -76.51 0.3 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.095 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.3 m -70.74 140.97 51.52 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.405 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -170.6 132.26 0.94 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -138.82 -91.85 0.19 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.403 0.281 . . . . 1.0 110.375 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.93 156.45 25.66 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-O 118.796 -0.621 . . . . 1.0 109.502 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -35.26 159.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.645 2.23 . . . . 1.0 113.785 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 tt -58.14 -24.49 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.678 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -51.53 179.85 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.7 -0.227 . . . . 1.0 110.45 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 80.02 -40.85 0.21 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.905 -0.406 . . . . 1.0 109.905 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.47 ' CZ ' ' CD2' ' A' ' 77' ' ' PHE . 61.6 t80 -126.44 -18.61 4.83 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.483 0.313 . . . . 1.0 110.991 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.23 3.16 60.58 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.221 -0.751 . . . . 1.0 111.221 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.71 -10.14 0.21 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 110.009 -0.367 . . . . 1.0 110.009 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.45 -130.91 1.53 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.651 -0.979 . . . . 1.0 110.651 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' O ' ' NE ' ' A' ' 105' ' ' ARG . 22.1 p-10 -164.02 -175.57 4.1 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -38.24 -33.82 0.11 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.543 0.527 . . . . 1.0 111.233 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.85 93.76 4.58 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 98' ' ' PHE . 7.2 ptp85 -141.35 154.15 45.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.682 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -156.18 131.62 9.48 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.349 -0.611 . . . . 1.0 109.349 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.508 ' CD2' HG21 ' A' ' 81' ' ' VAL . 9.9 m-85 -132.1 143.77 50.24 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.465 -0.569 . . . . 1.0 109.465 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 112' ' ' GLY . 9.1 p -127.88 140.57 48.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 111' ' ' ASN . 10.9 mp -101.61 147.96 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.2 mtp 46.66 -89.74 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.442 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 109' ' ' LEU . 16.9 m120 -155.86 81.5 1.01 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.804 0.335 . . . . 1.0 110.476 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.472 ' H ' ' CG2' ' A' ' 108' ' ' VAL . . . 74.74 23.3 75.39 Favored Glycine 0 N--CA 1.469 0.853 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -73.14 -75.05 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.571 -0.37 . . . . 1.0 110.671 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.92 126.96 53.63 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.476 0.485 . . . . 1.0 109.947 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -105.64 101.25 10.78 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.473 -0.195 . . . . 1.0 110.473 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.05 109.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -117.53 139.6 15.03 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 109.914 -1.275 . . . . 1.0 109.914 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -170.11 140.82 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -160.52 155.97 25.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.013 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 123' ' ' THR . 82.7 t80 -161.16 98.97 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.289 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 64.35 -67.52 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.525 0.516 . . . . 1.0 110.819 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 121' ' ' PHE . 30.3 m -154.78 121.65 5.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -148.6 5.48 0.7 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 125' ' ' MET . 3.9 mpp? -59.22 -57.25 13.86 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.17 -29.01 65.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.951 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.3 m -70.85 -43.4 68.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.435 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.8 -50.05 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 1.0 112.367 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 133' ' ' SER . 1.2 pp -63.78 -54.02 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.926 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -47.03 -37.36 9.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.072 -0.393 . . . . 1.0 111.068 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.94 -48.22 78.81 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.12 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -100.22 -64.25 1.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.811 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 129' ' ' ILE . 34.2 p 57.09 74.26 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -134.8 -44.87 0.73 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.956 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.9 tp -169.13 151.03 4.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.68 146.51 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.18 105.73 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 138.13 40.34 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.509 ' CD2' ' NE2' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -60.11 -169.65 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.042 0.449 . . . . 1.0 110.176 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.17 45.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.431 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.38 -128.11 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.7 m -163.44 -50.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.576 -0.367 . . . . 1.0 110.771 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.73 -52.51 5.86 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 92.1 p -55.15 -42.69 73.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.743 0.306 . . . . 1.0 110.88 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.74 -49.69 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.6 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.59 -31.24 6.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.001 0.188 . . . . 1.0 111.403 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.27 -50.79 29.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.999 0.428 . . . . 1.0 110.287 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.888 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.36 -46.64 31.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.764 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.98 -37.39 86.94 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.876 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.07 -11.61 59.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.61 36.51 26.83 Favored 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 123.473 0.483 . . . . 1.0 110.049 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -122.95 147.16 50.55 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.925 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -45.19 165.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.205 1.936 . . . . 1.0 112.47 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 59.9 tp -152.03 140.73 20.86 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.039 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.09 123.83 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.847 -1.168 . . . . 1.0 107.847 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -116.0 133.3 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 117.801 0.273 . . . . 1.0 111.169 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 77.4 m -72.66 105.13 4.15 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -89.28 141.52 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.874 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.56 -157.16 0.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.064 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.9 t70 58.34 21.29 8.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.451 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.5 m -85.75 90.15 7.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.687 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 163' ' ' LEU . 10.0 mp -63.55 -41.19 98.44 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.897 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' ASN . 43.3 ttp -130.1 -53.05 1.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.506 0.322 . . . . 1.0 110.755 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.417 ' OD1' ' CE2' ' A' ' 41' ' ' PHE . 4.0 p-10 -66.72 69.61 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.138 0.494 . . . . 1.0 110.635 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 164' ' ' MET . 76.7 m-20 -65.45 -25.82 67.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.383 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -51.18 -32.3 22.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.839 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.509 ' NE2' ' CD2' ' A' ' 139' ' ' HIS . 19.6 mm100 -60.7 -47.79 84.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.529 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -69.1 -30.14 68.37 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.487 0.184 . . . . 1.0 111.013 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.14 -54.16 45.08 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.02 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 175' ' ' PHE . 17.0 tt -68.61 -34.85 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.25 -65.04 0.63 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.294 0.569 . . . . 1.0 110.623 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.02 -34.26 28.71 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.065 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.04 -31.44 56.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.407 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' ILE . 3.5 t80 -63.19 -47.13 83.91 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.849 0.357 . . . . 1.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.53 -44.64 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -54.75 -46.85 74.38 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.113 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 178' ' ' LEU . 10.5 mp -98.33 9.47 42.99 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.071 0.462 . . . . 1.0 110.365 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 181' ' ' VAL . . . 173.66 91.11 0.08 OUTLIER Glycine 0 C--O 1.212 -1.239 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -49.51 70.17 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.086 0.954 . . . . 1.0 111.174 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 179' ' ' GLY . 7.6 p -73.8 141.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.889 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -59.25 114.04 2.45 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.263 0.554 . . . . 1.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.5 t -87.0 135.96 33.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.66 -0.7 . . . . 1.0 109.443 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.62 170.79 17.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -138.0 154.23 74.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.622 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.62 57.49 1.42 Allowed 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.558 2.172 . . . . 1.0 112.882 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.9 p -131.65 147.05 52.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.602 -0.888 . . . . 1.0 108.602 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -59.48 -51.91 67.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.616 0.245 . . . . 1.0 111.19 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 26.1 m -65.27 -24.86 67.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.925 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.04 -36.02 8.61 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 116.183 -0.462 . . . . 1.0 112.087 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -40.97 85.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 117.235 0.518 . . . . 1.0 111.556 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.0 pt -55.58 -34.66 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.873 0.368 . . . . 1.0 110.833 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.7 78.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.189 0.518 . . . . 1.0 109.775 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -62.78 -46.16 94.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.236 -0.746 . . . . 1.0 111.236 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.71 HD12 ' CD1' ' A' ' 60' ' ' TYR . 4.4 mm? -61.92 -44.13 97.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.912 0.356 . . . . 1.0 110.312 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -63.32 -52.14 63.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.623 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.56 71.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.177 -0.305 . . . . 1.0 110.177 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 97.1 p -60.48 -34.05 73.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.965 -0.294 . . . . 1.0 111.304 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -102.64 32.8 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 1.0 111.135 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 19.6 m -159.84 -29.17 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.159 -0.338 . . . . 1.0 110.607 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -108.75 152.13 25.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -122.21 170.82 9.51 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.6 tp -119.73 136.24 54.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -62.61 152.25 81.66 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.196 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -37.9 109.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.826 2.35 . . . . 1.0 112.554 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 206' ' ' PHE . 0.1 OUTLIER -61.53 151.75 76.62 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.332 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.03 -8.01 18.59 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.961 1.774 . . . . 1.0 111.705 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.7 p -49.96 132.57 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.608 0.242 . . . . 1.0 111.06 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 46.9 t -78.54 -74.73 0.26 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.449 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 211' ' ' ASN . 35.2 t60 -163.87 -150.87 0.16 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.606 ' H ' ' CG ' ' A' ' 210' ' ' HIS . 0.6 OUTLIER 34.62 63.46 1.92 Allowed Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 123.111 0.564 . . . . 1.0 111.072 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.79 -79.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.489 2.126 . . . . 1.0 112.032 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.4 m -60.0 -15.63 24.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.546 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.0 -51.99 65.8 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -51.24 -35.25 36.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.759 0.314 . . . . 1.0 110.689 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -59.81 -43.18 94.61 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 120.933 0.397 . . . . 1.0 110.191 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.1 tt -50.14 -37.32 33.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.875 0.369 . . . . 1.0 111.275 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 48.2 mt -60.88 -30.22 70.02 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.473 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.86 -47.42 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.49 -31.46 72.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.458 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 223' ' ' TYR . 19.9 m -60.75 -43.24 98.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.613 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.9 mt 58.77 -83.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.95 -0.568 . . . . 1.0 109.735 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 221' ' ' THR . 74.8 t80 -67.09 102.69 1.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.284 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 117.959 -1.02 . . . . 1.0 110.513 179.701 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 mt -63.59 -47.64 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.5 mt -131.86 -23.01 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' ' 115' ' ' LYS . 67.8 mt-10 -66.82 88.68 0.15 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.613 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -92.39 -73.4 0.55 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.3 110.87 7.03 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.4 125.11 52.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.844 0.458 . . . . 1.0 109.991 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.2 mp -91.73 107.19 19.04 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.188 0.518 . . . . 1.0 109.63 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -85.07 125.81 33.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.081 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.91 130.09 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -145.52 136.68 24.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.74 -26.6 31.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.451 . . . . 1.0 109.835 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.25 -112.09 3.93 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.95 -156.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.571 0.224 . . . . 1.0 110.627 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 t -53.6 170.53 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.7 t -139.67 82.75 17.65 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.62 16.37 1.97 Allowed 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.481 2.121 . . . . 1.0 111.702 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.08 65.0 28.28 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.98 -17.55 41.09 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.028 1.818 . . . . 1.0 111.941 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -79.99 -30.85 39.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.499 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.47 -44.92 56.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.797 0.332 . . . . 1.0 110.645 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 -29.41 46.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.029 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.5 p -51.31 -38.47 53.15 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.118 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -47.33 -28.34 1.97 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 1.0 110.605 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -92.23 -23.91 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.839 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 46' ' ' SER . 0.7 OUTLIER -120.67 24.79 10.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.968 0.507 . . . . 1.0 110.194 -177.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 46' ' ' SER . 40.3 t -104.72 -161.76 0.84 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.459 ' N ' ' OG ' ' A' ' 50' ' ' SER . 63.0 m-20 -71.27 -28.52 64.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.28 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.59 -51.51 69.51 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.855 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.7 t80 -70.14 -39.15 75.56 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.185 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.7 t -52.67 -46.2 67.12 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.678 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -71.66 -44.14 64.83 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.113 0.482 . . . . 1.0 110.586 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -68.41 -26.45 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.876 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 53' ' ' PHE . 56.1 tp -57.19 -44.64 83.78 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 58' ' ' ILE . 1.7 mp -55.11 -33.63 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -34.56 75.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.43 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -72.31 -18.89 61.75 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.71 34.38 2.85 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 37.33 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.862 0.465 . . . . 1.0 111.462 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -115.86 -95.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 122.618 0.367 . . . . 1.0 110.36 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.463 ' H ' HG23 ' A' ' 63' ' ' VAL . 42.5 ttm180 -168.42 149.87 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -130.29 118.07 20.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 66' ' ' ILE . 5.2 mp -108.98 132.01 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 tp -114.56 141.4 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -166.51 -166.98 0.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -147.03 164.49 32.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.38 -35.35 90.86 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -133.53 147.65 51.61 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.993 0.425 . . . . 1.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -62.96 -35.18 79.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.274 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -60.95 -49.18 78.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 96.5 p -77.27 102.05 6.53 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.186 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.4 p -169.98 88.91 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.992 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.28 -87.11 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 47.24 94.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.819 0.343 . . . . 1.0 110.145 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.87 -70.83 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.161 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -174.66 66.0 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.837 0.351 . . . . 1.0 110.318 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 80' ' ' LEU . 9.6 mp -63.34 -41.39 98.87 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.829 0.347 . . . . 1.0 110.339 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 82' ' ' GLN . 20.0 m -60.23 -45.86 95.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.863 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.475 ' N ' HG23 ' A' ' 81' ' ' VAL . 2.6 tm0? -66.53 -46.89 74.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.794 0.33 . . . . 1.0 110.84 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -55.52 -45.66 77.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.932 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.427 ' HA ' ' HE ' ' A' ' 84' ' ' ARG . 0.4 OUTLIER -74.16 -17.16 60.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.475 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.96 50.32 3.96 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.12 177.49 54.3 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 109.487 -1.445 . . . . 1.0 109.487 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -124.44 121.98 36.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -63.45 159.81 17.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.881 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -131.27 -178.8 5.0 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t -58.89 141.89 52.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.563 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -151.91 143.11 23.27 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -80.5 -73.8 0.35 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.629 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 94' ' ' PRO . 1.7 pp -59.67 151.56 61.64 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.95 -0.548 . . . . 1.0 110.221 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.464 ' O ' HD12 ' A' ' 93' ' ' ILE . 91.3 Cg_exo -42.26 174.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.42 2.08 . . . . 1.0 113.311 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.6 tp -64.53 -39.71 86.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.28 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 98' ' ' PHE . 88.5 m-20 48.94 55.38 9.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 50.52 -90.09 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.128 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.53 ' CE2' ' NE ' ' A' ' 105' ' ' ARG . 59.4 t80 -127.38 28.93 5.62 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.322 0.649 . . . . 1.0 110.133 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 22.3 74.63 Favored Glycine 0 N--CA 1.469 0.839 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 28.2 p -61.13 133.54 56.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.636 0.255 . . . . 1.0 110.463 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.07 -4.25 11.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -153.65 87.55 1.24 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.87 0.367 . . . . 1.0 110.058 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.8 p -61.04 103.4 0.27 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.333 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -171.02 67.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.016 0.436 . . . . 1.0 110.196 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.53 ' NE ' ' CE2' ' A' ' 98' ' ' PHE . 27.9 ptt-85 -131.36 161.72 31.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.821 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -155.95 119.61 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.75 159.84 40.06 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.52 143.61 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.8 mm? -95.88 137.42 34.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 72.9 mmm 47.12 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.014 0.821 . . . . 1.0 111.272 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 109' ' ' LEU . 19.8 p-10 -156.83 70.46 0.64 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.973 0.416 . . . . 1.0 110.551 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.2 27.13 64.63 Favored Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.576 -0.61 . . . . 1.0 111.576 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -91.9 -7.14 50.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.826 0.313 . . . . 1.0 110.728 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.65 131.55 0.89 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 99.3 mttt -98.73 141.66 31.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.83 112.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.87 130.82 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.139 0.576 . . . . 1.0 109.82 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -22.97 68.87 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -117.71 169.52 9.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.875 0.47 . . . . 1.0 110.438 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -168.6 173.71 7.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.112 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 122' ' ' SER . 88.2 t80 -65.62 166.98 9.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.43 . . . . 1.0 109.843 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.478 ' N ' ' CG ' ' A' ' 121' ' ' PHE . 40.7 t 53.15 96.98 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.807 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 124' ' ' LYS . 89.9 m -58.71 164.86 2.52 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.509 ' N ' HG22 ' A' ' 123' ' ' THR . 14.5 tptm 68.86 108.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.431 0.457 . . . . 1.0 110.263 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 126' ' ' GLN . 0.0 OUTLIER -49.77 -36.74 27.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.122 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.471 ' N ' ' SD ' ' A' ' 125' ' ' MET . 57.8 tt0 -57.3 -32.37 66.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.2 m -78.72 -34.84 45.59 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.835 0.35 . . . . 1.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.379 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -58.29 -48.97 83.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -59.45 -44.9 92.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.59 -0.277 . . . . 1.0 110.895 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -53.26 -42.9 66.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.504 -0.317 . . . . 1.0 111.411 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -98.43 -68.45 0.8 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p 71.52 33.37 1.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.03 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.74 -66.4 0.91 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.198 -0.668 . . . . 1.0 109.198 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 44.3 tp -165.95 142.84 5.3 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.818 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.38 147.24 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.01 125.51 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.145 -1.058 . . . . 1.0 108.145 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 59.7 p -137.57 134.58 35.78 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.7 -34.53 58.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.65 34.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.669 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 143' ' ' GLY . . . -61.67 -37.01 93.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.521 -1.032 . . . . 1.0 110.521 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.412 ' OG1' ' NH1' ' A' ' 216' ' ' ARG . 3.5 m 65.19 -65.49 0.16 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.099 0.476 . . . . 1.0 111.021 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' GLY . . . -66.52 -32.68 82.38 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 44.8 m -73.92 -33.89 64.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.769 0.319 . . . . 1.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.4 -28.74 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 120.974 0.416 . . . . 1.0 110.769 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -47.91 -51.11 24.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.618 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -63.18 -44.47 95.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.314 0.578 . . . . 1.0 110.859 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 75.0 m -59.88 -24.62 64.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.479 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.36 -48.4 23.21 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.3 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -75.08 -22.47 58.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.832 -0.622 . . . . 1.0 111.35 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.87 -6.75 50.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 51.41 31.07 6.8 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.171 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 78.9 mttt -108.8 155.86 39.95 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 123.326 0.391 . . . . 1.0 110.026 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -42.66 139.27 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.683 1.589 . . . . 1.0 111.91 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.757 ' C ' HD13 ' A' ' 156' ' ' ILE . 3.0 tm? -153.82 122.91 6.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.757 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -117.52 120.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.71 0.631 . . . . 1.0 109.731 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.08 115.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 110.196 -0.298 . . . . 1.0 110.196 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 94.7 m -72.33 102.5 3.15 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.29 137.07 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -130.48 171.98 12.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 29.0 p-10 -97.02 14.55 25.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.512 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 t -156.67 -136.49 0.05 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.563 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt 64.88 114.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 tpt 67.82 173.19 0.27 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.317 -0.402 . . . . 1.0 109.927 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.61 -65.6 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -154.22 9.41 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.814 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -62.97 -33.43 75.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.009 -0.367 . . . . 1.0 110.009 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -58.32 -38.52 77.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 1.0 110.412 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -78.45 -32.52 48.48 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.633 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.07 -50.2 67.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.707 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.88 -38.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.34 -56.33 4.73 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.196 0.998 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -49.84 -52.36 33.14 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.882 -1.053 . . . . 1.0 110.922 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -60.63 -30.88 70.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 1.0 110.478 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 181' ' ' VAL . 2.8 m-85 -74.89 -55.21 6.03 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.783 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.22 -25.89 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.692 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -48.55 -52.03 24.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.485 -0.932 . . . . 1.0 108.485 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.24 -29.96 70.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.701 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 129.75 81.53 0.27 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 112.106 -0.398 . . . . 1.0 112.106 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 36.6 46.88 0.48 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.62 0.724 . . . . 1.0 111.505 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.688 HG13 ' H ' ' A' ' 182' ' ' TRP . 2.5 p -48.12 -61.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.671 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . 0.688 ' H ' HG13 ' A' ' 181' ' ' VAL . 10.4 m0 -156.73 62.58 0.53 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.991 0.807 . . . . 1.0 110.377 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -111.93 130.43 55.85 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.363 -0.835 . . . . 1.0 108.99 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 49.2 t -164.26 127.44 2.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.071 -0.715 . . . . 1.0 109.071 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -81.5 153.14 70.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 110.686 -0.116 . . . . 1.0 110.686 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 84.26 0.45 Allowed 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.077 1.851 . . . . 1.0 112.588 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.9 m -132.19 148.82 52.48 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -48.19 -54.83 12.09 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.185 -0.206 . . . . 1.0 111.37 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.6 m -73.25 -44.98 58.44 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.986 0.422 . . . . 1.0 111.049 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -55.9 -44.81 87.47 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.029 -0.532 . . . . 1.0 112.427 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -40.98 71.36 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.93 0.365 . . . . 1.0 110.172 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.99 -45.44 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -59.3 -52.29 66.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.017 0.437 . . . . 1.0 110.187 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -54.56 -40.19 69.06 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -47.94 71.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.454 0.645 . . . . 1.0 109.928 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -59.99 -45.65 92.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.859 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.13 -52.0 66.71 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.035 0.445 . . . . 1.0 110.946 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 155' ' ' LEU . 39.9 p -65.09 -21.52 66.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.02 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -110.18 31.3 6.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.727 0.411 . . . . 1.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 56.3 m -145.88 -27.05 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 110.168 -0.308 . . . . 1.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.37 151.36 35.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.29 142.99 50.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.918 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.18 -161.24 0.79 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.938 -0.574 . . . . 1.0 109.569 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -73.2 144.91 85.17 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.886 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.84 -47.19 27.7 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.527 1.485 . . . . 1.0 113.374 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -139.73 86.4 13.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.241 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.4 -64.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.039 1.826 . . . . 1.0 111.721 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.17 145.59 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m -80.06 27.08 0.32 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.075 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 210' ' ' HIS . 14.0 t-80 53.89 57.14 6.28 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.806 0.336 . . . . 1.0 111.485 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.526 ' H ' ' CD ' ' A' ' 212' ' ' PRO . 19.6 m120 -106.59 -37.41 0.17 Allowed Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.968 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.526 ' CD ' ' H ' ' A' ' 211' ' ' ASN . 51.4 Cg_exo -56.75 -49.83 13.47 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 121.818 1.679 . . . . 1.0 113.162 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 50.2 m -65.34 -47.79 75.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.994 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.74 -51.45 64.9 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 120.772 0.32 . . . . 1.0 110.357 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -48.52 -43.25 35.11 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.86 0.362 . . . . 1.0 110.844 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.412 ' NH1' ' OG1' ' A' ' 142' ' ' THR . 41.8 mmm-85 -64.96 -39.27 93.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.855 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.6 tp -53.68 -41.71 67.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.941 0.401 . . . . 1.0 110.293 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.02 -28.77 68.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.505 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.4 t -75.34 -49.4 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.845 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -67.51 -12.49 60.46 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.198 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 26.0 m -63.22 -41.01 99.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.359 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 45.0 pt 38.71 32.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.071 0.548 . . . . 1.0 111.449 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -159.71 159.22 32.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.248 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.7 t . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.022 -0.99 . . . . 1.0 111.565 179.695 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 109.099 -1.6 . . . . 1.0 109.099 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 tp -65.12 140.77 19.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.952 0.406 . . . . 1.0 110.002 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.65 49.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.667 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -65.4 115.07 5.28 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -133.51 -117.39 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -76.53 94.8 3.77 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.707 0.289 . . . . 1.0 110.913 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.33 166.26 12.17 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.2 mt -132.26 101.0 5.19 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.626 ' CZ ' HD13 ' A' ' 66' ' ' ILE . 6.1 m-85 -95.0 127.12 40.81 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.023 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 137' ' ' ILE . 5.5 p -127.21 125.68 66.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.7 p -143.52 137.38 28.43 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.254 -0.884 . . . . 1.0 109.46 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.8 m -103.45 140.32 37.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.0 -89.48 0.03 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.263 -0.735 . . . . 1.0 111.263 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.56 -78.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.867 0.365 . . . . 1.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -167.12 160.51 13.96 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.297 -0.41 . . . . 1.0 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -72.16 144.49 87.35 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.744 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.78 -46.6 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.966 1.777 . . . . 1.0 111.054 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -139.32 160.72 60.85 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 123.069 0.23 . . . . 1.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.17 -10.62 29.49 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 122.089 1.859 . . . . 1.0 112.011 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -73.96 -29.56 62.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.876 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.441 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.2 mm? -63.15 -53.84 47.08 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.072 -0.251 . . . . 1.0 110.897 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 46' ' ' SER . 18.2 m -69.92 -42.67 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.711 0.291 . . . . 1.0 110.581 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.2 t -51.95 -53.19 44.23 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.102 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 53' ' ' PHE . 90.9 m -47.21 -36.14 8.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.771 -0.195 . . . . 1.0 111.294 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.9 t -72.8 -26.18 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 120.775 0.321 . . . . 1.0 111.439 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.24 33.28 3.09 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.365 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 46' ' ' SER . 29.2 t -98.35 -173.71 2.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' N ' ' OG ' ' A' ' 50' ' ' SER . 11.5 m-20 -56.38 -27.64 56.83 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.374 -1.284 . . . . 1.0 110.904 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -71.81 -53.56 12.94 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.669 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 47' ' ' CYS . 3.3 m-85 -68.55 -37.67 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.146 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 93.7 m -53.2 -45.9 68.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.639 0.256 . . . . 1.0 111.039 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.92 -40.96 71.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.27 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -67.99 -27.79 66.87 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -60.22 -39.41 86.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.358 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mm -48.89 -41.12 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.564 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -65.97 -40.94 91.72 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.303 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -65.43 -23.28 66.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.027 -0.36 . . . . 1.0 110.027 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' C ' ' CG ' ' A' ' 62' ' ' PHE . . . 93.49 20.3 32.56 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.784 -0.526 . . . . 1.0 111.784 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HA ' HD12 ' A' ' 57' ' ' LEU . 1.4 p90 43.02 78.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 117.801 0.801 . . . . 1.0 111.024 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.7 -85.76 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -168.81 135.05 1.78 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 66' ' ' ILE . 3.6 tt -133.25 131.39 40.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.662 -0.495 . . . . 1.0 109.662 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.626 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 1.7 mp -116.47 127.33 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.579 HD13 ' N ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -108.48 132.35 56.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.579 ' N ' HD13 ' A' ' 67' ' ' ILE . 57.2 tt0 -146.65 153.99 40.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.22 -151.33 0.39 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.012 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.94 -114.94 0.01 OUTLIER Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 72' ' ' ASN . 35.6 ttt180 -165.58 -149.96 0.12 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.231 -0.57 . . . . 1.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -59.51 -41.63 90.34 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.136 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.7 t -140.7 132.45 27.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.195 -0.457 . . . . 1.0 109.99 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.2 m -157.99 163.12 38.1 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.31 23.67 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.845 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -67.53 85.18 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 80' ' ' LEU . 70.8 mm-40 -61.91 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.657 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.532 ' N ' ' NE2' ' A' ' 97' ' ' GLN . 22.4 p80 -73.89 33.6 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.741 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 78' ' ' GLU . 1.9 pp -62.46 -32.47 73.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 1.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.2 t -62.81 -51.55 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.859 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -72.85 -32.51 65.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.279 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -50.96 -43.98 60.5 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.22 -0.445 . . . . 1.0 109.819 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.437 ' NE ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -79.37 -16.23 56.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.051 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.84 28.87 5.76 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.97 158.17 53.47 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -134.63 128.93 34.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.841 0.353 . . . . 1.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -52.82 159.93 1.03 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.358 -0.383 . . . . 1.0 109.99 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -119.43 152.07 37.47 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m 57.55 -130.95 1.48 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.145 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -61.79 115.86 4.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -89.06 99.37 12.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -155.34 98.41 2.34 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 110.162 -0.311 . . . . 1.0 110.162 178.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.74 116.02 1.57 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.607 1.538 . . . . 1.0 110.173 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.3 pt -92.89 -18.13 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.347 0.594 . . . . 1.0 109.933 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 98' ' ' PHE . 65.3 m-20 -156.29 41.05 0.37 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.914 -1.039 . . . . 1.0 111.299 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 79' ' ' HIS . 12.5 tt0 63.39 -1.52 0.56 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.533 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -72.98 -22.04 60.75 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.106 -0.331 . . . . 1.0 110.106 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.09 48.06 12.02 Favored Glycine 0 N--CA 1.465 0.597 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 47.2 t -55.69 129.61 39.88 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.736 0.303 . . . . 1.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.21 164.71 36.65 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.701 -0.96 . . . . 1.0 110.701 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 103' ' ' THR . 53.6 t0 54.54 -129.85 2.15 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.801 -0.199 . . . . 1.0 110.497 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.418 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 82.0 p -66.78 -39.05 87.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.699 0.285 . . . . 1.0 110.322 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -170.27 -74.38 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.321 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.426 ' CB ' ' H ' ' A' ' 118' ' ' GLY . 75.4 mmt-85 -123.42 119.19 29.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -160.69 119.44 2.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.275 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.44 161.42 27.12 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.31 135.77 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 111' ' ' ASN . 4.4 mm? -95.35 133.88 38.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.439 . . . . 1.0 109.964 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.4 mmm 50.01 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.924 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -148.94 48.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.383 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 27.45 29.14 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 111.955 -0.458 . . . . 1.0 111.955 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.4 -12.27 54.74 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.3 tp -168.0 137.34 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -102.98 140.39 37.31 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.62 142.19 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.078 -1.082 . . . . 1.0 108.078 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' ILE . 18.9 pt -142.53 131.14 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.426 ' H ' ' CB ' ' A' ' 105' ' ' ARG . . . -65.99 -139.72 0.04 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.42 ' CE2' ' O ' ' A' ' 120' ' ' ASP . 78.5 t80 -57.73 161.31 3.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.921 0.391 . . . . 1.0 110.498 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' CE2' ' A' ' 119' ' ' PHE . 54.3 p-10 -153.64 -177.06 6.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.076 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -65.16 153.97 39.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 123' ' ' THR . 79.5 p -59.3 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.917 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.401 ' N ' ' OG ' ' A' ' 122' ' ' SER . 25.7 m -61.65 106.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.052 -0.351 . . . . 1.0 110.052 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -168.01 -54.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.343 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 52.5 mtm -44.99 -45.88 10.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 1.0 111.572 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -59.25 -31.1 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.737 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 t -80.57 -52.28 7.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.798 0.332 . . . . 1.0 111.813 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 128' ' ' ILE . 1.5 mp -62.69 -43.72 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.876 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' SER . 78.0 mt -54.06 -53.2 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.23 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -51.1 -30.04 14.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.521 0.201 . . . . 1.0 111.06 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.86 -42.47 58.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.688 -0.233 . . . . 1.0 110.9 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.58 ' CD2' ' N ' ' A' ' 133' ' ' SER . 51.1 p90 -123.1 -51.88 1.88 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.58 ' N ' ' CD2' ' A' ' 132' ' ' TYR . 82.8 p 48.65 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.943 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -137.22 -52.39 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.2 tp -167.35 148.14 5.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.6 151.55 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 73.7 mt -117.71 115.63 49.17 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 N-CA-C 108.177 -1.046 . . . . 1.0 108.177 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.9 p -85.21 -161.38 0.58 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -159.74 83.97 0.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 52.28 17.61 0.76 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.81 -147.88 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.101 -1.199 . . . . 1.0 110.101 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -164.01 -60.6 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.324 -0.25 . . . . 1.0 110.324 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 -26.68 73.9 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 123.792 0.683 . . . . 1.0 111.946 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.5 m -70.3 -36.62 74.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.681 0.277 . . . . 1.0 111.313 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.18 -40.61 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.847 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -50.09 -40.84 46.88 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.798 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -52.11 66.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.512 0.672 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.8 p -70.36 -22.62 62.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.036 -0.984 . . . . 1.0 111.239 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.466 HD11 HD23 ' A' ' 203' ' ' LEU . 17.0 tp -73.23 -53.32 11.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.157 0.428 . . . . 1.0 112.157 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -67.29 -31.75 72.28 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.583 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 mp -70.04 -1.63 10.42 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 58.53 34.03 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.391 0.432 . . . . 1.0 110.6 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 133' ' ' SER . 97.8 mttt -113.2 126.32 28.38 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.44 157.15 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.416 1.41 . . . . 1.0 111.941 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.581 ' C ' HD13 ' A' ' 156' ' ' ILE . 5.4 tt -152.44 144.39 23.73 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.581 HD13 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -111.31 116.55 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 157' ' ' VAL . 14.0 p -103.71 117.32 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 57.2 m -74.07 104.35 4.86 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.427 -0.582 . . . . 1.0 109.427 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.01 138.51 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -160.24 -165.51 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.827 0.346 . . . . 1.0 110.174 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -65.34 -168.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.6 m -156.72 81.35 0.95 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.956 0.407 . . . . 1.0 109.927 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -35.36 12.66 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.797 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.1 mmt -82.51 36.15 0.47 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.193 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 167' ' ' HIS . 25.6 t70 54.89 31.23 15.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.663 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -66.02 74.89 0.08 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.068 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' ASP . 85.2 t60 -57.93 -30.38 65.89 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.995 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -49.72 -40.28 40.11 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.15 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -63.17 -46.56 86.58 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -45.41 -37.45 5.1 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.09 -42.55 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.148 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 169' ' ' GLN . . . -48.99 -60.58 2.65 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.867 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.74 -25.19 62.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.049 0.452 . . . . 1.0 110.393 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -72.58 -53.69 11.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.472 -0.785 . . . . 1.0 110.446 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 179' ' ' GLY . 58.0 t80 -64.47 -34.91 79.31 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.29 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.6 t -54.86 -56.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.281 0.363 . . . . 1.0 110.189 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -51.03 -30.63 15.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.149 -0.62 . . . . 1.0 109.939 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.26 21.32 12.77 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.499 -0.773 . . . . 1.0 113.013 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 175' ' ' PHE . . . -151.37 -24.63 0.05 OUTLIER Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 180' ' ' TYR . 73.1 t80 54.42 23.52 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 109.879 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 182' ' ' TRP . 3.2 p -50.18 98.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.19 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . 0.56 ' C ' ' O ' ' A' ' 181' ' ' VAL . 7.0 m-90 -9.74 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 124.004 0.815 . . . . 1.0 109.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 88.9 p -86.74 134.83 33.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.829 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -125.02 156.9 37.42 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.24 -0.891 . . . . 1.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -136.38 154.04 76.73 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.643 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.41 58.34 0.48 Allowed 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.588 2.192 . . . . 1.0 112.358 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 m -135.72 147.16 48.36 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.62 -48.71 28.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.0 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 190' ' ' GLY . 13.3 t -69.68 -44.18 71.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.027 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 184' ' ' CYS . . . -51.75 -51.66 37.96 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.245 -0.434 . . . . 1.0 112.134 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.78 -43.63 90.49 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.45 0.147 . . . . 1.0 110.63 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.14 -44.73 80.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.612 0.244 . . . . 1.0 110.46 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -54.1 -56.68 15.81 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.873 0.324 . . . . 1.0 111.873 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -58.53 -30.27 64.97 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -48.07 63.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.983 0.42 . . . . 1.0 110.54 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -64.22 -40.64 96.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.71 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.66 -40.74 88.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.2 m -71.27 -23.26 61.94 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.967 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -105.0 30.76 5.29 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.899 0.381 . . . . 1.0 110.753 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.1 p -141.7 -21.25 0.73 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -157.29 153.23 27.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.07 0.462 . . . . 1.0 109.771 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.75 153.92 32.6 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.178 -0.919 . . . . 1.0 109.219 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.466 HD23 HD11 ' A' ' 149' ' ' LEU . 5.2 tp -94.86 136.97 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.8 153.02 8.9 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.711 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.2 106.57 1.02 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.391 1.394 . . . . 1.0 111.148 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -140.82 87.16 11.35 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.46 111.58 3.29 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.562 1.508 . . . . 1.0 111.763 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 210' ' ' HIS . 22.0 t -63.24 98.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.057 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t 56.06 5.12 0.15 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.561 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 208' ' ' VAL . 85.4 t60 49.47 93.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.716 0.293 . . . . 1.0 110.632 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 212' ' ' PRO . 7.3 p-10 -144.84 73.69 14.93 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 211' ' ' ASN . 83.1 Cg_exo -49.56 -121.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.509 2.433 0 C-N-CA 123.077 2.518 . . . . 1.0 112.548 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 40.2 t -85.05 4.15 35.35 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.911 -0.493 . . . . 1.0 109.932 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -57.63 -49.73 75.49 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -46.44 -50.34 16.92 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.116 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -58.29 -40.88 83.13 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.751 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.5 tt -52.74 -49.7 64.92 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 62.8 mt -51.02 -36.19 38.19 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.231 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.77 -46.97 87.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -56.41 -45.5 80.65 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.73 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 81.3 p -63.1 -45.24 93.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.694 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.5 mt -84.28 115.54 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.29 -0.634 . . . . 1.0 109.29 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -80.38 106.15 12.17 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.749 -0.463 . . . . 1.0 109.749 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.096 -179.729 . . . . . . . . 0 0 . 1 stop_ save_